Term,Overlap,P.value,Adjusted.P.value,Old.P.value,Old.Adjusted.P.value,Odds.Ratio,Combined.Score,Genes,Cluster
Negative Regulation Of Cellular Process (GO:0048523),18/537,6.59670372185697e-07,0.000981589513812317,0,0,4.46543352601156,63.5499313742746,COL18A1;IFITM1;BTG2;TACSTD2;CXCL1;ENO1;ACVR1B;SOD2;CLU;RTN4;WARS1;RHOB;GJA1;CLDN3;PPP2R1A;ADAMTS1;PLXNB2;TP53,1
Regulation Of Cell Adhesion (GO:0030155),9/144,3.62255041046338e-06,0.00269517750538476,0,0,8.25870020964361,103.467740154094,PPP1CB;PPP2R1A;TPM1;ERBB2;TNC;SAA1;PLXNB2;PRKCA;LAMC1,1
Cellular Component Assembly (GO:0022607),11/260,1.29706270100764e-05,0.00643343099699788,0,0,5.5102703808866,62.0060984778402,NCKAP1;PPP2R1A;TUBGCP2;SLC2A1;HES1;LAMC1;TP53;BBLN;AP2M1;RTN4;AIF1L,1
Positive Regulation Of Gene Expression (GO:0010628),14/480,5.62437206547992e-05,0.018010888703401,0,0,3.77799453765119,36.9707599835046,HDAC1;TNC;ARID1A;CLU;WARS1;GJA1;CDH3;CLDN3;ERBB2;ERP29;SAA1;PLXNB2;VIM;TP53,1
Negative Regulation Of Cell Migration (GO:0030336),8/163,7.22517197897894e-05,0.018010888703401,0,0,6.34741935483871,60.5248932511289,IFITM1;GJA1;CLIC4;CLDN3;HDAC1;TPM1;TACSTD2;RHOB,1
Regulation Of Cell Migration (GO:0030334),13/434,7.98653634624826e-05,0.018010888703401,0,0,3.86702934641024,36.4860726958036,IFITM1;CLIC4;MMP7;HDAC1;TPM1;TNC;PRKCA;ACTN4;SOD2;RHOB;CLDN3;PLXNB2;TMSB10,1
Protein-Containing Complex Organization (GO:0043933),7/126,9.50750342793841e-05,0.018010888703401,0,0,7.20241139934235,66.7004094273905,PPP2R1A;TUBGCP2;SLC2A1;HES1;LAMC1;TP53;AP2M1,1
Maintenance Of Blood-Brain Barrier (GO:0035633),4/29,9.68327349645217e-05,0.018010888703401,0,0,19.3239024390244,178.601660080736,GJA1;CLDN3;LSR;LAMC1,1
Positive Regulation Of Multicellular Organismal Process (GO:0051240),12/387,0.000109311123363525,0.0180727723961028,0,0,3.99117948717949,36.4047949424529,SMARCE1;GJA1;MUC1;HDAC1;LCN2;SPP1;SAA1;PRKCA;ENO1;ARID1A;ACVR1B;RTN4,1
Negative Regulation Of Cell Motility (GO:2000146),7/133,0.000133378993898426,0.0198467942920858,0,0,6.79986197377502,60.6705166330076,IFITM1;CLIC4;CLDN3;HDAC1;TPM1;TACSTD2;RHOB,1
Regulation Of Cell Population Proliferation (GO:0042127),17/766,0.000255932862471032,0.0345681061795889,0,0,2.86838079912289,23.7232170537241,COL18A1;IFITM1;BTG2;JUP;HDAC1;HMGB2;CXCL1;SOD2;CLU;WARS1;KITLG;CLDN3;ADAMTS1;EPCAM;ERBB2;HES1;TP53,1
Regulation Of Stem Cell Proliferation (GO:0072091),3/16,0.000300825881419863,0.0345681061795889,0,0,27.7188811188811,224.771822890645,GJA1;EPCAM;HMGB2,1
Positive Regulation Of Pattern Recognition Receptor Signaling Pathway (GO:0062208),4/39,0.000314122750666263,0.0345681061795889,0,0,13.795818815331,111.273304481154,CYBA;PUM1;RTN4;LTF,1
Cell-Cell Junction Assembly (GO:0007043),5/71,0.000327907728485556,0.0345681061795889,0,0,9.18665179401376,73.7024707063026,GJA1;CDH3;JUP;CTNNA1;PRKCA,1
Regulation Of Angiogenesis (GO:0045765),8/205,0.000348468812294243,0.0345681061795889,0,0,4.98350253807107,39.6784569531099,COL4A2;JUP;ADAMTS1;ERBB2;PRKCA;HSPG2;WARS1;RHOB,1
Negative Regulation Of Amyloid Precursor Protein Catabolic Process (GO:1902992),3/18,0.000432966487331847,0.0394803180334954,0,0,24.0206060606061,186.035996359275,FLOT2;CLU;RTN4,1
Protein-Containing Complex Assembly (GO:0065003),10/328,0.000469558227546067,0.0394803180334954,0,0,3.88384682748189,29.7647077990577,GAK;PPP2R1A;TUBGCP2;SLC2A1;CYBA;HES1;LAMC1;CLU;TP53;AP2M1,1
Regulation Of Stem Cell Differentiation (GO:2000736),4/45,0.000547184906520704,0.0394803180334954,0,0,11.7733491969066,88.426373726339,HDAC1;TACSTD2;HES1;ZFP36L2,1
Regulation Of mRNA Catabolic Process (GO:0061013),4/46,0.000595405033648868,0.0394803180334954,0,0,11.4924506387921,85.3460259501547,PRKCA;VIM;PUM1;ZFP36L2,1
Positive Regulation Of Epithelial Cell Proliferation (GO:0050679),6/123,0.000607115897252585,0.0394803180334954,0,0,6.2408990186768,46.2250337511299,CDH3;ERBB2;HMGB2;PRKCA;LAMC1;RTN4,1
Negative Regulation Of Growth (GO:0045926),6/124,0.000633615432562158,0.0394803180334954,0,0,6.18769617074702,45.5666175973208,GJA1;PPP2R1A;TMPRSS4;ENO1;TP53;RTN4,1
Central Nervous System Development (GO:0007417),9/283,0.000667630548571489,0.0394803180334954,0,0,4.04035256851673,29.5421513599324,C3;NCKAP1;COL4A1;TUBGCP2;SLC2A1;PLXNB2;LSR;HSPG2;RTN4,1
Regulation Of Cell Growth (GO:0001558),8/227,0.000683665477912868,0.0394803180334954,0,0,4.47785388127854,32.6347863835331,GJA1;PPP2R1A;ERBB2;TNC;ENO1;S100A9;TP53;RTN4,1
Renal Filtration Cell Differentiation (GO:0061318),2/5,0.000689844266714301,0.0394803180334954,0,0,79.6345381526105,579.663361782624,CD24;PROM1,1
Glomerular Epithelial Cell Differentiation (GO:0072311),2/5,0.000689844266714301,0.0394803180334954,0,0,79.6345381526105,579.663361782624,CD24;PROM1,1
Negative Regulation Of Amyloid Precursor Protein Biosynthetic Process (GO:0042985),2/5,0.000689844266714301,0.0394803180334954,0,0,79.6345381526105,579.663361782624,ITM2B;ITM2C,1
Positive Regulation Of Cell Adhesion (GO:0045785),5/88,0.000879936280221086,0.048494266109962,0,0,7.29876561460566,51.351641035005,TPM1;ERBB2;SAA1;PRKCA;LAMC1,1
Tight Junction Assembly (GO:0120192),4/53,0.00102082072729906,0.0494003089405673,0,0,9.84718765555002,67.8190421217337,CLDN10;CLDN3;RAB13;LSR,1
Protein Homotetramerization (GO:0051289),4/53,0.00102082072729906,0.0494003089405673,0,0,9.84718765555002,67.8190421217337,SOD2;CLU;GLS;CRYZ,1
Desmosome Organization (GO:0002934),2/6,0.00102905413382087,0.0494003089405673,0,0,59.7228915662651,410.840652077024,JUP;PRKCA,1
Positive Regulation Of Macromolecule Metabolic Process (GO:0010604),10/364,0.00104306602641316,0.0494003089405673,0,0,3.48244296645927,23.9090283942764,GJA1;CDH3;CLDN3;ANXA2;HDAC1;TNC;ERP29;CLU;TP53;WARS1,1
Apical Junction Assembly (GO:0043297),4/54,0.00109533975496204,0.0494003089405673,0,0,9.64975609756098,65.7794025060077,CLDN10;CLDN3;RAB13;CTNNA1,1
Cytoplasmic Translation (GO:0002181),5/93,0.00112877049998608,0.0494003089405673,0,0,6.88232013385388,46.7077347684952,EIF4A1;RPL31;RPL29;RPL18;RPL19,1
Positive Regulation Of Cellular Component Biogenesis (GO:0044089),5/93,0.00112877049998608,0.0494003089405673,0,0,6.88232013385388,46.7077347684952,VCP;CLDN3;PRKCA;CLU;WARS1,1
Positive Regulation Of Peptidase Activity (GO:0010952),3/25,0.00116883430996422,0.0496921558064787,0,0,16.3719008264463,110.53895427828,VCP;NCSTN;CLDN3,1
Regulation Of Programmed Cell Death (GO:0043067),7/195,0.00132691537081497,0.0548458353270187,0,0,4.54301572617946,30.0970171634426,VCP;MECOM;DAPK1;ACTN4;CLU;TP53;RTN4,1
Negative Regulation Of Cell Population Proliferation (GO:0008285),10/379,0.00141053644934386,0.0567264388276666,0,0,3.33830743370725,21.9119328810876,COL18A1;IFITM1;BTG2;CLDN3;ADAMTS1;CXCL1;HES1;SOD2;TP53;WARS1,1
Positive Regulation Of Cellular Process (GO:0048522),13/594,0.00156313264081505,0.0612089834087578,0,0,2.7790017211704,17.9553062207576,SMARCE1;HDAC1;TPM1;PRKCA;LAMC1;ARID1A;KITLG;CDH3;EPCAM;ERBB2;SAA1;HES1;S100A9,1
Hemopoiesis (GO:0030097),5/101,0.00163040889885736,0.0622063702948653,0,0,6.30623721881391,40.4792601920652,KITLG;MECOM;PBXIP1;TP53;ZFP36L2,1
Negative Regulation Of Intrinsic Apoptotic Signaling Pathway (GO:2001243),4/61,0.00172709637729402,0.0642479852353374,0,0,8.46170303808301,53.8275472514904,ENO1;PTTG1IP;SOD2;CLU,1
"DNA Damage Response, Signal Transduction By P53 Class Mediator Resulting In Transcription Of P21 Class Mediator (GO:0006978)",2/8,0.00189976958912758,0.0673061225862342,0,0,39.8112449799197,249.458163527026,MUC1;TP53,1
Negative Regulation Of Glycoprotein Biosynthetic Process (GO:0010561),2/8,0.00189976958912758,0.0673061225862342,0,0,39.8112449799197,249.458163527026,ITM2B;ITM2C,1
"DNA Damage Response, Signal Transduction Resulting In Transcription (GO:0042772)",2/9,0.00242910096206067,0.0803222718121396,0,0,34.1222030981067,205.423649448639,MUC1;TP53,1
Positive Regulation Of ATP Metabolic Process (GO:1903580),2/9,0.00242910096206067,0.0803222718121396,0,0,34.1222030981067,205.423649448639,VCP;ENO1,1
Myelin Maintenance (GO:0043217),2/9,0.00242910096206067,0.0803222718121396,0,0,34.1222030981067,205.423649448639,DEGS1;CLU,1
Regulation Of Apoptotic Process (GO:0042981),14/705,0.0025559997645627,0.0808261639223294,0,0,2.51822128667281,15.0320481286234,VCP;DAPK1;HDAC1;ANXA5;ACTN4;CLU;FSTL1;RTN4;RHOB;BABAM2;ERBB2;TNFSF10;TP53;LTF,1
Epithelial Tube Morphogenesis (GO:0060562),3/33,0.00263964412111808,0.0808261639223294,0,0,12.0012121212121,71.2525305806008,COL4A1;HES1;RHOB,1
Positive Regulation Of Cellular Component Organization (GO:0051130),5/113,0.0026660479900076,0.0808261639223294,0,0,5.6021358782095,33.2047448048911,VCP;CLDN3;ANXA2;CLU;WARS1,1
Response To Molecule Of Bacterial Origin (GO:0002237),4/69,0.00271647000078585,0.0808261639223294,0,0,7.4172607879925,43.8243070818362,SLPI;HMGB2;CD24;S100A9,1
Positive Regulation Of Cell Differentiation (GO:0045597),8/283,0.00275898572600203,0.0808261639223294,0,0,3.55581818181818,20.9540530766816,SMARCE1;IFITM1;GJA1;KITLG;TACSTD2;LAMC1;ARID1A;LTF,1
Neutrophil Chemotaxis (GO:0030593),4/70,0.00286250640846204,0.0808261639223294,0,0,7.30450849963045,42.775623034631,KLF5;SAA1;CXCL1;S100A9,1
Response To Estrogen (GO:0043627),3/34,0.00287738558122914,0.0808261639223294,0,0,11.6134897360704,67.9490556394174,SLC34A2;KRT19;CD24,1
Regulation Of Melanin Biosynthetic Process (GO:0048021),2/10,0.00301965451741475,0.0808261639223294,0,0,29.855421686747,173.239453591739,CDH3;MFSD12,1
Positive Regulation Of Bone Resorption (GO:0045780),2/10,0.00301965451741475,0.0808261639223294,0,0,29.855421686747,173.239453591739,SPP1;PRKCA,1
Regulation Of Amyloid Precursor Protein Biosynthetic Process (GO:0042984),2/10,0.00301965451741475,0.0808261639223294,0,0,29.855421686747,173.239453591739,ITM2B;ITM2C,1
Cellular Response To Oxidative Stress (GO:0034599),5/117,0.00309837818387904,0.0808261639223294,0,0,5.40096406660824,31.2007022364629,DAPK1;TPM1;SOD2;TP53;ZFP36L2,1
Positive Regulation Of Angiogenesis (GO:0045766),5/119,0.00333252574116274,0.0808261639223294,0,0,5.30567215584975,30.2636854603376,PKM;JUP;PRKCA;JAK1;RHOB,1
Granulocyte Chemotaxis (GO:0071621),4/73,0.00333268477096155,0.0808261639223294,0,0,6.9858607281725,39.8471893539091,KLF5;SAA1;CXCL1;S100A9,1
Protein Tetramerization (GO:0051262),4/73,0.00333268477096155,0.0808261639223294,0,0,6.9858607281725,39.8471893539091,SOD2;CLU;GLS;CRYZ,1
Generation Of Neurons (GO:0048699),6/172,0.00336265493897996,0.0808261639223294,0,0,4.38777331548416,24.9884763417374,TUBGCP2;ERBB2;DCDC2;PLXNB2;RTN4;ITM2C,1
Regulation Of mRNA Stability (GO:0043488),4/74,0.00350040572209051,0.0808261639223294,0,0,6.88571428571429,38.9378631880705,PRKCA;VIM;PUM1;ZFP36L2,1
Positive Regulation Of Cellular Biosynthetic Process (GO:0031328),6/174,0.00355894810178276,0.0808261639223294,0,0,4.33509700176367,24.4425351786891,CDH3;NNMT;ERBB2;PLXNB2;VIM;CLU,1
Gene Expression (GO:0010467),8/296,0.00362352987584891,0.0808261639223294,0,0,3.39305555555556,19.0700126159265,RPL31;HNRNPA2B1;ADAR;HNRNPH3;RPL29;RPL18;WARS1;RPL19,1
Regulation Of Vascular Associated Smooth Muscle Cell Proliferation (GO:1904705),3/37,0.00366809217061815,0.0808261639223294,0,0,10.5871657754011,59.3737107195104,GJA1;TPM1;SOD2,1
Regulation Of Homotypic Cell-Cell Adhesion (GO:0034110),2/11,0.00367037677176558,0.0808261639223294,0,0,26.5368139223561,148.804148061216,PRKCA;JAK1,1
Podocyte Differentiation (GO:0072112),2/11,0.00367037677176558,0.0808261639223294,0,0,26.5368139223561,148.804148061216,CD24;PROM1,1
Macrophage Chemotaxis (GO:0048246),2/11,0.00367037677176558,0.0808261639223294,0,0,26.5368139223561,148.804148061216,KLF5;SAA1,1
Translation (GO:0006412),7/234,0.00369366878139677,0.0808261639223294,0,0,3.75502777245738,21.032417726989,MRPL53;RPL31;MRPL19;RPL29;RPL18;WARS1;RPL19,1
Extracellular Matrix Organization (GO:0030198),6/176,0.00376364136669056,0.0811637442555877,0,0,4.28366013071895,23.9129687000547,COL18A1;MMP7;COL4A2;COL4A1;ADAMTS1;LAMC1,1
Regulation Of Cell Motility (GO:2000145),5/123,0.00383861858327917,0.0815980635988486,0,0,5.12477903712176,28.5073148078022,TNC;TACSTD2;PLXNB2;TMSB10;RHOB,1
Neutrophil Migration (GO:1990266),4/77,0.00403781318192568,0.0846234649958509,0,0,6.60173738723689,36.3891199349122,KLF5;SAA1;CXCL1;S100A9,1
Negative Regulation Of Cell Growth (GO:0030308),5/125,0.0041112950532813,0.0846464729761351,0,0,5.03885480572597,27.6835549809633,GJA1;PPP2R1A;ENO1;TP53;RTN4,1
Retina Homeostasis (GO:0001895),3/39,0.00426185219913302,0.0846464729761351,0,0,9.9979797979798,54.5694878801368,PIGR;CDH3;LTF,1
Negative Regulation Of Stem Cell Differentiation (GO:2000737),2/12,0.0043802274322328,0.0846464729761351,0,0,23.8819277108434,129.694501314714,HES1;ZFP36L2,1
Cellular Component Maintenance (GO:0043954),2/12,0.0043802274322328,0.0846464729761351,0,0,23.8819277108434,129.694501314714,CLDN3;ITGA3,1
Regulation Of Transcription From RNA Polymerase II Promoter In Response To Stress (GO:0043618),2/12,0.0043802274322328,0.0846464729761351,0,0,23.8819277108434,129.694501314714,MUC1;TP53,1
Macrophage Migration (GO:1905517),2/12,0.0043802274322328,0.0846464729761351,0,0,23.8819277108434,129.694501314714,KLF5;SAA1,1
Endothelial Cell Migration (GO:0043542),3/40,0.00457929369929785,0.0862530256272811,0,0,9.72727272727273,52.3931385668786,RAB13;FSTL1;S100A9,1
Positive Regulation Of Stem Cell Population Maintenance (GO:1902459),3/40,0.00457929369929785,0.0862530256272811,0,0,9.72727272727273,52.3931385668786,SMARCE1;HDAC1;ARID1A,1
Regulation Of Release Of Cytochrome C From Mitochondria (GO:0090199),3/41,0.00491068048700766,0.0902110193168815,0,0,9.47081339712919,50.3500901851339,TNFSF10;CLU;TP53,1
Stem Cell Differentiation (GO:0048863),3/41,0.00491068048700766,0.0902110193168815,0,0,9.47081339712919,50.3500901851339,EPCAM;PUM1;TP53,1
Immune Response-Regulating Cell Surface Receptor Signaling Pathway (GO:0002768),2/13,0.0051481792506046,0.0922950689746945,0,0,21.7097480832421,114.391097841505,PIGR;CD24,1
Membrane Protein Intracellular Domain Proteolysis (GO:0031293),2/13,0.0051481792506046,0.0922950689746945,0,0,21.7097480832421,114.391097841505,NCSTN;MMP7,1
Positive Regulation Of Receptor-Mediated Endocytosis (GO:0048260),3/43,0.00561595848769471,0.0992688782758163,0,0,8.99636363636364,46.6204428803253,C3;ANXA2;CLU,1
Protein Localization To Membrane (GO:0072657),6/192,0.00572957304766515,0.0992688782758163,0,0,3.91198725607328,20.1941252104008,GAK;PIGR;JUP;RAB13;FLOT2;AGRN,1
Positive Regulation Of Amide Metabolic Process (GO:0034250),4/85,0.00573731420142487,0.0992688782758163,0,0,5.94730502860584,30.6926382079295,ERBB2;PLXNB2;VIM;CLU,1
Regulation Of Cell Differentiation (GO:0045595),6/193,0.00587328999790724,0.100150191009321,0,0,3.89086947910477,19.9887206762828,SMARCE1;PPP2R1A;HDAC1;FLOT2;CD24;ARID1A,1
Regulation Of ATP Biosynthetic Process (GO:2001169),2/14,0.00597321788178741,0.100150191009321,0,0,19.8995983935743,101.89528640006,VCP;ENO1,1
Bone Development (GO:0060348),3/44,0.00599016599450911,0.100150191009321,0,0,8.77649667405765,44.9149166960335,GJA1;TP53;LTF,1
Positive Regulation Of mRNA Catabolic Process (GO:0061014),3/45,0.00637895164582224,0.105465333877594,0,0,8.56709956709957,43.304559507076,BTG2;PUM1;ZFP36L2,1
Myofibril Assembly (GO:0030239),3/46,0.00678245620644656,0.108502771406092,0,0,8.36744186046512,41.7821178165812,KRT19;TPM1;OBSL1,1
Positive Regulation Of Sprouting Angiogenesis (GO:1903672),2/15,0.0068543417420515,0.108502771406092,0,0,18.3679332715477,91.5250787009994,PKM;JAK1,1
Protein Localization To Cell-Cell Junction (GO:0150105),2/15,0.0068543417420515,0.108502771406092,0,0,18.3679332715477,91.5250787009994,LSR;JAK1,1
Regulation Of Amyloid-Beta Clearance (GO:1900221),2/15,0.0068543417420515,0.108502771406092,0,0,18.3679332715477,91.5250787009994,HDAC1;CLU,1
Bicellular Tight Junction Assembly (GO:0070830),3/47,0.00720081372699984,0.111354016953556,0,0,8.17685950413223,40.3410371284725,CLDN10;CLDN3;RAB13,1
Ras Protein Signal Transduction (GO:0007265),5/144,0.007429290057344,0.111354016953556,0,0,4.34589751511674,21.3050019299559,NCKAP1;ARHGAP1;ARHGAP29;TP53;RHOB,1
Defense Response To Bacterium (GO:0042742),6/204,0.0076327526025266,0.111354016953556,0,0,3.67265245043023,17.9053072388541,RNF213;SLPI;LCN2;HMGB2;S100A9;LTF,1
Negative Regulation Of Gene Expression (GO:0010629),8/336,0.00763818114904216,0.111354016953556,0,0,2.97317073170732,14.4930054831021,BTG2;CLDN3;DAPK1;HDAC1;ERP29;FLOT2;PUM1;ZFP36L2,1
Negative Regulation Of Apoptotic Process (GO:0043066),10/482,0.00770156217313697,0.111354016953556,0,0,2.59600944003433,12.6330440467639,BABAM2;HDAC1;ANXA5;ERBB2;PRKCA;SOD2;CLU;TP53;FSTL1;LTF,1
Negative Regulation Of Intrinsic Apoptotic Signaling Pathway By P53 Class Mediator (GO:1902254),2/16,0.00779056187034388,0.111354016953556,0,0,17.0550774526678,82.7997113543851,MUC1;PTTG1IP,1
Ruffle Organization (GO:0031529),2/16,0.00779056187034388,0.111354016953556,0,0,17.0550774526678,82.7997113543851,TPM1;AIF1L,1
Positive Regulation Of Stem Cell Proliferation (GO:2000648),2/16,0.00779056187034388,0.111354016953556,0,0,17.0550774526678,82.7997113543851,GJA1;EPCAM,1
Negative Regulation Of ATP-dependent Activity (GO:0032780),2/16,0.00779056187034388,0.111354016953556,0,0,17.0550774526678,82.7997113543851,TP53;LTF,1
Negative Regulation Of Amyloid-Beta Formation (GO:1902430),2/16,0.00779056187034388,0.111354016953556,0,0,17.0550774526678,82.7997113543851,CLU;RTN4,1
Negative Regulation Of Amide Metabolic Process (GO:0034249),4/93,0.00785764232535175,0.111354016953556,0,0,5.41052343107701,26.220850225573,BTG2;DAPK1;CLU;RTN4,1
Positive Regulation Of Cell Migration (GO:0030335),7/272,0.00824847252102965,0.115789878408416,0,0,3.21033634126333,15.4023181292703,CLDN3;MMP7;PRKCA;ACTN4;ACVR1B;SOD2;RTN4,1
"DNA Damage Response, Signal Transduction By P53 Class Mediator Resulting In Cell Cycle Arrest (GO:0006977)",2/17,0.0087809017880115,0.119871393216157,0,0,15.9172690763052,75.3710731781226,MUC1;TP53,1
Negative Regulation Of Vascular Associated Smooth Muscle Cell Proliferation (GO:1904706),2/17,0.0087809017880115,0.119871393216157,0,0,15.9172690763052,75.3710731781226,TPM1;SOD2,1
Positive Regulation Of Transcription From RNA Polymerase II Promoter In Response To Stress (GO:0036003),2/17,0.0087809017880115,0.119871393216157,0,0,15.9172690763052,75.3710731781226,MUC1;TP53,1
Positive Regulation Of Protein-Containing Complex Assembly (GO:0031334),4/98,0.0094138581109566,0.125355880220382,0,0,5.12143227815257,23.8944131276593,VCP;CLU;TP53;WARS1,1
Rho Protein Signal Transduction (GO:0007266),3/52,0.00951963337695104,0.125355880220382,0,0,7.34063079777366,34.1662242168977,ARHGAP1;ARHGAP29;RHOB,1
Cellular Response To Ionizing Radiation (GO:0071479),3/52,0.00951963337695104,0.125355880220382,0,0,7.34063079777366,34.1662242168977,BABAM2;TP53;RHOB,1
Regulation Of Cell Development (GO:0060284),3/52,0.00951963337695104,0.125355880220382,0,0,7.34063079777366,34.1662242168977,ANXA2;HMGB2;HES1,1
Cell Junction Maintenance (GO:0034331),2/18,0.00982439735885421,0.127119158869348,0,0,14.921686746988,68.9812636324013,CLDN3;SDF4,1
Positive Regulation Of G Protein-Coupled Receptor Signaling Pathway (GO:0045745),2/18,0.00982439735885421,0.127119158869348,0,0,14.921686746988,68.9812636324013,C3;PRKCA,1
Negative Regulation Of Viral Genome Replication (GO:0045071),3/53,0.0100295635730378,0.12830559089197,0,0,7.19345454545455,33.1058473588543,IFITM1;SLPI;LTF,1
Antimicrobial Humoral Response (GO:0019730),4/100,0.0100885444451347,0.12830559089197,0,0,5.01422764227642,23.047168851594,SLPI;CXCL1;S100A9;LTF,1
Regulation Of Exocytosis (GO:0017157),3/54,0.0105551076038826,0.131983194240145,0,0,7.05204991087344,32.0949045346224,ANXA2;SEPTIN2;RAB13,1
Regulation Of Myoblast Differentiation (GO:0045661),3/54,0.0105551076038826,0.131983194240145,0,0,7.05204991087344,32.0949045346224,SMARCE1;FLOT2;ARID1A,1
Peptide Biosynthetic Process (GO:0043043),5/158,0.0108335026077782,0.132106535203011,0,0,3.94542684149324,17.8534977659928,RPL31;RPL29;RPL18;WARS1;RPL19,1
Regulation Of Cellular Response To Growth Factor Stimulus (GO:0090287),2/19,0.0109200966599263,0.132106535203011,0,0,14.0432317505315,63.4353907205545,ITGA3;FSTL1,1
Release Of Cytochrome C From Mitochondria (GO:0001836),2/19,0.0109200966599263,0.132106535203011,0,0,14.0432317505315,63.4353907205545,SOD2;CLU,1
Cortical Actin Cytoskeleton Organization (GO:0030866),2/19,0.0109200966599263,0.132106535203011,0,0,14.0432317505315,63.4353907205545,NCKAP1;RAB13,1
Response To Lipopolysaccharide (GO:0032496),5/159,0.0111113197801526,0.132337070723404,0,0,3.9196079993626,17.6374163690509,SLPI;HMGB2;CXCL1;VIM;S100A9,1
Nervous System Development (GO:0007399),9/433,0.0111170254303935,0.132337070723404,0,0,2.59095763616946,11.6574374560072,NCKAP1;ERBB2;SLC2A1;HOXB2;CXCL1;HES1;L1CAM;ACVR1B;ITM2B,1
Regulation Of Stem Cell Population Maintenance (GO:2000036),3/56,0.01165337074192,0.136537131212417,0,0,6.7852487135506,30.2090116012658,SMARCE1;HDAC1;ARID1A,1
Cellular Response To Peptide (GO:1901653),3/56,0.01165337074192,0.136537131212417,0,0,6.7852487135506,30.2090116012658,GJA1;VIM;TP53,1
Positive Regulation Of Protein Modification Process (GO:0031401),6/225,0.0119992312049033,0.139192132055942,0,0,3.31692880094707,14.6704865104272,C3;CLDN3;NNMT;ERBB2;ERP29;FAM20A,1
Positive Regulation Of Protein Processing (GO:0010954),2/20,0.012067059835495,0.139192132055942,0,0,13.2623828647925,58.5836037582424,ANXA2;ENO1,1
Endosome To Lysosome Transport (GO:0008333),3/57,0.0122262426917373,0.13994345481004,0,0,6.65925925925926,29.3285138281723,VCP;HOOK1;RHOB,1
Positive Regulation Of Translation (GO:0045727),4/108,0.0130982165543369,0.148779742235521,0,0,4.6266416510319,20.0577833106373,PKM;ERBB2;PLXNB2;VIM,1
Regulation Of Lipopolysaccharide-Mediated Signaling Pathway (GO:0031664),2/21,0.0132643589781189,0.149525501207886,0,0,12.5637285986049,54.3089107063482,PRKCA;LTF,1
Positive Regulation Of Cysteine-Type Endopeptidase Activity Involved In Apoptotic Process (GO:0043280),4/109,0.0135103694857308,0.150025595483339,0,0,4.58234610917538,19.7237821772589,VCP;DAPK1;TNFSF10;S100A9,1
Extracellular Structure Organization (GO:0043062),4/109,0.0135103694857308,0.150025595483339,0,0,4.58234610917538,19.7237821772589,MMP7;COL4A2;COL4A1;ADAMTS1,1
Response To Lipid (GO:0033993),4/110,0.0139306928145997,0.151499713340279,0,0,4.53888633225955,19.397660398629,SLPI;HMGB2;SPP1;S100A9,1
External Encapsulating Structure Organization (GO:0045229),4/110,0.0139306928145997,0.151499713340279,0,0,4.53888633225955,19.397660398629,MMP7;COL4A2;COL4A1;ADAMTS1,1
protein-DNA Complex Organization (GO:0071824),3/60,0.0140406236911735,0.151499713340279,0,0,6.30781499202552,26.907880087783,HDAC1;HMGB2;HMGN3,1
Positive Regulation Of Developmental Process (GO:0051094),6/233,0.0140503766404291,0.151499713340279,0,0,3.19872736172296,13.6429115072754,SMARCE1;GJA1;HDAC1;ARID1A;ACVR1B;RTN4,1
Brain Development (GO:0007420),5/169,0.0141611012851528,0.151595098649694,0,0,3.67873709411941,15.6613271090983,COL4A1;TUBGCP2;PLXNB2;HSPG2;RTN4,1
Positive Regulation Of Viral Life Cycle (GO:1903902),2/22,0.0145110779831343,0.153138184673077,0,0,11.9349397590361,50.5187252885131,TMPRSS4;KPNA6,1
Membrane Protein Ectodomain Proteolysis (GO:0006509),2/22,0.0145110779831343,0.153138184673077,0,0,11.9349397590361,50.5187252885131,NCSTN;MMP7,1
Negative Regulation Of Viral Process (GO:0048525),3/61,0.0146775318196613,0.153803995406028,0,0,6.1987460815047,26.1676185546296,IFITM1;SLPI;LTF,1
Positive Regulation Of Apoptotic Signaling Pathway (GO:2001235),3/62,0.015330580907863,0.159271450772101,0,0,6.09337442218798,25.4575436897655,TNFSF10;S100A9;TP53,1
Negative Regulation Of Programmed Cell Death (GO:0043069),8/381,0.0154133662037518,0.159271450772101,0,0,2.60844504021448,10.8837896487743,BABAM2;MECOM;HDAC1;ANXA5;ERBB2;TP53;FSTL1;LTF,1
Entrainment Of Circadian Clock By Photoperiod (GO:0043153),2/23,0.0158063124268222,0.162205468214562,0,0,11.3660355708549,47.1388810018912,PPP1CB;TP53,1
Regulation Of Secretion By Cell (GO:1903530),3/64,0.0166852686817438,0.170052601359143,0,0,5.8929955290611,24.1213805719092,SEPTIN2;RAB13;SAA1,1
Positive Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071902),4/117,0.0171059019888415,0.171261504114066,0,0,4.25620548240881,17.3156558112546,ERBB2;ERP29;CD24;LTF,1
Photoperiodism (GO:0009648),2/24,0.0171491694307768,0.171261504114066,0,0,10.8488499452355,44.109314169124,PPP1CB;TP53,1
Iron Ion Transport (GO:0006826),2/24,0.0171491694307768,0.171261504114066,0,0,10.8488499452355,44.109314169124,ARHGAP1;LTF,1
Antimicrobial Humoral Immune Response Mediated By Antimicrobial Peptide (GO:0061844),3/65,0.0173869789052759,0.172478830740337,0,0,5.79765395894428,23.4922891743681,CXCL1;S100A9;LTF,1
Negative Regulation Of Intrinsic Apoptotic Signaling Pathway In Response To DNA Damage (GO:1902230),2/25,0.0185387675354076,0.181484776925569,0,0,10.3766369827135,41.380899278138,MUC1;CLU,1
Positive Regulation Of Release Of Cytochrome C From Mitochondria (GO:0090200),2/25,0.0185387675354076,0.181484776925569,0,0,10.3766369827135,41.380899278138,TNFSF10;TP53,1
Regulation Of Viral Genome Replication (GO:0045069),3/67,0.018839276434051,0.183221198260574,0,0,5.61590909090909,22.3053318407787,IFITM1;SLPI;LTF,1
Macromolecule Biosynthetic Process (GO:0009059),5/183,0.0193087882303717,0.186568031732423,0,0,3.38698559316192,13.3690923883641,RPL31;RPL29;RPL18;WARS1;RPL19,1
Intermediate Filament Organization (GO:0045109),3/68,0.0195899081411738,0.188063118155269,0,0,5.52923076923077,21.7450310854728,KRT19;VIM;BBLN,1
Regulation Of Nucleotide-Excision Repair (GO:2000819),2/26,0.0199742365776016,0.188111797642223,0,0,9.94377510040161,38.9130944948488,SMARCE1;ARID1A,1
Positive Regulation Of Erythrocyte Differentiation (GO:0045648),2/26,0.0199742365776016,0.188111797642223,0,0,9.94377510040161,38.9130944948488,HMGB2;ACVR1B,1
Mitotic G1 DNA Damage Checkpoint Signaling (GO:0031571),2/26,0.0199742365776016,0.188111797642223,0,0,9.94377510040161,38.9130944948488,MUC1;TP53,1
Regulation Of Endopeptidase Activity (GO:0052548),3/69,0.0203568842080535,0.190509708814991,0,0,5.44517906336088,21.2053575824309,NCSTN;HDAC1;SERPING1,1
Cellular Response To Epidermal Growth Factor Stimulus (GO:0071364),2/27,0.0214547175585387,0.195856562742979,0,0,9.5455421686747,36.6721662794662,ERBB2;ZFP36L2,1
Clathrin-Dependent Endocytosis (GO:0072583),2/27,0.0214547175585387,0.195856562742979,0,0,9.5455421686747,36.6721662794662,GAK;AP2M1,1
Cortical Cytoskeleton Organization (GO:0030865),2/27,0.0214547175585387,0.195856562742979,0,0,9.5455421686747,36.6721662794662,NCKAP1;RAB13,1
Positive Regulation Of Mitotic Cell Cycle (GO:0045931),2/27,0.0214547175585387,0.195856562742979,0,0,9.5455421686747,36.6721662794662,HES1;PRKCA,1
Cellular Response To Oxygen-Containing Compound (GO:1901701),8/406,0.0216449331625724,0.196388174060413,0,0,2.44145728643216,9.35806643721563,VCP;CLIC4;DAPK1;TPM1;HMGB2;CXCL1;VIM;CLU,1
Response To Ionizing Radiation (GO:0010212),3/72,0.0227559734905172,0.20232716825293,0,0,5.20764163372859,19.700131251722,BABAM2;TP53;RHOB,1
Regulation Of Monoatomic Ion Transport (GO:0043269),2/28,0.0229793625233503,0.20232716825293,0,0,9.17794253938832,34.6298341760365,CLDN10;KCNJ16,1
Protein Localization To Golgi Apparatus (GO:0034067),2/28,0.0229793625233503,0.20232716825293,0,0,9.17794253938832,34.6298341760365,GAK;OBSL1,1
Mucosal Immune Response (GO:0002385),2/28,0.0229793625233503,0.20232716825293,0,0,9.17794253938832,34.6298341760365,PIGR;LTF,1
Regulation Of Bone Resorption (GO:0045124),2/28,0.0229793625233503,0.20232716825293,0,0,9.17794253938832,34.6298341760365,SPP1;PRKCA,1
Protein Homooligomerization (GO:0051260),4/129,0.0235304443826232,0.204643237879852,0,0,3.84526829268293,14.4176803857136,SOD2;CLU;GLS;CRYZ,1
Cellular Response To Reactive Oxygen Species (GO:0034614),3/73,0.0235884017747223,0.204643237879852,0,0,5.13298701298701,19.2333030458885,TPM1;CLU;RHOB,1
Regulation Of Signal Transduction (GO:0009966),5/193,0.0236549979269721,0.204643237879852,0,0,3.20519514423705,12.0008303037163,PPP2R1A;ITGA3;DCDC2;CD24;CLU,1
Regulation Of Cell Cycle Process (GO:0010564),4/130,0.0241233751116569,0.204893177743555,0,0,3.81455671699574,14.2075987197155,SMARCE1;PUM1;ARID1A;OBSL1,1
Regulation Of Muscle Contraction (GO:0006937),2/29,0.0245473344400033,0.204893177743555,0,0,8.83757251227131,32.7622246795726,TPM1;ENO1,1
Defense Response To Fungus (GO:0050832),2/29,0.0245473344400033,0.204893177743555,0,0,8.83757251227131,32.7622246795726,S100A9;LTF,1
Sarcomere Organization (GO:0045214),2/29,0.0245473344400033,0.204893177743555,0,0,8.83757251227131,32.7622246795726,KRT19;TPM1,1
Glycolytic Process (GO:0006096),2/29,0.0245473344400033,0.204893177743555,0,0,8.83757251227131,32.7622246795726,PKM;ENO1,1
Regulation Of Protein Phosphorylation (GO:0001932),6/265,0.024700464029135,0.204893177743555,0,0,2.7989417989418,10.3586967654957,C3;CLDN3;ERBB2;ERP29;PLXNB2;FAM20A,1
Synapse Organization (GO:0050808),4/131,0.0247253026754618,0.204893177743555,0,0,3.78432878816977,14.0017446495612,TNC;SDF4;L1CAM;AGRN,1
Positive Regulation Of Protein Metabolic Process (GO:0051247),5/196,0.0250723606328324,0.204893177743555,0,0,3.15436996113449,11.6269736397783,VCP;ERBB2;PLXNB2;VIM;CLU,1
Nucleosome Organization (GO:0034728),3/75,0.0253023359797558,0.204893177743555,0,0,4.98989898989899,18.3471527960593,SMARCE1;HMGB2;ARID1A,1
Positive Regulation Of Neurogenesis (GO:0050769),3/75,0.0253023359797558,0.204893177743555,0,0,4.98989898989899,18.3471527960593,VCAN;PLXNB2;OBSL1,1
Plasma Membrane Bounded Cell Projection Organization (GO:0120036),4/132,0.0253362531618374,0.204893177743555,0,0,3.75457317073171,13.8000049418764,BTG2;TPM1;RAB13;L1CAM,1
Epithelial Cell Differentiation (GO:0030855),4/132,0.0253362531618374,0.204893177743555,0,0,3.75457317073171,13.8000049418764,KRT19;HDAC1;HNRNPH3;FSTL1,1
DNA Geometric Change (GO:0032392),2/30,0.0261578070672307,0.207036260191698,0,0,8.52151462994837,31.0490553295416,HNRNPA2B1;HMGB2,1
Regulation Of Vasculature Development (GO:1901342),2/30,0.0261578070672307,0.207036260191698,0,0,8.52151462994837,31.0490553295416,ERBB2;WARS1,1
Response To Epidermal Growth Factor (GO:0070849),2/30,0.0261578070672307,0.207036260191698,0,0,8.52151462994837,31.0490553295416,ERBB2;ZFP36L2,1
Cytoplasmic Translational Initiation (GO:0002183),2/30,0.0261578070672307,0.207036260191698,0,0,8.52151462994837,31.0490553295416,EIF4A1;EIF2S3,1
Actomyosin Structure Organization (GO:0031032),3/77,0.0270816348617022,0.213214141133401,0,0,4.85454545454545,17.5195664753073,PDLIM1;KRT19;TPM1,1
Regulation Of Transmembrane Receptor Protein Serine/Threonine Kinase Signaling Pathway (GO:0090092),2/31,0.0278099648492844,0.217528687060365,0,0,8.22725384295804,29.4729922732104,ITGA3;FSTL1,1
Regulation Of Gene Expression (GO:0010468),16/1127,0.027981806314373,0.217528687060365,0,0,1.77374579563219,6.34327105261074,HDAC1;TMPRSS4;TNC;PUM1;ACVR1B;CLU;WARS1;GJA1;CDH3;CLDN3;PPP2R1A;ERP29;FLOT2;HNRNPH3;TP53;LTF,1
Regulation Of Translation (GO:0006417),5/202,0.0280682176852084,0.217528687060365,0,0,3.057363520289,10.9243187496226,BTG2;DAPK1;ERBB2;PLXNB2;VIM,1
Protein Localization To Plasma Membrane (GO:0072659),4/137,0.0285271801688065,0.219940124824788,0,0,3.61250687694847,12.8493183268255,GAK;JUP;RAB13;FLOT2,1
Response To Insulin (GO:0032868),3/79,0.0289261618590417,0.220728865878226,0,0,4.72631578947368,16.7453786166942,PKM;RAB13;SLC2A1,1
Positive Regulation Of Endocytosis (GO:0045807),3/79,0.0289261618590417,0.220728865878226,0,0,4.72631578947368,16.7453786166942,C3;CYBA;CLU,1
Regulation Of Metaphase/Anaphase Transition Of Cell Cycle (GO:1902099),2/32,0.0295030027795832,0.221719536040504,0,0,7.95261044176707,28.0191399653373,SMARCE1;ARID1A,1
miRNA Processing (GO:0035196),2/32,0.0295030027795832,0.221719536040504,0,0,7.95261044176707,28.0191399653373,HNRNPA2B1;PUM1,1
Muscle Cell Development (GO:0055001),2/32,0.0295030027795832,0.221719536040504,0,0,7.95261044176707,28.0191399653373,HES1;ACTN4,1
Regulation Of Canonical Wnt Signaling Pathway (GO:0060828),5/207,0.0307315056418679,0.222924381499819,0,0,2.98092692704853,10.3809793792375,VCP;CDH3;JUP;HDAC1;BICC1,1
Regulation Of Sprouting Angiogenesis (GO:1903670),2/33,0.0312361263037161,0.222924381499819,0,0,7.69568596968519,26.6746324839554,PKM;JAK1,1
Positive Regulation Of DNA Binding (GO:0043388),2/33,0.0312361263037161,0.222924381499819,0,0,7.69568596968519,26.6746324839554,HMGB2;HES1,1
Regulation Of G0 To G1 Transition (GO:0070316),2/33,0.0312361263037161,0.222924381499819,0,0,7.69568596968519,26.6746324839554,SMARCE1;ARID1A,1
Regulation Of Amyloid-Beta Formation (GO:1902003),2/33,0.0312361263037161,0.222924381499819,0,0,7.69568596968519,26.6746324839554,CLU;RTN4,1
Protein Localization To Cell Periphery (GO:1990778),4/142,0.0319469206258898,0.222924381499819,0,0,3.48073524213503,11.9865365420188,GAK;JUP;RAB13;FLOT2,1
Positive Regulation Of Proteasomal Ubiquitin-Dependent Protein Catabolic Process (GO:0032436),3/83,0.0328100826807823,0.222924381499819,0,0,4.48909090909091,15.3393107787087,VCP;SUMO2;CLU,1
Positive Regulation Of Ubiquitin-Dependent Protein Catabolic Process (GO:2000060),3/83,0.0328100826807823,0.222924381499819,0,0,4.48909090909091,15.3393107787087,VCP;SUMO2;CLU,1
Negative Regulation Of Mitotic Cell Cycle (GO:0045930),2/34,0.0330085511810145,0.222924381499819,0,0,7.45481927710843,25.4283037510686,BTG2;ZFP36L2,1
Apoptotic Mitochondrial Changes (GO:0008637),2/34,0.0330085511810145,0.222924381499819,0,0,7.45481927710843,25.4283037510686,SOD2;CLU,1
Cellular Response To Hydrogen Peroxide (GO:0070301),2/34,0.0330085511810145,0.222924381499819,0,0,7.45481927710843,25.4283037510686,CLU;RHOB,1
Superoxide Metabolic Process (GO:0006801),2/34,0.0330085511810145,0.222924381499819,0,0,7.45481927710843,25.4283037510686,CYBA;SOD2,1
Membrane Protein Proteolysis (GO:0033619),2/34,0.0330085511810145,0.222924381499819,0,0,7.45481927710843,25.4283037510686,NCSTN;MMP7,1
Regulation Of Axon Extension (GO:0030516),2/35,0.034819503382133,0.222924381499819,0,0,7.22855056589996,24.2704195124005,L1CAM;RTN4,1
Positive Regulation Of Canonical Wnt Signaling Pathway (GO:0090263),3/85,0.0348489395529398,0.222924381499819,0,0,4.37915742793792,14.6996603724895,VCP;CDH3;JUP,1
Integrin-Mediated Signaling Pathway (GO:0007229),3/85,0.0348489395529398,0.222924381499819,0,0,4.37915742793792,14.6996603724895,ADAMTS1;ITGA3;ITGB6,1
mRNA Metabolic Process (GO:0016071),3/85,0.0348489395529398,0.222924381499819,0,0,4.37915742793792,14.6996603724895,HNRNPA2B1;TP53;ZFP36L2,1
Negative Regulation Of Protein Metabolic Process (GO:0051248),4/147,0.0355974333627057,0.222924381499819,0,0,3.35817840695889,11.201142757002,BTG2;DAPK1;FLOT2;CLU,1
Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901990),3/86,0.0358924507107431,0.222924381499819,0,0,4.32617743702081,14.3941799655764,SMARCE1;ARID1A;ZFP36L2,1
"DNA Damage Response, Signal Transduction By P53 Class Mediator (GO:0030330)",2/36,0.0366682189653567,0.222924381499819,0,0,7.01559177888023,23.1924580735297,MUC1;TP53,1
Regulation Of Erythrocyte Differentiation (GO:0045646),2/36,0.0366682189653567,0.222924381499819,0,0,7.01559177888023,23.1924580735297,HMGB2;ACVR1B,1
Positive Regulation Of Myeloid Cell Differentiation (GO:0045639),2/36,0.0366682189653567,0.222924381499819,0,0,7.01559177888023,23.1924580735297,HMGB2;ACVR1B,1
Neuron Development (GO:0048666),4/150,0.0378990646832363,0.222924381499819,0,0,3.28867357166722,10.7632657295781,UGDH;BTG2;RAB13;L1CAM,1
Negative Regulation Of Smooth Muscle Cell Proliferation (GO:0048662),2/37,0.0385539439807625,0.222924381499819,0,0,6.81480206540448,22.1869297949975,TPM1;SOD2,1
Type I Interferon-Mediated Signaling Pathway (GO:0060337),2/37,0.0385539439807625,0.222924381499819,0,0,6.81480206540448,22.1869297949975,IFITM1;JAK1,1
Positive Regulation Of Cell Motility (GO:2000147),5/221,0.0390141001546437,0.222924381499819,0,0,2.78573051579187,9.0364422244255,CLDN3;MMP7;PRKCA;ACTN4;SOD2,1
Negative Regulation Of Nucleic Acid-Templated Transcription (GO:1903507),8/456,0.0390978402054291,0.222924381499819,0,0,2.16339285714286,7.01304477511479,SMARCE1;MECOM;HDAC1;HMGB2;PBXIP1;HES1;ENO1;TP53,1
Positive Regulation Of DNA Repair (GO:0045739),3/89,0.0391187443164741,0.222924381499819,0,0,4.17463002114165,13.5306168402391,SMARCE1;BABAM2;ARID1A,1
Cellular Response To Organic Cyclic Compound (GO:0071407),4/152,0.0394799794670317,0.222924381499819,0,0,3.24390243902439,10.4841680668002,JUP;CTNNA1;SPP1;CLU,1
Positive Regulation Of NF-kappaB Transcription Factor Activity (GO:0051092),4/152,0.0394799794670317,0.222924381499819,0,0,3.24390243902439,10.4841680668002,FLOT2;CLU;S100A9;LTF,1
Positive Regulation Of Proteasomal Protein Catabolic Process (GO:1901800),3/90,0.0402259211970959,0.222924381499819,0,0,4.1264367816092,13.259246931119,VCP;SUMO2;CLU,1
Cellular Response To Type I Interferon (GO:0071357),2/38,0.0404759343399634,0.222924381499819,0,0,6.62516733601071,21.2472276360142,IFITM1;JAK1,1
Positive Regulation Of Axonogenesis (GO:0050772),2/38,0.0404759343399634,0.222924381499819,0,0,6.62516733601071,21.2472276360142,PLXNB2;L1CAM,1
Positive Regulation Of Myoblast Differentiation (GO:0045663),2/38,0.0404759343399634,0.222924381499819,0,0,6.62516733601071,21.2472276360142,SMARCE1;ARID1A,1
Negative Regulation Of Glial Cell Proliferation (GO:0060253),1/5,0.04130414695089,0.222924381499819,0,0,29.6826347305389,94.5923939883117,HES1,1
ERBB2-EGFR Signaling Pathway (GO:0038134),1/5,0.04130414695089,0.222924381499819,0,0,29.6826347305389,94.5923939883117,ERBB2,1
Regulation Of Establishment Of T Cell Polarity (GO:1903903),1/5,0.04130414695089,0.222924381499819,0,0,29.6826347305389,94.5923939883117,FLOT2,1
L-ascorbic Acid Metabolic Process (GO:0019852),1/5,0.04130414695089,0.222924381499819,0,0,29.6826347305389,94.5923939883117,SLC2A1,1
Negative Regulation Of Morphogenesis Of An Epithelium (GO:1905331),1/5,0.04130414695089,0.222924381499819,0,0,29.6826347305389,94.5923939883117,TACSTD2,1
Negative Regulation Of Protein Localization To Chromatin (GO:0120186),1/5,0.04130414695089,0.222924381499819,0,0,29.6826347305389,94.5923939883117,VCP,1
Negative Regulation Of Trophoblast Cell Migration (GO:1901164),1/5,0.04130414695089,0.222924381499819,0,0,29.6826347305389,94.5923939883117,GJA1,1
Nephron Tubule Development (GO:0072080),1/5,0.04130414695089,0.222924381499819,0,0,29.6826347305389,94.5923939883117,HNF1B,1
Regulation Of Morphogenesis Of A Branching Structure (GO:0060688),1/5,0.04130414695089,0.222924381499819,0,0,29.6826347305389,94.5923939883117,RTN4,1
Neuroblast Proliferation (GO:0007405),1/5,0.04130414695089,0.222924381499819,0,0,29.6826347305389,94.5923939883117,PLXNB2,1
Astrocyte Differentiation (GO:0048708),1/5,0.04130414695089,0.222924381499819,0,0,29.6826347305389,94.5923939883117,S100A9,1
Autocrine Signaling (GO:0035425),1/5,0.04130414695089,0.222924381499819,0,0,29.6826347305389,94.5923939883117,S100A9,1
Notochord Development (GO:0030903),1/5,0.04130414695089,0.222924381499819,0,0,29.6826347305389,94.5923939883117,COL18A1,1
Regulation Of Pentose-Phosphate Shunt (GO:0043456),1/5,0.04130414695089,0.222924381499819,0,0,29.6826347305389,94.5923939883117,TP53,1
Bundle Of His cell-Purkinje Myocyte Adhesion Involved In Cell Communication (GO:0086073),1/5,0.04130414695089,0.222924381499819,0,0,29.6826347305389,94.5923939883117,JUP,1
Regulation Of Plasma Membrane Repair (GO:1905684),1/5,0.04130414695089,0.222924381499819,0,0,29.6826347305389,94.5923939883117,ANXA2,1
Regulation Of Post-Transcriptional Gene Silencing By RNA (GO:1900368),1/5,0.04130414695089,0.222924381499819,0,0,29.6826347305389,94.5923939883117,PUM1,1
Regulation Of pro-B Cell Differentiation (GO:2000973),1/5,0.04130414695089,0.222924381499819,0,0,29.6826347305389,94.5923939883117,HES1,1
Cellular Response To Granulocyte Macrophage Colony-Stimulating Factor Stimulus (GO:0097011),1/5,0.04130414695089,0.222924381499819,0,0,29.6826347305389,94.5923939883117,ZFP36L2,1
Regulation Of Thymocyte Apoptotic Process (GO:0070243),1/5,0.04130414695089,0.222924381499819,0,0,29.6826347305389,94.5923939883117,TP53,1
Response To Granulocyte Macrophage Colony-Stimulating Factor (GO:0097012),1/5,0.04130414695089,0.222924381499819,0,0,29.6826347305389,94.5923939883117,ZFP36L2,1
Response To Testosterone (GO:0033574),1/5,0.04130414695089,0.222924381499819,0,0,29.6826347305389,94.5923939883117,SPP1,1
Ruffle Assembly (GO:0097178),1/5,0.04130414695089,0.222924381499819,0,0,29.6826347305389,94.5923939883117,AIF1L,1
Enamel Mineralization (GO:0070166),1/5,0.04130414695089,0.222924381499819,0,0,29.6826347305389,94.5923939883117,FAM20A,1
Positive Regulation Of Epithelial Cell Differentiation Involved In Kidney Development (GO:2000698),1/5,0.04130414695089,0.222924381499819,0,0,29.6826347305389,94.5923939883117,PROM1,1
Synaptic Vesicle Uncoating (GO:0016191),1/5,0.04130414695089,0.222924381499819,0,0,29.6826347305389,94.5923939883117,GAK,1
Gastrulation With Mouth Forming Second (GO:0001702),1/5,0.04130414695089,0.222924381499819,0,0,29.6826347305389,94.5923939883117,UGDH,1
Positive Regulation Of Mitochondrial Membrane Potential (GO:0010918),1/5,0.04130414695089,0.222924381499819,0,0,29.6826347305389,94.5923939883117,VCP,1
Positive Regulation Of Osteoblast Proliferation (GO:0033690),1/5,0.04130414695089,0.222924381499819,0,0,29.6826347305389,94.5923939883117,LTF,1
Hydrogen Peroxide Biosynthetic Process (GO:0050665),1/5,0.04130414695089,0.222924381499819,0,0,29.6826347305389,94.5923939883117,CYBA,1
Interleukin-4-Mediated Signaling Pathway (GO:0035771),1/5,0.04130414695089,0.222924381499819,0,0,29.6826347305389,94.5923939883117,JAK1,1
Intracellular Oxygen Homeostasis (GO:0032364),1/5,0.04130414695089,0.222924381499819,0,0,29.6826347305389,94.5923939883117,SOD2,1
Intracellular Phosphate Ion Homeostasis (GO:0030643),1/5,0.04130414695089,0.222924381499819,0,0,29.6826347305389,94.5923939883117,SLC34A2,1
Iron Coordination Entity Transport (GO:1901678),1/5,0.04130414695089,0.222924381499819,0,0,29.6826347305389,94.5923939883117,LCN2,1
Positive Regulation Of Vascular Associated Smooth Muscle Cell Differentiation (GO:1905065),1/5,0.04130414695089,0.222924381499819,0,0,29.6826347305389,94.5923939883117,SOD2,1
Positive Regulation Of Vesicle Fusion (GO:0031340),1/5,0.04130414695089,0.222924381499819,0,0,29.6826347305389,94.5923939883117,ANXA2,1
Pronephros Development (GO:0048793),1/5,0.04130414695089,0.222924381499819,0,0,29.6826347305389,94.5923939883117,HNF1B,1
Protein Import (GO:0017038),1/5,0.04130414695089,0.222924381499819,0,0,29.6826347305389,94.5923939883117,CLU,1
Protein Localization To Membrane Raft (GO:1903044),1/5,0.04130414695089,0.222924381499819,0,0,29.6826347305389,94.5923939883117,FLOT2,1
Radial Glial Cell Differentiation (GO:0060019),1/5,0.04130414695089,0.222924381499819,0,0,29.6826347305389,94.5923939883117,HES1,1
Morphogenesis Of An Endothelium (GO:0003159),1/5,0.04130414695089,0.222924381499819,0,0,29.6826347305389,94.5923939883117,RHOB,1
Regulation Of Basement Membrane Organization (GO:0110011),1/5,0.04130414695089,0.222924381499819,0,0,29.6826347305389,94.5923939883117,LAMC1,1
Negative Regulation Of Cellular Response To Hypoxia (GO:1900038),1/5,0.04130414695089,0.222924381499819,0,0,29.6826347305389,94.5923939883117,ENO1,1
Positive Regulation Of MAP Kinase Activity (GO:0043406),3/91,0.0413488772136761,0.222924381499819,0,0,4.07933884297521,12.9955905908064,ERBB2;ERP29;CD24,1
Cellular Response To Growth Factor Stimulus (GO:0071363),4/155,0.0419211541674616,0.223067264753029,0,0,3.17896947181392,10.0835789683583,HDAC1;ERBB2;ACVR1B;ZFP36L2,1
Regulation Of Receptor-Mediated Endocytosis (GO:0048259),2/39,0.0424334557041264,0.223067264753029,0,0,6.44578313253012,20.3675027152556,C3;CLU,1
Positive Regulation Of Intrinsic Apoptotic Signaling Pathway (GO:2001244),2/39,0.0424334557041264,0.223067264753029,0,0,6.44578313253012,20.3675027152556,S100A9;TP53,1
Positive Regulation Of Lymphocyte Differentiation (GO:0045621),2/39,0.0424334557041264,0.223067264753029,0,0,6.44578313253012,20.3675027152556,SMARCE1;ARID1A,1
Negative Regulation Of Cell-Substrate Adhesion (GO:0010812),2/39,0.0424334557041264,0.223067264753029,0,0,6.44578313253012,20.3675027152556,TACSTD2;ACTN4,1
Apoptotic Process (GO:0006915),5/228,0.0436199908742838,0.223067264753029,0,0,2.69732317257696,8.44866279883106,NCKAP1;PPP2R1A;DAPK1;RTN4;RHOB,1
Negative Regulation Of Protein Localization (GO:1903828),2/40,0.0444257833931067,0.223067264753029,0,0,6.27584020291693,19.5425601632557,VCP;CTNNA1,1
Synaptic Vesicle Endocytosis (GO:0048488),2/40,0.0444257833931067,0.223067264753029,0,0,6.27584020291693,19.5425601632557,GAK;AP2M1,1
Water-Soluble Vitamin Metabolic Process (GO:0006767),2/40,0.0444257833931067,0.223067264753029,0,0,6.27584020291693,19.5425601632557,NNMT;SLC2A1,1
Vesicle Organization (GO:0016050),3/94,0.0448118082461777,0.223067264753029,0,0,3.94425574425574,12.2480326664614,ANXA2;HOOK1;AP2M1,1
Positive Regulation Of Phosphorylation (GO:0042327),5/231,0.0456899350810558,0.223067264753029,0,0,2.6611108094902,8.21186129147263,C3;CLDN3;ERBB2;ERP29;FAM20A,1
Positive Regulation Of Epithelial Cell Migration (GO:0010634),3/95,0.0459972570941273,0.223067264753029,0,0,3.90118577075099,12.0124278932603,PRKCA;RTN4;RHOB,1
Carbohydrate Catabolic Process (GO:0016052),2/41,0.0464522022622377,0.223067264753029,0,0,6.11461229533519,18.767771537614,PKM;ENO1,1
Positive Regulation Of Response To Biotic Stimulus (GO:0002833),2/41,0.0464522022622377,0.223067264753029,0,0,6.11461229533519,18.767771537614,CYBA;PRKCA,1
Lymphocyte Migration (GO:0072676),2/41,0.0464522022622377,0.223067264753029,0,0,6.11461229533519,18.767771537614,KLF5;SAA1,1
G-quadruplex DNA Unwinding (GO:0044806),1/6,0.0493591852655947,0.223067264753029,0,0,23.7449101796407,71.4396824869037,HNRNPA2B1,1
Regulation Of Glial Cell Apoptotic Process (GO:0034350),1/6,0.0493591852655947,0.223067264753029,0,0,23.7449101796407,71.4396824869037,PRKCA,1
Negative Regulation Of Oligodendrocyte Differentiation (GO:0048715),1/6,0.0493591852655947,0.223067264753029,0,0,23.7449101796407,71.4396824869037,HES1,1
Negative Regulation Of Ruffle Assembly (GO:1900028),1/6,0.0493591852655947,0.223067264753029,0,0,23.7449101796407,71.4396824869037,TACSTD2,1
Adenosine To Inosine Editing (GO:0006382),1/6,0.0493591852655947,0.223067264753029,0,0,23.7449101796407,71.4396824869037,ADAR,1
Regulation Of Osteoclast Development (GO:2001204),1/6,0.0493591852655947,0.223067264753029,0,0,23.7449101796407,71.4396824869037,LTF,1
Nucleotide Catabolic Process (GO:0009166),1/6,0.0493591852655947,0.223067264753029,0,0,23.7449101796407,71.4396824869037,VCP,1
Cardiac Muscle Cell-Cardiac Muscle Cell Adhesion (GO:0086042),1/6,0.0493591852655947,0.223067264753029,0,0,23.7449101796407,71.4396824869037,JUP,1
Pharyngeal Arch Artery Morphogenesis (GO:0061626),1/6,0.0493591852655947,0.223067264753029,0,0,23.7449101796407,71.4396824869037,HES1,1
Cellular Response To Interleukin-9 (GO:0071355),1/6,0.0493591852655947,0.223067264753029,0,0,23.7449101796407,71.4396824869037,JAK1,1
Polyamine Biosynthetic Process (GO:0006596),1/6,0.0493591852655947,0.223067264753029,0,0,23.7449101796407,71.4396824869037,SAT1,1
Regulation Of Transforming Growth Factor Beta2 Production (GO:0032909),1/6,0.0493591852655947,0.223067264753029,0,0,23.7449101796407,71.4396824869037,CDH3,1
Regulation Of Vascular Associated Smooth Muscle Cell Apoptotic Process (GO:1905459),1/6,0.0493591852655947,0.223067264753029,0,0,23.7449101796407,71.4396824869037,SOD2,1
Clathrin Coat Disassembly (GO:0072318),1/6,0.0493591852655947,0.223067264753029,0,0,23.7449101796407,71.4396824869037,GAK,1
Definitive Hemopoiesis (GO:0060216),1/6,0.0493591852655947,0.223067264753029,0,0,23.7449101796407,71.4396824869037,ZFP36L2,1
Positive Regulation Of Lipopolysaccharide-Mediated Signaling Pathway (GO:0031666),1/6,0.0493591852655947,0.223067264753029,0,0,23.7449101796407,71.4396824869037,PRKCA,1
Vascular Associated Smooth Muscle Cell Development (GO:0097084),1/6,0.0493591852655947,0.223067264753029,0,0,23.7449101796407,71.4396824869037,HES1,1
Xenobiotic Glucuronidation (GO:0052697),1/6,0.0493591852655947,0.223067264753029,0,0,23.7449101796407,71.4396824869037,UGT1A6,1
Interleukin-9-Mediated Signaling Pathway (GO:0038113),1/6,0.0493591852655947,0.223067264753029,0,0,23.7449101796407,71.4396824869037,JAK1,1
protein-DNA Covalent Cross-Linking Repair (GO:0106300),1/6,0.0493591852655947,0.223067264753029,0,0,23.7449101796407,71.4396824869037,VCP,1
Mitotic Nuclear Membrane Disassembly (GO:0007077),1/6,0.0493591852655947,0.223067264753029,0,0,23.7449101796407,71.4396824869037,PRKCA,1
Positive Regulation Of Cold-Induced Thermogenesis (GO:0120162),3/98,0.0496460494155202,0.223067264753029,0,0,3.77741626794258,11.3429632952103,GJA1;MUC1;LCN2,1
Regulation Of Filopodium Assembly (GO:0051489),2/43,0.0506044999990996,0.223067264753029,0,0,5.81575080811049,17.3525416072154,AGRN;CLU,1
Positive Regulation Of miRNA Transcription (GO:1902895),2/43,0.0506044999990996,0.223067264753029,0,0,5.81575080811049,17.3525416072154,KLF5;TP53,1
mRNA Destabilization (GO:0061157),2/43,0.0506044999990996,0.223067264753029,0,0,5.81575080811049,17.3525416072154,PUM1;ZFP36L2,1
Supramolecular Fiber Organization (GO:0097435),6/316,0.0509400513818611,0.223067264753029,0,0,2.33237753882915,6.94373470040404,COL18A1;KRT19;TUBGCP2;HOOK1;TPM1;VIM,1
Positive Regulation Of Cell Population Proliferation (GO:0008284),8/483,0.0516271906303901,0.223067264753029,0,0,2.03757894736842,6.03878657183337,GJA1;KITLG;HDAC1;EPCAM;ERBB2;HES1;LAMC1;LTF,1
Regulation Of Transport (GO:0051049),2/44,0.0527289953113972,0.223067264753029,0,0,5.67699368904188,16.7050636052466,CLDN10;CLDN3,1
Regulation Of Viral Entry Into Host Cell (GO:0046596),2/44,0.0527289953113972,0.223067264753029,0,0,5.67699368904188,16.7050636052466,IFITM1;TMPRSS4,1
Positive Regulation Of Biosynthetic Process (GO:0009891),2/44,0.0527289953113972,0.223067264753029,0,0,5.67699368904188,16.7050636052466,CYBA;VIM,1
Extracellular Matrix Disassembly (GO:0022617),2/44,0.0527289953113972,0.223067264753029,0,0,5.67699368904188,16.7050636052466,MMP7;LAMC1,1
Positive Regulation Of Osteoblast Differentiation (GO:0045669),2/44,0.0527289953113972,0.223067264753029,0,0,5.67699368904188,16.7050636052466,IFITM1;LTF,1
Lymphocyte Chemotaxis (GO:0048247),2/44,0.0527289953113972,0.223067264753029,0,0,5.67699368904188,16.7050636052466,KLF5;SAA1,1
Positive Regulation Of Transcription By RNA Polymerase II (GO:0045944),13/938,0.0529608458806929,0.223067264753029,0,0,1.71432258064516,5.03702671296302,JUP;ANXA2;HDAC1;HMGB2;HNF1B;MUC1;KLF5;EPCAM;HOXB2;NCOA7;HES1;AGRN;TP53,1
Epidermal Growth Factor Receptor Signaling Pathway (GO:0007173),2/45,0.0548848144674761,0.223067264753029,0,0,5.54469038946484,16.0935668327161,PIGR;ERBB2,1
Positive Regulation Of Programmed Cell Death (GO:0043068),5/245,0.0561162435820733,0.223067264753029,0,0,2.5040899795501,7.21260539425631,DAPK1;TNFSF10;CLU;TP53;RHOB,1
Positive Regulation Of DNA-binding Transcription Factor Activity (GO:0051091),5/246,0.0569094002775919,0.223067264753029,0,0,2.49357228317593,7.14731313031665,JUP;FLOT2;CLU;S100A9;LTF,1
Regulation Of Nervous System Development (GO:0051960),2/46,0.0570712884234023,0.223067264753029,0,0,5.4184008762322,15.5153423046995,HMGB2;HES1,1
Cellular Component Disassembly (GO:0022411),2/46,0.0570712884234023,0.223067264753029,0,0,5.4184008762322,15.5153423046995,MMP7;LAMC1,1
Response To Hydrogen Peroxide (GO:0042542),2/46,0.0570712884234023,0.223067264753029,0,0,5.4184008762322,15.5153423046995,CLU;RHOB,1
Epithelial Cell Migration (GO:0010631),2/46,0.0570712884234023,0.223067264753029,0,0,5.4184008762322,15.5153423046995,FSTL1;S100A9,1
Cell-Cell Adhesion Via Plasma-Membrane Adhesion Molecules (GO:0098742),4/172,0.0573326068178311,0.223067264753029,0,0,2.8548199767712,8.16160418666014,CLDN10;CDH3;PLXNB2;L1CAM,1
Negative Regulation Of Glial Cell Apoptotic Process (GO:0034351),1/7,0.0573469458661565,0.223067264753029,0,0,19.7864271457086,56.5621868384733,PRKCA,1
ER Overload Response (GO:0006983),1/7,0.0573469458661565,0.223067264753029,0,0,19.7864271457086,56.5621868384733,TP53,1
Negative Regulation Of Intracellular Transport (GO:0032387),1/7,0.0573469458661565,0.223067264753029,0,0,19.7864271457086,56.5621868384733,ARHGAP1,1
NADH Metabolic Process (GO:0006734),1/7,0.0573469458661565,0.223067264753029,0,0,19.7864271457086,56.5621868384733,VCP,1
Notch Receptor Processing (GO:0007220),1/7,0.0573469458661565,0.223067264753029,0,0,19.7864271457086,56.5621868384733,NCSTN,1
T-helper 17 Cell Lineage Commitment (GO:0072540),1/7,0.0573469458661565,0.223067264753029,0,0,19.7864271457086,56.5621868384733,JAK1,1
UV Protection (GO:0009650),1/7,0.0573469458661565,0.223067264753029,0,0,19.7864271457086,56.5621868384733,SDF4,1
Regulation Of Mammary Gland Epithelial Cell Proliferation (GO:0033599),1/7,0.0573469458661565,0.223067264753029,0,0,19.7864271457086,56.5621868384733,RTN4,1
Atrial Cardiac Muscle Cell To AV Node Cell Signaling (GO:0086026),1/7,0.0573469458661565,0.223067264753029,0,0,19.7864271457086,56.5621868384733,GJA1,1
Cellular Response To Interleukin-2 (GO:0071352),1/7,0.0573469458661565,0.223067264753029,0,0,19.7864271457086,56.5621868384733,JAK1,1
Regulation Of Transforming Growth Factor Beta Activation (GO:1901388),1/7,0.0573469458661565,0.223067264753029,0,0,19.7864271457086,56.5621868384733,ITGB6,1
Positive Regulation Of Arp2/3 Complex-Mediated Actin Nucleation (GO:2000601),1/7,0.0573469458661565,0.223067264753029,0,0,19.7864271457086,56.5621868384733,NCKAP1,1
Positive Regulation Of Apoptotic Cell Clearance (GO:2000427),1/7,0.0573469458661565,0.223067264753029,0,0,19.7864271457086,56.5621868384733,C3,1
Positive Regulation Of Astrocyte Differentiation (GO:0048711),1/7,0.0573469458661565,0.223067264753029,0,0,19.7864271457086,56.5621868384733,HES1,1
Cytochrome Complex Assembly (GO:0017004),1/7,0.0573469458661565,0.223067264753029,0,0,19.7864271457086,56.5621868384733,CYBA,1
Response To Hydroperoxide (GO:0033194),1/7,0.0573469458661565,0.223067264753029,0,0,19.7864271457086,56.5621868384733,DAPK1,1
Dendritic Spine Maintenance (GO:0097062),1/7,0.0573469458661565,0.223067264753029,0,0,19.7864271457086,56.5621868384733,ITGA3,1
Positive Regulation Of Execution Phase Of Apoptosis (GO:1900119),1/7,0.0573469458661565,0.223067264753029,0,0,19.7864271457086,56.5621868384733,TP53,1
Sodium-Dependent Phosphate Transport (GO:0044341),1/7,0.0573469458661565,0.223067264753029,0,0,19.7864271457086,56.5621868384733,SLC34A2,1
Spermidine Metabolic Process (GO:0008216),1/7,0.0573469458661565,0.223067264753029,0,0,19.7864271457086,56.5621868384733,SAT1,1
Positive Regulation Of Gluconeogenesis (GO:0045722),1/7,0.0573469458661565,0.223067264753029,0,0,19.7864271457086,56.5621868384733,NNMT,1
Stress-Induced Premature Senescence (GO:0090400),1/7,0.0573469458661565,0.223067264753029,0,0,19.7864271457086,56.5621868384733,TP53,1
Positive Regulation Of Melanin Biosynthetic Process (GO:0048023),1/7,0.0573469458661565,0.223067264753029,0,0,19.7864271457086,56.5621868384733,CDH3,1
Positive Regulation Of Membrane Potential (GO:0045838),1/7,0.0573469458661565,0.223067264753029,0,0,19.7864271457086,56.5621868384733,VCP,1
Tooth Mineralization (GO:0034505),1/7,0.0573469458661565,0.223067264753029,0,0,19.7864271457086,56.5621868384733,FAM20A,1
Positive Regulation Of Plasminogen Activation (GO:0010756),1/7,0.0573469458661565,0.223067264753029,0,0,19.7864271457086,56.5621868384733,ENO1,1
Histone H2A K63-linked Deubiquitination (GO:0070537),1/7,0.0573469458661565,0.223067264753029,0,0,19.7864271457086,56.5621868384733,BABAM2,1
Positive Regulation Of Secondary Metabolite Biosynthetic Process (GO:1900378),1/7,0.0573469458661565,0.223067264753029,0,0,19.7864271457086,56.5621868384733,CDH3,1
Interleukin-2-Mediated Signaling Pathway (GO:0038110),1/7,0.0573469458661565,0.223067264753029,0,0,19.7864271457086,56.5621868384733,JAK1,1
Leukocyte Aggregation (GO:0070486),1/7,0.0573469458661565,0.223067264753029,0,0,19.7864271457086,56.5621868384733,S100A9,1
protein-RNA Complex Disassembly (GO:0032988),1/7,0.0573469458661565,0.223067264753029,0,0,19.7864271457086,56.5621868384733,VCP,1
Regulation Of DNA-templated Transcription In Response To Stress (GO:0043620),1/7,0.0573469458661565,0.223067264753029,0,0,19.7864271457086,56.5621868384733,MUC1,1
Regulation Of Apoptotic Cell Clearance (GO:2000425),1/7,0.0573469458661565,0.223067264753029,0,0,19.7864271457086,56.5621868384733,C3,1
Positive Regulation Of Vasculature Development (GO:1904018),3/104,0.0573527936618805,0.223067264753029,0,0,3.55193519351935,10.1533265364681,JUP;PRKCA;RHOB,1
Neuron Differentiation (GO:0030182),4/173,0.0583221544768147,0.223067264753029,0,0,2.83778322990331,8.06433647099314,UGDH;ERBB2;RTN4;ITM2C,1
Cellular Response To Organonitrogen Compound (GO:0071417),3/105,0.0586893406688036,0.223067264753029,0,0,3.51693404634581,9.97225649542111,JUP;CTNNA1;CLU,1
Lysosomal Transport (GO:0007041),3/105,0.0586893406688036,0.223067264753029,0,0,3.51693404634581,9.97225649542111,GAK;HOOK1;RHOB,1
Positive Regulation Of DNA-templated Transcription (GO:0045893),16/1243,0.058828930454335,0.223067264753029,0,0,1.59610517736885,4.52195994302204,JUP;ANXA2;HDAC1;HMGB2;HNF1B;ARID1A;KLF5;MECOM;EPCAM;ERBB2;SPP1;HOXB2;NCOA7;HES1;AGRN;TP53,1
Vesicle-Mediated Transport (GO:0016192),7/411,0.0589197705029681,0.223067264753029,0,0,2.09083082221266,5.92035177571818,TINAGL1;ANXA2;HOOK1;RAB13;ARHGAP1;AP2M1;RHOB,1
Response To Organonitrogen Compound (GO:0010243),2/47,0.0592877570476896,0.223067264753029,0,0,5.29772423025435,14.9679381448922,VCP;CLU,1
Positive Regulation Of Smooth Muscle Cell Proliferation (GO:0048661),2/47,0.0592877570476896,0.223067264753029,0,0,5.29772423025435,14.9679381448922,GJA1;HDAC1,1
Regulation Of T Cell Differentiation (GO:0045580),2/47,0.0592877570476896,0.223067264753029,0,0,5.29772423025435,14.9679381448922,SMARCE1;ARID1A,1
Regulation Of Neuron Projection Development (GO:0010975),4/174,0.0593208352549246,0.223067264753029,0,0,2.82094691535151,7.96859584276306,GAK;PLXNB2;S100A9;ITM2C,1
Response To Calcium Ion (GO:0051592),3/106,0.0600405401573749,0.223067264753029,0,0,3.48261253309797,9.7956671232034,CLIC4;ANXA11;CLU,1
Positive Regulation Of Cell Growth (GO:0030307),3/106,0.0600405401573749,0.223067264753029,0,0,3.48261253309797,9.7956671232034,ERBB2;L1CAM;S100A9,1
Regulation Of G1/S Transition Of Mitotic Cell Cycle (GO:2000045),3/106,0.0600405401573749,0.223067264753029,0,0,3.48261253309797,9.7956671232034,SMARCE1;ADAMTS1;ARID1A,1
Proteolysis (GO:0006508),6/330,0.0603174407743918,0.223067264753029,0,0,2.22999542752629,6.26212594344912,NCSTN;TINAGL1;MMP7;ADAMTS1;ANPEP;TMPRSS4,1
Negative Regulation Of Translation (GO:0017148),3/107,0.0614063019988063,0.223067264753029,0,0,3.44895104895105,9.62341086871933,BTG2;DAPK1;PUM1,1
Positive Regulation Of T Cell Activation (GO:0050870),3/107,0.0614063019988063,0.223067264753029,0,0,3.44895104895105,9.62341086871933,SMARCE1;FLOT2;ARID1A,1
Regulation Of Intrinsic Apoptotic Signaling Pathway (GO:2001242),2/48,0.0615335690140115,0.223067264753029,0,0,5.18229439497119,14.4491302808446,S100A9;TP53,1
Cellular Response To Radiation (GO:0071478),2/48,0.0615335690140115,0.223067264753029,0,0,5.18229439497119,14.4491302808446,TP53;RHOB,1
Cytoplasmic Microtubule Organization (GO:0031122),2/48,0.0615335690140115,0.223067264753029,0,0,5.18229439497119,14.4491302808446,TUBGCP2;HOOK1,1
Positive Regulation Of Reactive Oxygen Species Metabolic Process (GO:2000379),2/48,0.0615335690140115,0.223067264753029,0,0,5.18229439497119,14.4491302808446,CYBA;TP53,1
Regulation Of DNA Binding (GO:0051101),2/48,0.0615335690140115,0.223067264753029,0,0,5.18229439497119,14.4491302808446,HMGB2;HES1,1
Positive Regulation Of Metabolic Process (GO:0009893),3/108,0.06278653448869,0.223067264753029,0,0,3.41593073593074,9.45534631179557,GJA1;MUC1;LCN2,1
Antibacterial Humoral Response (GO:0019731),2/49,0.0638080817107226,0.223067264753029,0,0,5.07177646757242,13.9568970174984,SLPI;LTF,1
Regulation Of Mitotic Metaphase/Anaphase Transition (GO:0030071),2/49,0.0638080817107226,0.223067264753029,0,0,5.07177646757242,13.9568970174984,SMARCE1;ARID1A,1
Positive Regulation Of miRNA Metabolic Process (GO:2000630),2/49,0.0638080817107226,0.223067264753029,0,0,5.07177646757242,13.9568970174984,KLF5;TP53,1
Interferon-Mediated Signaling Pathway (GO:0140888),2/49,0.0638080817107226,0.223067264753029,0,0,5.07177646757242,13.9568970174984,IFITM1;JAK1,1
Regulation Of Proteasomal Ubiquitin-Dependent Protein Catabolic Process (GO:0032434),3/109,0.0641811444014134,0.223067264753029,0,0,3.38353344768439,9.29133785491706,VCP;SUMO2;CLU,1
Cell-Matrix Adhesion (GO:0007160),3/109,0.0641811444014134,0.223067264753029,0,0,3.38353344768439,9.29133785491706,ITGA3;ITGB6;L1CAM,1
Positive Regulation Of Wnt Signaling Pathway (GO:0030177),3/109,0.0641811444014134,0.223067264753029,0,0,3.38353344768439,9.29133785491706,VCP;CDH3;JUP,1
Regulation Of Wnt Signaling Pathway (GO:0030111),3/109,0.0641811444014134,0.223067264753029,0,0,3.38353344768439,9.29133785491706,PPP2R1A;ITGA3;DCDC2,1
Negative Regulation Of Glial Cell Differentiation (GO:0045686),1/8,0.0652679868887543,0.223067264753029,0,0,16.9589392643285,46.2852462027755,HES1,1
DNA Topological Change (GO:0006265),1/8,0.0652679868887543,0.223067264753029,0,0,16.9589392643285,46.2852462027755,HMGB2,1
Regulation Of Glial Cell Proliferation (GO:0060251),1/8,0.0652679868887543,0.223067264753029,0,0,16.9589392643285,46.2852462027755,HES1,1
Regulation Of Helicase Activity (GO:0051095),1/8,0.0652679868887543,0.223067264753029,0,0,16.9589392643285,46.2852462027755,TP53,1
T-helper 17 Cell Differentiation (GO:0072539),1/8,0.0652679868887543,0.223067264753029,0,0,16.9589392643285,46.2852462027755,JAK1,1
Acid Secretion (GO:0046717),1/8,0.0652679868887543,0.223067264753029,0,0,16.9589392643285,46.2852462027755,UGT1A6,1
Regulation Of Intrinsic Apoptotic Signaling Pathway By P53 Class Mediator (GO:1902253),1/8,0.0652679868887543,0.223067264753029,0,0,16.9589392643285,46.2852462027755,PTTG1IP,1
Negative Regulation Of Systemic Arterial Blood Pressure (GO:0003085),1/8,0.0652679868887543,0.223067264753029,0,0,16.9589392643285,46.2852462027755,SOD2,1
Amyloid-Beta Formation (GO:0034205),1/8,0.0652679868887543,0.223067264753029,0,0,16.9589392643285,46.2852462027755,NCSTN,1
Regulation Of Morphogenesis Of An Epithelium (GO:1905330),1/8,0.0652679868887543,0.223067264753029,0,0,16.9589392643285,46.2852462027755,GJA1,1
Regulation Of Nephron Tubule Epithelial Cell Differentiation (GO:0072182),1/8,0.0652679868887543,0.223067264753029,0,0,16.9589392643285,46.2852462027755,PROM1,1
Nuclear Membrane Disassembly (GO:0051081),1/8,0.0652679868887543,0.223067264753029,0,0,16.9589392643285,46.2852462027755,PRKCA,1
Nucleic Acid Transport (GO:0050657),1/8,0.0652679868887543,0.223067264753029,0,0,16.9589392643285,46.2852462027755,HNRNPA2B1,1
Bundle Of His Cell To Purkinje Myocyte Communication (GO:0086069),1/8,0.0652679868887543,0.223067264753029,0,0,16.9589392643285,46.2852462027755,JUP,1
Regulation Of Toll-Like Receptor 3 Signaling Pathway (GO:0034139),1/8,0.0652679868887543,0.223067264753029,0,0,16.9589392643285,46.2852462027755,FLOT2,1
Cellular Response To Muramyl Dipeptide (GO:0071225),1/8,0.0652679868887543,0.223067264753029,0,0,16.9589392643285,46.2852462027755,VIM,1
Positive Regulation Of ATP Biosynthetic Process (GO:2001171),1/8,0.0652679868887543,0.223067264753029,0,0,16.9589392643285,46.2852462027755,VCP,1
Cellular Response To Platelet-Derived Growth Factor Stimulus (GO:0036120),1/8,0.0652679868887543,0.223067264753029,0,0,16.9589392643285,46.2852462027755,HDAC1,1
Regulation Of Tumor Necrosis Factor Superfamily Cytokine Production (GO:1903555),1/8,0.0652679868887543,0.223067264753029,0,0,16.9589392643285,46.2852462027755,LTF,1
Regulation Of Vesicle Fusion (GO:0031338),1/8,0.0652679868887543,0.223067264753029,0,0,16.9589392643285,46.2852462027755,ANXA2,1
Dehydroascorbic Acid Transport (GO:0070837),1/8,0.0652679868887543,0.223067264753029,0,0,16.9589392643285,46.2852462027755,SLC2A1,1
Response To Misfolded Protein (GO:0051788),1/8,0.0652679868887543,0.223067264753029,0,0,16.9589392643285,46.2852462027755,CLU,1
Response To Vitamin (GO:0033273),1/8,0.0652679868887543,0.223067264753029,0,0,16.9589392643285,46.2852462027755,SPP1,1
Response To Vitamin D (GO:0033280),1/8,0.0652679868887543,0.223067264753029,0,0,16.9589392643285,46.2852462027755,SPP1,1
Semaphorin-Plexin Signaling Pathway Involved In Axon Guidance (GO:1902287),1/8,0.0652679868887543,0.223067264753029,0,0,16.9589392643285,46.2852462027755,PLXNB2,1
Sequestering Of Actin Monomers (GO:0042989),1/8,0.0652679868887543,0.223067264753029,0,0,16.9589392643285,46.2852462027755,TMSB10,1
Endothelial Cell Chemotaxis (GO:0035767),1/8,0.0652679868887543,0.223067264753029,0,0,16.9589392643285,46.2852462027755,RAB13,1
Synapse Pruning (GO:0098883),1/8,0.0652679868887543,0.223067264753029,0,0,16.9589392643285,46.2852462027755,C3,1
Formation Of Translation Preinitiation Complex (GO:0001731),1/8,0.0652679868887543,0.223067264753029,0,0,16.9589392643285,46.2852462027755,EIF2S3,1
Positive Regulation Of Megakaryocyte Differentiation (GO:0045654),1/8,0.0652679868887543,0.223067264753029,0,0,16.9589392643285,46.2852462027755,HMGB2,1
Positive Regulation Of Membrane Invagination (GO:1905155),1/8,0.0652679868887543,0.223067264753029,0,0,16.9589392643285,46.2852462027755,C3,1
Tyrosine Phosphorylation Of STAT Protein (GO:0007260),1/8,0.0652679868887543,0.223067264753029,0,0,16.9589392643285,46.2852462027755,JAK1,1
Unsaturated Fatty Acid Biosynthetic Process (GO:0006636),1/8,0.0652679868887543,0.223067264753029,0,0,16.9589392643285,46.2852462027755,DEGS1,1
Vascular Associated Smooth Muscle Cell Differentiation (GO:0035886),1/8,0.0652679868887543,0.223067264753029,0,0,16.9589392643285,46.2852462027755,HES1,1
Positive Regulation Of Smooth Muscle Cell Apoptotic Process (GO:0034393),1/8,0.0652679868887543,0.223067264753029,0,0,16.9589392643285,46.2852462027755,SOD2,1
Protein Hexamerization (GO:0034214),1/8,0.0652679868887543,0.223067264753029,0,0,16.9589392643285,46.2852462027755,UGDH,1
Protein Localization To Perinuclear Region Of Cytoplasm (GO:1905719),1/8,0.0652679868887543,0.223067264753029,0,0,16.9589392643285,46.2852462027755,HOOK1,1
Mesodermal Cell Differentiation (GO:0048333),1/8,0.0652679868887543,0.223067264753029,0,0,16.9589392643285,46.2852462027755,ITGA3,1
Endosomal Transport (GO:0016197),4/180,0.0655036295036247,0.223067264753029,0,0,2.7239467849224,7.42452480689194,ARL4C;TINAGL1;RAB13;ARHGAP1,1
Regulation Of Epithelial Cell Migration (GO:0010632),2/50,0.0661106611264017,0.223067264753029,0,0,4.96586345381526,13.4893969101837,TACSTD2;RTN4,1
Cell Chemotaxis (GO:0060326),2/50,0.0661106611264017,0.223067264753029,0,0,4.96586345381526,13.4893969101837,RAB13;HMGB2,1
Positive Regulation Of Developmental Growth (GO:0048639),2/50,0.0661106611264017,0.223067264753029,0,0,4.96586345381526,13.4893969101837,L1CAM;AGRN,1
Positive Regulation Of Transport (GO:0051050),2/50,0.0661106611264017,0.223067264753029,0,0,4.96586345381526,13.4893969101837,CDH3;ANXA2,1
Pyruvate Metabolic Process (GO:0006090),2/50,0.0661106611264017,0.223067264753029,0,0,4.96586345381526,13.4893969101837,PKM;ENO1,1
Negative Regulation Of Cell Projection Organization (GO:0031345),2/50,0.0661106611264017,0.223067264753029,0,0,4.96586345381526,13.4893969101837,GAK;ITM2C,1
RNA Modification (GO:0009451),2/51,0.0684406817751828,0.226388176884279,0,0,4.86427342021146,13.0449494467084,DTWD2;ADAR,1
Amide Biosynthetic Process (GO:0043604),2/51,0.0684406817751828,0.226388176884279,0,0,4.86427342021146,13.0449494467084,DEGS1;GLS,1
Regulation Of Smoothened Signaling Pathway (GO:0008589),2/51,0.0684406817751828,0.226388176884279,0,0,4.86427342021146,13.0449494467084,VCP;DCDC2,1
Regulation Of Substrate Adhesion-Dependent Cell Spreading (GO:1900024),2/51,0.0684406817751828,0.226388176884279,0,0,4.86427342021146,13.0449494467084,TACSTD2;ACTN4,1
RNA Processing (GO:0006396),4/183,0.0687166518542777,0.226388176884279,0,0,2.67788527047282,7.1707440344528,PPP2R1A;HNRNPA2B1;ADAR;HNRNPH3,1
Regulation Of Protein Localization To Nucleus (GO:1900180),2/52,0.0707975265631299,0.226388176884279,0,0,4.76674698795181,12.6220181407437,CTNNA1;JAK1,1
Positive Regulation Of Transcription Initiation By RNA Polymerase II (GO:0060261),2/52,0.0707975265631299,0.226388176884279,0,0,4.76674698795181,12.6220181407437,HNF1B;TP53,1
Regulation Of MAP Kinase Activity (GO:0043405),3/114,0.0713664913598289,0.226388176884279,0,0,3.23030303030303,8.5277636338245,ERBB2;ERP29;CD24,1
Negative Regulation Of Macromolecule Metabolic Process (GO:0010605),4/186,0.0720098858578346,0.226388176884279,0,0,2.63334226748861,6.92819675196634,CLDN3;HDAC1;ERP29;FLOT2,1
Negative Regulation Of Hormone Secretion (GO:0046888),1/9,0.0731228619700588,0.226388176884279,0,0,14.8383233532934,38.8113294432538,GJA1,1
ER-associated Misfolded Protein Catabolic Process (GO:0071712),1/9,0.0731228619700588,0.226388176884279,0,0,14.8383233532934,38.8113294432538,VCP,1
NAD Biosynthesis Via Nicotinamide Riboside Salvage Pathway (GO:0034356),1/9,0.0731228619700588,0.226388176884279,0,0,14.8383233532934,38.8113294432538,NNMT,1
Regulation Of Hair Cycle (GO:0042634),1/9,0.0731228619700588,0.226388176884279,0,0,14.8383233532934,38.8113294432538,CDH3,1
Negative Regulation Of Telomerase Activity (GO:0051974),1/9,0.0731228619700588,0.226388176884279,0,0,14.8383233532934,38.8113294432538,TP53,1
Negative Regulation Of Transcription By Competitive Promoter Binding (GO:0010944),1/9,0.0731228619700588,0.226388176884279,0,0,14.8383233532934,38.8113294432538,MUC1,1
Negative Regulation Of Transforming Growth Factor Beta Production (GO:0071635),1/9,0.0731228619700588,0.226388176884279,0,0,14.8383233532934,38.8113294432538,CDH3,1
Negative Regulation Of Tyrosine Phosphorylation Of STAT Protein (GO:0042532),1/9,0.0731228619700588,0.226388176884279,0,0,14.8383233532934,38.8113294432538,PPP2R1A,1
Neuron Remodeling (GO:0016322),1/9,0.0731228619700588,0.226388176884279,0,0,14.8383233532934,38.8113294432538,C3,1
Axon Regeneration (GO:0031103),1/9,0.0731228619700588,0.226388176884279,0,0,14.8383233532934,38.8113294432538,TNC,1
Biomineral Tissue Development (GO:0031214),1/9,0.0731228619700588,0.226388176884279,0,0,14.8383233532934,38.8113294432538,FAM20A,1
Calcium Import Into The Mitochondrion (GO:0036444),1/9,0.0731228619700588,0.226388176884279,0,0,14.8383233532934,38.8113294432538,MICU2,1
Regulation Of Protein Localization To Chromatin (GO:1905634),1/9,0.0731228619700588,0.226388176884279,0,0,14.8383233532934,38.8113294432538,VCP,1
Peptidyl-Cysteine Modification (GO:0018198),1/9,0.0731228619700588,0.226388176884279,0,0,14.8383233532934,38.8113294432538,S100A9,1
Regulation Of Tau-Protein Kinase Activity (GO:1902947),1/9,0.0731228619700588,0.226388176884279,0,0,14.8383233532934,38.8113294432538,CLU,1
Cellular Response To Purine-Containing Compound (GO:0071415),1/9,0.0731228619700588,0.226388176884279,0,0,14.8383233532934,38.8113294432538,CLU,1
Positive Regulation Of RIG-I Signaling Pathway (GO:1900246),1/9,0.0731228619700588,0.226388176884279,0,0,14.8383233532934,38.8113294432538,PUM1,1
Regulation Of Viral-Induced Cytoplasmic Pattern Recognition Receptor Signaling Pathway (GO:0039531),1/9,0.0731228619700588,0.226388176884279,0,0,14.8383233532934,38.8113294432538,FLOT2,1
Positive Regulation Of T Cell Apoptotic Process (GO:0070234),1/9,0.0731228619700588,0.226388176884279,0,0,14.8383233532934,38.8113294432538,TP53,1
Response To Platelet-Derived Growth Factor (GO:0036119),1/9,0.0731228619700588,0.226388176884279,0,0,14.8383233532934,38.8113294432538,HDAC1,1
Endothelial Tube Morphogenesis (GO:0061154),1/9,0.0731228619700588,0.226388176884279,0,0,14.8383233532934,38.8113294432538,RHOB,1
Excitatory Synapse Assembly (GO:1904861),1/9,0.0731228619700588,0.226388176884279,0,0,14.8383233532934,38.8113294432538,PLXNB2,1
Positive Regulation Of miRNA-mediated Gene Silencing (GO:2000637),1/9,0.0731228619700588,0.226388176884279,0,0,14.8383233532934,38.8113294432538,PUM1,1
Type II Interferon-Mediated Signaling Pathway (GO:0060333),1/9,0.0731228619700588,0.226388176884279,0,0,14.8383233532934,38.8113294432538,JAK1,1
Hematopoietic Stem Cell Differentiation (GO:0060218),1/9,0.0731228619700588,0.226388176884279,0,0,14.8383233532934,38.8113294432538,TP53,1
"Positive Regulation Of Phagocytosis, Engulfment (GO:0060100)",1/9,0.0731228619700588,0.226388176884279,0,0,14.8383233532934,38.8113294432538,C3,1
Long-Chain Fatty Acid Import Into Cell (GO:0044539),1/9,0.0731228619700588,0.226388176884279,0,0,14.8383233532934,38.8113294432538,SLC2A1,1
Negative Regulation Of Cell Adhesion Mediated By Integrin (GO:0033629),1/9,0.0731228619700588,0.226388176884279,0,0,14.8383233532934,38.8113294432538,MUC1,1
Negative Regulation Of Cell-Cell Adhesion Mediated By Cadherin (GO:2000048),1/9,0.0731228619700588,0.226388176884279,0,0,14.8383233532934,38.8113294432538,EPCAM,1
Blood Vessel Morphogenesis (GO:0048514),2/53,0.0731805867482111,0.226388176884279,0,0,4.67304512166312,12.2191956847846,COL4A1;HES1,1
Cellular Response To Alcohol (GO:0097306),2/53,0.0731805867482111,0.226388176884279,0,0,4.67304512166312,12.2191956847846,JUP;CTNNA1,1
Positive Regulation Of Signal Transduction (GO:0009967),5/266,0.0741236388903113,0.228829822964281,0,0,2.30014338434055,5.98502089267012,C3;CDH3;DCDC2;PRKCA;LAMC1,1
Negative Regulation Of Neuron Projection Development (GO:0010977),2/54,0.0755892617887063,0.229765715703207,0,0,4.58294717330862,11.8351908907058,GAK;ITM2C,1
Endoplasmic Reticulum Organization (GO:0007029),2/54,0.0755892617887063,0.229765715703207,0,0,4.58294717330862,11.8351908907058,GAK;RTN4,1
Epidermal Cell Differentiation (GO:0009913),2/54,0.0755892617887063,0.229765715703207,0,0,4.58294717330862,11.8351908907058,CLIC4;HDAC1,1
Regulation Of Blood Vessel Endothelial Cell Migration (GO:0043535),2/54,0.0755892617887063,0.229765715703207,0,0,4.58294717330862,11.8351908907058,JUP;PRKCA,1
Cellular Response To Molecule Of Bacterial Origin (GO:0071219),3/117,0.0758439568478458,0.229765715703207,0,0,3.14481658692185,8.11072491088375,HMGB2;CXCL1;VIM,1
Chromatin Organization (GO:0006325),5/268,0.0759856068437689,0.229765715703207,0,0,2.28241853087313,5.88227492099896,SMARCE1;HDAC1;HMGB2;ARID1A;HMGN3,1
Protein Localization (GO:0008104),6/351,0.0761930352672231,0.229765715703207,0,0,2.09200214707461,5.38582861027741,ARL4C;GJA1;HOOK1;ERP29;NBEAL1;TP53,1
Positive Regulation Of Cell Projection Organization (GO:0031346),3/118,0.0773635394992209,0.229765715703207,0,0,3.11731225296443,7.97794919800557,PLXNB2;OBSL1;S100A9,1
Protein Modification Process (GO:0036211),10/711,0.0774590564757112,0.229765715703207,0,0,1.72727929359505,4.41839042664567,PPP1CB;PPP2R1A;DAPK1;QPCT;ERBB2;PRKCA;FAM20A;ACVR1B;JAK1;PPM1G,1
Positive Regulation Of Apoptotic Process (GO:0043065),5/270,0.0778728550391046,0.229765715703207,0,0,2.2649612223637,5.78171633413445,DAPK1;TNFSF10;CLU;TP53;RHOB,1
Neuron Migration (GO:0001764),2/55,0.0780229592855711,0.229765715703207,0,0,4.49624914753353,11.4688171610773,TUBGCP2;DCDC2,1
Ceramide Metabolic Process (GO:0006672),2/55,0.0780229592855711,0.229765715703207,0,0,4.49624914753353,11.4688171610773,PPP2R1A;DEGS1,1
Neuron Projection Development (GO:0031175),4/192,0.0788340058407913,0.229765715703207,0,0,2.54852101712507,6.47429038985046,NCKAP1;BTG2;RAB13;L1CAM,1
Regulation Of Protein-Containing Complex Assembly (GO:0043254),3/119,0.0788964935077348,0.229765715703207,0,0,3.09028213166144,7.8481376543327,VCP;CLU;WARS1,1
Cellular Response To Tumor Necrosis Factor (GO:0071356),3/119,0.0788964935077348,0.229765715703207,0,0,3.09028213166144,7.8481376543327,ACTN4;TP53;ZFP36L2,1
Mitotic DNA Damage Checkpoint Signaling (GO:0044773),2/56,0.0804810948635521,0.229765715703207,0,0,4.41276215975011,11.1189822963093,BABAM2;TP53,1
Negative Regulation Of Lipopolysaccharide-Mediated Signaling Pathway (GO:0031665),1/10,0.0809121203148388,0.229765715703207,0,0,13.1889554224884,33.1621993556878,LTF,1
T-helper Cell Lineage Commitment (GO:0002295),1/10,0.0809121203148388,0.229765715703207,0,0,13.1889554224884,33.1621993556878,JAK1,1
Acidic Amino Acid Transport (GO:0015800),1/10,0.0809121203148388,0.229765715703207,0,0,13.1889554224884,33.1621993556878,GJA1,1
Neuron Projection Fasciculation (GO:0106030),1/10,0.0809121203148388,0.229765715703207,0,0,13.1889554224884,33.1621993556878,RTN4,1
Basement Membrane Organization (GO:0071711),1/10,0.0809121203148388,0.229765715703207,0,0,13.1889554224884,33.1621993556878,COL4A1,1
Nuclear Pore Complex Assembly (GO:0051292),1/10,0.0809121203148388,0.229765715703207,0,0,13.1889554224884,33.1621993556878,RTN4,1
"Regulation Of Phagocytosis, Engulfment (GO:0060099)",1/10,0.0809121203148388,0.229765715703207,0,0,13.1889554224884,33.1621993556878,C3,1
Cellular Response To Interleukin-15 (GO:0071350),1/10,0.0809121203148388,0.229765715703207,0,0,13.1889554224884,33.1621993556878,JAK1,1
Regulation Of Toll-Like Receptor 2 Signaling Pathway (GO:0034135),1/10,0.0809121203148388,0.229765715703207,0,0,13.1889554224884,33.1621993556878,CYBA,1
Regulation Of Toll-Like Receptor 9 Signaling Pathway (GO:0034163),1/10,0.0809121203148388,0.229765715703207,0,0,13.1889554224884,33.1621993556878,RTN4,1
Cellular Response To Type III Interferon (GO:0071358),1/10,0.0809121203148388,0.229765715703207,0,0,13.1889554224884,33.1621993556878,JAK1,1
Removal Of Superoxide Radicals (GO:0019430),1/10,0.0809121203148388,0.229765715703207,0,0,13.1889554224884,33.1621993556878,SOD2,1
Positive Regulation Of Actin Nucleation (GO:0051127),1/10,0.0809121203148388,0.229765715703207,0,0,13.1889554224884,33.1621993556878,NCKAP1,1
Positive Regulation Of Cellular Respiration (GO:1901857),1/10,0.0809121203148388,0.229765715703207,0,0,13.1889554224884,33.1621993556878,VCP,1
Positive Regulation Of Cellular Senescence (GO:2000774),1/10,0.0809121203148388,0.229765715703207,0,0,13.1889554224884,33.1621993556878,TP53,1
Positive Regulation Of Lipid Localization (GO:1905954),1/10,0.0809121203148388,0.229765715703207,0,0,13.1889554224884,33.1621993556878,C3,1
Positive Regulation Of Macrophage Differentiation (GO:0045651),1/10,0.0809121203148388,0.229765715703207,0,0,13.1889554224884,33.1621993556878,PRKCA,1
Type III Interferon-Mediated Signaling Pathway (GO:0038196),1/10,0.0809121203148388,0.229765715703207,0,0,13.1889554224884,33.1621993556878,JAK1,1
Hematopoietic Stem Cell Proliferation (GO:0071425),1/10,0.0809121203148388,0.229765715703207,0,0,13.1889554224884,33.1621993556878,MECOM,1
Positive Regulation Of Post-Transcriptional Gene Silencing By RNA (GO:1900370),1/10,0.0809121203148388,0.229765715703207,0,0,13.1889554224884,33.1621993556878,PUM1,1
Interleukin-15-Mediated Signaling Pathway (GO:0035723),1/10,0.0809121203148388,0.229765715703207,0,0,13.1889554224884,33.1621993556878,JAK1,1
Positive Regulation Of Toll-Like Receptor 4 Signaling Pathway (GO:0034145),1/10,0.0809121203148388,0.229765715703207,0,0,13.1889554224884,33.1621993556878,LTF,1
Positive Regulation Of Transcription From RNA Polymerase II Promoter In Response To Endoplasmic Reticulum Stress (GO:1990440),1/10,0.0809121203148388,0.229765715703207,0,0,13.1889554224884,33.1621993556878,TP53,1
Maintenance Of Synapse Structure (GO:0099558),1/10,0.0809121203148388,0.229765715703207,0,0,13.1889554224884,33.1621993556878,SDF4,1
Mitotic G1/S Transition Checkpoint Signaling (GO:0044819),1/10,0.0809121203148388,0.229765715703207,0,0,13.1889554224884,33.1621993556878,TP53,1
Muscle Filament Sliding (GO:0030049),1/10,0.0809121203148388,0.229765715703207,0,0,13.1889554224884,33.1621993556878,TPM1,1
Membrane Lipid Biosynthetic Process (GO:0046467),2/57,0.0829630921252412,0.235141106823541,0,0,4.33231106243154,10.784679454455,SCCPDH;DEGS1,1
Positive Regulation Of Macromolecule Biosynthetic Process (GO:0010557),3/122,0.0835745085381161,0.235975082931151,0,0,3.01191749427044,7.47562960167268,ERBB2;PLXNB2;VIM,1
Receptor-Mediated Endocytosis (GO:0006898),3/122,0.0835745085381161,0.235975082931151,0,0,3.01191749427044,7.47562960167268,GAK;HSPG2;AP2M1,1
Peptidyl-Threonine Phosphorylation (GO:0018107),2/58,0.0854683824727845,0.237641124744305,0,0,4.25473321858864,10.4649791259873,PRKCA;ACVR1B,1
Response To Organic Cyclic Compound (GO:0014070),2/58,0.0854683824727845,0.237641124744305,0,0,4.25473321858864,10.4649791259873,SPP1;CLU,1
Positive Regulation Of Mitochondrion Organization (GO:0010822),2/58,0.0854683824727845,0.237641124744305,0,0,4.25473321858864,10.4649791259873,TNFSF10;TP53,1
Inorganic Anion Transport (GO:0015698),2/58,0.0854683824727845,0.237641124744305,0,0,4.25473321858864,10.4649791259873,SLC34A2;CLIC4,1
Cellular Response To Lipopolysaccharide (GO:0071222),3/124,0.0867580541149581,0.237641124744305,0,0,2.9618332081142,7.24059230331588,HMGB2;CXCL1;VIM,1
Protein Dephosphorylation (GO:0006470),3/124,0.0867580541149581,0.237641124744305,0,0,2.9618332081142,7.24059230331588,PPP1CB;PPP2R1A;PPM1G,1
Regulation Of miRNA Transcription (GO:1902893),2/59,0.0879964051324522,0.237641124744305,0,0,4.17987740435426,10.1590219775935,KLF5;TP53,1
Regulation Of Mitotic Cell Cycle (GO:0007346),3/125,0.0883689552669257,0.237641124744305,0,0,2.93740685543964,7.12683801705753,BTG2;PRKCA;OBSL1,1
Response To Cytokine (GO:0034097),3/125,0.0883689552669257,0.237641124744305,0,0,2.93740685543964,7.12683801705753,IFITM1;PRKCA;ADAR,1
Regulation Of Endocytic Recycling (GO:2001135),1/11,0.0886363066082588,0.237641124744305,0,0,11.8694610778443,28.7622409824155,ARHGAP1,1
Golgi To Lysosome Transport (GO:0090160),1/11,0.0886363066082588,0.237641124744305,0,0,11.8694610778443,28.7622409824155,GAK,1
Negative Regulation Of Myotube Differentiation (GO:0010832),1/11,0.0886363066082588,0.237641124744305,0,0,11.8694610778443,28.7622409824155,HDAC1,1
Regulation Of Muscle System Process (GO:0090257),1/11,0.0886363066082588,0.237641124744305,0,0,11.8694610778443,28.7622409824155,TPM1,1
Biogenic Amine Biosynthetic Process (GO:0042401),1/11,0.0886363066082588,0.237641124744305,0,0,11.8694610778443,28.7622409824155,SAT1,1
Polyamine Metabolic Process (GO:0006595),1/11,0.0886363066082588,0.237641124744305,0,0,11.8694610778443,28.7622409824155,SAT1,1
Cellular Response To Superoxide (GO:0071451),1/11,0.0886363066082588,0.237641124744305,0,0,11.8694610778443,28.7622409824155,SOD2,1
Central Nervous System Myelination (GO:0022010),1/11,0.0886363066082588,0.237641124744305,0,0,11.8694610778443,28.7622409824155,CLU,1
Regulation Of Ventricular Cardiac Muscle Cell Action Potential (GO:0098911),1/11,0.0886363066082588,0.237641124744305,0,0,11.8694610778443,28.7622409824155,JUP,1
Endoplasmic Reticulum Membrane Organization (GO:0090158),1/11,0.0886363066082588,0.237641124744305,0,0,11.8694610778443,28.7622409824155,RTN4,1
Epithelial Cell-Cell Adhesion (GO:0090136),1/11,0.0886363066082588,0.237641124744305,0,0,11.8694610778443,28.7622409824155,JUP,1
Positive Regulation Of Keratinocyte Proliferation (GO:0010838),1/11,0.0886363066082588,0.237641124744305,0,0,11.8694610778443,28.7622409824155,CDH3,1
Glutamine Family Amino Acid Biosynthetic Process (GO:0009084),1/11,0.0886363066082588,0.237641124744305,0,0,11.8694610778443,28.7622409824155,GLS,1
Positive Regulation Of Muscle Contraction (GO:0045933),1/11,0.0886363066082588,0.237641124744305,0,0,11.8694610778443,28.7622409824155,ENO1,1
Vitamin D Metabolic Process (GO:0042359),1/11,0.0886363066082588,0.237641124744305,0,0,11.8694610778443,28.7622409824155,UGT1A6,1
Post-Transcriptional Gene Silencing (GO:0016441),1/11,0.0886363066082588,0.237641124744305,0,0,11.8694610778443,28.7622409824155,PUM1,1
Regulation Of Amyloid Precursor Protein Catabolic Process (GO:1902991),1/11,0.0886363066082588,0.237641124744305,0,0,11.8694610778443,28.7622409824155,FLOT2,1
Negative Regulation Of Amyloid Fibril Formation (GO:1905907),1/11,0.0886363066082588,0.237641124744305,0,0,11.8694610778443,28.7622409824155,CLU,1
Regulation Of Astrocyte Differentiation (GO:0048710),1/11,0.0886363066082588,0.237641124744305,0,0,11.8694610778443,28.7622409824155,HES1,1
Positive Regulation Of Phagocytosis (GO:0050766),2/60,0.0905466069708271,0.240416762063337,0,0,4.10760282509348,9.86601247729074,C3;CYBA,1
Homophilic Cell Adhesion Via Plasma Membrane Adhesion Molecules (GO:0007156),2/60,0.0905466069708271,0.240416762063337,0,0,4.10760282509348,9.86601247729074,PLXNB2;L1CAM,1
Regulation Of Tumor Necrosis Factor Production (GO:0032680),3/127,0.0916284520916545,0.240416762063337,0,0,2.88973607038123,6.90650805544686,CYBA;CLU;LTF,1
Regulation Of Anatomical Structure Morphogenesis (GO:0022603),3/127,0.0916284520916545,0.240416762063337,0,0,2.88973607038123,6.90650805544686,CLDN3;ERBB2;WARS1,1
Regulation Of DNA Repair (GO:0006282),3/129,0.0949374498225328,0.240416762063337,0,0,2.84357864357864,6.69531120594126,SMARCE1;BABAM2;ARID1A,1
Cell Junction Organization (GO:0034330),2/62,0.0957113735877215,0.240416762063337,0,0,3.97028112449799,9.31593965665533,CLDN3;L1CAM,1
Negative Regulation Of Epidermal Growth Factor-Activated Receptor Activity (GO:0007175),1/12,0.0962959611490246,0.240416762063337,0,0,10.7898747958628,25.251855826797,GPRC5A,1
DNA Conformation Change (GO:0071103),1/12,0.0962959611490246,0.240416762063337,0,0,10.7898747958628,25.251855826797,HMGB2,1
Negative Regulation Of Intrinsic Apoptotic Signaling Pathway In Response To DNA Damage By P53 Class Mediator (GO:1902166),1/12,0.0962959611490246,0.240416762063337,0,0,10.7898747958628,25.251855826797,MUC1,1
Negative Regulation Of Locomotion (GO:0040013),1/12,0.0962959611490246,0.240416762063337,0,0,10.7898747958628,25.251855826797,TACSTD2,1
V(D)J Recombination (GO:0033151),1/12,0.0962959611490246,0.240416762063337,0,0,10.7898747958628,25.251855826797,HMGB2,1
Actin-Myosin Filament Sliding (GO:0033275),1/12,0.0962959611490246,0.240416762063337,0,0,10.7898747958628,25.251855826797,TPM1,1
Adult Locomotory Behavior (GO:0008344),1/12,0.0962959611490246,0.240416762063337,0,0,10.7898747958628,25.251855826797,PUM1,1
Negative Regulation Of Substrate Adhesion-Dependent Cell Spreading (GO:1900025),1/12,0.0962959611490246,0.240416762063337,0,0,10.7898747958628,25.251855826797,TACSTD2,1
Atrial Cardiac Muscle Cell Action Potential (GO:0086014),1/12,0.0962959611490246,0.240416762063337,0,0,10.7898747958628,25.251855826797,GJA1,1
Axonal Fasciculation (GO:0007413),1/12,0.0962959611490246,0.240416762063337,0,0,10.7898747958628,25.251855826797,RTN4,1
Cell Projection Assembly (GO:0030031),1/12,0.0962959611490246,0.240416762063337,0,0,10.7898747958628,25.251855826797,NCKAP1,1
Phosphate Ion Homeostasis (GO:0055062),1/12,0.0962959611490246,0.240416762063337,0,0,10.7898747958628,25.251855826797,SLC34A2,1
Positive Regulation By Symbiont Of Entry Into Host (GO:0075294),1/12,0.0962959611490246,0.240416762063337,0,0,10.7898747958628,25.251855826797,TMPRSS4,1
Regulation Of Vascular Associated Smooth Muscle Cell Migration (GO:1904752),1/12,0.0962959611490246,0.240416762063337,0,0,10.7898747958628,25.251855826797,TPM1,1
Defense Response To Tumor Cell (GO:0002357),1/12,0.0962959611490246,0.240416762063337,0,0,10.7898747958628,25.251855826797,DAPK1,1
Response To Muramyl Dipeptide (GO:0032495),1/12,0.0962959611490246,0.240416762063337,0,0,10.7898747958628,25.251855826797,VIM,1
Positive Regulation Of Cell Morphogenesis Involved In Differentiation (GO:0010770),1/12,0.0962959611490246,0.240416762063337,0,0,10.7898747958628,25.251855826797,OBSL1,1
Semaphorin-Plexin Signaling Pathway Involved In Neuron Projection Guidance (GO:1902285),1/12,0.0962959611490246,0.240416762063337,0,0,10.7898747958628,25.251855826797,PLXNB2,1
Endothelium Development (GO:0003158),1/12,0.0962959611490246,0.240416762063337,0,0,10.7898747958628,25.251855826797,FSTL1,1
Epithelial Cell Morphogenesis (GO:0003382),1/12,0.0962959611490246,0.240416762063337,0,0,10.7898747958628,25.251855826797,CLDN3,1
Steroid Catabolic Process (GO:0006706),1/12,0.0962959611490246,0.240416762063337,0,0,10.7898747958628,25.251855826797,SPP1,1
Positive Regulation Of Integrin-Mediated Signaling Pathway (GO:2001046),1/12,0.0962959611490246,0.240416762063337,0,0,10.7898747958628,25.251855826797,LAMC1,1
Eye Photoreceptor Cell Differentiation (GO:0001754),1/12,0.0962959611490246,0.240416762063337,0,0,10.7898747958628,25.251855826797,PROM1,1
Fatty Acid Transmembrane Transport (GO:1902001),1/12,0.0962959611490246,0.240416762063337,0,0,10.7898747958628,25.251855826797,SLC2A1,1
Glucose Import (GO:0046323),1/12,0.0962959611490246,0.240416762063337,0,0,10.7898747958628,25.251855826797,SLC2A1,1
Positive Regulation Of Nuclear-Transcribed mRNA poly(A) Tail Shortening (GO:0060213),1/12,0.0962959611490246,0.240416762063337,0,0,10.7898747958628,25.251855826797,BTG2,1
Positive Regulation Of Purine Nucleotide Biosynthetic Process (GO:1900373),1/12,0.0962959611490246,0.240416762063337,0,0,10.7898747958628,25.251855826797,VCP,1
Positive Regulation Of Reactive Oxygen Species Biosynthetic Process (GO:1903428),1/12,0.0962959611490246,0.240416762063337,0,0,10.7898747958628,25.251855826797,CYBA,1
Positive Regulation Of Viral Entry Into Host Cell (GO:0046598),1/12,0.0962959611490246,0.240416762063337,0,0,10.7898747958628,25.251855826797,TMPRSS4,1
Lipid Droplet Formation (GO:0140042),1/12,0.0962959611490246,0.240416762063337,0,0,10.7898747958628,25.251855826797,RNF213,1
Primary miRNA Processing (GO:0031053),1/12,0.0962959611490246,0.240416762063337,0,0,10.7898747958628,25.251855826797,HNRNPA2B1,1
Negative Regulation By Host Of Viral Process (GO:0044793),1/12,0.0962959611490246,0.240416762063337,0,0,10.7898747958628,25.251855826797,LTF,1
Negative Regulation By Host Of Viral Transcription (GO:0043922),1/12,0.0962959611490246,0.240416762063337,0,0,10.7898747958628,25.251855826797,HDAC1,1
Negative Regulation Of Cell Cycle Phase Transition (GO:1901988),1/12,0.0962959611490246,0.240416762063337,0,0,10.7898747958628,25.251855826797,ZFP36L2,1
Negative Regulation Of Complement Activation (GO:0045916),1/12,0.0962959611490246,0.240416762063337,0,0,10.7898747958628,25.251855826797,SERPING1,1
Protein Stabilization (GO:0050821),4/208,0.09853320677399,0.245590304321101,0,0,2.34672405547585,5.43820835982025,FLOT2;CLU;TSPAN1;RTN4,1
Positive Regulation Of Protein Phosphorylation (GO:0001934),6/377,0.0988323177492773,0.24592389433265,0,0,1.94279724468404,4.49627516151704,C3;CLDN3;ERBB2;ERP29;FAM20A;TP53,1
Circulatory System Development (GO:0072359),3/132,0.0999917454197033,0.248139213727203,0,0,2.77702607470049,6.39456808376991,PDLIM1;GJA1;HSPG2,1
Positive Regulation Of T Cell Differentiation (GO:0045582),2/64,0.100958407500983,0.248139213727203,0,0,3.84181888845705,8.80946994698019,SMARCE1;ARID1A,1
Positive Regulation Of Cysteine-Type Endopeptidase Activity (GO:2001056),2/64,0.100958407500983,0.248139213727203,0,0,3.84181888845705,8.80946994698019,DAPK1;TNFSF10,1
Endocytic Recycling (GO:0032456),2/64,0.100958407500983,0.248139213727203,0,0,3.84181888845705,8.80946994698019,ARL4C;RAB13,1
Canonical Wnt Signaling Pathway (GO:0060070),2/65,0.10361147099436,0.248139213727203,0,0,3.78064639510423,8.57113078171622,CDH3;JUP,1
Regulation Of Tyrosine Phosphorylation Of STAT Protein (GO:0042509),2/65,0.10361147099436,0.248139213727203,0,0,3.78064639510423,8.57113078171622,PPP2R1A;HES1,1
ERBB2 Signaling Pathway (GO:0038128),1/13,0.103891619725838,0.248139213727203,0,0,9.89021956087824,22.3954828131026,ERBB2,1
T Cell Differentiation In Thymus (GO:0033077),1/13,0.103891619725838,0.248139213727203,0,0,9.89021956087824,22.3954828131026,ZFP36L2,1
Regulation Of Intrinsic Apoptotic Signaling Pathway In Response To DNA Damage By P53 Class Mediator (GO:1902165),1/13,0.103891619725838,0.248139213727203,0,0,9.89021956087824,22.3954828131026,MUC1,1
Negative Regulation Of Receptor Internalization (GO:0002091),1/13,0.103891619725838,0.248139213727203,0,0,9.89021956087824,22.3954828131026,ANXA2,1
Amyloid Precursor Protein Catabolic Process (GO:0042987),1/13,0.103891619725838,0.248139213727203,0,0,9.89021956087824,22.3954828131026,NCSTN,1
Regulation Of Response To Endoplasmic Reticulum Stress (GO:1905897),1/13,0.103891619725838,0.248139213727203,0,0,9.89021956087824,22.3954828131026,CLU,1
Cellular Response To Arsenic-Containing Substance (GO:0071243),1/13,0.103891619725838,0.248139213727203,0,0,9.89021956087824,22.3954828131026,VCP,1
Cellular Response To Interleukin-4 (GO:0071353),1/13,0.103891619725838,0.248139213727203,0,0,9.89021956087824,22.3954828131026,JAK1,1
Regulation Of Trophoblast Cell Migration (GO:1901163),1/13,0.103891619725838,0.248139213727203,0,0,9.89021956087824,22.3954828131026,GJA1,1
Chondroitin Sulfate Biosynthetic Process (GO:0030206),1/13,0.103891619725838,0.248139213727203,0,0,9.89021956087824,22.3954828131026,UGDH,1
Clathrin Coat Assembly (GO:0048268),1/13,0.103891619725838,0.248139213727203,0,0,9.89021956087824,22.3954828131026,GAK,1
Embryonic Hemopoiesis (GO:0035162),1/13,0.103891619725838,0.248139213727203,0,0,9.89021956087824,22.3954828131026,KITLG,1
Endothelial Cell Differentiation (GO:0045446),1/13,0.103891619725838,0.248139213727203,0,0,9.89021956087824,22.3954828131026,FSTL1,1
Thymus Development (GO:0048538),1/13,0.103891619725838,0.248139213727203,0,0,9.89021956087824,22.3954828131026,HES1,1
Glutamine Metabolic Process (GO:0006541),1/13,0.103891619725838,0.248139213727203,0,0,9.89021956087824,22.3954828131026,GLS,1
Positive Regulation Of Protein Deacetylation (GO:0090312),1/13,0.103891619725838,0.248139213727203,0,0,9.89021956087824,22.3954828131026,NNMT,1
Interleukin-6-Mediated Signaling Pathway (GO:0070102),1/13,0.103891619725838,0.248139213727203,0,0,9.89021956087824,22.3954828131026,JAK1,1
"Negative Regulation Of DNA Damage Response, Signal Transduction By P53 Class Mediator (GO:0043518)",1/13,0.103891619725838,0.248139213727203,0,0,9.89021956087824,22.3954828131026,PTTG1IP,1
Regulation Of Cell Fate Commitment (GO:0010453),1/13,0.103891619725838,0.248139213727203,0,0,9.89021956087824,22.3954828131026,HDAC1,1
Negative Regulation Of Endopeptidase Activity (GO:0010951),2/66,0.106283551231312,0.252635661712767,0,0,3.72138554216867,8.34202434371569,SERPING1;LTF,1
Peptidyl-Threonine Modification (GO:0018210),2/66,0.106283551231312,0.252635661712767,0,0,3.72138554216867,8.34202434371569,PRKCA;ACVR1B,1
Cellular Response To Type II Interferon (GO:0071346),2/66,0.106283551231312,0.252635661712767,0,0,3.72138554216867,8.34202434371569,DAPK1;JAK1,1
Activation Of Cysteine-Type Endopeptidase Activity Involved In Apoptotic Process (GO:0006919),2/67,0.108974146463296,0.25507482292459,0,0,3.66394810009268,8.12167081946926,VCP;S100A9,1
Regulation Of Neurogenesis (GO:0050767),2/67,0.108974146463296,0.25507482292459,0,0,3.66394810009268,8.12167081946926,HMGB2;HES1,1
Peptidyl-Tyrosine Phosphorylation (GO:0018108),2/67,0.108974146463296,0.25507482292459,0,0,3.66394810009268,8.12167081946926,ERBB2;JAK1,1
Negative Regulation Of Smooth Muscle Cell Migration (GO:0014912),1/14,0.111423813777543,0.25507482292459,0,0,9.1289728235836,20.032747651479,TPM1,1
Regulation Of Macrophage Differentiation (GO:0045649),1/14,0.111423813777543,0.25507482292459,0,0,9.1289728235836,20.032747651479,PRKCA,1
Regulation Of Non-Canonical Wnt Signaling Pathway (GO:2000050),1/14,0.111423813777543,0.25507482292459,0,0,9.1289728235836,20.032747651479,RNF213,1
Regulation Of Nuclear-Transcribed mRNA poly(A) Tail Shortening (GO:0060211),1/14,0.111423813777543,0.25507482292459,0,0,9.1289728235836,20.032747651479,BTG2,1
Nuclear Pore Organization (GO:0006999),1/14,0.111423813777543,0.25507482292459,0,0,9.1289728235836,20.032747651479,RTN4,1
Bone Morphogenesis (GO:0060349),1/14,0.111423813777543,0.25507482292459,0,0,9.1289728235836,20.032747651479,LTF,1
Regulation Of Phosphate Metabolic Process (GO:0019220),1/14,0.111423813777543,0.25507482292459,0,0,9.1289728235836,20.032747651479,CD24,1
Odontogenesis Of Dentin-Containing Tooth (GO:0042475),1/14,0.111423813777543,0.25507482292459,0,0,9.1289728235836,20.032747651479,HDAC1,1
Regulation Of Vesicle Size (GO:0097494),1/14,0.111423813777543,0.25507482292459,0,0,9.1289728235836,20.032747651479,AP2M1,1
Contractile Actin Filament Bundle Assembly (GO:0030038),1/14,0.111423813777543,0.25507482292459,0,0,9.1289728235836,20.032747651479,PDLIM1,1
Positive Regulation Of Cytoplasmic Translation (GO:2000767),1/14,0.111423813777543,0.25507482292459,0,0,9.1289728235836,20.032747651479,PKM,1
Endoderm Development (GO:0007492),1/14,0.111423813777543,0.25507482292459,0,0,9.1289728235836,20.032747651479,LAMC1,1
Positive Regulation Of Histone Acetylation (GO:0035066),1/14,0.111423813777543,0.25507482292459,0,0,9.1289728235836,20.032747651479,MUC1,1
Stress Fiber Assembly (GO:0043149),1/14,0.111423813777543,0.25507482292459,0,0,9.1289728235836,20.032747651479,PDLIM1,1
"Positive Regulation Of Nuclear-Transcribed mRNA Catabolic Process, Deadenylation-Dependent Decay (GO:1900153)",1/14,0.111423813777543,0.25507482292459,0,0,9.1289728235836,20.032747651479,ZFP36L2,1
Membrane Raft Organization (GO:0031579),1/14,0.111423813777543,0.25507482292459,0,0,9.1289728235836,20.032747651479,ANXA2,1
Protein Localization To Vacuole (GO:0072665),1/14,0.111423813777543,0.25507482292459,0,0,9.1289728235836,20.032747651479,RTN4,1
Mitochondrial Calcium Ion Transmembrane Transport (GO:0006851),1/14,0.111423813777543,0.25507482292459,0,0,9.1289728235836,20.032747651479,MICU2,1
Negative Regulation Of Androgen Receptor Signaling Pathway (GO:0060766),1/14,0.111423813777543,0.25507482292459,0,0,9.1289728235836,20.032747651479,HDAC1,1
Regulation Of Branching Involved In Ureteric Bud Morphogenesis (GO:0090189),1/14,0.111423813777543,0.25507482292459,0,0,9.1289728235836,20.032747651479,TACSTD2,1
Regulation Of Cell Fate Specification (GO:0042659),1/14,0.111423813777543,0.25507482292459,0,0,9.1289728235836,20.032747651479,HDAC1,1
Skin Development (GO:0043588),2/68,0.111682761868624,0.255274884271142,0,0,3.60825118656444,7.90962184383711,CLIC4;ITGA3,1
Negative Regulation Of Wnt Signaling Pathway (GO:0030178),3/140,0.113980177158295,0.260126539281507,0,0,2.61380225613802,5.67647468253975,RNF213;HDAC1;BICC1,1
Cellular Response To Calcium Ion (GO:0071277),2/69,0.114408909528181,0.260705141466973,0,0,3.55421686746988,7.70545801398161,CLIC4;CLU,1
Regulation Of Cellular Biosynthetic Process (GO:0031326),2/70,0.117152108413687,0.261318890219673,0,0,3.50177179305457,7.50878663238125,C3;MFSD12,1
3'-UTR-mediated mRNA Destabilization (GO:0061158),1/15,0.118893070348601,0.261318890219673,0,0,8.4764756201882,18.050915555378,ZFP36L2,1
T Cell Homeostasis (GO:0043029),1/15,0.118893070348601,0.261318890219673,0,0,8.4764756201882,18.050915555378,PPP2R1A,1
Regulation Of Intrinsic Apoptotic Signaling Pathway In Response To DNA Damage (GO:1902229),1/15,0.118893070348601,0.261318890219673,0,0,8.4764756201882,18.050915555378,CLU,1
Regulation Of miRNA-mediated Gene Silencing (GO:0060964),1/15,0.118893070348601,0.261318890219673,0,0,8.4764756201882,18.050915555378,PUM1,1
Amyloid-Beta Metabolic Process (GO:0050435),1/15,0.118893070348601,0.261318890219673,0,0,8.4764756201882,18.050915555378,NCSTN,1
Astrocyte Development (GO:0014002),1/15,0.118893070348601,0.261318890219673,0,0,8.4764756201882,18.050915555378,S100A9,1
Nucleotide-Sugar Biosynthetic Process (GO:0009226),1/15,0.118893070348601,0.261318890219673,0,0,8.4764756201882,18.050915555378,UGDH,1
Cardiac Myofibril Assembly (GO:0055003),1/15,0.118893070348601,0.261318890219673,0,0,8.4764756201882,18.050915555378,OBSL1,1
Cellular Glucuronidation (GO:0052695),1/15,0.118893070348601,0.261318890219673,0,0,8.4764756201882,18.050915555378,UGT1A6,1
Cellular Response To Corticosteroid Stimulus (GO:0071384),1/15,0.118893070348601,0.261318890219673,0,0,8.4764756201882,18.050915555378,ZFP36L2,1
Renal Filtration (GO:0097205),1/15,0.118893070348601,0.261318890219673,0,0,8.4764756201882,18.050915555378,ITGA3,1
Dendritic Cell Chemotaxis (GO:0002407),1/15,0.118893070348601,0.261318890219673,0,0,8.4764756201882,18.050915555378,CLU,1
Positive Regulation Of Collagen Biosynthetic Process (GO:0032967),1/15,0.118893070348601,0.261318890219673,0,0,8.4764756201882,18.050915555378,VIM,1
Endoplasmic Reticulum To Cytosol Transport (GO:1903513),1/15,0.118893070348601,0.261318890219673,0,0,8.4764756201882,18.050915555378,VCP,1
Endosome To Lysosome Transport Via Multivesicular Body Sorting Pathway (GO:0032510),1/15,0.118893070348601,0.261318890219673,0,0,8.4764756201882,18.050915555378,VCP,1
Positive Regulation Of Glucose Metabolic Process (GO:0010907),1/15,0.118893070348601,0.261318890219673,0,0,8.4764756201882,18.050915555378,NNMT,1
Glucuronate Metabolic Process (GO:0019585),1/15,0.118893070348601,0.261318890219673,0,0,8.4764756201882,18.050915555378,UGT1A6,1
Glutamine Family Amino Acid Catabolic Process (GO:0009065),1/15,0.118893070348601,0.261318890219673,0,0,8.4764756201882,18.050915555378,GLS,1
Positive Regulation Of Muscle Cell Differentiation (GO:0051149),1/15,0.118893070348601,0.261318890219673,0,0,8.4764756201882,18.050915555378,LAMC1,1
Vasodilation (GO:0042311),1/15,0.118893070348601,0.261318890219673,0,0,8.4764756201882,18.050915555378,SOD2,1
Positive Regulation Of Transmembrane Transport (GO:0034764),1/15,0.118893070348601,0.261318890219673,0,0,8.4764756201882,18.050915555378,C3,1
Regulation Of Activin Receptor Signaling Pathway (GO:0032925),1/15,0.118893070348601,0.261318890219673,0,0,8.4764756201882,18.050915555378,ACVR1B,1
Regulation Of Amyloid Fibril Formation (GO:1905906),1/15,0.118893070348601,0.261318890219673,0,0,8.4764756201882,18.050915555378,CLU,1
Protein Autoubiquitination (GO:0051865),2/71,0.119911884213446,0.263169444999421,0,0,3.45084686572376,7.31923965991333,BABAM2;RNF213,1
Positive Regulation Of Protein Localization To Nucleus (GO:1900182),2/72,0.122687769302466,0.265860358566324,0,0,3.4013769363167,7.13647184798028,JUP;JAK1,1
Negative Regulation Of Cell Adhesion (GO:0007162),2/72,0.122687769302466,0.265860358566324,0,0,3.4013769363167,7.13647184798028,MUC1;PLXNB2,1
Protein Transport (GO:0015031),5/313,0.124337357551201,0.265860358566324,0,0,1.94446657636842,4.05373988278045,ARL4C;RAB13;ERP29;ARHGAP1;CLU,1
Regulation Of Cold-Induced Thermogenesis (GO:0120161),3/146,0.124930161397255,0.265860358566324,0,0,2.50336935791481,5.20700928242725,GJA1;MUC1;LCN2,1
Negative Regulation Of Response To External Stimulus (GO:0032102),3/146,0.124930161397255,0.265860358566324,0,0,2.50336935791481,5.20700928242725,CLDN3;SAA1;LTF,1
Monocarboxylic Acid Transport (GO:0015718),2/73,0.125479302676938,0.265860358566324,0,0,3.35330052604785,6.96015903684841,SLC16A4;UGT1A6,1
Cellular Response To Lipid (GO:0071396),4/228,0.126031137232434,0.265860358566324,0,0,2.13501742160279,4.42210419544203,HMGB2;SPP1;CXCL1;VIM,1
Chromatin Remodeling (GO:0006338),4/228,0.126031137232434,0.265860358566324,0,0,2.13501742160279,4.42210419544203,SMARCE1;MECOM;HDAC1;ARID1A,1
Regulation Of Interleukin-1 Production (GO:0032652),1/16,0.126299912181657,0.265860358566324,0,0,7.91097804391218,16.3685725911791,SAA1,1
Negative Regulation Of Receptor Signaling Pathway Via JAK-STAT (GO:0046426),1/16,0.126299912181657,0.265860358566324,0,0,7.91097804391218,16.3685725911791,PPP2R1A,1
Negative Regulation Of Release Of Cytochrome C From Mitochondria (GO:0090201),1/16,0.126299912181657,0.265860358566324,0,0,7.91097804391218,16.3685725911791,CLU,1
Activin Receptor Signaling Pathway (GO:0032924),1/16,0.126299912181657,0.265860358566324,0,0,7.91097804391218,16.3685725911791,ACVR1B,1
Regulation Of Osteoblast Proliferation (GO:0033688),1/16,0.126299912181657,0.265860358566324,0,0,7.91097804391218,16.3685725911791,LTF,1
Regulation Of Plasminogen Activation (GO:0010755),1/16,0.126299912181657,0.265860358566324,0,0,7.91097804391218,16.3685725911791,ENO1,1
Cell Communication By Electrical Coupling Involved In Cardiac Conduction (GO:0086064),1/16,0.126299912181657,0.265860358566324,0,0,7.91097804391218,16.3685725911791,GJA1,1
Regulation Of Response To Cytokine Stimulus (GO:0060759),1/16,0.126299912181657,0.265860358566324,0,0,7.91097804391218,16.3685725911791,CD24,1
Pharyngeal System Development (GO:0060037),1/16,0.126299912181657,0.265860358566324,0,0,7.91097804391218,16.3685725911791,HES1,1
Cellular Response To Gamma Radiation (GO:0071480),1/16,0.126299912181657,0.265860358566324,0,0,7.91097804391218,16.3685725911791,TP53,1
Regulation Of Transforming Growth Factor Beta Production (GO:0071634),1/16,0.126299912181657,0.265860358566324,0,0,7.91097804391218,16.3685725911791,ITGB6,1
Chondroitin Sulfate Metabolic Process (GO:0030204),1/16,0.126299912181657,0.265860358566324,0,0,7.91097804391218,16.3685725911791,UGDH,1
Reverse Cholesterol Transport (GO:0043691),1/16,0.126299912181657,0.265860358566324,0,0,7.91097804391218,16.3685725911791,CLU,1
Positive Regulation Of Collagen Metabolic Process (GO:0010714),1/16,0.126299912181657,0.265860358566324,0,0,7.91097804391218,16.3685725911791,VIM,1
Endoplasmic Reticulum Tubular Network Organization (GO:0071786),1/16,0.126299912181657,0.265860358566324,0,0,7.91097804391218,16.3685725911791,RTN4,1
Positive Regulation Of Homotypic Cell-Cell Adhesion (GO:0034112),1/16,0.126299912181657,0.265860358566324,0,0,7.91097804391218,16.3685725911791,JAK1,1
Positive Regulation Of Muscle Hypertrophy (GO:0014742),1/16,0.126299912181657,0.265860358566324,0,0,7.91097804391218,16.3685725911791,PRKCA,1
Protein Kinase A Signaling (GO:0010737),1/16,0.126299912181657,0.265860358566324,0,0,7.91097804391218,16.3685725911791,RAB13,1
Regulation Of NMDA Receptor Activity (GO:2000310),1/16,0.126299912181657,0.265860358566324,0,0,7.91097804391218,16.3685725911791,DAPK1,1
Dephosphorylation (GO:0016311),3/147,0.126791260863463,0.265860358566324,0,0,2.48585858585859,5.13382786538754,PPP1CB;PPP2R1A;PPM1G,1
Negative Regulation Of Neuron Apoptotic Process (GO:0043524),2/74,0.128286029820789,0.265860358566324,0,0,3.30655957161981,6.78999660411451,SOD2;CLU,1
Gland Development (GO:0048732),2/74,0.128286029820789,0.265860358566324,0,0,3.30655957161981,6.78999660411451,LSR;HES1,1
Import Into Nucleus (GO:0051170),2/74,0.128286029820789,0.265860358566324,0,0,3.30655957161981,6.78999660411451,KPNA6;PTTG1IP,1
Regulation Of Cell Cycle G1/S Phase Transition (GO:1902806),2/74,0.128286029820789,0.265860358566324,0,0,3.30655957161981,6.78999660411451,SMARCE1;ARID1A,1
Regulation Of Plasma Membrane Bounded Cell Projection Assembly (GO:0120032),2/75,0.131107502676942,0.265860358566324,0,0,3.26109919128569,6.62569804382088,DCDC2;CLU,1
Regulation Of Stress Fiber Assembly (GO:0051492),2/75,0.131107502676942,0.265860358566324,0,0,3.26109919128569,6.62569804382088,TPM1;TACSTD2,1
Defense Response To Gram-negative Bacterium (GO:0050829),2/75,0.131107502676942,0.265860358566324,0,0,3.26109919128569,6.62569804382088,HMGB2;LTF,1
Regulation Of BMP Signaling Pathway (GO:0030510),2/75,0.131107502676942,0.265860358566324,0,0,3.26109919128569,6.62569804382088,ITGA3;FSTL1,1
Regulation Of Cellular Respiration (GO:0043457),1/17,0.133644857666405,0.265860358566324,0,0,7.41616766467066,14.9255514638969,VCP,1
Negative Regulation Of Fibroblast Proliferation (GO:0048147),1/17,0.133644857666405,0.265860358566324,0,0,7.41616766467066,14.9255514638969,TP53,1
Golgi To Vacuole Transport (GO:0006896),1/17,0.133644857666405,0.265860358566324,0,0,7.41616766467066,14.9255514638969,GAK,1
NAD Biosynthetic Process (GO:0009435),1/17,0.133644857666405,0.265860358566324,0,0,7.41616766467066,14.9255514638969,NNMT,1
NLS-bearing Protein Import Into Nucleus (GO:0006607),1/17,0.133644857666405,0.265860358566324,0,0,7.41616766467066,14.9255514638969,KPNA6,1
Regulation Of Glucose Transmembrane Transport (GO:0010827),1/17,0.133644857666405,0.265860358566324,0,0,7.41616766467066,14.9255514638969,C3,1
Regulation Of Hematopoietic Progenitor Cell Differentiation (GO:1901532),1/17,0.133644857666405,0.265860358566324,0,0,7.41616766467066,14.9255514638969,KITLG,1
Rac Protein Signal Transduction (GO:0016601),1/17,0.133644857666405,0.265860358566324,0,0,7.41616766467066,14.9255514638969,NCKAP1,1
Negative Regulation Of Oxidative Stress-Induced Intrinsic Apoptotic Signaling Pathway (GO:1902176),1/17,0.133644857666405,0.265860358566324,0,0,7.41616766467066,14.9255514638969,SOD2,1
Negative Regulation Of Striated Muscle Cell Differentiation (GO:0051154),1/17,0.133644857666405,0.265860358566324,0,0,7.41616766467066,14.9255514638969,HDAC1,1
Amyloid Precursor Protein Metabolic Process (GO:0042982),1/17,0.133644857666405,0.265860358566324,0,0,7.41616766467066,14.9255514638969,NCSTN,1
Androgen Receptor Signaling Pathway (GO:0030521),1/17,0.133644857666405,0.265860358566324,0,0,7.41616766467066,14.9255514638969,ARID1A,1
Neuron Maturation (GO:0042551),1/17,0.133644857666405,0.265860358566324,0,0,7.41616766467066,14.9255514638969,C3,1
Base Conversion Or Substitution Editing (GO:0016553),1/17,0.133644857666405,0.265860358566324,0,0,7.41616766467066,14.9255514638969,ADAR,1
Regulation Of Oxidative Phosphorylation (GO:0002082),1/17,0.133644857666405,0.265860358566324,0,0,7.41616766467066,14.9255514638969,VCP,1
Carboxylic Acid Biosynthetic Process (GO:0046394),1/17,0.133644857666405,0.265860358566324,0,0,7.41616766467066,14.9255514638969,UGDH,1
Regulation Of Receptor Signaling Pathway Via STAT (GO:1904892),1/17,0.133644857666405,0.265860358566324,0,0,7.41616766467066,14.9255514638969,HES1,1
Peptidyl-Threonine Dephosphorylation (GO:0035970),1/17,0.133644857666405,0.265860358566324,0,0,7.41616766467066,14.9255514638969,PPM1G,1
Cellular Response To Glucocorticoid Stimulus (GO:0071385),1/17,0.133644857666405,0.265860358566324,0,0,7.41616766467066,14.9255514638969,ZFP36L2,1
Regulation Of Telomere Maintenance Via Telomere Lengthening (GO:1904356),1/17,0.133644857666405,0.265860358566324,0,0,7.41616766467066,14.9255514638969,HNRNPA2B1,1
Positive Regulation Of Amyloid-Beta Formation (GO:1902004),1/17,0.133644857666405,0.265860358566324,0,0,7.41616766467066,14.9255514638969,CLU,1
Response To Interferon-Alpha (GO:0035455),1/17,0.133644857666405,0.265860358566324,0,0,7.41616766467066,14.9255514638969,IFITM1,1
Positive Regulation Of Cardiac Muscle Hypertrophy (GO:0010613),1/17,0.133644857666405,0.265860358566324,0,0,7.41616766467066,14.9255514638969,PRKCA,1
"Retrograde Protein Transport, ER To Cytosol (GO:0030970)",1/17,0.133644857666405,0.265860358566324,0,0,7.41616766467066,14.9255514638969,VCP,1
Embryonic Digit Morphogenesis (GO:0042733),1/17,0.133644857666405,0.265860358566324,0,0,7.41616766467066,14.9255514638969,HDAC1,1
Positive Regulation Of Dendrite Morphogenesis (GO:0050775),1/17,0.133644857666405,0.265860358566324,0,0,7.41616766467066,14.9255514638969,OBSL1,1
Embryonic Heart Tube Development (GO:0035050),1/17,0.133644857666405,0.265860358566324,0,0,7.41616766467066,14.9255514638969,HES1,1
Positive Regulation Of Glial Cell Differentiation (GO:0045687),1/17,0.133644857666405,0.265860358566324,0,0,7.41616766467066,14.9255514638969,HES1,1
Positive Regulation Of Heart Rate (GO:0010460),1/17,0.133644857666405,0.265860358566324,0,0,7.41616766467066,14.9255514638969,TPM1,1
Facultative Heterochromatin Formation (GO:0140718),1/17,0.133644857666405,0.265860358566324,0,0,7.41616766467066,14.9255514638969,HDAC1,1
Positive Regulation Of Stem Cell Differentiation (GO:2000738),1/17,0.133644857666405,0.265860358566324,0,0,7.41616766467066,14.9255514638969,TACSTD2,1
Intracellular Estrogen Receptor Signaling Pathway (GO:0030520),1/17,0.133644857666405,0.265860358566324,0,0,7.41616766467066,14.9255514638969,ARID1A,1
Negative Regulation Of Rho Protein Signal Transduction (GO:0035024),1/17,0.133644857666405,0.265860358566324,0,0,7.41616766467066,14.9255514638969,ITGA3,1
Regulation Of Aerobic Respiration (GO:1903715),1/17,0.133644857666405,0.265860358566324,0,0,7.41616766467066,14.9255514638969,VCP,1
Wnt Signaling Pathway (GO:0016055),2/76,0.133943279590948,0.266098264394301,0,0,3.21686746987952,6.46699366697546,JUP;CD24,1
Embryonic Organ Development (GO:0048568),2/77,0.136792925150706,0.270675362532249,0,0,3.17381526104418,6.31362941337985,COL18A1;KITLG,1
Positive Regulation Of Endothelial Cell Proliferation (GO:0001938),2/77,0.136792925150706,0.270675362532249,0,0,3.17381526104418,6.31362941337985,HMGB2;PRKCA,1
Negative Regulation Of Blood Vessel Morphogenesis (GO:2000181),2/77,0.136792925150706,0.270675362532249,0,0,3.17381526104418,6.31362941337985,COL4A2;HSPG2,1
Inflammatory Response (GO:0006954),4/236,0.13784984408704,0.271634054826328,0,0,2.0605550883095,4.08317591904013,CYBA;CXCL1;HSPG2;S100A9,1
Positive Regulation Of Tumor Necrosis Factor Production (GO:0032760),2/78,0.13965601023819,0.271634054826328,0,0,3.13189600507292,6.1653657567022,CYBA;CLU,1
Epithelium Development (GO:0060429),3/154,0.140091790932387,0.271634054826328,0,0,2.36977724262492,4.65769626929297,KRT19;TNC;HNRNPH3,1
Regulation Of Collagen Biosynthetic Process (GO:0032965),1/18,0.14092842091796,0.271634054826328,0,0,6.97957027122226,13.6764900756588,VIM,1
Regulation Of Epithelial Cell Differentiation (GO:0030856),1/18,0.14092842091796,0.271634054826328,0,0,6.97957027122226,13.6764900756588,CD24,1
Negative Regulation Of Signal Transduction By P53 Class Mediator (GO:1901797),1/18,0.14092842091796,0.271634054826328,0,0,6.97957027122226,13.6764900756588,PTTG1IP,1
Negative Regulation Of Viral Entry Into Host Cell (GO:0046597),1/18,0.14092842091796,0.271634054826328,0,0,6.97957027122226,13.6764900756588,IFITM1,1
Regulation Of Oligodendrocyte Differentiation (GO:0048713),1/18,0.14092842091796,0.271634054826328,0,0,6.97957027122226,13.6764900756588,HES1,1
Regulation Of Oxidative Stress-Induced Intrinsic Apoptotic Signaling Pathway (GO:1902175),1/18,0.14092842091796,0.271634054826328,0,0,6.97957027122226,13.6764900756588,SOD2,1
Nucleosome Disassembly (GO:0006337),1/18,0.14092842091796,0.271634054826328,0,0,6.97957027122226,13.6764900756588,SMARCE1,1
Regulation Of Protein Deacetylation (GO:0090311),1/18,0.14092842091796,0.271634054826328,0,0,6.97957027122226,13.6764900756588,NNMT,1
Response To Ethanol (GO:0045471),1/18,0.14092842091796,0.271634054826328,0,0,6.97957027122226,13.6764900756588,SDF4,1
Dendritic Cell Migration (GO:0036336),1/18,0.14092842091796,0.271634054826328,0,0,6.97957027122226,13.6764900756588,CLU,1
Detection Of Mechanical Stimulus (GO:0050982),1/18,0.14092842091796,0.271634054826328,0,0,6.97957027122226,13.6764900756588,JUP,1
Epithelial Cell Development (GO:0002064),1/18,0.14092842091796,0.271634054826328,0,0,6.97957027122226,13.6764900756588,CLDN3,1
Positive Regulation Of Neuroblast Proliferation (GO:0002052),1/18,0.14092842091796,0.271634054826328,0,0,6.97957027122226,13.6764900756588,VCAN,1
Intracellular Sodium Ion Homeostasis (GO:0006883),1/18,0.14092842091796,0.271634054826328,0,0,6.97957027122226,13.6764900756588,TMPRSS4,1
Regulation Of RIG-I Signaling Pathway (GO:0039535),1/18,0.14092842091796,0.271634054826328,0,0,6.97957027122226,13.6764900756588,PUM1,1
Regulation Of Cell Cycle G2/M Phase Transition (GO:1902749),1/18,0.14092842091796,0.271634054826328,0,0,6.97957027122226,13.6764900756588,TP53,1
Regulation Of Cell-Cell Adhesion Mediated By Cadherin (GO:2000047),1/18,0.14092842091796,0.271634054826328,0,0,6.97957027122226,13.6764900756588,EPCAM,1
Positive Regulation Of Response To External Stimulus (GO:0032103),3/155,0.14202937015164,0.273308997925681,0,0,2.35406698564593,4.59448293813983,CYBA;PRKCA;S100A9,1
Positive Regulation Of Catabolic Process (GO:0009896),2/79,0.142532111821457,0.273308997925681,0,0,3.09106556094508,6.02197670490501,VCP;CLU,1
Positive Regulation Of Protein Localization To Membrane (GO:1905477),2/79,0.142532111821457,0.273308997925681,0,0,3.09106556094508,6.02197670490501,ITGA3;ERBB2,1
Protein Import Into Nucleus (GO:0006606),2/79,0.142532111821457,0.273308997925681,0,0,3.09106556094508,6.02197670490501,KPNA6;PTTG1IP,1
Calcium Ion Transmembrane Transport (GO:0070588),2/80,0.145420812990944,0.274164837020469,0,0,3.05128205128205,5.88324887577193,MICU2;CLU,1
Regulation Of Protein Localization To Plasma Membrane (GO:1903076),2/80,0.145420812990944,0.274164837020469,0,0,3.05128205128205,5.88324887577193,ITGA3;AP2M1,1
Response To Type II Interferon (GO:0034341),2/80,0.145420812990944,0.274164837020469,0,0,3.05128205128205,5.88324887577193,IFITM1;DAPK1,1
Wound Healing (GO:0042060),2/80,0.145420812990944,0.274164837020469,0,0,3.05128205128205,5.88324887577193,TPM1;ERBB2,1
RNA Destabilization (GO:0050779),1/19,0.148151111890283,0.274164837020469,0,0,6.59148369926813,12.5865864309831,PUM1,1
Regulation Of Insulin-Like Growth Factor Receptor Signaling Pathway (GO:0043567),1/19,0.148151111890283,0.274164837020469,0,0,6.59148369926813,12.5865864309831,CDH3,1
Regulation Of Integrin-Mediated Signaling Pathway (GO:2001044),1/19,0.148151111890283,0.274164837020469,0,0,6.59148369926813,12.5865864309831,LAMC1,1
Regulation Of Lymphocyte Differentiation (GO:0045619),1/19,0.148151111890283,0.274164837020469,0,0,6.59148369926813,12.5865864309831,ZFP36L2,1
Regulation Of Megakaryocyte Differentiation (GO:0045652),1/19,0.148151111890283,0.274164837020469,0,0,6.59148369926813,12.5865864309831,HMGB2,1
Regulation Of Nuclear Division (GO:0051783),1/19,0.148151111890283,0.274164837020469,0,0,6.59148369926813,12.5865864309831,OBSL1,1
Calcium-Independent Cell-Cell Adhesion Via Plasma Membrane Cell-Adhesion Molecules (GO:0016338),1/19,0.148151111890283,0.274164837020469,0,0,6.59148369926813,12.5865864309831,CLDN10,1
Cardiac Ventricle Development (GO:0003231),1/19,0.148151111890283,0.274164837020469,0,0,6.59148369926813,12.5865864309831,HES1,1
Phosphate Ion Transport (GO:0006817),1/19,0.148151111890283,0.274164837020469,0,0,6.59148369926813,12.5865864309831,SLC34A2,1
Phosphatidylcholine Biosynthetic Process (GO:0006656),1/19,0.148151111890283,0.274164837020469,0,0,6.59148369926813,12.5865864309831,MUC1,1
Cellular Response To Misfolded Protein (GO:0071218),1/19,0.148151111890283,0.274164837020469,0,0,6.59148369926813,12.5865864309831,VCP,1
Pore Complex Assembly (GO:0046931),1/19,0.148151111890283,0.274164837020469,0,0,6.59148369926813,12.5865864309831,RTN4,1
Chondroitin Sulfate Proteoglycan Biosynthetic Process (GO:0050650),1/19,0.148151111890283,0.274164837020469,0,0,6.59148369926813,12.5865864309831,UGDH,1
Positive Regulation Of Activated T Cell Proliferation (GO:0042104),1/19,0.148151111890283,0.274164837020469,0,0,6.59148369926813,12.5865864309831,CD24,1
Positive Regulation Of Axon Extension (GO:0045773),1/19,0.148151111890283,0.274164837020469,0,0,6.59148369926813,12.5865864309831,L1CAM,1
Epithelial Structure Maintenance (GO:0010669),1/19,0.148151111890283,0.274164837020469,0,0,6.59148369926813,12.5865864309831,LSR,1
Establishment Of Skin Barrier (GO:0061436),1/19,0.148151111890283,0.274164837020469,0,0,6.59148369926813,12.5865864309831,LSR,1
Superoxide Anion Generation (GO:0042554),1/19,0.148151111890283,0.274164837020469,0,0,6.59148369926813,12.5865864309831,CYBA,1
Gastrulation (GO:0007369),1/19,0.148151111890283,0.274164837020469,0,0,6.59148369926813,12.5865864309831,UGDH,1
Xenobiotic Catabolic Process (GO:0042178),1/19,0.148151111890283,0.274164837020469,0,0,6.59148369926813,12.5865864309831,CRYZ,1
Intrinsic Apoptotic Signaling Pathway In Response To DNA Damage By P53 Class Mediator (GO:0042771),1/19,0.148151111890283,0.274164837020469,0,0,6.59148369926813,12.5865864309831,TP53,1
Receptor Clustering (GO:0043113),1/19,0.148151111890283,0.274164837020469,0,0,6.59148369926813,12.5865864309831,PIGR,1
Regulation Of B Cell Differentiation (GO:0045577),1/19,0.148151111890283,0.274164837020469,0,0,6.59148369926813,12.5865864309831,ZFP36L2,1
Cytoskeleton-Dependent Cytokinesis (GO:0061640),2/81,0.148321702823573,0.274164837020469,0,0,3.01250571907885,5.74898064980142,SEPTIN2;RHOB,1
Positive Regulation Of Growth (GO:0045927),2/81,0.148321702823573,0.274164837020469,0,0,3.01250571907885,5.74898064980142,ERBB2;S100A9,1
Regulation Of Phosphorylation (GO:0042325),2/82,0.151234376331584,0.278855950410654,0,0,2.97469879518072,5.61898138789619,PLXNB2;CD24,1
Positive Regulation Of Tumor Necrosis Factor Superfamily Cytokine Production (GO:1903557),2/82,0.151234376331584,0.278855950410654,0,0,2.97469879518072,5.61898138789619,CYBA;CLU,1
Phosphorylation (GO:0016310),6/429,0.153448259345739,0.279451503157044,0,0,1.6994133613519,3.18536653975695,DAPK1;ERBB2;PRKCA;FAM20A;ACVR1B;JAK1,1
Positive Regulation Of Intracellular Signal Transduction (GO:1902533),7/525,0.154099101556031,0.279451503157044,0,0,1.62111801242236,3.03174903584508,GJA1;ERBB2;TNFSF10;S100A9;TP53;RTN4;LTF,1
Vesicle-Mediated Transport To The Plasma Membrane (GO:0098876),2/83,0.154158434432463,0.279451503157044,0,0,2.93782537557638,5.49307070947477,ARL4C;RAB13,1
Negative Regulation Of Protein Localization To Cell Periphery (GO:1904376),1/20,0.155313436230427,0.279451503157044,0,0,6.24424834541444,11.6287263526142,AP2M1,1
Negative Regulation Of Protein Localization To Plasma Membrane (GO:1903077),1/20,0.155313436230427,0.279451503157044,0,0,6.24424834541444,11.6287263526142,AP2M1,1
Negative Regulation Of Reproductive Process (GO:2000242),1/20,0.155313436230427,0.279451503157044,0,0,6.24424834541444,11.6287263526142,GJA1,1
Negative Regulation Of Stem Cell Population Maintenance (GO:1902455),1/20,0.155313436230427,0.279451503157044,0,0,6.24424834541444,11.6287263526142,HDAC1,1
Ameboidal-Type Cell Migration (GO:0001667),1/20,0.155313436230427,0.279451503157044,0,0,6.24424834541444,11.6287263526142,PDLIM1,1
Negative Regulation Of Viral Life Cycle (GO:1903901),1/20,0.155313436230427,0.279451503157044,0,0,6.24424834541444,11.6287263526142,IFITM1,1
Calcium-Mediated Signaling Using Intracellular Calcium Source (GO:0035584),1/20,0.155313436230427,0.279451503157044,0,0,6.24424834541444,11.6287263526142,CLU,1
Cell Projection Organization (GO:0030030),1/20,0.155313436230427,0.279451503157044,0,0,6.24424834541444,11.6287263526142,NCKAP1,1
Response To Fibroblast Growth Factor (GO:0071774),1/20,0.155313436230427,0.279451503157044,0,0,6.24424834541444,11.6287263526142,ZFP36L2,1
Positive Regulation Of Lipid Storage (GO:0010884),1/20,0.155313436230427,0.279451503157044,0,0,6.24424834541444,11.6287263526142,C3,1
Glutamate Metabolic Process (GO:0006536),1/20,0.155313436230427,0.279451503157044,0,0,6.24424834541444,11.6287263526142,GLS,1
Xenobiotic Transport (GO:0042908),1/20,0.155313436230427,0.279451503157044,0,0,6.24424834541444,11.6287263526142,GJA1,1
Positive Regulation Of Vascular Associated Smooth Muscle Cell Proliferation (GO:1904707),1/20,0.155313436230427,0.279451503157044,0,0,6.24424834541444,11.6287263526142,GJA1,1
Protein Deacylation (GO:0035601),1/20,0.155313436230427,0.279451503157044,0,0,6.24424834541444,11.6287263526142,HDAC1,1
Mesoderm Formation (GO:0001707),1/20,0.155313436230427,0.279451503157044,0,0,6.24424834541444,11.6287263526142,ITGA3,1
Microglial Cell Activation (GO:0001774),1/20,0.155313436230427,0.279451503157044,0,0,6.24424834541444,11.6287263526142,CLU,1
protein-DNA Complex Disassembly (GO:0032986),1/20,0.155313436230427,0.279451503157044,0,0,6.24424834541444,11.6287263526142,SMARCE1,1
Protein Autophosphorylation (GO:0046777),3/162,0.155837758869558,0.280056262316306,0,0,2.24962835906232,4.18192373722624,DAPK1;ERBB2;ACVR1B,1
Regulation Of Cysteine-Type Endopeptidase Activity Involved In Apoptotic Process (GO:0043281),2/84,0.157093483776811,0.281632655252886,0,0,2.9018513076697,5.3710778287049,DAPK1;TNFSF10,1
Positive Regulation Of Double-Strand Break Repair (GO:2000781),2/84,0.157093483776811,0.281632655252886,0,0,2.9018513076697,5.3710778287049,SMARCE1;ARID1A,1
Regulation Of Osteoblast Differentiation (GO:0045667),2/85,0.160039136825861,0.284854348800098,0,0,2.86674408477283,5.25284093641166,IFITM1;LTF,1
Positive Regulation Of Endothelial Cell Migration (GO:0010595),2/85,0.160039136825861,0.284854348800098,0,0,2.86674408477283,5.25284093641166,PRKCA;RHOB,1
Epidermis Development (GO:0008544),2/85,0.160039136825861,0.284854348800098,0,0,2.86674408477283,5.25284093641166,HDAC1;FLOT2,1
Establishment Of Protein Localization To Organelle (GO:0072594),2/85,0.160039136825861,0.284854348800098,0,0,2.86674408477283,5.25284093641166,KPNA6;PTTG1IP,1
Positive Regulation Of Protein Localization (GO:1903829),2/85,0.160039136825861,0.284854348800098,0,0,2.86674408477283,5.25284093641166,RTN4;JAK1,1
Negative Regulation Of Cell Cycle (GO:0045786),2/85,0.160039136825861,0.284854348800098,0,0,2.86674408477283,5.25284093641166,BTG2;RHOB,1
Negative Regulation Of Osteoclast Differentiation (GO:0045671),1/21,0.162415895462553,0.285667674288745,0,0,5.93173652694611,10.7814945197071,LTF,1
Regulation Of Lipid Storage (GO:0010883),1/21,0.162415895462553,0.285667674288745,0,0,5.93173652694611,10.7814945197071,C3,1
Aminoglycan Biosynthetic Process (GO:0006023),1/21,0.162415895462553,0.285667674288745,0,0,5.93173652694611,10.7814945197071,UGDH,1
Peptide Catabolic Process (GO:0043171),1/21,0.162415895462553,0.285667674288745,0,0,5.93173652694611,10.7814945197071,ANPEP,1
Chaperone-Mediated Protein Complex Assembly (GO:0051131),1/21,0.162415895462553,0.285667674288745,0,0,5.93173652694611,10.7814945197071,CLU,1
Positive Regulation Of Amyloid Precursor Protein Catabolic Process (GO:1902993),1/21,0.162415895462553,0.285667674288745,0,0,5.93173652694611,10.7814945197071,CLU,1
Skin Epidermis Development (GO:0098773),1/21,0.162415895462553,0.285667674288745,0,0,5.93173652694611,10.7814945197071,LSR,1
Innate Immune Response In Mucosa (GO:0002227),1/21,0.162415895462553,0.285667674288745,0,0,5.93173652694611,10.7814945197071,LTF,1
Positive Regulation Of Smoothened Signaling Pathway (GO:0045880),1/21,0.162415895462553,0.285667674288745,0,0,5.93173652694611,10.7814945197071,DCDC2,1
Mitochondrial Calcium Ion Homeostasis (GO:0051560),1/21,0.162415895462553,0.285667674288745,0,0,5.93173652694611,10.7814945197071,MICU2,1
Negative Regulation Of Angiogenesis (GO:0016525),2/86,0.162995011653625,0.286347789067998,0,0,2.8324727481354,5.13820663339792,COL4A2;HSPG2,1
Double-Strand Break Repair (GO:0006302),3/168,0.167992956416153,0.292184209303868,0,0,2.16716253443526,3.86585653626454,BABAM2;VCP;HMGB2,1
Regulation Of Double-Strand Break Repair (GO:2000779),2/88,0.168935926844254,0.292184209303868,0,0,2.76632109834688,4.91917112021583,SMARCE1;ARID1A,1
Regulation Of Endothelial Cell Migration (GO:0010594),2/88,0.168935926844254,0.292184209303868,0,0,2.76632109834688,4.91917112021583,PRKCA;RHOB,1
Negative Regulation Of Neuron Death (GO:1901215),2/88,0.168935926844254,0.292184209303868,0,0,2.76632109834688,4.91917112021583,SOD2;CLU,1
Negative Regulation Of Protein Kinase Activity (GO:0006469),2/88,0.168935926844254,0.292184209303868,0,0,2.76632109834688,4.91917112021583,ADAR;WARS1,1
Positive Regulation Of Plasma Membrane Bounded Cell Projection Assembly (GO:0120034),2/88,0.168935926844254,0.292184209303868,0,0,2.76632109834688,4.91917112021583,NCKAP1;AGRN,1
NAD Metabolic Process (GO:0019674),1/22,0.169458986982015,0.292184209303868,0,0,5.6489877388081,10.0277686460028,VCP,1
Negative Regulation Of Protein Localization To Nucleus (GO:1900181),1/22,0.169458986982015,0.292184209303868,0,0,5.6489877388081,10.0277686460028,CTNNA1,1
Response To Gamma Radiation (GO:0010332),1/22,0.169458986982015,0.292184209303868,0,0,5.6489877388081,10.0277686460028,TP53,1
Cytoskeleton-Dependent Intracellular Transport (GO:0030705),1/22,0.169458986982015,0.292184209303868,0,0,5.6489877388081,10.0277686460028,HOOK1,1
Dendritic Cell Differentiation (GO:0097028),1/22,0.169458986982015,0.292184209303868,0,0,5.6489877388081,10.0277686460028,CLU,1
Glucose Transmembrane Transport (GO:1904659),1/22,0.169458986982015,0.292184209303868,0,0,5.6489877388081,10.0277686460028,SLC2A1,1
Hexose Transmembrane Transport (GO:0008645),1/22,0.169458986982015,0.292184209303868,0,0,5.6489877388081,10.0277686460028,SLC2A1,1
Postreplication Repair (GO:0006301),1/22,0.169458986982015,0.292184209303868,0,0,5.6489877388081,10.0277686460028,VCP,1
Modulation By Host Of Viral Process (GO:0044788),1/22,0.169458986982015,0.292184209303868,0,0,5.6489877388081,10.0277686460028,LTF,1
Negative Regulation Of Axonogenesis (GO:0050771),1/22,0.169458986982015,0.292184209303868,0,0,5.6489877388081,10.0277686460028,RTN4,1
Cytokine-Mediated Signaling Pathway (GO:0019221),4/257,0.170846132265108,0.294235005567686,0,0,1.88749638484527,3.3351908966638,CXCL1;ACTN4;TP53;JAK1,1
Cellular Response To Chemical Stress (GO:0062197),2/89,0.171920231094128,0.294666091631361,0,0,2.73438581913862,4.81450060310702,SOD2;ZFP36L2,1
Cellular Response To Peptide Hormone Stimulus (GO:0071375),2/89,0.171920231094128,0.294666091631361,0,0,2.73438581913862,4.81450060310702,PKM;RAB13,1
Regulation Of Vesicle-Mediated Transport (GO:0060627),2/89,0.171920231094128,0.294666091631361,0,0,2.73438581913862,4.81450060310702,SEPTIN2;RAB13,1
Regulation Of Cellular Response To Transforming Growth Factor Beta Stimulus (GO:1903844),1/23,0.176443204061521,0.294666091631361,0,0,5.39194338595536,9.35370745831293,ITGA3,1
Negative Regulation Of Epidermal Growth Factor Receptor Signaling Pathway (GO:0042059),1/23,0.176443204061521,0.294666091631361,0,0,5.39194338595536,9.35370745831293,GPRC5A,1
Regulation Of Extracellular Matrix Organization (GO:1903053),1/23,0.176443204061521,0.294666091631361,0,0,5.39194338595536,9.35370745831293,LAMC1,1
Negative Regulation Of Neuron Differentiation (GO:0045665),1/23,0.176443204061521,0.294666091631361,0,0,5.39194338595536,9.35370745831293,HES1,1
Negative Regulation Of Oxidative Stress-Induced Cell Death (GO:1903202),1/23,0.176443204061521,0.294666091631361,0,0,5.39194338595536,9.35370745831293,SOD2,1
Negative Regulation Of Protein Tyrosine Kinase Activity (GO:0061099),1/23,0.176443204061521,0.294666091631361,0,0,5.39194338595536,9.35370745831293,GPRC5A,1
Regulation Of Myotube Differentiation (GO:0010830),1/23,0.176443204061521,0.294666091631361,0,0,5.39194338595536,9.35370745831293,HDAC1,1
Artery Development (GO:0060840),1/23,0.176443204061521,0.294666091631361,0,0,5.39194338595536,9.35370745831293,HES1,1
"Regulation Of Nuclear-Transcribed mRNA Catabolic Process, Deadenylation-Dependent Decay (GO:1900151)",1/23,0.176443204061521,0.294666091631361,0,0,5.39194338595536,9.35370745831293,ZFP36L2,1
Cell-Cell Signaling By Wnt (GO:0198738),1/23,0.176443204061521,0.294666091631361,0,0,5.39194338595536,9.35370745831293,CD24,1
Cellular Response To Interleukin-6 (GO:0071354),1/23,0.176443204061521,0.294666091631361,0,0,5.39194338595536,9.35370745831293,JAK1,1
Regulation Of Toll-Like Receptor 4 Signaling Pathway (GO:0034143),1/23,0.176443204061521,0.294666091631361,0,0,5.39194338595536,9.35370745831293,LTF,1
Positive Regulation Of Lamellipodium Assembly (GO:0010592),1/23,0.176443204061521,0.294666091631361,0,0,5.39194338595536,9.35370745831293,NCKAP1,1
Glial Cell Development (GO:0021782),1/23,0.176443204061521,0.294666091631361,0,0,5.39194338595536,9.35370745831293,S100A9,1
Translesion Synthesis (GO:0019985),1/23,0.176443204061521,0.294666091631361,0,0,5.39194338595536,9.35370745831293,VCP,1
Positive Regulation Of Morphogenesis Of An Epithelium (GO:1905332),1/23,0.176443204061521,0.294666091631361,0,0,5.39194338595536,9.35370745831293,GJA1,1
Heparan Sulfate Proteoglycan Biosynthetic Process (GO:0015012),1/23,0.176443204061521,0.294666091631361,0,0,5.39194338595536,9.35370745831293,UGDH,1
Hepaticobiliary System Development (GO:0061008),1/23,0.176443204061521,0.294666091631361,0,0,5.39194338595536,9.35370745831293,LSR,1
Positive Regulation Of Protein Targeting To Membrane (GO:0090314),1/23,0.176443204061521,0.294666091631361,0,0,5.39194338595536,9.35370745831293,ERBB2,1
Protein Localization To Cell Junction (GO:1902414),1/23,0.176443204061521,0.294666091631361,0,0,5.39194338595536,9.35370745831293,JAK1,1
Microtubule Nucleation (GO:0007020),1/23,0.176443204061521,0.294666091631361,0,0,5.39194338595536,9.35370745831293,TUBGCP2,1
Negative Regulation Of Actin Filament Polymerization (GO:0030837),1/23,0.176443204061521,0.294666091631361,0,0,5.39194338595536,9.35370745831293,TMSB10,1
Regulation Of Cardiac Muscle Hypertrophy (GO:0010611),1/23,0.176443204061521,0.294666091631361,0,0,5.39194338595536,9.35370745831293,PRKCA,1
Regulation Of Cell Junction Assembly (GO:1901888),1/23,0.176443204061521,0.294666091631361,0,0,5.39194338595536,9.35370745831293,CLDN3,1
Regulation Of Epithelial Cell Proliferation (GO:0050678),2/91,0.177914733272824,0.296458144580025,0,0,2.67266820089346,4.61423034069954,ERBB2;LAMC1,1
Positive Regulation Of Binding (GO:0051099),2/91,0.177914733272824,0.296458144580025,0,0,2.67266820089346,4.61423034069954,HMGB2;HES1,1
Positive Regulation Of Neuron Projection Development (GO:0010976),2/92,0.180924227288033,0.298200137059939,0,0,2.64283801874163,4.5183992937987,PLXNB2;S100A9,1
Positive Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043123),3/175,0.182509830855408,0.298200137059939,0,0,2.07822410147992,3.5349578618065,GJA1;TNFSF10;LTF,1
Regulation Of Cysteine-Type Endopeptidase Activity (GO:2000116),1/24,0.183369035893712,0.298200137059939,0,0,5.15725071595939,8.74801008085748,LTF,1
Regulation Of Cytoplasmic Translation (GO:2000765),1/24,0.183369035893712,0.298200137059939,0,0,5.15725071595939,8.74801008085748,PKM,1
ERK1 And ERK2 Cascade (GO:0070371),1/24,0.183369035893712,0.298200137059939,0,0,5.15725071595939,8.74801008085748,ZFP36L2,1
Regulation Of Execution Phase Of Apoptosis (GO:1900117),1/24,0.183369035893712,0.298200137059939,0,0,5.15725071595939,8.74801008085748,TP53,1
Regulation Of Heterotypic Cell-Cell Adhesion (GO:0034114),1/24,0.183369035893712,0.298200137059939,0,0,5.15725071595939,8.74801008085748,FLOT2,1
Neuromuscular Junction Development (GO:0007528),1/24,0.183369035893712,0.298200137059939,0,0,5.15725071595939,8.74801008085748,TNC,1
Regulation Of Muscle Cell Differentiation (GO:0051147),1/24,0.183369035893712,0.298200137059939,0,0,5.15725071595939,8.74801008085748,LAMC1,1
Regulation Of Neuroblast Proliferation (GO:1902692),1/24,0.183369035893712,0.298200137059939,0,0,5.15725071595939,8.74801008085748,VCAN,1
Cell Morphogenesis Involved In Differentiation (GO:0000904),1/24,0.183369035893712,0.298200137059939,0,0,5.15725071595939,8.74801008085748,CLDN3,1
Regulation Of Ruffle Assembly (GO:1900027),1/24,0.183369035893712,0.298200137059939,0,0,5.15725071595939,8.74801008085748,TACSTD2,1
Positive Regulation Of ERBB Signaling Pathway (GO:1901186),1/24,0.183369035893712,0.298200137059939,0,0,5.15725071595939,8.74801008085748,RTN4,1
Regulation Of Viral Life Cycle (GO:1903900),1/24,0.183369035893712,0.298200137059939,0,0,5.15725071595939,8.74801008085748,KPNA6,1
Response To Purine-Containing Compound (GO:0014074),1/24,0.183369035893712,0.298200137059939,0,0,5.15725071595939,8.74801008085748,CLU,1
Dicarboxylic Acid Transport (GO:0006835),1/24,0.183369035893712,0.298200137059939,0,0,5.15725071595939,8.74801008085748,GJA1,1
Early Endosome To Late Endosome Transport (GO:0045022),1/24,0.183369035893712,0.298200137059939,0,0,5.15725071595939,8.74801008085748,HOOK1,1
Endosome Transport Via Multivesicular Body Sorting Pathway (GO:0032509),1/24,0.183369035893712,0.298200137059939,0,0,5.15725071595939,8.74801008085748,VCP,1
Gliogenesis (GO:0042063),1/24,0.183369035893712,0.298200137059939,0,0,5.15725071595939,8.74801008085748,VCAN,1
Positive Regulation Of Vascular Endothelial Growth Factor Production (GO:0010575),1/24,0.183369035893712,0.298200137059939,0,0,5.15725071595939,8.74801008085748,C3,1
Protein Exit From Endoplasmic Reticulum (GO:0032527),1/24,0.183369035893712,0.298200137059939,0,0,5.15725071595939,8.74801008085748,VCP,1
Mononuclear Cell Differentiation (GO:1903131),1/24,0.183369035893712,0.298200137059939,0,0,5.15725071595939,8.74801008085748,CLU,1
Regulation Of Endothelial Cell Proliferation (GO:0001936),2/93,0.183941422692072,0.298804407167908,0,0,2.61366344498875,4.42529270710623,HMGB2;PRKCA,1
Positive Regulation Of Hydrolase Activity (GO:0051345),3/176,0.184610946606131,0.299564982060984,0,0,2.06610614818707,3.49069596461791,ERBB2;HMGB2;AGRN,1
Sphingolipid Metabolic Process (GO:0006665),2/94,0.186965980552777,0.302427999875939,0,0,2.58512310110005,4.33480835265569,PPP2R1A;DEGS1,1
Positive Regulation Of Nucleic Acid-Templated Transcription (GO:1903508),7/557,0.189189827685518,0.302427999875939,0,0,1.52426877470356,2.5379141994176,MECOM;HDAC1;HMGB2;SPP1;HNF1B;ARID1A;TP53,1
Negative Regulation Of Protein Localization To Membrane (GO:1905476),1/25,0.190236967663897,0.302427999875939,0,0,4.94211576846307,8.20136592691404,AP2M1,1
Regulation Of Keratinocyte Proliferation (GO:0010837),1/25,0.190236967663897,0.302427999875939,0,0,4.94211576846307,8.20136592691404,CDH3,1
Negative Regulation Of Protein Transport (GO:0051224),1/25,0.190236967663897,0.302427999875939,0,0,4.94211576846307,8.20136592691404,ERP29,1
Negative Regulation Of Response To Endoplasmic Reticulum Stress (GO:1903573),1/25,0.190236967663897,0.302427999875939,0,0,4.94211576846307,8.20136592691404,CLU,1
Negative Regulation Of Response To Wounding (GO:1903035),1/25,0.190236967663897,0.302427999875939,0,0,4.94211576846307,8.20136592691404,CLDN3,1
Negative Regulation Of Signaling Receptor Activity (GO:2000272),1/25,0.190236967663897,0.302427999875939,0,0,4.94211576846307,8.20136592691404,GPRC5A,1
Negative Regulation Of Smoothened Signaling Pathway (GO:0045879),1/25,0.190236967663897,0.302427999875939,0,0,4.94211576846307,8.20136592691404,VCP,1
Negative Regulation Of Stress Fiber Assembly (GO:0051497),1/25,0.190236967663897,0.302427999875939,0,0,4.94211576846307,8.20136592691404,TACSTD2,1
Regulation Of Platelet Aggregation (GO:0090330),1/25,0.190236967663897,0.302427999875939,0,0,4.94211576846307,8.20136592691404,PRKCA,1
Cardiac Conduction System Development (GO:0003161),1/25,0.190236967663897,0.302427999875939,0,0,4.94211576846307,8.20136592691404,GJA1,1
Sodium Ion Homeostasis (GO:0055078),1/25,0.190236967663897,0.302427999875939,0,0,4.94211576846307,8.20136592691404,TMPRSS4,1
Ventricular Cardiac Muscle Tissue Development (GO:0003229),1/25,0.190236967663897,0.302427999875939,0,0,4.94211576846307,8.20136592691404,TPM1,1
Vesicle-Mediated Transport Between Endosomal Compartments (GO:0098927),1/25,0.190236967663897,0.302427999875939,0,0,4.94211576846307,8.20136592691404,HOOK1,1
Mitotic Cell Cycle Checkpoint Signaling (GO:0007093),1/25,0.190236967663897,0.302427999875939,0,0,4.94211576846307,8.20136592691404,BABAM2,1
Regulation Of B Cell Activation (GO:0050864),1/25,0.190236967663897,0.302427999875939,0,0,4.94211576846307,8.20136592691404,ZFP36L2,1
Regulation Of Actin Cytoskeleton Reorganization (GO:2000249),1/25,0.190236967663897,0.302427999875939,0,0,4.94211576846307,8.20136592691404,CLU,1
Regulation Of Cell Cycle Phase Transition (GO:1901987),1/25,0.190236967663897,0.302427999875939,0,0,4.94211576846307,8.20136592691404,TP53,1
Positive Regulation Of Supramolecular Fiber Organization (GO:1902905),2/96,0.193035853170994,0.306549999486061,0,0,2.52986413740067,4.16132125161692,NCKAP1;CLU,1
Fc Receptor Signaling Pathway (GO:0038093),1/26,0.197047480505057,0.307666999991107,0,0,4.74419161676647,7.70604054885606,PIGR,1
Regulation Of Epidermal Growth Factor-Activated Receptor Activity (GO:0007176),1/26,0.197047480505057,0.307666999991107,0,0,4.74419161676647,7.70604054885606,GPRC5A,1
Negative Regulation Of Receptor-Mediated Endocytosis (GO:0048261),1/26,0.197047480505057,0.307666999991107,0,0,4.74419161676647,7.70604054885606,ANXA2,1
Calcium-Ion Regulated Exocytosis (GO:0017156),1/26,0.197047480505057,0.307666999991107,0,0,4.74419161676647,7.70604054885606,SDF4,1
Cardiac Muscle Cell Development (GO:0055013),1/26,0.197047480505057,0.307666999991107,0,0,4.74419161676647,7.70604054885606,OBSL1,1
Regulation Of Reactive Oxygen Species Biosynthetic Process (GO:1903426),1/26,0.197047480505057,0.307666999991107,0,0,4.74419161676647,7.70604054885606,CYBA,1
Cell-Cell Adhesion Mediated By Cadherin (GO:0044331),1/26,0.197047480505057,0.307666999991107,0,0,4.74419161676647,7.70604054885606,CDH3,1
Regulation Of Transcription By RNA Polymerase III (GO:0006359),1/26,0.197047480505057,0.307666999991107,0,0,4.74419161676647,7.70604054885606,ZFP36L2,1
Regulation Of Vascular Endothelial Growth Factor Production (GO:0010574),1/26,0.197047480505057,0.307666999991107,0,0,4.74419161676647,7.70604054885606,C3,1
Cellular Response To Xenobiotic Stimulus (GO:0071466),1/26,0.197047480505057,0.307666999991107,0,0,4.74419161676647,7.70604054885606,TP53,1
Response To Glucocorticoid (GO:0051384),1/26,0.197047480505057,0.307666999991107,0,0,4.74419161676647,7.70604054885606,ZFP36L2,1
Dendritic Spine Organization (GO:0097061),1/26,0.197047480505057,0.307666999991107,0,0,4.74419161676647,7.70604054885606,ITGA3,1
Positive Regulation Of Monooxygenase Activity (GO:0032770),1/26,0.197047480505057,0.307666999991107,0,0,4.74419161676647,7.70604054885606,CDH3,1
Protein Targeting To Lysosome (GO:0006622),1/26,0.197047480505057,0.307666999991107,0,0,4.74419161676647,7.70604054885606,CLU,1
Negative Regulation Of Catalytic Activity (GO:0043086),1/26,0.197047480505057,0.307666999991107,0,0,4.74419161676647,7.70604054885606,TP53,1
Regulation Of Cardiac Muscle Cell Contraction (GO:0086004),1/26,0.197047480505057,0.307666999991107,0,0,4.74419161676647,7.70604054885606,JUP,1
Negative Regulation Of Macromolecule Biosynthetic Process (GO:0010558),2/98,0.199131234124098,0.309620978450008,0,0,2.47690763052209,3.99721174639209,BTG2;DAPK1,1
MAPK Cascade (GO:0000165),2/98,0.199131234124098,0.309620978450008,0,0,2.47690763052209,3.99721174639209,PPP1CB;ZFP36L2,1
RNA Splicing (GO:0008380),2/98,0.199131234124098,0.309620978450008,0,0,2.47690763052209,3.99721174639209,PPP2R1A;HNRNPH3,1
Mitochondrial Translation (GO:0032543),2/98,0.199131234124098,0.309620978450008,0,0,2.47690763052209,3.99721174639209,MRPL53;MRPL19,1
Axon Development (GO:0061564),2/99,0.202187695811543,0.312635015310295,0,0,2.45124829213762,3.91846459167834,L1CAM;RTN4,1
Cellular Response To Insulin Stimulus (GO:0032869),2/99,0.202187695811543,0.312635015310295,0,0,2.45124829213762,3.91846459167834,PKM;RAB13,1
DNA Synthesis Involved In DNA Repair (GO:0000731),1/27,0.203801051647168,0.312635015310295,0,0,4.56149239981575,7.25555997850712,VCP,1
Regulation Of Peptidase Activity (GO:0052547),1/27,0.203801051647168,0.312635015310295,0,0,4.56149239981575,7.25555997850712,HDAC1,1
Cell Surface Receptor Signaling Pathway Involved In Cell-Cell Signaling (GO:1905114),1/27,0.203801051647168,0.312635015310295,0,0,4.56149239981575,7.25555997850712,CD24,1
Chaperone Cofactor-Dependent Protein Refolding (GO:0051085),1/27,0.203801051647168,0.312635015310295,0,0,4.56149239981575,7.25555997850712,GAK,1
Respiratory Tube Development (GO:0030323),1/27,0.203801051647168,0.312635015310295,0,0,4.56149239981575,7.25555997850712,ITGA3,1
Positive Regulation Of Nitric Oxide Biosynthetic Process (GO:0045429),1/27,0.203801051647168,0.312635015310295,0,0,4.56149239981575,7.25555997850712,CLU,1
Ventricular Septum Morphogenesis (GO:0060412),1/27,0.203801051647168,0.312635015310295,0,0,4.56149239981575,7.25555997850712,HES1,1
Positive Regulation Of Response To Wounding (GO:1903036),1/27,0.203801051647168,0.312635015310295,0,0,4.56149239981575,7.25555997850712,CLDN3,1
Protein Quality Control For Misfolded Or Incompletely Synthesized Proteins (GO:0006515),1/27,0.203801051647168,0.312635015310295,0,0,4.56149239981575,7.25555997850712,VCP,1
Myeloid Cell Development (GO:0061515),1/27,0.203801051647168,0.312635015310295,0,0,4.56149239981575,7.25555997850712,ANXA2,1
Regulation Of Androgen Receptor Signaling Pathway (GO:0060765),1/27,0.203801051647168,0.312635015310295,0,0,4.56149239981575,7.25555997850712,HDAC1,1
Regulation Of Organelle Organization (GO:0033043),2/100,0.20524959092647,0.314209250307189,0,0,2.42611261372019,3.84181852553833,CLIC4;S100A9,1
Response To UV (GO:0009411),2/100,0.20524959092647,0.314209250307189,0,0,2.42611261372019,3.84181852553833,SDF4;TP53,1
Visual Perception (GO:0007601),2/101,0.20831661485484,0.316385104590765,0,0,2.40148472678593,3.76719989281605,COL18A1;CRYZ,1
Regulation Of Chromosome Segregation (GO:0051983),1/28,0.210498154264017,0.316385104590765,0,0,4.39232645819472,6.844467420254,PUM1,1
Regulation Of Lipid Biosynthetic Process (GO:0046890),1/28,0.210498154264017,0.316385104590765,0,0,4.39232645819472,6.844467420254,C3,1
Negative Regulation Of Wound Healing (GO:0061045),1/28,0.210498154264017,0.316385104590765,0,0,4.39232645819472,6.844467420254,CLDN3,1
Regulation Of Platelet Activation (GO:0010543),1/28,0.210498154264017,0.316385104590765,0,0,4.39232645819472,6.844467420254,PRKCA,1
Regulation Of Protein Targeting To Membrane (GO:0090313),1/28,0.210498154264017,0.316385104590765,0,0,4.39232645819472,6.844467420254,ERBB2,1
Regulation Of Protein Transport (GO:0051223),1/28,0.210498154264017,0.316385104590765,0,0,4.39232645819472,6.844467420254,SAA1,1
Cell-Substrate Junction Assembly (GO:0007044),1/28,0.210498154264017,0.316385104590765,0,0,4.39232645819472,6.844467420254,LAMC1,1
Establishment Of Endothelial Barrier (GO:0061028),1/28,0.210498154264017,0.316385104590765,0,0,4.39232645819472,6.844467420254,CLDN3,1
Glycosaminoglycan Metabolic Process (GO:0030203),1/28,0.210498154264017,0.316385104590765,0,0,4.39232645819472,6.844467420254,UGDH,1
Positive Regulation Of Nitric Oxide Metabolic Process (GO:1904407),1/28,0.210498154264017,0.316385104590765,0,0,4.39232645819472,6.844467420254,CLU,1
Hematopoietic Progenitor Cell Differentiation (GO:0002244),1/28,0.210498154264017,0.316385104590765,0,0,4.39232645819472,6.844467420254,TP53,1
Positive Regulation Of Protein Import Into Nucleus (GO:0042307),1/28,0.210498154264017,0.316385104590765,0,0,4.39232645819472,6.844467420254,JUP,1
Primary Neural Tube Formation (GO:0014020),1/28,0.210498154264017,0.316385104590765,0,0,4.39232645819472,6.844467420254,PLXNB2,1
"Regulation Of DNA Damage Response, Signal Transduction By P53 Class Mediator (GO:0043516)",1/28,0.210498154264017,0.316385104590765,0,0,4.39232645819472,6.844467420254,PTTG1IP,1
Negative Regulation Of G2/M Transition Of Mitotic Cell Cycle (GO:0010972),1/28,0.210498154264017,0.316385104590765,0,0,4.39232645819472,6.844467420254,BABAM2,1
Negative Regulation Of Actin Filament Bundle Assembly (GO:0032232),1/28,0.210498154264017,0.316385104590765,0,0,4.39232645819472,6.844467420254,TACSTD2,1
Regulation Of Cardiac Muscle Cell Action Potential (GO:0098901),1/28,0.210498154264017,0.316385104590765,0,0,4.39232645819472,6.844467420254,JUP,1
Calcium Ion Homeostasis (GO:0055074),2/102,0.211388467719415,0.316763383652054,0,0,2.37734939759036,3.69453827712276,FAM20A;ATP13A3,1
Regulation Of Protein Secretion (GO:0050708),2/102,0.211388467719415,0.316763383652054,0,0,2.37734939759036,3.69453827712276,ERP29;SAA1,1
Sensory Perception Of Light Stimulus (GO:0050953),2/102,0.211388467719415,0.316763383652054,0,0,2.37734939759036,3.69453827712276,COL18A1;CRYZ,1
Endocytosis (GO:0006897),3/189,0.212470793088231,0.318064929693449,0,0,1.92043010752688,2.97465164453489,GAK;ANXA11;HSPG2,1
Inorganic Cation Import Across Plasma Membrane (GO:0098659),2/103,0.214464854168248,0.319904173844067,0,0,2.3536919957056,3.62376633087363,KCNJ16;CLU,1
Mitochondrial Gene Expression (GO:0140053),2/103,0.214464854168248,0.319904173844067,0,0,2.3536919957056,3.62376633087363,MRPL53;MRPL19,1
RNA Biosynthetic Process (GO:0032774),1/29,0.217139257783943,0.319904173844067,0,0,4.23524379811805,6.46813374552729,ZFP36L2,1
Negative Regulation Of Plasma Membrane Bounded Cell Projection Assembly (GO:0120033),1/29,0.217139257783943,0.319904173844067,0,0,4.23524379811805,6.46813374552729,TACSTD2,1
Regulation Of Monoatomic Ion Transmembrane Transport (GO:0034765),1/29,0.217139257783943,0.319904173844067,0,0,4.23524379811805,6.46813374552729,KCNJ16,1
Regulation Of Neuron Migration (GO:2001222),1/29,0.217139257783943,0.319904173844067,0,0,4.23524379811805,6.46813374552729,PLXNB2,1
Carbohydrate Derivative Biosynthetic Process (GO:1901137),1/29,0.217139257783943,0.319904173844067,0,0,4.23524379811805,6.46813374552729,SCCPDH,1
Response To Alcohol (GO:0097305),1/29,0.217139257783943,0.319904173844067,0,0,4.23524379811805,6.46813374552729,SDF4,1
Response To Interferon-Beta (GO:0035456),1/29,0.217139257783943,0.319904173844067,0,0,4.23524379811805,6.46813374552729,IFITM1,1
Positive Regulation Of Endopeptidase Activity (GO:0010950),1/29,0.217139257783943,0.319904173844067,0,0,4.23524379811805,6.46813374552729,NCSTN,1
Establishment Of Mitotic Spindle Orientation (GO:0000132),1/29,0.217139257783943,0.319904173844067,0,0,4.23524379811805,6.46813374552729,GJA1,1
Tube Closure (GO:0060606),1/29,0.217139257783943,0.319904173844067,0,0,4.23524379811805,6.46813374552729,PLXNB2,1
Positive Regulation Of Neural Precursor Cell Proliferation (GO:2000179),1/29,0.217139257783943,0.319904173844067,0,0,4.23524379811805,6.46813374552729,VCAN,1
Heterotypic Cell-Cell Adhesion (GO:0034113),1/29,0.217139257783943,0.319904173844067,0,0,4.23524379811805,6.46813374552729,JUP,1
Lipid Droplet Organization (GO:0034389),1/29,0.217139257783943,0.319904173844067,0,0,4.23524379811805,6.46813374552729,RNF213,1
Morphogenesis Of An Epithelium (GO:0002009),1/29,0.217139257783943,0.319904173844067,0,0,4.23524379811805,6.46813374552729,TNC,1
Regulation Of Neuron Apoptotic Process (GO:0043523),2/105,0.220630069407523,0.324404687033986,0,0,2.30775529301673,3.48763643556048,SOD2;CLU,1
Intrinsic Apoptotic Signaling Pathway (GO:0097193),2/105,0.220630069407523,0.324404687033986,0,0,2.30775529301673,3.48763643556048,CD24;TP53,1
Negative Regulation Of Peptidyl-Tyrosine Phosphorylation (GO:0050732),1/30,0.223724827602369,0.327016250955132,0,0,4.08899442494322,6.12260849453427,PPP2R1A,1
Artery Morphogenesis (GO:0048844),1/30,0.223724827602369,0.327016250955132,0,0,4.08899442494322,6.12260849453427,HES1,1
Cardiac Muscle Cell Action Potential Involved In Contraction (GO:0086002),1/30,0.223724827602369,0.327016250955132,0,0,4.08899442494322,6.12260849453427,GJA1,1
Mitotic G2 DNA Damage Checkpoint Signaling (GO:0007095),1/30,0.223724827602369,0.327016250955132,0,0,4.08899442494322,6.12260849453427,BABAM2,1
Regulation Of Arp2/3 Complex-Mediated Actin Nucleation (GO:0034315),1/30,0.223724827602369,0.327016250955132,0,0,4.08899442494322,6.12260849453427,NCKAP1,1
Negative Regulation Of Axon Extension (GO:0030517),1/30,0.223724827602369,0.327016250955132,0,0,4.08899442494322,6.12260849453427,RTN4,1
Endomembrane System Organization (GO:0010256),3/196,0.227835300511994,0.330714212477285,0,0,1.85011775788978,2.73656889238102,GAK;HOOK1;OBSL1,1
DNA Repair (GO:0006281),4/291,0.229225995737969,0.330714212477285,0,0,1.66100110478457,2.44673249694464,BABAM2;VCP;BTG2;TP53,1
Negative Regulation Of Developmental Growth (GO:0048640),1/31,0.230255325353809,0.330714212477285,0,0,3.95249500998004,5.80450166640263,RTN4,1
Regulation Of Dendrite Morphogenesis (GO:0048814),1/31,0.230255325353809,0.330714212477285,0,0,3.95249500998004,5.80450166640263,OBSL1,1
Negative Regulation Of Intracellular Steroid Hormone Receptor Signaling Pathway (GO:0033144),1/31,0.230255325353809,0.330714212477285,0,0,3.95249500998004,5.80450166640263,HDAC1,1
Regulation Of Gluconeogenesis (GO:0006111),1/31,0.230255325353809,0.330714212477285,0,0,3.95249500998004,5.80450166640263,NNMT,1
Cardiac Muscle Tissue Morphogenesis (GO:0055008),1/31,0.230255325353809,0.330714212477285,0,0,3.95249500998004,5.80450166640263,TPM1,1
Regulation Of Response To Biotic Stimulus (GO:0002831),1/31,0.230255325353809,0.330714212477285,0,0,3.95249500998004,5.80450166640263,DAPK1,1
Positive Regulation Of G1/S Transition Of Mitotic Cell Cycle (GO:1900087),1/31,0.230255325353809,0.330714212477285,0,0,3.95249500998004,5.80450166640263,ADAMTS1,1
Endodermal Cell Differentiation (GO:0035987),1/31,0.230255325353809,0.330714212477285,0,0,3.95249500998004,5.80450166640263,COL4A2,1
Positive Regulation Of Extrinsic Apoptotic Signaling Pathway (GO:2001238),1/31,0.230255325353809,0.330714212477285,0,0,3.95249500998004,5.80450166640263,TNFSF10,1
Positive Regulation Of Glucose Transmembrane Transport (GO:0010828),1/31,0.230255325353809,0.330714212477285,0,0,3.95249500998004,5.80450166640263,C3,1
Positive Regulation Of Lamellipodium Organization (GO:1902745),1/31,0.230255325353809,0.330714212477285,0,0,3.95249500998004,5.80450166640263,NCKAP1,1
Positive Regulation Of Proteolysis Involved In Protein Catabolic Process (GO:1903052),1/31,0.230255325353809,0.330714212477285,0,0,3.95249500998004,5.80450166640263,CLU,1
Presynaptic Endocytosis (GO:0140238),1/31,0.230255325353809,0.330714212477285,0,0,3.95249500998004,5.80450166640263,AP2M1,1
Receptor Signaling Pathway Via STAT (GO:0097696),1/31,0.230255325353809,0.330714212477285,0,0,3.95249500998004,5.80450166640263,JAK1,1
Negative Regulation Of DNA Biosynthetic Process (GO:2000279),1/31,0.230255325353809,0.330714212477285,0,0,3.95249500998004,5.80450166640263,TP53,1
Regulation Of Cell Morphogenesis (GO:0022604),1/31,0.230255325353809,0.330714212477285,0,0,3.95249500998004,5.80450166640263,CLDN3,1
Cellular Response To Salt (GO:1902075),2/109,0.233002409539011,0.334337112241126,0,0,2.2210336673798,3.23539414467825,CLIC4;CLU,1
'De Novo' Post-Translational Protein Folding (GO:0051084),1/32,0.236731208830002,0.335801752849421,0,0,3.82480200888546,5.5108891779409,GAK,1
Negative Regulation Of Fat Cell Differentiation (GO:0045599),1/32,0.236731208830002,0.335801752849421,0,0,3.82480200888546,5.5108891779409,ZFP36L2,1
Amide Transport (GO:0042886),1/32,0.236731208830002,0.335801752849421,0,0,3.82480200888546,5.5108891779409,GJA1,1
Neural Tube Closure (GO:0001843),1/32,0.236731208830002,0.335801752849421,0,0,3.82480200888546,5.5108891779409,PLXNB2,1
Phosphatidylinositol 3-Kinase Signaling (GO:0014065),1/32,0.236731208830002,0.335801752849421,0,0,3.82480200888546,5.5108891779409,ERBB2,1
Regulation Of Transcription By RNA Polymerase I (GO:0006356),1/32,0.236731208830002,0.335801752849421,0,0,3.82480200888546,5.5108891779409,ERBB2,1
Regulation Of Transmembrane Transport (GO:0034762),1/32,0.236731208830002,0.335801752849421,0,0,3.82480200888546,5.5108891779409,KCNJ16,1
Respiratory System Development (GO:0060541),1/32,0.236731208830002,0.335801752849421,0,0,3.82480200888546,5.5108891779409,ITGA3,1
Transition Metal Ion Transport (GO:0000041),1/32,0.236731208830002,0.335801752849421,0,0,3.82480200888546,5.5108891779409,LTF,1
Gluconeogenesis (GO:0006094),1/32,0.236731208830002,0.335801752849421,0,0,3.82480200888546,5.5108891779409,ENO1,1
Vesicle Budding From Membrane (GO:0006900),1/32,0.236731208830002,0.335801752849421,0,0,3.82480200888546,5.5108891779409,AP2M1,1
Proteoglycan Biosynthetic Process (GO:0030166),1/32,0.236731208830002,0.335801752849421,0,0,3.82480200888546,5.5108891779409,UGDH,1
RNA Metabolic Process (GO:0016070),2/111,0.239205199658734,0.338343476323381,0,0,2.18005968829446,3.11843045251235,ADAR;HNRNPH3,1
Regulation Of Transforming Growth Factor Beta Receptor Signaling Pathway (GO:0017015),2/111,0.239205199658734,0.338343476323381,0,0,2.18005968829446,3.11843045251235,ITGA3;HDAC1,1
Cytoskeleton Organization (GO:0007010),2/111,0.239205199658734,0.338343476323381,0,0,2.18005968829446,3.11843045251235,TPM1;OBSL1,1
Regulation Of Cell Cycle (GO:0051726),4/298,0.241835456338299,0.338774871643747,0,0,1.62087273933964,2.30082515234438,MECOM;PUM1;TP53;RHOB,1
Small GTPase Mediated Signal Transduction (GO:0007264),2/112,0.242309834880907,0.338774871643747,0,0,2.16013143483023,3.06206852843704,ARHGAP1;TP53,1
Negative Regulation Of Epithelial Cell Migration (GO:0010633),1/33,0.243152932066883,0.338774871643747,0,0,3.70508982035928,5.23923666427588,TACSTD2,1
Actin Filament Bundle Assembly (GO:0051017),1/33,0.243152932066883,0.338774871643747,0,0,3.70508982035928,5.23923666427588,AIF1L,1
Actin Filament Bundle Organization (GO:0061572),1/33,0.243152932066883,0.338774871643747,0,0,3.70508982035928,5.23923666427588,AIF1L,1
Regulation Of Lamellipodium Assembly (GO:0010591),1/33,0.243152932066883,0.338774871643747,0,0,3.70508982035928,5.23923666427588,NCKAP1,1
Carboxylic Acid Metabolic Process (GO:0019752),1/33,0.243152932066883,0.338774871643747,0,0,3.70508982035928,5.23923666427588,SLC2A1,1
Cardiac Muscle Contraction (GO:0060048),1/33,0.243152932066883,0.338774871643747,0,0,3.70508982035928,5.23923666427588,TPM1,1
Signal Transduction By P53 Class Mediator (GO:0072331),1/33,0.243152932066883,0.338774871643747,0,0,3.70508982035928,5.23923666427588,TP53,1
Glycolipid Metabolic Process (GO:0006664),1/33,0.243152932066883,0.338774871643747,0,0,3.70508982035928,5.23923666427588,SCCPDH,1
Ventricular Cardiac Muscle Tissue Morphogenesis (GO:0055010),1/33,0.243152932066883,0.338774871643747,0,0,3.70508982035928,5.23923666427588,TPM1,1
Lung Development (GO:0030324),1/33,0.243152932066883,0.338774871643747,0,0,3.70508982035928,5.23923666427588,ITGA3,1
Protein K63-linked Deubiquitination (GO:0070536),1/33,0.243152932066883,0.338774871643747,0,0,3.70508982035928,5.23923666427588,BABAM2,1
Regulation Of Activated T Cell Proliferation (GO:0046006),1/33,0.243152932066883,0.338774871643747,0,0,3.70508982035928,5.23923666427588,CD24,1
Negative Regulation Of Blood Vessel Endothelial Cell Migration (GO:0043537),1/33,0.243152932066883,0.338774871643747,0,0,3.70508982035928,5.23923666427588,JUP,1
Regulation Of Cell Adhesion Mediated By Integrin (GO:0033628),1/33,0.243152932066883,0.338774871643747,0,0,3.70508982035928,5.23923666427588,MUC1,1
Protein Phosphorylation (GO:0006468),6/500,0.244607111152454,0.34048211543017,0,0,1.44984255510571,2.0415261777146,DAPK1;ERBB2;PRKCA;FAM20A;ACVR1B;JAK1,1
Regulation Of MAPK Cascade (GO:0043408),3/204,0.245643361059057,0.340943220040345,0,0,1.77575757575758,2.49294086180303,PPP2R1A;ERBB2;CD24,1
Regulation Of Cytoskeleton Organization (GO:0051493),2/114,0.248524325294112,0.340943220040345,0,0,2.12134251290878,2.9533639114297,CLIC4;S100A9,1
Response To Endoplasmic Reticulum Stress (GO:0034976),2/114,0.248524325294112,0.340943220040345,0,0,2.12134251290878,2.9533639114297,VCP;TP53,1
Negative Regulation Of Canonical Wnt Signaling Pathway (GO:0090090),2/114,0.248524325294112,0.340943220040345,0,0,2.12134251290878,2.9533639114297,HDAC1;BICC1,1
Cellular Response To Amyloid-Beta (GO:1904646),1/34,0.249520945311785,0.340943220040345,0,0,3.59263291598621,4.98733762789356,GJA1,1
Semaphorin-Plexin Signaling Pathway (GO:0071526),1/34,0.249520945311785,0.340943220040345,0,0,3.59263291598621,4.98733762789356,PLXNB2,1
Embryonic Limb Morphogenesis (GO:0030326),1/34,0.249520945311785,0.340943220040345,0,0,3.59263291598621,4.98733762789356,HDAC1,1
Smoothened Signaling Pathway (GO:0007224),1/34,0.249520945311785,0.340943220040345,0,0,3.59263291598621,4.98733762789356,SEPTIN2,1
Establishment Of Mitotic Spindle Localization (GO:0040001),1/34,0.249520945311785,0.340943220040345,0,0,3.59263291598621,4.98733762789356,GJA1,1
Glial Cell Differentiation (GO:0010001),1/34,0.249520945311785,0.340943220040345,0,0,3.59263291598621,4.98733762789356,VCAN,1
Transcription Initiation-Coupled Chromatin Remodeling (GO:0045815),1/34,0.249520945311785,0.340943220040345,0,0,3.59263291598621,4.98733762789356,TP53,1
Positive Regulation Of Neuron Death (GO:1901216),1/34,0.249520945311785,0.340943220040345,0,0,3.59263291598621,4.98733762789356,CLU,1
Positive Regulation Of Organelle Organization (GO:0010638),1/34,0.249520945311785,0.340943220040345,0,0,3.59263291598621,4.98733762789356,ANXA2,1
Histone Deubiquitination (GO:0016578),1/34,0.249520945311785,0.340943220040345,0,0,3.59263291598621,4.98733762789356,BABAM2,1
Positive Regulation Of Transcription By RNA Polymerase I (GO:0045943),1/34,0.249520945311785,0.340943220040345,0,0,3.59263291598621,4.98733762789356,ERBB2,1
Microtubule Polymerization (GO:0046785),1/34,0.249520945311785,0.340943220040345,0,0,3.59263291598621,4.98733762789356,TUBGCP2,1
Negative Regulation Of JNK Cascade (GO:0046329),1/34,0.249520945311785,0.340943220040345,0,0,3.59263291598621,4.98733762789356,MECOM,1
Negative Regulation Of Ras Protein Signal Transduction (GO:0046580),1/34,0.249520945311785,0.340943220040345,0,0,3.59263291598621,4.98733762789356,ITGA3,1
Regulation Of Blood Circulation (GO:1903522),1/34,0.249520945311785,0.340943220040345,0,0,3.59263291598621,4.98733762789356,TPM1,1
Negative Regulation Of Cell Cycle Process (GO:0010948),1/34,0.249520945311785,0.340943220040345,0,0,3.59263291598621,4.98733762789356,TP53,1
Regulation Of Cellular Senescence (GO:2000772),1/35,0.255835695162147,0.345761593461649,0,0,3.48679112363508,4.75326289460529,TP53,1
Adherens Junction Organization (GO:0034332),1/35,0.255835695162147,0.345761593461649,0,0,3.48679112363508,4.75326289460529,CDH3,1
Regulatory ncRNA Processing (GO:0070918),1/35,0.255835695162147,0.345761593461649,0,0,3.48679112363508,4.75326289460529,PUM1,1
Dendrite Morphogenesis (GO:0048813),1/35,0.255835695162147,0.345761593461649,0,0,3.48679112363508,4.75326289460529,DCDC2,1
Endoderm Formation (GO:0001706),1/35,0.255835695162147,0.345761593461649,0,0,3.48679112363508,4.75326289460529,COL4A2,1
Establishment Of Spindle Orientation (GO:0051294),1/35,0.255835695162147,0.345761593461649,0,0,3.48679112363508,4.75326289460529,GJA1,1
tRNA Aminoacylation For Protein Translation (GO:0006418),1/35,0.255835695162147,0.345761593461649,0,0,3.48679112363508,4.75326289460529,WARS1,1
Hexose Biosynthetic Process (GO:0019319),1/35,0.255835695162147,0.345761593461649,0,0,3.48679112363508,4.75326289460529,ENO1,1
Positive Regulation Of Telomere Maintenance Via Telomere Lengthening (GO:1904358),1/35,0.255835695162147,0.345761593461649,0,0,3.48679112363508,4.75326289460529,HNRNPA2B1,1
Intrinsic Apoptotic Signaling Pathway By P53 Class Mediator (GO:0072332),1/35,0.255835695162147,0.345761593461649,0,0,3.48679112363508,4.75326289460529,TP53,1
Liver Development (GO:0001889),1/35,0.255835695162147,0.345761593461649,0,0,3.48679112363508,4.75326289460529,LSR,1
Macrophage Activation (GO:0042116),1/35,0.255835695162147,0.345761593461649,0,0,3.48679112363508,4.75326289460529,CLU,1
Protein Maturation (GO:0051604),2/117,0.257855449846483,0.34785939199598,0,0,2.06568884232582,2.79974402062673,NCSTN;TMPRSS4,1
Protein Processing (GO:0016485),2/117,0.257855449846483,0.34785939199598,0,0,2.06568884232582,2.79974402062673,NCSTN;TMPRSS4,1
Regulation Of Small GTPase Mediated Signal Transduction (GO:0051056),2/118,0.260967379564724,0.350405449328673,0,0,2.0477773161612,2.75090185280622,ARHGAP1;ARHGAP29,1
Negative Regulation Of Protein Kinase B Signaling (GO:0051898),1/36,0.262097624397052,0.350405449328673,0,0,3.38699743370402,4.53531905684231,PPP2R1A,1
Negative Regulation Of Sequestering Of Calcium Ion (GO:0051283),1/36,0.262097624397052,0.350405449328673,0,0,3.38699743370402,4.53531905684231,CLU,1
Regulation Of Receptor Internalization (GO:0002090),1/36,0.262097624397052,0.350405449328673,0,0,3.38699743370402,4.53531905684231,ANXA2,1
Substrate Adhesion-Dependent Cell Spreading (GO:0034446),1/36,0.262097624397052,0.350405449328673,0,0,3.38699743370402,4.53531905684231,LAMC1,1
Histone Deacetylation (GO:0016575),1/36,0.262097624397052,0.350405449328673,0,0,3.38699743370402,4.53531905684231,HDAC1,1
Positive Regulation Of Signaling Receptor Activity (GO:2000273),1/36,0.262097624397052,0.350405449328673,0,0,3.38699743370402,4.53531905684231,HDAC1,1
Interstrand Cross-Link Repair (GO:0036297),1/36,0.262097624397052,0.350405449328673,0,0,3.38699743370402,4.53531905684231,VCP,1
Lytic Vacuole Organization (GO:0080171),1/36,0.262097624397052,0.350405449328673,0,0,3.38699743370402,4.53531905684231,HOOK1,1
Receptor Signaling Pathway Via JAK-STAT (GO:0007259),1/36,0.262097624397052,0.350405449328673,0,0,3.38699743370402,4.53531905684231,JAK1,1
Positive Regulation Of MAPK Cascade (GO:0043410),4/310,0.263804548506347,0.352370887053361,0,0,1.55635262234975,2.07391270128369,ERBB2;ERP29;PRKCA;CD24,1
Regulation Of GTPase Activity (GO:0043087),3/214,0.26819641725662,0.355196683593621,0,0,1.69073675140026,2.22506986784361,ERBB2;PLXNB2;AGRN,1
Negative Regulation Of Endothelial Cell Migration (GO:0010596),1/37,0.268307172284429,0.355196683593621,0,0,3.29274783765802,4.33201409555255,JUP,1
Negative Regulation Of Stress-Activated MAPK Cascade (GO:0032873),1/37,0.268307172284429,0.355196683593621,0,0,3.29274783765802,4.33201409555255,MECOM,1
Negative Regulation Of Transferase Activity (GO:0051348),1/37,0.268307172284429,0.355196683593621,0,0,3.29274783765802,4.33201409555255,TP53,1
Calcium Ion Import Across Plasma Membrane (GO:0098703),1/37,0.268307172284429,0.355196683593621,0,0,3.29274783765802,4.33201409555255,CLU,1
Ventricular Septum Development (GO:0003281),1/37,0.268307172284429,0.355196683593621,0,0,3.29274783765802,4.33201409555255,HES1,1
Positive Regulation Of Receptor Signaling Pathway Via JAK-STAT (GO:0046427),1/37,0.268307172284429,0.355196683593621,0,0,3.29274783765802,4.33201409555255,HES1,1
Positive Regulation Of Receptor Signaling Pathway Via STAT (GO:1904894),1/37,0.268307172284429,0.355196683593621,0,0,3.29274783765802,4.33201409555255,HES1,1
Positive Regulation Of Signaling (GO:0023056),1/37,0.268307172284429,0.355196683593621,0,0,3.29274783765802,4.33201409555255,ANXA2,1
Muscle Cell Differentiation (GO:0042692),1/37,0.268307172284429,0.355196683593621,0,0,3.29274783765802,4.33201409555255,ACTN4,1
Protein Localization To Nucleus (GO:0034504),2/122,0.273416801981055,0.361099543969713,0,0,1.97911646586345,2.56643491392437,KPNA6;PTTG1IP,1
Calcium-Dependent Cell-Cell Adhesion Via Plasma Membrane Cell Adhesion Molecules (GO:0016339),1/38,0.274464774347947,0.361099543969713,0,0,3.20359281437126,4.14202879511733,CDH3,1
Regulation Of Protein Import Into Nucleus (GO:0042306),1/38,0.274464774347947,0.361099543969713,0,0,3.20359281437126,4.14202879511733,JUP,1
Positive Regulation Of Bone Mineralization (GO:0030501),1/38,0.274464774347947,0.361099543969713,0,0,3.20359281437126,4.14202879511733,LTF,1
Response To Transforming Growth Factor Beta (GO:0071559),1/38,0.274464774347947,0.361099543969713,0,0,3.20359281437126,4.14202879511733,ZFP36L2,1
Tumor Necrosis Factor-Mediated Signaling Pathway (GO:0033209),1/38,0.274464774347947,0.361099543969713,0,0,3.20359281437126,4.14202879511733,TP53,1
Membrane Assembly (GO:0071709),1/38,0.274464774347947,0.361099543969713,0,0,3.20359281437126,4.14202879511733,ANXA2,1
Organonitrogen Compound Biosynthetic Process (GO:1901566),2/123,0.276528486934106,0.363493276111263,0,0,1.96266055959375,2.5228852089687,MUC1;DEGS1,1
Positive Regulation Of Defense Response (GO:0031349),2/124,0.279639477700598,0.364619601318177,0,0,1.94647442227928,2.48030298412524,CYBA;S100A9,1
Enzyme-Linked Receptor Protein Signaling Pathway (GO:0007167),2/124,0.279639477700598,0.364619601318177,0,0,1.94647442227928,2.48030298412524,ERBB2;ACVR1B,1
Regulation Of DNA Metabolic Process (GO:0051052),2/124,0.279639477700598,0.364619601318177,0,0,1.94647442227928,2.48030298412524,BABAM2;PPP2R1A,1
Negative Regulation Of Mitochondrion Organization (GO:0010823),1/39,0.280570862573463,0.364619601318177,0,0,3.11913016073117,3.96419284014564,CLU,1
RNA Transport (GO:0050658),1/39,0.280570862573463,0.364619601318177,0,0,3.11913016073117,3.96419284014564,HNRNPA2B1,1
Negative Regulation Of Protein Secretion (GO:0050709),1/39,0.280570862573463,0.364619601318177,0,0,3.11913016073117,3.96419284014564,ERP29,1
Regulation Of Mitochondrial Membrane Potential (GO:0051881),1/39,0.280570862573463,0.364619601318177,0,0,3.11913016073117,3.96419284014564,VCP,1
Regulation Of Nitric Oxide Biosynthetic Process (GO:0045428),1/39,0.280570862573463,0.364619601318177,0,0,3.11913016073117,3.96419284014564,CLU,1
Odontogenesis (GO:0042476),1/39,0.280570862573463,0.364619601318177,0,0,3.11913016073117,3.96419284014564,HDAC1,1
Positive Regulation Of ATP-dependent Activity (GO:0032781),1/39,0.280570862573463,0.364619601318177,0,0,3.11913016073117,3.96419284014564,TPM1,1
Release Of Sequestered Calcium Ion Into Cytosol (GO:0051209),1/39,0.280570862573463,0.364619601318177,0,0,3.11913016073117,3.96419284014564,CLU,1
Heterochromatin Organization (GO:0070828),1/39,0.280570862573463,0.364619601318177,0,0,3.11913016073117,3.96419284014564,MECOM,1
Vitamin Transport (GO:0051180),1/39,0.280570862573463,0.364619601318177,0,0,3.11913016073117,3.96419284014564,SLC2A1,1
Positive Regulation Of Intracellular Protein Transport (GO:0090316),2/126,0.285858553209168,0.36862514056225,0,0,1.91488534784298,2.39793080172766,JUP;ERBB2,1
Regulation Of Cytokine-Mediated Signaling Pathway (GO:0001959),1/40,0.286625865343093,0.36862514056225,0,0,3.03899892522647,3.797464736411,CD24,1
Negative Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901991),1/40,0.286625865343093,0.36862514056225,0,0,3.03899892522647,3.797464736411,ZFP36L2,1
Notch Signaling Pathway (GO:0007219),1/40,0.286625865343093,0.36862514056225,0,0,3.03899892522647,3.797464736411,HES1,1
Negative Regulation Of Secretion By Cell (GO:1903531),1/40,0.286625865343093,0.36862514056225,0,0,3.03899892522647,3.797464736411,ERP29,1
Cellular Response To Heat (GO:0034605),1/40,0.286625865343093,0.36862514056225,0,0,3.03899892522647,3.797464736411,VCP,1
Positive Regulation Of Catalytic Activity (GO:0043085),1/40,0.286625865343093,0.36862514056225,0,0,3.03899892522647,3.797464736411,NCSTN,1
Positive Regulation Of Cell Cycle G1/S Phase Transition (GO:1902808),1/40,0.286625865343093,0.36862514056225,0,0,3.03899892522647,3.797464736411,ADAMTS1,1
Positive Regulation Of Myeloid Leukocyte Differentiation (GO:0002763),1/40,0.286625865343093,0.36862514056225,0,0,3.03899892522647,3.797464736411,PRKCA,1
Positive Regulation Of Wound Healing (GO:0090303),1/40,0.286625865343093,0.36862514056225,0,0,3.03899892522647,3.797464736411,CLDN3,1
Protein Deacetylation (GO:0006476),1/40,0.286625865343093,0.36862514056225,0,0,3.03899892522647,3.797464736411,HDAC1,1
Negative Regulation Of Cell-Cell Adhesion (GO:0022408),1/40,0.286625865343093,0.36862514056225,0,0,3.03899892522647,3.797464736411,EPCAM,1
Cytosolic Transport (GO:0016482),2/127,0.288966234836366,0.371314125592844,0,0,1.89946987951807,2.3580882054753,GAK;HOOK1,1
Intracellular Protein Transport (GO:0006886),4/325,0.291764040004032,0.372802867120751,0,0,1.48248613327255,1.82614107417998,ARL4C;KPNA6;ERP29;PTTG1IP,1
Regulation Of Heart Rate By Cardiac Conduction (GO:0086091),1/41,0.29263020752489,0.372802867120751,0,0,2.96287425149701,3.64091486117759,JUP,1
Regulation Of Microtubule-Based Process (GO:0032886),1/41,0.29263020752489,0.372802867120751,0,0,2.96287425149701,3.64091486117759,ERBB2,1
Positive Regulation Of Actin Filament Polymerization (GO:0030838),1/41,0.29263020752489,0.372802867120751,0,0,2.96287425149701,3.64091486117759,NCKAP1,1
Detection Of Chemical Stimulus Involved In Sensory Perception Of Bitter Taste (GO:0001580),1/41,0.29263020752489,0.372802867120751,0,0,2.96287425149701,3.64091486117759,PIGR,1
Double-Strand Break Repair Via Nonhomologous End Joining (GO:0006303),1/41,0.29263020752489,0.372802867120751,0,0,2.96287425149701,3.64091486117759,HMGB2,1
Heart Contraction (GO:0060047),1/41,0.29263020752489,0.372802867120751,0,0,2.96287425149701,3.64091486117759,TPM1,1
Visual System Development (GO:0150063),1/41,0.29263020752489,0.372802867120751,0,0,2.96287425149701,3.64091486117759,C3,1
Positive Regulation Of Viral Process (GO:0048524),1/41,0.29263020752489,0.372802867120751,0,0,2.96287425149701,3.64091486117759,KPNA6,1
Protein Localization To Lysosome (GO:0061462),1/41,0.29263020752489,0.372802867120751,0,0,2.96287425149701,3.64091486117759,RTN4,1
Golgi Organization (GO:0007030),2/130,0.298279507853199,0.375247849642967,0,0,1.8546686746988,2.24363773874312,GAK;OBSL1,1
Positive Regulation Of Peptidyl-Tyrosine Phosphorylation (GO:0050731),2/130,0.298279507853199,0.375247849642967,0,0,1.8546686746988,2.24363773874312,HES1;TP53,1
Amino Acid Transmembrane Transport (GO:0003333),1/42,0.298584310468598,0.375247849642967,0,0,2.89046297648605,3.49371109445797,MFSD12,1
Regulation Of Neurotransmitter Receptor Activity (GO:0099601),1/42,0.298584310468598,0.375247849642967,0,0,2.89046297648605,3.49371109445797,DAPK1,1
Branching Morphogenesis Of An Epithelial Tube (GO:0048754),1/42,0.298584310468598,0.375247849642967,0,0,2.89046297648605,3.49371109445797,COL4A1,1
Cardiac Ventricle Morphogenesis (GO:0003208),1/42,0.298584310468598,0.375247849642967,0,0,2.89046297648605,3.49371109445797,TPM1,1
Cellular Response To Glucose Starvation (GO:0042149),1/42,0.298584310468598,0.375247849642967,0,0,2.89046297648605,3.49371109445797,TP53,1
Regulation Of Ubiquitin-Dependent Protein Catabolic Process (GO:2000058),1/42,0.298584310468598,0.375247849642967,0,0,2.89046297648605,3.49371109445797,CLU,1
Ceramide Biosynthetic Process (GO:0046513),1/42,0.298584310468598,0.375247849642967,0,0,2.89046297648605,3.49371109445797,DEGS1,1
Collagen Fibril Organization (GO:0030199),1/42,0.298584310468598,0.375247849642967,0,0,2.89046297648605,3.49371109445797,COL18A1,1
Sensory Perception Of Bitter Taste (GO:0050913),1/42,0.298584310468598,0.375247849642967,0,0,2.89046297648605,3.49371109445797,PIGR,1
Embryonic Heart Tube Morphogenesis (GO:0003143),1/42,0.298584310468598,0.375247849642967,0,0,2.89046297648605,3.49371109445797,HES1,1
Keratinocyte Differentiation (GO:0030216),1/42,0.298584310468598,0.375247849642967,0,0,2.89046297648605,3.49371109445797,CLIC4,1
Potassium Ion Import Across Plasma Membrane (GO:1990573),1/42,0.298584310468598,0.375247849642967,0,0,2.89046297648605,3.49371109445797,KCNJ16,1
Modulation By Host Of Symbiont Process (GO:0051851),1/42,0.298584310468598,0.375247849642967,0,0,2.89046297648605,3.49371109445797,HDAC1,1
Regulation Of Axonogenesis (GO:0050770),1/42,0.298584310468598,0.375247849642967,0,0,2.89046297648605,3.49371109445797,PLXNB2,1
Regulation Of Primary Metabolic Process (GO:0080090),1/43,0.304488592033136,0.379145627569294,0,0,2.821499857428,3.35510658603259,RNF213,1
Response To Amyloid-Beta (GO:1904645),1/43,0.304488592033136,0.379145627569294,0,0,2.821499857428,3.35510658603259,GJA1,1
Positive Regulation Of Cell-Matrix Adhesion (GO:0001954),1/43,0.304488592033136,0.379145627569294,0,0,2.821499857428,3.35510658603259,JUP,1
Skeletal System Morphogenesis (GO:0048705),1/43,0.304488592033136,0.379145627569294,0,0,2.821499857428,3.35510658603259,LTF,1
Glycolipid Biosynthetic Process (GO:0009247),1/43,0.304488592033136,0.379145627569294,0,0,2.821499857428,3.35510658603259,SCCPDH,1
Positive Regulation Of Stress Fiber Assembly (GO:0051496),1/43,0.304488592033136,0.379145627569294,0,0,2.821499857428,3.35510658603259,TPM1,1
Intracellular Steroid Hormone Receptor Signaling Pathway (GO:0030518),1/43,0.304488592033136,0.379145627569294,0,0,2.821499857428,3.35510658603259,ARID1A,1
Lysosome Organization (GO:0007040),1/43,0.304488592033136,0.379145627569294,0,0,2.821499857428,3.35510658603259,HOOK1,1
mRNA Catabolic Process (GO:0006402),1/43,0.304488592033136,0.379145627569294,0,0,2.821499857428,3.35510658603259,ZFP36L2,1
mRNA Transcription (GO:0009299),1/43,0.304488592033136,0.379145627569294,0,0,2.821499857428,3.35510658603259,TP53,1
Regulation Of Cell-Cell Adhesion (GO:0022407),1/43,0.304488592033136,0.379145627569294,0,0,2.821499857428,3.35510658603259,FLOT2,1
Negative Regulation Of Multicellular Organismal Process (GO:0051241),3/231,0.307015180308341,0.381972063794992,0,0,1.56331738437002,1.84605597331558,GJA1;HDAC1;TACSTD2,1
Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043122),3/232,0.309309460346504,0.384185589295771,0,0,1.5564112743152,1.82631324355586,GJA1;TNFSF10;LTF,1
Autophagosome Maturation (GO:0097352),1/44,0.310343466621987,0.384185589295771,0,0,2.75574432530288,3.2244292995634,VCP,1
Cellular Response To Ketone (GO:1901655),1/44,0.310343466621987,0.384185589295771,0,0,2.75574432530288,3.2244292995634,SPP1,1
Embryonic Organ Morphogenesis (GO:0048562),1/44,0.310343466621987,0.384185589295771,0,0,2.75574432530288,3.2244292995634,HES1,1
Synaptic Vesicle Recycling (GO:0036465),1/44,0.310343466621987,0.384185589295771,0,0,2.75574432530288,3.2244292995634,AP2M1,1
Positive Regulation Of Nucleocytoplasmic Transport (GO:0046824),1/44,0.310343466621987,0.384185589295771,0,0,2.75574432530288,3.2244292995634,JUP,1
Non-Membrane-Bounded Organelle Assembly (GO:0140694),2/135,0.313757864009891,0.387620709514235,0,0,1.78449134885406,2.06846410313711,RNF213;TUBGCP2,1
Cellular Response To Metal Ion (GO:0071248),2/135,0.313757864009891,0.387620709514235,0,0,1.78449134885406,2.06846410313711,CLIC4;CLU,1
Positive Regulation Of GTPase Activity (GO:0043547),3/234,0.313899835325708,0.387620709514235,0,0,1.54277843368752,1.78758858246991,ERBB2;ARHGAP29;AGRN,1
Negative Regulation Of Response To Biotic Stimulus (GO:0002832),1/45,0.316149345231882,0.388785310500034,0,0,2.69297768100163,3.10107304178759,LTF,1
Regulation Of Protein Modification Process (GO:0031399),1/45,0.316149345231882,0.388785310500034,0,0,2.69297768100163,3.10107304178759,PLXNB2,1
Regulation Of Telomerase Activity (GO:0051972),1/45,0.316149345231882,0.388785310500034,0,0,2.69297768100163,3.10107304178759,TP53,1
Detection Of Chemical Stimulus Involved In Sensory Perception Of Taste (GO:0050912),1/45,0.316149345231882,0.388785310500034,0,0,2.69297768100163,3.10107304178759,PIGR,1
Establishment Of Protein Localization To Extracellular Region (GO:0035592),1/45,0.316149345231882,0.388785310500034,0,0,2.69297768100163,3.10107304178759,RAB13,1
Regulation Of Protein Kinase B Signaling (GO:0051896),2/136,0.316845363391457,0.389319488626332,0,0,1.7710843373494,2.03558061692893,PPP2R1A;RTN4,1
Protein Localization To Organelle (GO:0033365),2/137,0.31992974033967,0.391977965212404,0,0,1.75787594823739,2.00337012516326,GAK;OBSL1,1
Negative Regulation Of Cellular Biosynthetic Process (GO:0031327),2/137,0.31992974033967,0.391977965212404,0,0,1.75787594823739,2.00337012516326,BTG2;DAPK1,1
Regulation Of Fibroblast Proliferation (GO:0048145),1/46,0.321906635409649,0.391977965212404,0,0,2.63300066533599,2.98448973899324,TP53,1
T Cell Differentiation (GO:0030217),1/46,0.321906635409649,0.391977965212404,0,0,2.63300066533599,2.98448973899324,ZFP36L2,1
Cardiac Conduction (GO:0061337),1/46,0.321906635409649,0.391977965212404,0,0,2.63300066533599,2.98448973899324,JUP,1
Positive Regulation Of Blood Vessel Endothelial Cell Migration (GO:0043536),1/46,0.321906635409649,0.391977965212404,0,0,2.63300066533599,2.98448973899324,PRKCA,1
Positive Regulation Of Cell-Cell Adhesion (GO:0022409),1/46,0.321906635409649,0.391977965212404,0,0,2.63300066533599,2.98448973899324,JAK1,1
Development Of Primary Male Sexual Characteristics (GO:0046546),1/46,0.321906635409649,0.391977965212404,0,0,2.63300066533599,2.98448973899324,KITLG,1
Male Gonad Development (GO:0008584),1/46,0.321906635409649,0.391977965212404,0,0,2.63300066533599,2.98448973899324,KITLG,1
Protein Sumoylation (GO:0016925),1/46,0.321906635409649,0.391977965212404,0,0,2.63300066533599,2.98448973899324,SUMO2,1
Mitotic G2/M Transition Checkpoint (GO:0044818),1/46,0.321906635409649,0.391977965212404,0,0,2.63300066533599,2.98448973899324,BABAM2,1
Intracellular Calcium Ion Homeostasis (GO:0006874),2/139,0.326088470860531,0.396745416713385,0,0,1.73203763960953,1.94089808550899,MICU2;ATP13A3,1
Regulation Of Wound Healing (GO:0061041),1/47,0.327615741397724,0.39770542904856,0,0,2.57563134600365,2.87418276231149,CLDN3,1
Secondary Alcohol Metabolic Process (GO:1902652),1/47,0.327615741397724,0.39770542904856,0,0,2.57563134600365,2.87418276231149,UGT1A6,1
Regulation Of Inflammatory Response (GO:0050727),3/240,0.327679338718774,0.39770542904856,0,0,1.50326045262754,1.67721741343569,TNC;SAA1;S100A9,1
Cellular Defense Response (GO:0006968),1/48,0.333277064019215,0.403512018926438,0,0,2.52070327430246,2.76970114388682,DCDC2,1
Post-Translational Protein Modification (GO:0043687),1/48,0.333277064019215,0.403512018926438,0,0,2.52070327430246,2.76970114388682,PRKCA,1
Myelination (GO:0042552),1/48,0.333277064019215,0.403512018926438,0,0,2.52070327430246,2.76970114388682,DEGS1,1
Positive Regulation Of Transferase Activity (GO:0051347),2/143,0.338361409776148,0.408315635087223,0,0,1.68256002734342,1.82329051750612,ERBB2;HNRNPA2B1,1
Negative Regulation Of Tumor Necrosis Factor Superfamily Cytokine Production (GO:1903556),1/49,0.338891000895645,0.408315635087223,0,0,2.46806387225549,2.67063454499929,LTF,1
Neurogenesis (GO:0022008),1/49,0.338891000895645,0.408315635087223,0,0,2.46806387225549,2.67063454499929,ERBB2,1
Unsaturated Fatty Acid Metabolic Process (GO:0033559),1/49,0.338891000895645,0.408315635087223,0,0,2.46806387225549,2.67063454499929,DEGS1,1
Intrinsic Apoptotic Signaling Pathway In Response To DNA Damage (GO:0008630),1/49,0.338891000895645,0.408315635087223,0,0,2.46806387225549,2.67063454499929,TP53,1
Regulation Of Cell Communication (GO:0010646),1/49,0.338891000895645,0.408315635087223,0,0,2.46806387225549,2.67063454499929,ITGB6,1
Regulation Of Transcription By RNA Polymerase II (GO:0006357),19/2028,0.342898710835242,0.412810098481262,0,0,1.13127503415837,1.21082649718787,SMARCE1;JUP;ANXA2;HDAC1;HMGB2;IRF2BP2;HNF1B;ENO1;ARID1A;SOD2;MUC1;KLF5;MECOM;EPCAM;HOXB2;NCOA7;HES1;AGRN;TP53,1
Blood Circulation (GO:0008015),1/50,0.344457946244357,0.41303473527594,0,0,2.41757301723084,2.57660887054472,SERPING1,1
Plasma Membrane Bounded Cell Projection Morphogenesis (GO:0120039),1/50,0.344457946244357,0.41303473527594,0,0,2.41757301723084,2.57660887054472,NCKAP1,1
Positive Regulation Of Cell Death (GO:0010942),1/50,0.344457946244357,0.41303473527594,0,0,2.41757301723084,2.57660887054472,CLU,1
tRNA Processing (GO:0008033),1/50,0.344457946244357,0.41303473527594,0,0,2.41757301723084,2.57660887054472,DTWD2,1
Positive Regulation Of Protein Kinase Activity (GO:0045860),2/145,0.34447318983699,0.41303473527594,0,0,1.65885921307608,1.76791098370398,CLU;LTF,1
Neuron Projection Morphogenesis (GO:0048812),2/146,0.34752239813053,0.416355336890684,0,0,1.64725568942436,1.74102763201289,NCKAP1;DCDC2,1
Regulation Of DNA-templated Transcription (GO:0006355),18/1922,0.349583807298753,0.416947715944299,0,0,1.12991596638655,1.18755518776546,SMARCE1;HDAC1;HMGB2;IRF2BP2;HNF1B;PBXIP1;ENO1;ARID1A;ACVR1B;SOD2;ZFP36L2;KLF5;MECOM;PPP2R1A;SPP1;NCOA7;HES1;TP53,1
Cholesterol Transport (GO:0030301),1/51,0.349978291138729,0.416947715944299,0,0,2.36910179640719,2.48728242990725,CLU,1
Positive Regulation Of Actin Filament Bundle Assembly (GO:0032233),1/51,0.349978291138729,0.416947715944299,0,0,2.36910179640719,2.48728242990725,TPM1,1
Positive Regulation Of Protein Localization To Cell Periphery (GO:1904377),1/51,0.349978291138729,0.416947715944299,0,0,2.36910179640719,2.48728242990725,ITGA3,1
Positive Regulation Of Protein Localization To Plasma Membrane (GO:1903078),1/51,0.349978291138729,0.416947715944299,0,0,2.36910179640719,2.48728242990725,ITGA3,1
Receptor Internalization (GO:0031623),1/51,0.349978291138729,0.416947715944299,0,0,2.36910179640719,2.48728242990725,AP2M1,1
Regulated Exocytosis (GO:0045055),1/51,0.349978291138729,0.416947715944299,0,0,2.36910179640719,2.48728242990725,SDF4,1
Negative Regulation Of Innate Immune Response (GO:0045824),1/52,0.355452423228919,0.421780865841014,0,0,2.32253140777269,2.40234257345565,SERPING1,1
Negative Regulation Of Response To Stimulus (GO:0048585),1/52,0.355452423228919,0.421780865841014,0,0,2.32253140777269,2.40234257345565,CLU,1
Cardiac Muscle Tissue Development (GO:0048738),1/52,0.355452423228919,0.421780865841014,0,0,2.32253140777269,2.40234257345565,GJA1,1
Sprouting Angiogenesis (GO:0002040),1/52,0.355452423228919,0.421780865841014,0,0,2.32253140777269,2.40234257345565,RNF213,1
Positive Regulation Of Telomere Maintenance (GO:0032206),1/52,0.355452423228919,0.421780865841014,0,0,2.32253140777269,2.40234257345565,HNRNPA2B1,1
Axon Guidance (GO:0007411),2/149,0.356641630227735,0.422518109696552,0,0,1.61339234488976,1.66344596808191,PLXNB2;L1CAM,1
Skeletal System Development (GO:0001501),2/149,0.356641630227735,0.422518109696552,0,0,1.61339234488976,1.66344596808191,COL18A1;GJA1,1
protein-RNA Complex Assembly (GO:0022618),2/150,0.359671462461773,0.424834273780256,0,0,1.60240963855422,1.63856683985612,EIF2S3;ADAR,1
Negative Regulation Of DNA-templated Transcription (GO:0045892),10/1025,0.359713610930277,0.424834273780256,0,0,1.17334913013656,1.19968740286867,SMARCE1;MUC1;MECOM;HDAC1;HMGB2;IRF2BP2;PBXIP1;HES1;ENO1;TP53,1
Regulation Of Macromolecule Biosynthetic Process (GO:0010556),1/53,0.36088072718968,0.424834273780256,0,0,2.27775218793183,2.3215027299842,S100A9,1
Carboxylic Acid Transport (GO:0046942),1/53,0.36088072718968,0.424834273780256,0,0,2.27775218793183,2.3215027299842,SLC16A4,1
Regulation Of Receptor Signaling Pathway Via JAK-STAT (GO:0046425),1/53,0.36088072718968,0.424834273780256,0,0,2.27775218793183,2.3215027299842,HES1,1
Endosome Organization (GO:0007032),1/53,0.36088072718968,0.424834273780256,0,0,2.27775218793183,2.3215027299842,HOOK1,1
Gonad Development (GO:0008406),1/53,0.36088072718968,0.424834273780256,0,0,2.27775218793183,2.3215027299842,KITLG,1
Negative Regulation Of Cysteine-Type Endopeptidase Activity (GO:2000117),1/53,0.36088072718968,0.424834273780256,0,0,2.27775218793183,2.3215027299842,LTF,1
Protein Modification By Small Protein Conjugation (GO:0032446),4/364,0.365818706657988,0.428122712897856,0,0,1.31924119241192,1.32665190487908,PCNP;VCP;RNF213;SUMO2,1
ERBB Signaling Pathway (GO:0038127),1/54,0.366263584354147,0.428122712897856,0,0,2.23466274997175,2.24449980009496,PIGR,1
Negative Regulation Of Protein Catabolic Process (GO:0042177),1/54,0.366263584354147,0.428122712897856,0,0,2.23466274997175,2.24449980009496,ANXA2,1
Regulation Of Lipid Metabolic Process (GO:0019216),1/54,0.366263584354147,0.428122712897856,0,0,2.23466274997175,2.24449980009496,RNF213,1
Nucleosome Assembly (GO:0006334),1/54,0.366263584354147,0.428122712897856,0,0,2.23466274997175,2.24449980009496,HMGB2,1
Organelle Disassembly (GO:1903008),1/54,0.366263584354147,0.428122712897856,0,0,2.23466274997175,2.24449980009496,VCP,1
Peptidyl-Tyrosine Modification (GO:0018212),1/54,0.366263584354147,0.428122712897856,0,0,2.23466274997175,2.24449980009496,ERBB2,1
Regulation Of Smooth Muscle Cell Proliferation (GO:0048660),1/54,0.366263584354147,0.428122712897856,0,0,2.23466274997175,2.24449980009496,HDAC1,1
Protein K63-linked Ubiquitination (GO:0070534),1/54,0.366263584354147,0.428122712897856,0,0,2.23466274997175,2.24449980009496,RNF213,1
Phosphatidylcholine Metabolic Process (GO:0046470),1/55,0.371601372985619,0.433001443228349,0,0,2.19316921712131,2.17109184863007,MUC1,1
Cellular Response To Fibroblast Growth Factor Stimulus (GO:0044344),1/55,0.371601372985619,0.433001443228349,0,0,2.19316921712131,2.17109184863007,ZFP36L2,1
Response To Peptide Hormone (GO:0043434),1/55,0.371601372985619,0.433001443228349,0,0,2.19316921712131,2.17109184863007,SLC2A1,1
Positive Regulation Of Tyrosine Phosphorylation Of STAT Protein (GO:0042531),1/55,0.371601372985619,0.433001443228349,0,0,2.19316921712131,2.17109184863007,HES1,1
Regulation Of Mitotic Nuclear Division (GO:0007088),1/56,0.376894468131574,0.437115330147921,0,0,2.15318454001089,2.10105606309301,OBSL1,1
Nucleotide-Excision Repair (GO:0006289),1/56,0.376894468131574,0.437115330147921,0,0,2.15318454001089,2.10105606309301,TP53,1
Peptide Metabolic Process (GO:0006518),1/56,0.376894468131574,0.437115330147921,0,0,2.15318454001089,2.10105606309301,ANPEP,1
Regulation Of Reactive Oxygen Species Metabolic Process (GO:2000377),1/56,0.376894468131574,0.437115330147921,0,0,2.15318454001089,2.10105606309301,TP53,1
Positive Regulation Of DNA-templated Transcription Initiation (GO:2000144),1/56,0.376894468131574,0.437115330147921,0,0,2.15318454001089,2.10105606309301,HNF1B,1
Positive Regulation Of Cellular Metabolic Process (GO:0031325),1/56,0.376894468131574,0.437115330147921,0,0,2.15318454001089,2.10105606309301,TP53,1
RNA Catabolic Process (GO:0006401),1/57,0.382143241847668,0.440797785945217,0,0,2.11462788708298,2.03418693898467,ZFP36L2,1
Regulation Of Transcription Initiation By RNA Polymerase II (GO:0060260),1/57,0.382143241847668,0.440797785945217,0,0,2.11462788708298,2.03418693898467,HNF1B,1
Chemokine-Mediated Signaling Pathway (GO:0070098),1/57,0.382143241847668,0.440797785945217,0,0,2.11462788708298,2.03418693898467,CXCL1,1
Signal Transduction In Response To DNA Damage (GO:0042770),1/57,0.382143241847668,0.440797785945217,0,0,2.11462788708298,2.03418693898467,TP53,1
Striated Muscle Contraction (GO:0006941),1/57,0.382143241847668,0.440797785945217,0,0,2.11462788708298,2.03418693898467,TPM1,1
Post-Transcriptional Regulation Of Gene Expression (GO:0010608),1/57,0.382143241847668,0.440797785945217,0,0,2.11462788708298,2.03418693898467,PUM1,1
Monoatomic Anion Transport (GO:0006820),1/57,0.382143241847668,0.440797785945217,0,0,2.11462788708298,2.03418693898467,CLIC4,1
Regulation Of Neuron Death (GO:1901214),1/58,0.387348062975381,0.444732961193956,0,0,2.07742409917008,1.97029466770912,CLU,1
Regulation Of Phagocytosis (GO:0050764),1/58,0.387348062975381,0.444732961193956,0,0,2.07742409917008,1.97029466770912,CYBA,1
Renal System Development (GO:0072001),1/58,0.387348062975381,0.444732961193956,0,0,2.07742409917008,1.97029466770912,HNF1B,1
Selective Autophagy (GO:0061912),1/58,0.387348062975381,0.444732961193956,0,0,2.07742409917008,1.97029466770912,RNF213,1
Glycosaminoglycan Biosynthetic Process (GO:0006024),1/58,0.387348062975381,0.444732961193956,0,0,2.07742409917008,1.97029466770912,UGDH,1
mRNA Transport (GO:0051028),1/58,0.387348062975381,0.444732961193956,0,0,2.07742409917008,1.97029466770912,HNRNPA2B1,1
DNA-templated Transcription Initiation (GO:0006352),1/59,0.392509297414906,0.447208142843323,0,0,2.04150320049556,1.90920369656138,ZFP36L2,1
Negative Regulation Of Protein-Containing Complex Assembly (GO:0031333),1/59,0.392509297414906,0.447208142843323,0,0,2.04150320049556,1.90920369656138,CLU,1
Anterior/Posterior Pattern Specification (GO:0009952),1/59,0.392509297414906,0.447208142843323,0,0,2.04150320049556,1.90920369656138,HES1,1
Regulation Of Multicellular Organismal Development (GO:2000026),1/59,0.392509297414906,0.447208142843323,0,0,2.04150320049556,1.90920369656138,CD24,1
Cellular Response To Chemokine (GO:1990869),1/59,0.392509297414906,0.447208142843323,0,0,2.04150320049556,1.90920369656138,CXCL1,1
Glucose Metabolic Process (GO:0006006),1/59,0.392509297414906,0.447208142843323,0,0,2.04150320049556,1.90920369656138,ENO1,1
Heart Morphogenesis (GO:0003007),1/59,0.392509297414906,0.447208142843323,0,0,2.04150320049556,1.90920369656138,HES1,1
protein-DNA Complex Assembly (GO:0065004),1/59,0.392509297414906,0.447208142843323,0,0,2.04150320049556,1.90920369656138,HMGB2,1
Mitotic Cytokinesis (GO:0000281),1/59,0.392509297414906,0.447208142843323,0,0,2.04150320049556,1.90920369656138,RHOB,1
Regulation Of Cell Death (GO:0010941),1/59,0.392509297414906,0.447208142843323,0,0,2.04150320049556,1.90920369656138,CLU,1
Regulation Of Extrinsic Apoptotic Signaling Pathway (GO:2001236),1/60,0.397627308095733,0.452346662420834,0,0,2.00679995940323,1.85075144385457,TNFSF10,1
Negative Regulation Of Peptidase Activity (GO:0010466),1/60,0.397627308095733,0.452346662420834,0,0,2.00679995940323,1.85075144385457,SERPING1,1
Positive Regulation Of Cell Junction Assembly (GO:1901890),1/61,0.402702454697009,0.457770246439381,0,0,1.97325349301397,1.79478714999769,CLDN3,1
DNA Damage Response (GO:0006974),4/384,0.403849855425123,0.458724110589758,0,0,1.24852374839538,1.13205160864195,BABAM2;VCP;BTG2;TP53,1
Plasma Membrane Bounded Cell Projection Assembly (GO:0120031),3/275,0.407509495446071,0.461025699240953,0,0,1.30748663101604,1.17371903994322,SEPTIN2;DCDC2;AIF1L,1
Negative Regulation Of Kinase Activity (GO:0033673),1/62,0.407735094221165,0.461025699240953,0,0,1.94080691076863,1.74117084296752,WARS1,1
Phosphatidylinositol-Mediated Signaling (GO:0048015),1/62,0.407735094221165,0.461025699240953,0,0,1.94080691076863,1.74117084296752,ERBB2,1
Fat Cell Differentiation (GO:0045444),1/62,0.407735094221165,0.461025699240953,0,0,1.94080691076863,1.74117084296752,SDF4,1
mRNA Export From Nucleus (GO:0006406),1/62,0.407735094221165,0.461025699240953,0,0,1.94080691076863,1.74117084296752,HNRNPA2B1,1
Protein-Containing Complex Disassembly (GO:0032984),1/62,0.407735094221165,0.461025699240953,0,0,1.94080691076863,1.74117084296752,VCP,1
Regulation Of Cytokine Production (GO:0001817),2/167,0.41029103403089,0.463211728860368,0,0,1.43607155896313,1.27937968301257,SAA1;LTF,1
Membrane Organization (GO:0061024),2/167,0.41029103403089,0.463211728860368,0,0,1.43607155896313,1.27937968301257,ANXA2;AP2M1,1
Positive Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901992),1/63,0.412725580494754,0.465254290739541,0,0,1.90940699246668,1.68977241399707,ADAMTS1,1
Regulation Of Cellular Catabolic Process (GO:0031329),1/63,0.412725580494754,0.465254290739541,0,0,1.90940699246668,1.68977241399707,DAPK1,1
Cellular Response To Virus (GO:0098586),1/64,0.417674264467587,0.469410351607077,0,0,1.87900389696797,1.6404707819286,JAK1,1
Response To Metal Ion (GO:0010038),1/64,0.417674264467587,0.469410351607077,0,0,1.87900389696797,1.6404707819286,ANXA11,1
Positive Regulation Of Interleukin-1 Production (GO:0032732),1/64,0.417674264467587,0.469410351607077,0,0,1.87900389696797,1.6404707819286,SAA1,1
Negative Regulation Of Cell Death (GO:0060548),1/64,0.417674264467587,0.469410351607077,0,0,1.87900389696797,1.6404707819286,MECOM,1
Heart Development (GO:0007507),2/171,0.4219250959399,0.472073020697433,0,0,1.40179653525344,1.20964874949909,PDLIM1;GJA1,1
Metal Ion Transport (GO:0030001),2/171,0.4219250959399,0.472073020697433,0,0,1.40179653525344,1.20964874949909,KCNJ16;CLU,1
RNA Export From Nucleus (GO:0006405),1/65,0.422581494333993,0.472073020697433,0,0,1.84955089820359,1.59315314071084,HNRNPA2B1,1
Cellular Response To Light Stimulus (GO:0071482),1/65,0.422581494333993,0.472073020697433,0,0,1.84955089820359,1.59315314071084,TP53,1
Positive Regulation Of T Cell Proliferation (GO:0042102),1/65,0.422581494333993,0.472073020697433,0,0,1.84955089820359,1.59315314071084,CD24,1
Positive Regulation Of Cell Cycle (GO:0045787),1/65,0.422581494333993,0.472073020697433,0,0,1.84955089820359,1.59315314071084,PRKCA,1
Fatty Acid Biosynthetic Process (GO:0006633),1/65,0.422581494333993,0.472073020697433,0,0,1.84955089820359,1.59315314071084,DEGS1,1
Regulation Of Cell-Matrix Adhesion (GO:0001952),1/65,0.422581494333993,0.472073020697433,0,0,1.84955089820359,1.59315314071084,JUP,1
Response To Reactive Oxygen Species (GO:0000302),1/66,0.427447615102881,0.477150826161356,0,0,1.82100414555504,1.54771428225089,TPM1,1
tRNA Modification (GO:0006400),1/67,0.432272969291957,0.481814365772608,0,0,1.79332244601706,1.50405597918147,DTWD2,1
Protein Secretion (GO:0009306),1/67,0.432272969291957,0.481814365772608,0,0,1.79332244601706,1.50405597918147,RAB13,1
DNA Metabolic Process (GO:0006259),3/288,0.436536627810136,0.486055418322392,0,0,1.24701754385965,1.03363163621533,VCP;BTG2;HMGB2,1
B Cell Differentiation (GO:0030183),1/68,0.437057896314087,0.486055418322392,0,0,1.76646706586826,1.46208643120444,IRF2BP2,1
Cell-Cell Junction Organization (GO:0045216),1/68,0.437057896314087,0.486055418322392,0,0,1.76646706586826,1.46208643120444,CDH3,1
Regulation Of Heart Contraction (GO:0008016),1/69,0.441802732816012,0.490233010015082,0,0,1.74040154984149,1.42171975890568,TPM1,1
Regulation Of Monoatomic Ion Transmembrane Transporter Activity (GO:0032412),1/69,0.441802732816012,0.490233010015082,0,0,1.74040154984149,1.42171975890568,DAPK1,1
Phagocytosis (GO:0006909),1/69,0.441802732816012,0.490233010015082,0,0,1.74040154984149,1.42171975890568,ANXA11,1
Sulfur Compound Biosynthetic Process (GO:0044272),1/70,0.446507812794535,0.493980390660422,0,0,1.7150915560184,1.38287554481335,UGDH,1
Positive Regulation Of Protein Polymerization (GO:0032273),1/70,0.446507812794535,0.493980390660422,0,0,1.7150915560184,1.38287554481335,NCKAP1,1
Regulation Of G Protein-Coupled Receptor Signaling Pathway (GO:0008277),1/70,0.446507812794535,0.493980390660422,0,0,1.7150915560184,1.38287554481335,C3,1
Regulation Of Actin Filament Polymerization (GO:0030833),1/70,0.446507812794535,0.493980390660422,0,0,1.7150915560184,1.38287554481335,NCKAP1,1
"RNA Splicing, Via Transesterification Reactions With Bulged Adenosine As Nucleophile (GO:0000377)",2/180,0.447663963425388,0.494891513801617,0,0,1.33031000406119,1.06918665895735,HNRNPA2B1;HNRNPH3,1
Regulation Of Cilium Assembly (GO:1902017),1/71,0.451173467315437,0.496190775584162,0,0,1.69050470487596,1.34547841736824,DCDC2,1
Regulation Of Hydrolase Activity (GO:0051336),1/71,0.451173467315437,0.496190775584162,0,0,1.69050470487596,1.34547841736824,PLXNB2,1
Negative Regulation Of Protein Binding (GO:0032091),1/71,0.451173467315437,0.496190775584162,0,0,1.69050470487596,1.34547841736824,SLPI,1
Negative Regulation Of Supramolecular Fiber Organization (GO:1902904),1/71,0.451173467315437,0.496190775584162,0,0,1.69050470487596,1.34547841736824,CLU,1
Positive Regulation Of Cell-Substrate Adhesion (GO:0010811),1/71,0.451173467315437,0.496190775584162,0,0,1.69050470487596,1.34547841736824,JUP,1
Synapse Assembly (GO:0007416),1/71,0.451173467315437,0.496190775584162,0,0,1.69050470487596,1.34547841736824,PLXNB2,1
Kidney Development (GO:0001822),1/71,0.451173467315437,0.496190775584162,0,0,1.69050470487596,1.34547841736824,HNF1B,1
Cellular Response To Hypoxia (GO:0071456),1/72,0.455800024817281,0.49980135366847,0,0,1.66661044108965,1.30945766970655,TP53,1
Plasma Membrane Organization (GO:0007009),1/72,0.455800024817281,0.49980135366847,0,0,1.66661044108965,1.30945766970655,DEGS1,1
Cholesterol Homeostasis (GO:0042632),1/72,0.455800024817281,0.49980135366847,0,0,1.66661044108965,1.30945766970655,CD24,1
Second-Messenger-Mediated Signaling (GO:0019932),1/72,0.455800024817281,0.49980135366847,0,0,1.66661044108965,1.30945766970655,PPP2R1A,1
Regulation Of Intracellular Signal Transduction (GO:1902531),3/297,0.456324673289364,0.500008183987167,0,0,1.20828695114409,0.947962397479406,ARHGAP1;ARHGAP29;CD24,1
Cellular Response To Decreased Oxygen Levels (GO:0036294),1/73,0.460387810972019,0.502609730540252,0,0,1.64337990685296,1.27474691354286,TP53,1
Sterol Homeostasis (GO:0055092),1/73,0.460387810972019,0.502609730540252,0,0,1.64337990685296,1.27474691354286,CD24,1
Ubiquitin-Dependent ERAD Pathway (GO:0030433),1/73,0.460387810972019,0.502609730540252,0,0,1.64337990685296,1.27474691354286,VCP,1
Positive Regulation Of Secretion By Cell (GO:1903532),1/73,0.460387810972019,0.502609730540252,0,0,1.64337990685296,1.27474691354286,ANXA2,1
Regulation Of Rho Protein Signal Transduction (GO:0035023),1/73,0.460387810972019,0.502609730540252,0,0,1.64337990685296,1.27474691354286,ITGA3,1
Regulation Of Fat Cell Differentiation (GO:0045598),1/75,0.469448358408346,0.511750298396791,0,0,1.59880239520958,1.20900954147361,ZFP36L2,1
Regulation Of DNA Replication (GO:0006275),1/75,0.469448358408346,0.511750298396791,0,0,1.59880239520958,1.20900954147361,PPP2R1A,1
Positive Regulation Of Interleukin-6 Production (GO:0032755),1/76,0.473921757702946,0.51624859111419,0,0,1.57740518962076,1.17786902295425,CYBA,1
Intracellular Monoatomic Cation Homeostasis (GO:0030003),2/190,0.475499794158197,0.5175886566989,0,0,1.25890797231479,0.935858124481144,TMPRSS4;ATP13A3,1
Negative Regulation Of Transforming Growth Factor Beta Receptor Signaling Pathway (GO:0030512),1/77,0.478357661579222,0.518424035273039,0,0,1.55657106838954,1.14781018283293,HDAC1,1
Cell Morphogenesis Involved In Neuron Differentiation (GO:0048667),1/77,0.478357661579222,0.518424035273039,0,0,1.55657106838954,1.14781018283293,DCDC2,1
Chloride Transport (GO:0006821),1/77,0.478357661579222,0.518424035273039,0,0,1.55657106838954,1.14781018283293,CLIC4,1
Sphingolipid Biosynthetic Process (GO:0030148),1/77,0.478357661579222,0.518424035273039,0,0,1.55657106838954,1.14781018283293,DEGS1,1
Positive Regulation Of Response To Stimulus (GO:0048584),1/77,0.478357661579222,0.518424035273039,0,0,1.55657106838954,1.14781018283293,BABAM2,1
Monoatomic Cation Homeostasis (GO:0055080),1/77,0.478357661579222,0.518424035273039,0,0,1.55657106838954,1.14781018283293,FAM20A,1
Cellular Response To Cytokine Stimulus (GO:0071345),3/308,0.480110409699991,0.519944897841038,0,0,1.16405365126677,0.854111773095919,DAPK1;ZFP36L2;JAK1,1
Organonitrogen Compound Catabolic Process (GO:1901565),1/78,0.482756382525847,0.522050506684927,0,0,1.53627809316432,1.1187839772227,ANPEP,1
Proteolysis Involved In Protein Catabolic Process (GO:0051603),1/78,0.482756382525847,0.522050506684927,0,0,1.53627809316432,1.1187839772227,VCP,1
Regulation Of Neuron Differentiation (GO:0045664),1/79,0.487118230249416,0.524480409993583,0,0,1.51650545063719,1.09074413833994,HES1,1
Cellular Response To UV (GO:0034644),1/79,0.487118230249416,0.524480409993583,0,0,1.51650545063719,1.09074413833994,TP53,1
Positive Regulation Of Cytoskeleton Organization (GO:0051495),1/79,0.487118230249416,0.524480409993583,0,0,1.51650545063719,1.09074413833994,NCKAP1,1
Vesicle Fusion (GO:0006906),1/79,0.487118230249416,0.524480409993583,0,0,1.51650545063719,1.09074413833994,RAB13,1
Positive Regulation Of Protein Modification By Small Protein Conjugation Or Removal (GO:1903322),1/79,0.487118230249416,0.524480409993583,0,0,1.51650545063719,1.09074413833994,PTTG1IP,1
Negative Regulation Of Cellular Component Organization (GO:0051129),1/79,0.487118230249416,0.524480409993583,0,0,1.51650545063719,1.09074413833994,CLU,1
Regulation Of Organelle Assembly (GO:1902115),1/80,0.491443512146995,0.528754841702624,0,0,1.49723338133859,1.06364698446895,DCDC2,1
Spindle Assembly (GO:0051225),1/81,0.495732532875902,0.532215013650319,0,0,1.47844311377246,1.03745124773693,TUBGCP2,1
Histone Modification (GO:0016570),1/81,0.495732532875902,0.532215013650319,0,0,1.47844311377246,1.03745124773693,HDAC1,1
Macromolecule Modification (GO:0043412),1/81,0.495732532875902,0.532215013650319,0,0,1.47844311377246,1.03745124773693,QPCT,1
Protein Ubiquitination (GO:0016567),4/434,0.496487731401842,0.532641488338818,0,0,1.10051049347703,0.770573602315606,PCNP;BABAM2;VCP;RNF213,1
DNA-templated Transcription (GO:0006351),2/199,0.499818918611586,0.535621716816812,0,0,1.20084398507737,0.832796602312413,TP53;ZFP36L2,1
Negative Regulation Of Apoptotic Signaling Pathway (GO:2001234),1/82,0.499985594528596,0.535621716816812,0,0,1.46011680343018,1.01211791353355,CLU,1
Calcium Ion Transmembrane Import Into Cytosol (GO:0097553),1/83,0.50420299698048,0.538975617461892,0,0,1.44223747626698,0.987610071874104,CLU,1
Epigenetic Regulation Of Gene Expression (GO:0040029),1/83,0.50420299698048,0.538975617461892,0,0,1.44223747626698,0.987610071874104,TP53,1
Vascular Transport (GO:0010232),1/83,0.50420299698048,0.538975617461892,0,0,1.44223747626698,0.987610071874104,SLC2A1,1
Organic Substance Transport (GO:0071702),2/201,0.505125222269281,0.539573819624328,0,0,1.18865411394321,0.811790038087891,CLU;MFSD12,1
Positive Regulation Of Cytokine Production (GO:0001819),3/320,0.505496324370794,0.539582877090202,0,0,1.11930025810152,0.76360287916346,C3;SAA1;CYBA,1
Positive Regulation Of Protein Ubiquitination (GO:0031398),1/84,0.508385037279497,0.54227737309813,0,0,1.42478897626434,0.963892782848041,PTTG1IP,1
Regulation Of Kinase Activity (GO:0043549),1/85,0.512532010300429,0.54435947989082,0,0,1.40775591673795,0.940932948675833,ERBB2,1
Calcium-Mediated Signaling (GO:0019722),1/85,0.512532010300429,0.54435947989082,0,0,1.40775591673795,0.940932948675833,CLU,1
Response To Interleukin-1 (GO:0070555),1/85,0.512532010300429,0.54435947989082,0,0,1.40775591673795,0.940932948675833,PRKCA,1
Defense Response To Gram-positive Bacterium (GO:0050830),1/85,0.512532010300429,0.54435947989082,0,0,1.40775591673795,0.940932948675833,HMGB2,1
Transport Across Blood-Brain Barrier (GO:0150104),1/85,0.512532010300429,0.54435947989082,0,0,1.40775591673795,0.940932948675833,SLC2A1,1
Mitotic Spindle Organization (GO:0007052),1/85,0.512532010300429,0.54435947989082,0,0,1.40775591673795,0.940932948675833,VCP,1
Negative Regulation Of Binding (GO:0051100),1/86,0.516644208254036,0.548335650415126,0,0,1.39112363508278,0.918699198479639,SLPI,1
Negative Regulation Of Cell Differentiation (GO:0045596),2/207,0.52082526163928,0.552379179842658,0,0,1.15351160740523,0.752482550760225,HES1;ZFP36L2,1
Regulation Of Nucleic Acid-Templated Transcription (GO:1903506),4/452,0.528401200606577,0.559216245452313,0,0,1.05531358885017,0.673183941211874,PPP2R1A;ACTN4;ACVR1B;TP53,1
ERAD Pathway (GO:0036503),1/89,0.528775038542611,0.559216245452313,0,0,1.34349482852477,0.856064419464344,VCP,1
Organic Anion Transport (GO:0015711),1/89,0.528775038542611,0.559216245452313,0,0,1.34349482852477,0.856064419464344,SLC2A1,1
Sensory Perception Of Mechanical Stimulus (GO:0050954),1/89,0.528775038542611,0.559216245452313,0,0,1.34349482852477,0.856064419464344,DCDC2,1
"mRNA Splicing, Via Spliceosome (GO:0000398)",2/211,0.531107035747895,0.561283571869935,0,0,1.13120424280855,0.715816660537581,HNRNPA2B1;HNRNPH3,1
Regulation Of Peptidyl-Tyrosine Phosphorylation (GO:0050730),1/90,0.532751011222853,0.562621366003978,0,0,1.32833209984525,0.836452197570149,TP53,1
Regulation Of RNA Metabolic Process (GO:0051252),1/91,0.536693634329066,0.565981663984161,0,0,1.31350632069195,0.81743157848235,HNRNPH3,1
Regulation Of Actin Cytoskeleton Organization (GO:0032956),1/91,0.536693634329066,0.565981663984161,0,0,1.31350632069195,0.81743157848235,CLU,1
mRNA Processing (GO:0006397),2/214,0.538720042594686,0.567716305510547,0,0,1.11502614230507,0.68970972818522,HNRNPA2B1;HNRNPH3,1
Sensory Perception Of Sound (GO:0007605),1/92,0.540603186122169,0.568895007743838,0,0,1.29900638283872,0.79897953306283,DCDC2,1
Positive Regulation Of Protein Catabolic Process (GO:0045732),1/92,0.540603186122169,0.568895007743838,0,0,1.29900638283872,0.79897953306283,VCP,1
Positive Regulation Of Protein Kinase B Signaling (GO:0051897),1/93,0.544479942147204,0.5725697200813,0,0,1.28482166102577,0.781074147636773,RTN4,1
Peptidyl-Lysine Modification (GO:0018205),1/94,0.548324176088141,0.575798429089029,0,0,1.27094198699375,0.763694557261812,SUMO2,1
Muscle Contraction (GO:0006936),1/94,0.548324176088141,0.575798429089029,0,0,1.27094198699375,0.763694557261812,TPM1,1
Cell Junction Assembly (GO:0034329),1/95,0.552136159103913,0.578984217580425,0,0,1.25735762517518,0.746820887047665,CDH3,1
Positive Regulation Of Transmembrane Receptor Protein Serine/Threonine Kinase Signaling Pathway (GO:0090100),1/95,0.552136159103913,0.578984217580425,0,0,1.25735762517518,0.746820887047665,ACVR1B,1
Proteasomal Protein Catabolic Process (GO:0010498),2/220,0.553690628659752,0.580205391158952,0,0,1.08400574776169,0.640809109162814,PCNP;VCP,1
Cellular Response To Transforming Growth Factor Beta Stimulus (GO:0071560),1/96,0.555916160013578,0.582127548276006,0,0,1.24405924992121,0.730434195448227,ZFP36L2,1
Regulation Of Defense Response (GO:0031347),1/97,0.559664445779497,0.585228879353402,0,0,1.2310379241517,0.714516420673955,TNC,1
Regulation Of Protein Localization (GO:0032880),1/97,0.559664445779497,0.585228879353402,0,0,1.2310379241517,0.714516420673955,VCP,1
Protein Complex Oligomerization (GO:0051259),1/100,0.570721645453221,0.596372056484827,0,0,1.19355228936067,0.669408186906394,UGDH,1
Cilium Organization (GO:0044782),2/228,0.57311624501351,0.598454015845686,0,0,1.04520737818531,0.581832154535123,SEPTIN2;DCDC2,1
Activation Of GTPase Activity (GO:0090630),1/102,0.577939326928243,0.602222491925228,0,0,1.16979901582973,0.641384875357916,ARHGAP29,1
Protein Catabolic Process (GO:0030163),1/102,0.577939326928243,0.602222491925228,0,0,1.16979901582973,0.641384875357916,VCP,1
Regulation Of RNA Splicing (GO:0043484),1/102,0.577939326928243,0.602222491925228,0,0,1.16979901582973,0.641384875357916,HNRNPH3,1
Positive Regulation Of Inflammatory Response (GO:0050729),1/104,0.585036363567034,0.608339698803457,0,0,1.14696819952328,0.614868173337975,S100A9,1
Positive Regulation Of Kinase Activity (GO:0033674),1/104,0.585036363567034,0.608339698803457,0,0,1.14696819952328,0.614868173337975,ERBB2,1
Macroautophagy (GO:0016236),1/104,0.585036363567034,0.608339698803457,0,0,1.14696819952328,0.614868173337975,VCP,1
Negative Regulation Of MAPK Cascade (GO:0043409),1/105,0.588540267880922,0.611555809082969,0,0,1.13588208198987,0.602142370990268,PPP2R1A,1
Regulation Of Cellular Response To Stress (GO:0080135),1/107,0.595460085717827,0.617883268862013,0,0,1.11433736300983,0.577695799735771,BABAM2,1
Positive Regulation Of Autophagy (GO:0010508),1/107,0.595460085717827,0.617883268862013,0,0,1.11433736300983,0.577695799735771,DAPK1,1
Ubiquitin-Dependent Protein Catabolic Process (GO:0006511),3/367,0.598272588592605,0.619699731721266,0,0,0.972427572427572,0.499544596578348,PCNP;VCP;RNF213,1
Positive Regulation Of DNA Metabolic Process (GO:0051054),1/108,0.598876488047836,0.619699731721266,0,0,1.10386703229056,0.565952516012625,BABAM2,1
Response To Tumor Necrosis Factor (GO:0034612),1/108,0.598876488047836,0.619699731721266,0,0,1.10386703229056,0.565952516012625,ZFP36L2,1
Glycerophospholipid Biosynthetic Process (GO:0046474),1/108,0.598876488047836,0.619699731721266,0,0,1.10386703229056,0.565952516012625,MUC1,1
Negative Regulation Of Developmental Process (GO:0051093),1/109,0.602264208567481,0.622772162855047,0,0,1.09359059658461,0.554515003843877,HDAC1,1
Adenylate Cyclase-Activating G Protein-Coupled Receptor Signaling Pathway (GO:0007189),1/110,0.605623486527483,0.625376646740385,0,0,1.08350271933198,0.543373141515395,ADGRE3,1
Regulation Of JNK Cascade (GO:0046328),1/110,0.605623486527483,0.625376646740385,0,0,1.08350271933198,0.543373141515395,MECOM,1
Cilium Assembly (GO:0060271),2/243,0.607874285225642,0.627075698599106,0,0,0.97940308953657,0.487534308014065,SEPTIN2;DCDC2,1
Negative Regulation Of Inflammatory Response (GO:0050728),1/111,0.608954559459481,0.627075698599106,0,0,1.0735982580294,0.532517220926658,SAA1,1
Negative Regulation Of Transmembrane Receptor Protein Serine/Threonine Kinase Signaling Pathway (GO:0090101),1/111,0.608954559459481,0.627075698599106,0,0,1.0735982580294,0.532517220926658,HDAC1,1
Mitotic Cell Cycle Phase Transition (GO:0044772),1/111,0.608954559459481,0.627075698599106,0,0,1.0735982580294,0.532517220926658,ACVR1B,1
Regulation Of ERK1 And ERK2 Cascade (GO:0070372),2/244,0.610114021425898,0.627835175575198,0,0,0.975306183411331,0.481907971546547,ERBB2;PRKCA,1
Calcium Ion Transport (GO:0006816),1/112,0.61225766254873,0.628303035774145,0,0,1.06387225548902,0.52193792845649,CLU,1
Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071900),1/112,0.61225766254873,0.628303035774145,0,0,1.06387225548902,0.52193792845649,LTF,1
Protein Deubiquitination (GO:0016579),1/112,0.61225766254873,0.628303035774145,0,0,1.06387225548902,0.52193792845649,BABAM2,1
Negative Regulation Of Defense Response (GO:0031348),1/112,0.61225766254873,0.628303035774145,0,0,1.06387225548902,0.52193792845649,SAA1,1
Regulation Of Protein Ubiquitination (GO:0031396),1/113,0.615533029448367,0.631228909592812,0,0,1.05431993156544,0.511626324419936,PTTG1IP,1
Regulation Of Interleukin-6 Production (GO:0032675),1/114,0.618780891530764,0.634122566527394,0,0,1.04493667532192,0.501573826366613,CYBA,1
Negative Regulation Of Transcription By RNA Polymerase II (GO:0000122),6/763,0.622571091758928,0.637567642489528,0,0,0.933264836831547,0.442271829648426,HDAC1;HMGB2;IRF2BP2;HES1;ENO1;TP53,1
Regulation Of Protein Binding (GO:0043393),1/118,0.631501856101374,0.646268749572796,0,0,1.00900762577409,0.463794792803947,SLPI,1
Regulation Of Protein Kinase Activity (GO:0045859),1/119,0.634615600581581,0.649008944099926,0,0,1.00040596772557,0.454920424869917,WARS1,1
Regulation Of Protein Catabolic Process (GO:0042176),1/122,0.643800773313709,0.657498662107617,0,0,0.975454050576533,0.429556758391292,VCP,1
Potassium Ion Transport (GO:0006813),1/122,0.643800773313709,0.657498662107617,0,0,0.975454050576533,0.429556758391292,KCNJ16,1
Neuron Projection Guidance (GO:0097485),1/124,0.649796332580184,0.663166627489241,0,0,0.95949564286062,0.413635021200122,L1CAM,1
Cellular Response To Starvation (GO:0009267),1/126,0.655691564528341,0.668724501725957,0,0,0.944047904191617,0.398449367810017,TP53,1
Regulation Of Response To External Stimulus (GO:0032101),1/127,0.658602080433835,0.671147813650962,0,0,0.936507936507937,0.391119194605285,TNC,1
Negative Regulation Of Signal Transduction (GO:0009968),2/267,0.658969728322617,0.671147813650962,0,0,0.889611275289839,0.371037007967098,VCP;LTF,1
Transmembrane Receptor Protein Serine/Threonine Kinase Signaling Pathway (GO:0007178),1/130,0.667187694567914,0.679052865606741,0,0,0.914589425799564,0.370119589666532,ACVR1B,1
Organelle Organization (GO:0006996),3/418,0.685321315161935,0.697032205714942,0,0,0.850690032858708,0.321448096826267,GAK;TPM1;OBSL1,1
Potassium Ion Transmembrane Transport (GO:0071805),1/137,0.686395198413774,0.697647578715639,0,0,0.867206762944699,0.32633140182572,KCNJ16,1
Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway (GO:0007169),2/284,0.691859632710852,0.702721592814845,0,0,0.835255917286166,0.307685048824482,COL4A2;ERBB2,1
Actin Filament Organization (GO:0007015),1/144,0.704500396694064,0.715072708240633,0,0,0.824462962187513,0.288781660967064,TPM1,1
Positive Regulation Of Cellular Catabolic Process (GO:0031331),1/146,0.709479739945178,0.719635891641735,0,0,0.813008465826967,0.279043479615967,DAPK1,1
Defense Response To Symbiont (GO:0140546),1/148,0.714375668843448,0.72410830738355,0,0,0.801865656442218,0.269704553192417,IFITM1,1
Negative Regulation Of Protein Phosphorylation (GO:0001933),1/149,0.716792787940347,0.725569842486556,0,0,0.796407185628743,0.265178489135397,WARS1,1
Negative Regulation Of DNA-binding Transcription Factor Activity (GO:0043433),1/149,0.716792787940347,0.725569842486556,0,0,0.796407185628743,0.265178489135397,HES1,1
Regulation Of Cellular Component Organization (GO:0051128),1/153,0.72625961301481,0.734652824042173,0,0,0.77529152221872,0.247975236876854,TNC,1
Peptidyl-Serine Phosphorylation (GO:0018105),1/158,0.737651920816915,0.745669876477969,0,0,0.750410008009459,0.228337171796927,PRKCA,1
Regulation Of Macromolecule Metabolic Process (GO:0060255),1/162,0.74642540606943,0.754026479450992,0,0,0.731617510320973,0.213968558485097,TMPRSS4,1
Adenylate Cyclase-Modulating G Protein-Coupled Receptor Signaling Pathway (GO:0007188),1/163,0.74857281422467,0.755682732405908,0,0,0.72706438973904,0.210548249771705,ADGRE3,1
Proteasome-Mediated Ubiquitin-Dependent Protein Catabolic Process (GO:0043161),2/319,0.751384824684348,0.75800719941038,0,0,0.741704990308236,0.212006983052837,PCNP;VCP,1
Peptidyl-Serine Modification (GO:0018209),1/166,0.754907173233831,0.761044629926789,0,0,0.713736164035565,0.200674407220778,PRKCA,1
Organelle Assembly (GO:0070925),2/322,0.75599954035143,0.761629868681738,0,0,0.734638554216868,0.205489063810194,SEPTIN2;DCDC2,1
Positive Regulation Of ERK1 And ERK2 Cascade (GO:0070374),1/179,0.780572650646778,0.785853927038164,0,0,0.661172037946579,0.16379047035826,PRKCA,1
Axonogenesis (GO:0007409),1/188,0.796757797632441,0.801606222364484,0,0,0.629062730154664,0.142925907564824,L1CAM,1
Defense Response To Virus (GO:0051607),1/189,0.7984812189324,0.802797333629332,0,0,0.625684800611543,0.140806505178177,IFITM1,1
Transcription By RNA Polymerase II (GO:0006366),1/192,0.803564801613151,0.806818100405107,0,0,0.615763237922062,0.134665848632033,ANXA2,1
Modification-Dependent Protein Catabolic Process (GO:0019941),1/192,0.803564801613151,0.806818100405107,0,0,0.615763237922062,0.134665848632033,RNF213,1
Golgi Vesicle Transport (GO:0048193),1/197,0.811755685031964,0.814492555177048,0,0,0.599902236343639,0.125113129574074,RAB13,1
Protein Polyubiquitination (GO:0000209),1/226,0.852990864701457,0.855290031452674,0,0,0.521809713905522,0.0829711055704319,RNF213,1
Negative Regulation Of Intracellular Signal Transduction (GO:1902532),1/231,0.859131137774919,0.860866756235071,0,0,0.510335850039052,0.077486183084107,PPP2R1A,1
Regulation Of Autophagy (GO:0010506),1/241,0.870657190931759,0.871829004109326,0,0,0.488822355289421,0.0677052987155998,DAPK1,1
Monoatomic Cation Transmembrane Transport (GO:0098655),1/281,0.908111035996598,0.908721736088055,0,0,0.418135158254919,0.0403034715121279,CLU,1
Inorganic Cation Transmembrane Transport (GO:0098662),1/284,0.910439751383641,0.910439751383641,0,0,0.413639152789827,0.0388107494969078,CLU,1
Antigen Processing And Presentation Of Exogenous Peptide Antigen Via MHC Class II (GO:0019886),7/26,2.65571819215804e-12,2.18467184922562e-09,0,0,118.322580645161,3153.80627031398,HLA-DMB;CTSL;HLA-DRA;IFI30;CTSD;CTSS;HLA-DPA1,2
Antigen Processing And Presentation Of Peptide Antigen Via MHC Class II (GO:0002495),7/28,4.75445451409274e-12,2.18467184922562e-09,0,0,107.043010752688,2790.81886223032,HLA-DMB;CTSL;HLA-DRA;IFI30;CTSD;CTSS;HLA-DPA1,2
Antigen Processing And Presentation Of Exogenous Peptide Antigen (GO:0002478),7/31,1.04734086003418e-11,3.20835416790472e-09,0,0,93.6485215053763,2367.63892588977,HLA-DMB;CTSL;HLA-DRA;IFI30;CTSD;CTSS;HLA-DPA1,2
Protein Catabolic Process (GO:0030163),7/102,6.06579499737359e-08,1.39361640064658e-05,0,0,23.5741935483871,391.756305079085,CTSL;CTSZ;APOE;CTSD;SLC16A3;CTSS;CTSB,2
Microglial Cell Activation (GO:0001774),4/20,6.02772346225622e-07,0.000110789557236269,0,0,76.5961538461538,1096.98914694121,C1QA;GRN;TYROBP;ITGB2,2
Regulation Of T Cell Activation (GO:0050863),5/62,2.34336413567315e-06,0.000358925273447272,0,0,27.2395833333333,353.131860782661,HLA-DMB;GPNMB;LAPTM5;HLA-DRA;HLA-DPA1,2
Immunoglobulin Mediated Immune Response (GO:0016064),4/30,3.32204761336163e-06,0.000436137393811335,0,0,47.112426035503,594.319919544091,CD74;HLA-DMB;HLA-DRA;HLA-DPA1,2
Positive Regulation Of Neuron Death (GO:1901216),4/34,5.56361359360642e-06,0.00058421183038767,0,0,40.8225641025641,493.922928548609,C1QA;GRN;TYROBP;ITGB2,2
Phospholipid Efflux (GO:0033700),3/11,6.35703841553504e-06,0.00058421183038767,0,0,113.198863636364,1354.5317099322,APOC2;APOC1;APOE,2
Cellular Response To Thyroid Hormone Stimulus (GO:0097067),3/11,6.35703841553504e-06,0.00058421183038767,0,0,113.198863636364,1354.5317099322,CTSL;CTSS;CTSB,2
Response To Thyroid Hormone (GO:0097066),3/12,8.45511781738829e-06,0.000706386661289076,0,0,100.616161616162,1175.27108690604,CTSL;CTSS;CTSB,2
MHC Class II Protein Complex Assembly (GO:0002399),3/14,1.39203619560006e-05,0.000984062510581892,0,0,82.3140495867769,920.448699934427,HLA-DMB;HLA-DRA;HLA-DPA1,2
Peptide Antigen Assembly With MHC Class II Protein Complex (GO:0002503),3/14,1.39203619560006e-05,0.000984062510581892,0,0,82.3140495867769,920.448699934427,HLA-DMB;HLA-DRA;HLA-DPA1,2
Positive Regulation Of Leukocyte Cell-Cell Adhesion (GO:1903039),4/44,1.58682752455825e-05,0.00104163892504931,0,0,30.6015384615385,338.183376339778,HLA-DMB;ITGB2;HLA-DRA;HLA-DPA1,2
Proteolysis (GO:0006508),8/330,1.75900227682242e-05,0.00107768206159987,0,0,7.98655941350168,87.4382796957674,SRGN;MMP12;ADAMDEC1;CTSL;CTSZ;CTSD;CTSS;CTSB,2
Positive Regulation Of Lymphocyte Activation (GO:0051251),4/47,2.06878076945736e-05,0.00118825595445707,0,0,28.4622540250447,306.992905093598,HLA-DMB;TYROBP;HLA-DRA;HLA-DPA1,2
Intracellular Iron Ion Homeostasis (GO:0006879),4/50,2.65043726216908e-05,0.00143279520231376,0,0,26.6020066889632,280.337289075486,FTH1;HMOX1;CYB561A3;FTL,2
Peptide Antigen Assembly With MHC Protein Complex (GO:0002501),3/18,3.08989779334227e-05,0.00157756448448975,0,0,60.3515151515152,626.737657206113,HLA-DMB;HLA-DRA;HLA-DPA1,2
Immunoglobulin Production Involved In Immunoglobulin-Mediated Immune Response (GO:0002381),3/19,3.66019405504688e-05,0.00177037807188847,0,0,56.5767045454546,577.954193689741,HLA-DMB;HLA-DRA;HLA-DPA1,2
Negative Regulation Of B Cell Activation (GO:0050869),3/20,4.29547950629664e-05,0.00197377283314331,0,0,53.2459893048128,535.407712036511,LYN;TYROBP;LAPTM5,2
Regulation Of Neuron Death (GO:1901214),4/58,4.78247147942384e-05,0.00209290061409072,0,0,22.6518518518519,225.339897503053,C1QA;TYROBP;GPNMB;ITGB2,2
Cholesterol Efflux (GO:0033344),3/23,6.62377138534983e-05,0.00276692995597113,0,0,45.2522727272727,435.429159184779,APOC2;APOC1;APOE,2
Positive Regulation Of Peptidase Activity (GO:0010952),3/25,8.55989518729149e-05,0.0034202363813569,0,0,41.1342975206612,385.257147051806,GRN;CTSL;CTSS,2
Phagocytosis (GO:0006909),4/69,9.47086618888476e-05,0.00362655251149379,0,0,18.8080473372781,174.251011998997,TYROBP;ITGB2;CD14;TGM2,2
Regulation Of Peptidase Activity (GO:0052547),3/27,0.000108323021483952,0.00382426077998153,0,0,37.7026515151515,344.240020013589,CTSL;CTSS;CTSB,2
Cell Junction Disassembly (GO:0150146),2/5,0.000116517194602267,0.00382426077998153,0,0,198.28855721393,1795.99299593375,C1QB;C1QC,2
Humoral Immune Response Mediated By Circulating Immunoglobulin (GO:0002455),2/5,0.000116517194602267,0.00382426077998153,0,0,198.28855721393,1795.99299593375,C1QB;C1QC,2
Lipoprotein Metabolic Process (GO:0042157),2/5,0.000116517194602267,0.00382426077998153,0,0,198.28855721393,1795.99299593375,APOE;CTSD,2
Proteolysis Involved In Protein Catabolic Process (GO:0051603),4/78,0.000152667353222111,0.00483797577969379,0,0,16.5130977130977,145.104704098251,CTSL;CTSZ;CTSS;CTSB,2
Positive Regulation Of Immune Response (GO:0050778),4/80,0.000168398736116719,0.0050081562324707,0,0,16.0769230769231,139.695213533749,CD74;HLA-DMB;ITGB2;HLA-DRA,2
Positive Regulation Of Receptor Catabolic Process (GO:2000646),2/6,0.000174386288834671,0.0050081562324707,0,0,148.708955223881,1286.96264196369,LAPTM5;APOE,2
Intracellular Sequestering Of Iron Ion (GO:0006880),2/6,0.000174386288834671,0.0050081562324707,0,0,148.708955223881,1286.96264196369,FTH1;FTL,2
Negative Regulation Of Endocytosis (GO:0045806),3/33,0.000199083357299852,0.00554416985935044,0,0,30.1530303030303,256.957699839058,SNX3;APOC2;APOC1,2
Positive Regulation Of Aspartic-Type Peptidase Activity (GO:1905247),2/7,0.00024359667862016,0.00639615279005505,0,0,118.961194029851,989.756736615592,LYN;GRN,2
Very-Low-Density Lipoprotein Particle Remodeling (GO:0034372),2/7,0.00024359667862016,0.00639615279005505,0,0,118.961194029851,989.756736615592,APOC2;APOE,2
Regulation Of Cytokine Production (GO:0001817),5/167,0.000279088273151551,0.00712450341739653,0,0,9.5336612654321,78.0233163371535,SRGN;LYN;GPNMB;LITAF;PLD3,2
Negative Regulation Of Long-Term Synaptic Potentiation (GO:1900272),2/8,0.000324071709884352,0.00754868204787752,0,0,99.1293532338308,796.45932271971,TYROBP;APOE,2
Synapse Pruning (GO:0098883),2/8,0.000324071709884352,0.00754868204787752,0,0,99.1293532338308,796.45932271971,C1QB;C1QC,2
Triglyceride-Rich Lipoprotein Particle Remodeling (GO:0034370),2/8,0.000324071709884352,0.00754868204787752,0,0,99.1293532338308,796.45932271971,APOC2;APOE,2
Negative Regulation Of Lymphocyte Proliferation (GO:0050672),3/39,0.000328571185227769,0.00754868204787752,0,0,25.1199494949495,201.48101189959,LYN;TYROBP;GPNMB,2
Positive Regulation Of Apoptotic Process (GO:0043065),6/270,0.000336774715955362,0.00754868204787752,0,0,7.09487734487735,56.7313228396918,GRN;CTSL;CTSD;CTSS;TGM2;GADD45G,2
Extracellular Matrix Disassembly (GO:0022617),3/44,0.000470322100539523,0.0100517676836238,0,0,22.0509977827051,168.95679085168,MMP12;CAPG;CTSS,2
Regulation Of B Cell Proliferation (GO:0030888),3/44,0.000470322100539523,0.0100517676836238,0,0,22.0509977827051,168.95679085168,LYN;CD74;TYROBP,2
Lipoprotein Catabolic Process (GO:0042159),2/10,0.00051851096464888,0.0103589473154852,0,0,74.339552238806,562.34521406921,APOE;CTSD,2
Negative Regulation Of B Cell Proliferation (GO:0030889),2/10,0.00051851096464888,0.0103589473154852,0,0,74.339552238806,562.34521406921,LYN;TYROBP,2
Negative Regulation Of Cholesterol Transport (GO:0032375),2/10,0.00051851096464888,0.0103589473154852,0,0,74.339552238806,562.34521406921,APOC2;APOC1,2
Cellular Component Disassembly (GO:0022411),3/46,0.000536422621669964,0.0104887742407382,0,0,21.0232558139535,158.317482879455,MMP12;CAPG;CTSS,2
Macrophage Activation Involved In Immune Response (GO:0002281),2/11,0.000632323761872464,0.0121063653575165,0,0,66.0762852404644,486.725120291354,GRN;TYROBP,2
Positive Regulation Of Cell Death (GO:0010942),3/50,0.000685821661037112,0.0128626552345532,0,0,19.2301740812379,140.089759271884,C1QA;TYROBP;ITGB2,2
Cholesterol Transport (GO:0030301),3/51,0.000726892904067874,0.0133602915767675,0,0,18.8285984848485,136.069223953048,APOC2;APOC1;APOE,2
Astrocyte Activation (GO:0048143),2/12,0.000757098346017804,0.013380257307507,0,0,59.4656716417911,427.321350971091,C1QA;GRN,2
Positive Regulation Of Myeloid Leukocyte Mediated Immunity (GO:0002888),2/12,0.000757098346017804,0.013380257307507,0,0,59.4656716417911,427.321350971091,TYROBP;ITGB2,2
Positive Regulation Of Cytokine Production (GO:0001819),6/320,0.000823122277410838,0.0142726296781238,0,0,5.94995450409463,42.2589913385489,CD74;TYROBP;LAPTM5;HMOX1;CD14;HLA-DPA1,2
Regulation Of Lipid Metabolic Process (GO:0019216),3/54,0.000859406908989732,0.0146258323955845,0,0,17.7183600713013,125.078653102564,APOC2;PSAP;APOC1,2
Cellular Response To Lipopolysaccharide (GO:0071222),4/124,0.000891457587225602,0.014650828281714,0,0,10.1594871794872,71.3465500352044,LYN;CD14;VIM;CD68,2
Positive Regulation Of Superoxide Anion Generation (GO:0032930),2/13,0.00089275993882044,0.014650828281714,0,0,54.0569877883311,379.544535543116,TYROBP;ITGB2,2
Regulation Of Leukocyte Activation (GO:0002694),2/14,0.00103923413351442,0.016466485667237,0,0,49.5497512437811,340.370681524533,LYN;CD74,2
Regulation Of Superoxide Anion Generation (GO:0032928),2/14,0.00103923413351442,0.016466485667237,0,0,49.5497512437811,340.370681524533,TYROBP;ITGB2,2
Phospholipid Transport (GO:0015914),3/59,0.00111259297795138,0.0170412157789554,0,0,16.1323051948052,109.716807376724,APOC2;APOC1;APOE,2
Positive Regulation Of Proteolysis (GO:0045862),3/59,0.00111259297795138,0.0170412157789554,0,0,16.1323051948052,109.716807376724,CTSL;APOE;CTSS,2
Regulation Of Lipoprotein Lipase Activity (GO:0051004),2/15,0.00119644689354032,0.0174529316692627,0,0,45.735935706085,307.729625735492,APOC2;APOC1,2
High-Density Lipoprotein Particle Remodeling (GO:0034375),2/15,0.00119644689354032,0.0174529316692627,0,0,45.735935706085,307.729625735492,APOC1;APOE,2
Positive Regulation Of Syncytium Formation By Plasma Membrane Fusion (GO:0060143),2/15,0.00119644689354032,0.0174529316692627,0,0,45.735935706085,307.729625735492,CD53;TYROBP,2
Reverse Cholesterol Transport (GO:0043691),2/16,0.00136432455078224,0.0189971857904376,0,0,42.4669509594883,280.158544128242,APOC2;APOE,2
Positive Regulation Of Myeloid Leukocyte Cytokine Production Involved In Immune Response (GO:0061081),2/16,0.00136432455078224,0.0189971857904376,0,0,42.4669509594883,280.158544128242,CD74;LAPTM5,2
Glycoprotein Catabolic Process (GO:0006516),2/16,0.00136432455078224,0.0189971857904376,0,0,42.4669509594883,280.158544128242,MMP12;CTSL,2
Carbohydrate Derivative Catabolic Process (GO:1901136),2/17,0.00154279380451973,0.020952581400933,0,0,39.6338308457711,256.595776076302,FUCA1;SAMHD1,2
Regulation Of Cell Adhesion (GO:0030155),4/144,0.00155035422770777,0.020952581400933,0,0,8.69934065934066,56.2783995553957,LYN;ADAMDEC1;TGFBI;TGM2,2
Negative Regulation Of Leukocyte Cell-Cell Adhesion (GO:1903038),2/19,0.00193121572465896,0.0249970035346702,0,0,34.9675153643547,218.533178623166,GPNMB;LAPTM5,2
Cellular Response To Lectin (GO:1990858),2/19,0.00193121572465896,0.0249970035346702,0,0,34.9675153643547,218.533178623166,LYN;TYROBP,2
Stimulatory C-type Lectin Receptor Signaling Pathway (GO:0002223),2/19,0.00193121572465896,0.0249970035346702,0,0,34.9675153643547,218.533178623166,LYN;TYROBP,2
Positive Regulation Of Lymphocyte Proliferation (GO:0050671),3/74,0.00213823906399642,0.0272922458307321,0,0,12.7144686299616,78.1656625786047,CD74;HLA-DMB;HLA-DPA1,2
Regulation Of Membrane Protein Ectodomain Proteolysis (GO:0051043),2/21,0.00236113353212718,0.0293488021601199,0,0,31.2835820895522,189.222295861339,TIMP2;APOE,2
Regulation Of Immune Response (GO:0050776),3/77,0.00239516883787703,0.0293488021601199,0,0,12.1971744471744,73.6014287285796,LYN;HLA-DRA;SAMHD1,2
Regulation Of T Cell Proliferation (GO:0042129),3/77,0.00239516883787703,0.0293488021601199,0,0,12.1971744471744,73.6014287285796,HLA-DMB;GPNMB;HLA-DPA1,2
Cellular Response To Low-Density Lipoprotein Particle Stimulus (GO:0071404),2/22,0.00259147399914311,0.0313363763843752,0,0,29.7179104477612,176.985861250654,ITGB2;CD68,2
Regulation Of Cholesterol Transport (GO:0032374),2/23,0.00283197388192611,0.0325322999686262,0,0,28.3013503909026,166.037833964786,APOC2;APOC1,2
Negative Regulation Of Lymphocyte Activation (GO:0051250),2/23,0.00283197388192611,0.0325322999686262,0,0,28.3013503909026,166.037833964786,GPNMB;LAPTM5,2
Regulation Of Toll-Like Receptor 4 Signaling Pathway (GO:0034143),2/23,0.00283197388192611,0.0325322999686262,0,0,28.3013503909026,166.037833964786,LYN;CD14,2
Positive Regulation Of Neuron Apoptotic Process (GO:0043525),2/23,0.00283197388192611,0.0325322999686262,0,0,28.3013503909026,166.037833964786,GRN;TYROBP,2
Acylglycerol Homeostasis (GO:0055090),2/24,0.00308256240753893,0.0349737636114602,0,0,27.0135685210312,156.192293197393,APOC2;APOE,2
Positive Regulation Of Hydrolase Activity (GO:0051345),4/176,0.00321069321644212,0.0355497236856663,0,0,7.06940966010733,40.5873783580555,CTSL;PSAP;CTSS;TGM2,2
Extracellular Matrix Organization (GO:0030198),4/176,0.00321069321644212,0.0355497236856663,0,0,7.06940966010733,40.5873783580555,MMP12;CAPG;TGFBI;CTSS,2
Negative Regulation Of Protein Transport (GO:0051224),2/25,0.0033431691568994,0.0357257295697335,0,0,25.8377676833225,147.296878041843,SNX3;APOE,2
Regulation Of Monocyte Chemotaxis (GO:0090025),2/25,0.0033431691568994,0.0357257295697335,0,0,25.8377676833225,147.296878041843,LYN;PLA2G7,2
Negative Regulation Of Cytokine Production (GO:0001818),4/178,0.00334321299564426,0.0357257295697335,0,0,6.98744473916888,39.834185398346,SRGN;TYROBP;GPNMB;LAPTM5,2
Regulation Of Type II Interferon Production (GO:0032649),3/87,0.00338652589468572,0.0357726126116802,0,0,10.7397186147186,61.0869899360714,LAPTM5;CD14;HLA-DPA1,2
Negative Regulation Of Neuron Death (GO:1901215),3/88,0.00349746729938551,0.036494641926857,0,0,10.6128342245989,60.0231784644956,GRN;GPNMB;APOE,2
Negative Regulation Of Lipid Metabolic Process (GO:0045833),2/26,0.00361372406457452,0.036494641926857,0,0,24.7599502487562,139.225607340287,APOC2;APOC1,2
Regulation Of Fatty Acid Biosynthetic Process (GO:0042304),2/26,0.00361372406457452,0.036494641926857,0,0,24.7599502487562,139.225607340287,APOC2;APOC1,2
Negative Regulation Of Receptor-Mediated Endocytosis (GO:0048261),2/26,0.00361372406457452,0.036494641926857,0,0,24.7599502487562,139.225607340287,APOC2;APOC1,2
Positive Regulation Of Neuron Projection Development (GO:0010976),3/92,0.00396340569561867,0.0395909764594952,0,0,10.1338100102145,56.0465725387638,SNX3;LYN;APOE,2
Apoptotic Cell Clearance (GO:0043277),2/28,0.00418439985127567,0.04079796404514,0,0,22.8530424799082,125.15221878495,TYROBP;TGM2,2
Cellular Response To Hormone Stimulus (GO:0032870),3/94,0.00420986393551384,0.04079796404514,0,0,9.91008991008991,54.2114121034584,CTSL;CTSS;CTSB,2
Intracellular Monoatomic Cation Homeostasis (GO:0030003),4/190,0.00421741739313199,0.04079796404514,0,0,6.53267162944582,35.7241260096856,FTH1;HMOX1;CYB561A3;FTL,2
Regulation Of Defense Response (GO:0031347),3/97,0.00459669875098094,0.0440038140849113,0,0,9.59235976789168,51.6300792868325,GRN;APOE;SAMHD1,2
Regulation Of Vasculature Development (GO:1901342),2/30,0.00479403625548916,0.0449563195795361,0,0,21.2185501066098,113.31517536895,GPNMB;HMOX1,2
Innate Immune Response Activating Cell Surface Receptor Signaling Pathway (GO:0002220),2/30,0.00479403625548916,0.0449563195795361,0,0,21.2185501066098,113.31517536895,LYN;TYROBP,2
Regulation Of Long-Term Synaptic Potentiation (GO:1900271),2/31,0.00511329323709684,0.04699116484892,0,0,20.4858466289243,108.081516136767,TYROBP;APOE,2
Triglyceride Homeostasis (GO:0070328),2/31,0.00511329323709684,0.04699116484892,0,0,20.4858466289243,108.081516136767,APOC2;APOE,2
Lysosomal Transport (GO:0007041),3/105,0.00573111640473348,0.0520797739063837,0,0,8.83645276292335,45.6123989129325,GRN;PSAP;LAPTM5,2
Glycolipid Metabolic Process (GO:0006664),2/33,0.0057803448731786,0.0520797739063837,0,0,19.1622532498796,98.7486850607751,GM2A;FUCA1,2
Positive Regulation Of T Cell Activation (GO:0050870),3/107,0.00603857905901605,0.0538781956819005,0,0,8.66564685314685,44.2778726065201,HLA-DMB;HLA-DRA;HLA-DPA1,2
Macrophage Activation (GO:0042116),2/35,0.00648499754948315,0.0573049302689906,0,0,17.9990954319313,90.6841916510007,C1QA;ITGB2,2
Negative Regulation Of Inflammatory Response (GO:0050728),3/111,0.00668271053942584,0.0584896284355462,0,0,8.34301346801347,41.7837437261111,LYN;GRN;APOE,2
Negative Regulation Of Smooth Muscle Cell Proliferation (GO:0048662),2/37,0.00722671699242012,0.0620687188414401,0,0,16.9688699360341,83.6560269677748,HMOX1;APOE,2
Positive Regulation Of Immune Effector Process (GO:0002699),2/37,0.00722671699242012,0.0620687188414401,0,0,16.9688699360341,83.6560269677748,HLA-DMB;HLA-DRA,2
Cellular Response To Molecule Of Bacterial Origin (GO:0071219),3/117,0.00772304654044892,0.065102401729118,0,0,7.90151515151515,38.4293852789165,CD14;VIM;CD68,2
Protein Processing (GO:0016485),3/117,0.00772304654044892,0.065102401729118,0,0,7.90151515151515,38.4293852789165,SRGN;CTSL;CTSS,2
Positive Regulation Of Cell Projection Organization (GO:0031346),3/118,0.00790519802477962,0.065102401729118,0,0,7.83241106719368,37.910708286856,SNX3;LYN;APOE,2
Cellular Response To Lipid (GO:0071396),4/228,0.00797583913842803,0.065102401729118,0,0,5.41401098901099,26.1569192689634,LYN;CD14;VIM;CD68,2
Regulation Of Receptor-Mediated Endocytosis (GO:0048259),2/39,0.008004974314897,0.065102401729118,0,0,16.0500201694232,77.4845562375616,APOC2;APOC1,2
Positive Regulation Of Lipid Biosynthetic Process (GO:0046889),2/39,0.008004974314897,0.065102401729118,0,0,16.0500201694232,77.4845562375616,APOC2;APOE,2
Receptor-Mediated Endocytosis (GO:0006898),3/122,0.00865913635599508,0.0692725389187327,0,0,7.56760886172651,35.9396361390866,CTSL;ITGB2;APOE,2
Regulation Of Chemokine Production (GO:0032642),2/41,0.00881924597768414,0.0692725389187327,0,0,15.2254114045159,72.0286640735087,CD74;HMOX1,2
Negative Regulation Of Proteolysis (GO:0045861),2/41,0.00881924597768414,0.0692725389187327,0,0,15.2254114045159,72.0286640735087,TIMP2;CTSB,2
Acylglycerol Metabolic Process (GO:0006639),2/41,0.00881924597768414,0.0692725389187327,0,0,15.2254114045159,72.0286640735087,APOC1;APOE,2
Positive Regulation Of Intracellular Signal Transduction (GO:1902533),6/525,0.00943907505791313,0.0735127964256116,0,0,3.56216166620791,16.6099939613028,LYN;CD74;LAPTM5;HMOX1;LITAF;TGM2,2
Regulation Of Primary Metabolic Process (GO:0080090),2/43,0.00966901373244494,0.0743070178407676,0,0,14.4812522752093,67.17605253596,PSAP;APOE,2
Negative Regulation Of Cell Population Proliferation (GO:0008285),5/379,0.00992976947832326,0.0743070178407676,0,0,4.08526905080214,18.8421515157649,LYN;GPNMB;FTH1;HMOX1;APOE,2
Regulation Of ERK1 And ERK2 Cascade (GO:0070372),4/244,0.0100596162684729,0.0743070178407676,0,0,5.04897435897436,23.2213754544537,LYN;CD74;GPNMB;APOE,2
Negative Regulation Of Immune System Process (GO:0002683),2/44,0.0101070481285048,0.0743070178407676,0,0,14.135749822317,64.9470172770087,LYN;HMOX1,2
Regulation Of Viral Entry Into Host Cell (GO:0046596),2/44,0.0101070481285048,0.0743070178407676,0,0,14.135749822317,64.9470172770087,SNX3;CD74,2
Positive Regulation Of Biosynthetic Process (GO:0009891),2/44,0.0101070481285048,0.0743070178407676,0,0,14.135749822317,64.9470172770087,APOE;VIM,2
Positive Regulation Of Cytokine-Mediated Signaling Pathway (GO:0001961),2/44,0.0101070481285048,0.0743070178407676,0,0,14.135749822317,64.9470172770087,CD74;LAPTM5,2
Positive Regulation Of Programmed Cell Death (GO:0043068),4/245,0.0102004787071954,0.0743987296183535,0,0,5.02776891158634,23.0539325016821,LAPTM5;CTSD;TGM2;GADD45G,2
Negative Regulation Of Cellular Process (GO:0048523),6/537,0.0104756518810233,0.0746069973174341,0,0,3.47950856425433,15.8620412000385,LYN;ADAMDEC1;GPNMB;FTH1;TGFBI;HOPX,2
Synapse Organization (GO:0050808),3/131,0.0105056777695533,0.0746069973174341,0,0,7.03231534090909,32.0380995003018,C1QB;C1QA;C1QC,2
Triglyceride Metabolic Process (GO:0006641),2/45,0.0105537645824444,0.0746069973174341,0,0,13.8063172509545,62.8363141049501,APOC1;APOE,2
Regulation Of Apoptotic Signaling Pathway (GO:2001233),2/45,0.0105537645824444,0.0746069973174341,0,0,13.8063172509545,62.8363141049501,CTSL;CTSS,2
Regulation Of Fibroblast Proliferation (GO:0048145),2/46,0.0110090997812215,0.0766466871132012,0,0,13.4918588873813,60.8352382407309,CD74;FTH1,2
Vacuolar Transport (GO:0007034),2/46,0.0110090997812215,0.0766466871132012,0,0,13.4918588873813,60.8352382407309,GRN;PSAP,2
Cellular Defense Response (GO:0006968),2/48,0.0119453747754556,0.0819238762585349,0,0,12.9039584685269,57.1311292621071,TYROBP;LSP1,2
Positive Regulation Of Reactive Oxygen Species Metabolic Process (GO:2000379),2/48,0.0119453747754556,0.0819238762585349,0,0,12.9039584685269,57.1311292621071,TYROBP;ITGB2,2
Negative Regulation Of T Cell Activation (GO:0050868),2/49,0.0124261895535353,0.0845901348125849,0,0,12.6287710384249,55.4144029066289,GPNMB;LAPTM5,2
Cellular Response To Oxygen-Containing Compound (GO:1901701),5/406,0.0130728172448712,0.0883376400590929,0,0,3.80494077306733,16.5028660723978,LYN;CD14;VIM;CD68;TGM2,2
Regulation Of Protein Phosphorylation (GO:0001932),4/265,0.0132914608296896,0.0883553262252848,0,0,4.63778367226643,20.038163466907,LYN;CD74;GPNMB;ITGB2,2
Positive Regulation Of Leukocyte Mediated Cytotoxicity (GO:0001912),2/51,0.0134128635161965,0.0883553262252848,0,0,12.1120925982333,52.2217846639774,TYROBP;HLA-DRA,2
Negative Regulation Of MAP Kinase Activity (GO:0043407),2/51,0.0134128635161965,0.0883553262252848,0,0,12.1120925982333,52.2217846639774,LYN;APOE,2
Positive Regulation Of Signal Transduction (GO:0009967),4/266,0.0134600061714253,0.0883553262252848,0,0,4.61984732824427,19.9024524178572,CD63;CD74;CTSL;CTSS,2
Negative Regulation Of Innate Immune Response (GO:0045824),2/52,0.0139185995903711,0.0907176810180922,0,0,11.8692537313433,50.7354720518067,GRN;SAMHD1,2
Positive Regulation Of Cellular Catabolic Process (GO:0031331),3/146,0.0140556104358766,0.0909655351448632,0,0,6.28989192625556,26.8247137126965,APOC2;LAPTM5;APOE,2
Negative Regulation Of Metabolic Process (GO:0009892),2/53,0.0144325201711686,0.0914723174986478,0,0,11.6359379572725,49.3162615834763,APOC2;APOC1,2
Carboxylic Acid Transport (GO:0046942),2/53,0.0144325201711686,0.0914723174986478,0,0,11.6359379572725,49.3162615834763,PSAP;SLC16A3,2
Positive Regulation Of Chemokine Production (GO:0032722),2/53,0.0144325201711686,0.0914723174986478,0,0,11.6359379572725,49.3162615834763,CD74;HMOX1,2
Negative Regulation Of Protein Catabolic Process (GO:0042177),2/54,0.0149545644899604,0.0934914609950588,0,0,11.4115958668197,47.9599556774216,SNX3;TIMP2,2
Regulation Of Smooth Muscle Cell Proliferation (GO:0048660),2/54,0.0149545644899604,0.0934914609950588,0,0,11.4115958668197,47.9599556774216,HMOX1;APOE,2
Pattern Recognition Receptor Signaling Pathway (GO:0002221),2/56,0.016022782801093,0.0948504731355172,0,0,10.9878385848535,45.4209079168642,CD14;CTSS,2
Regulation Of Phagocytosis (GO:0050764),2/58,0.0171227745483908,0.0948504731355172,0,0,10.5943496801706,43.0908842756189,SNX3;TGM2,2
Positive Regulation Of Type II Interferon Production (GO:0032729),2/58,0.0171227745483908,0.0948504731355172,0,0,10.5943496801706,43.0908842756189,CD14;HLA-DPA1,2
Negative Regulation Of Endoplasmic Reticulum Calcium Ion Concentration (GO:0032471),1/5,0.01713294726931,0.0948504731355172,0,0,73.2610294117647,297.934432634127,TGM2,2
Regulation Of Endothelial Cell-Matrix Adhesion Via Fibronectin (GO:1904904),1/5,0.01713294726931,0.0948504731355172,0,0,73.2610294117647,297.934432634127,MMP12,2
Negative Regulation Of Lipoprotein Lipase Activity (GO:0051005),1/5,0.01713294726931,0.0948504731355172,0,0,73.2610294117647,297.934432634127,APOC1,2
His-Purkinje System Development (GO:0003164),1/5,0.01713294726931,0.0948504731355172,0,0,73.2610294117647,297.934432634127,HOPX,2
Negative Regulation Of Toll-Like Receptor 2 Signaling Pathway (GO:0034136),1/5,0.01713294726931,0.0948504731355172,0,0,73.2610294117647,297.934432634127,LYN,2
Regulation Of Neutrophil Activation (GO:1902563),1/5,0.01713294726931,0.0948504731355172,0,0,73.2610294117647,297.934432634127,GRN,2
"Positive Regulation Of CD4-positive, CD25-positive, Alpha-Beta Regulatory T Cell Differentiation (GO:0032831)",1/5,0.01713294726931,0.0948504731355172,0,0,73.2610294117647,297.934432634127,HLA-DRA,2
Regulation Of Type 2 Immune Response (GO:0002828),1/5,0.01713294726931,0.0948504731355172,0,0,73.2610294117647,297.934432634127,CD74,2
Regulation Of Very-Low-Density Lipoprotein Particle Remodeling (GO:0010901),1/5,0.01713294726931,0.0948504731355172,0,0,73.2610294117647,297.934432634127,APOC2,2
Glycolipid Transport (GO:0046836),1/5,0.01713294726931,0.0948504731355172,0,0,73.2610294117647,297.934432634127,PSAP,2
Inflammatory Response To Wounding (GO:0090594),1/5,0.01713294726931,0.0948504731355172,0,0,73.2610294117647,297.934432634127,HMOX1,2
Interleukin-5-Mediated Signaling Pathway (GO:0038043),1/5,0.01713294726931,0.0948504731355172,0,0,73.2610294117647,297.934432634127,LYN,2
Isoleucine Metabolic Process (GO:0006549),1/5,0.01713294726931,0.0948504731355172,0,0,73.2610294117647,297.934432634127,SDS,2
Leukocyte Apoptotic Process (GO:0071887),1/5,0.01713294726931,0.0948504731355172,0,0,73.2610294117647,297.934432634127,CTSL,2
Purine Deoxyribonucleotide Catabolic Process (GO:0009155),1/5,0.01713294726931,0.0948504731355172,0,0,73.2610294117647,297.934432634127,SAMHD1,2
Regulation Of T Cell Activation Via T Cell Receptor Contact With Antigen Bound To MHC Molecule On Antigen Presenting Cell (GO:2001188),1/5,0.01713294726931,0.0948504731355172,0,0,73.2610294117647,297.934432634127,HLA-DMB,2
Response To Lipopolysaccharide (GO:0032496),3/159,0.017620109688926,0.0967290943530264,0,0,5.76194638694639,23.2708560365286,CD14;VIM;CD68,2
Regulation Of Type I Interferon Production (GO:0032479),2/59,0.0176845368120344,0.0967290943530264,0,0,10.407960199005,41.9967922534141,TYROBP;CD14,2
Negative Regulation Of Peptidase Activity (GO:0010466),2/60,0.0182540646638675,0.0967290943530264,0,0,10.2279979413278,40.9464345733815,TIMP2;CTSB,2
Positive Regulation Of Interleukin-8 Production (GO:0032757),2/61,0.0188312994871132,0.0967290943530264,0,0,10.0541360991652,39.9373905755653,CD74;CD14,2
Positive Regulation Of Apoptotic Signaling Pathway (GO:2001235),2/62,0.0194161829566514,0.0967290943530264,0,0,9.88606965174129,38.9674105026706,CTSL;CTSS,2
DNA Strand Resection Involved In Replication Fork Processing (GO:0110025),1/6,0.0205246718159305,0.0967290943530264,0,0,58.6058823529412,227.749937710711,SAMHD1,2
Negative Regulation Of Lipoprotein Particle Clearance (GO:0010985),1/6,0.0205246718159305,0.0967290943530264,0,0,58.6058823529412,227.749937710711,APOC2,2
Negative Regulation Of Membrane Protein Ectodomain Proteolysis (GO:0051045),1/6,0.0205246718159305,0.0967290943530264,0,0,58.6058823529412,227.749937710711,TIMP2,2
Regulation Of Metallopeptidase Activity (GO:1905048),1/6,0.0205246718159305,0.0967290943530264,0,0,58.6058823529412,227.749937710711,TIMP2,2
Antigen Processing And Presentation Of Exogenous Peptide Antigen Via MHC Class I (GO:0042590),1/6,0.0205246718159305,0.0967290943530264,0,0,58.6058823529412,227.749937710711,IFI30,2
Regulation Of Osteoclast Development (GO:2001204),1/6,0.0205246718159305,0.0967290943530264,0,0,58.6058823529412,227.749937710711,TYROBP,2
Bleb Assembly (GO:0032060),1/6,0.0205246718159305,0.0967290943530264,0,0,58.6058823529412,227.749937710711,EMP3,2
Nucleotide Catabolic Process (GO:0009166),1/6,0.0205246718159305,0.0967290943530264,0,0,58.6058823529412,227.749937710711,SAMHD1,2
Regulation Of Prostaglandin Biosynthetic Process (GO:0031392),1/6,0.0205246718159305,0.0967290943530264,0,0,58.6058823529412,227.749937710711,CD74,2
Cellular Response To Monoamine Stimulus (GO:0071868),1/6,0.0205246718159305,0.0967290943530264,0,0,58.6058823529412,227.749937710711,TGM2,2
Regulation Of Transforming Growth Factor Beta1 Production (GO:0032908),1/6,0.0205246718159305,0.0967290943530264,0,0,58.6058823529412,227.749937710711,TYROBP,2
Cholesterol Catabolic Process (GO:0006707),1/6,0.0205246718159305,0.0967290943530264,0,0,58.6058823529412,227.749937710711,APOE,2
Positive Regulation Of Amyloid-Beta Clearance (GO:1900223),1/6,0.0205246718159305,0.0967290943530264,0,0,58.6058823529412,227.749937710711,APOE,2
Positive Regulation Of Aspartic-Type Endopeptidase Activity Involved In Amyloid Precursor Protein Catabolic Process (GO:1902961),1/6,0.0205246718159305,0.0967290943530264,0,0,58.6058823529412,227.749937710711,LYN,2
Response To Cocaine (GO:0042220),1/6,0.0205246718159305,0.0967290943530264,0,0,58.6058823529412,227.749937710711,TGM2,2
Development Of Primary Female Sexual Characteristics (GO:0046545),1/6,0.0205246718159305,0.0967290943530264,0,0,58.6058823529412,227.749937710711,LHFPL2,2
Sterol Catabolic Process (GO:0016127),1/6,0.0205246718159305,0.0967290943530264,0,0,58.6058823529412,227.749937710711,APOE,2
Positive Regulation Of Lipoprotein Lipase Activity (GO:0051006),1/6,0.0205246718159305,0.0967290943530264,0,0,58.6058823529412,227.749937710711,APOC2,2
Positive Regulation Of Steroid Metabolic Process (GO:0045940),1/6,0.0205246718159305,0.0967290943530264,0,0,58.6058823529412,227.749937710711,APOE,2
Positive Regulation Of Triglyceride Catabolic Process (GO:0010898),1/6,0.0205246718159305,0.0967290943530264,0,0,58.6058823529412,227.749937710711,APOC2,2
Positive Regulation Of Unsaturated Fatty Acid Biosynthetic Process (GO:2001280),1/6,0.0205246718159305,0.0967290943530264,0,0,58.6058823529412,227.749937710711,CD74,2
Membrane Invagination (GO:0010324),1/6,0.0205246718159305,0.0967290943530264,0,0,58.6058823529412,227.749937710711,SNX3,2
Regulation Of T-helper Cell Differentiation (GO:0045622),1/6,0.0205246718159305,0.0967290943530264,0,0,58.6058823529412,227.749937710711,HLA-DRA,2
Regulation Of Antigen Receptor-Mediated Signaling Pathway (GO:0050854),1/6,0.0205246718159305,0.0967290943530264,0,0,58.6058823529412,227.749937710711,LYN,2
Positive Regulation Of T Cell Proliferation (GO:0042102),2/65,0.0212161465390204,0.09947774831306,0,0,9.41388296612177,36.2716228931025,HLA-DMB;HLA-DPA1,2
Response To Reactive Oxygen Species (GO:0000302),2/66,0.0218310473790006,0.0998115776966959,0,0,9.26632462686567,35.438336973133,HMOX1;APOE,2
Positive Regulation Of MAPK Cascade (GO:0043410),4/310,0.0222702829545693,0.0998115776966959,0,0,3.94670688788336,15.0152546120751,CD74;GPNMB;LAPTM5;APOE,2
Regulation Of Neuron Projection Development (GO:0010975),3/174,0.0223043785680366,0.0998115776966959,0,0,5.25252525252525,19.9752078904309,SNX3;LYN;APOE,2
Negative Regulation Of Cellular Catabolic Process (GO:0031330),2/67,0.0224533097382319,0.0998115776966959,0,0,9.12330654420207,34.6349659977225,APOC1;TIMP2,2
Positive Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043123),3/175,0.0226385404913842,0.0998115776966959,0,0,5.22172304439746,19.7804168639266,CD74;HMOX1;LITAF,2
Regulation Of Dopamine Metabolic Process (GO:0042053),1/7,0.0239048624297549,0.0998115776966959,0,0,48.8357843137255,182.336868459542,ITGB2,2
Negative Regulation Of Leukocyte Proliferation (GO:0070664),1/7,0.0239048624297549,0.0998115776966959,0,0,48.8357843137255,182.336868459542,LYN,2
Regulation Of Extent Of Cell Growth (GO:0061387),1/7,0.0239048624297549,0.0998115776966959,0,0,48.8357843137255,182.336868459542,APOE,2
Negative Regulation Of Microglial Cell Activation (GO:1903979),1/7,0.0239048624297549,0.0998115776966959,0,0,48.8357843137255,182.336868459542,GRN,2
Regulation Of Leukocyte Degranulation (GO:0043300),1/7,0.0239048624297549,0.0998115776966959,0,0,48.8357843137255,182.336868459542,LYN,2
Regulation Of Lymphocyte Apoptotic Process (GO:0070228),1/7,0.0239048624297549,0.0998115776966959,0,0,48.8357843137255,182.336868459542,LYN,2
Platelet Activating Factor Metabolic Process (GO:0046469),1/7,0.0239048624297549,0.0998115776966959,0,0,48.8357843137255,182.336868459542,PLA2G7,2
"Positive Regulation Of CD4-positive, Alpha-Beta T Cell Differentiation (GO:0043372)",1/7,0.0239048624297549,0.0998115776966959,0,0,48.8357843137255,182.336868459542,HLA-DRA,2
Positive Regulation Of CoA-transferase Activity (GO:1905920),1/7,0.0239048624297549,0.0998115776966959,0,0,48.8357843137255,182.336868459542,APOE,2
Sialylation (GO:0097503),1/7,0.0239048624297549,0.0998115776966959,0,0,48.8357843137255,182.336868459542,ST3GAL1,2
Somatic Hypermutation Of Immunoglobulin Genes (GO:0016446),1/7,0.0239048624297549,0.0998115776966959,0,0,48.8357843137255,182.336868459542,SAMHD1,2
Positive Regulation Of Isomerase Activity (GO:0010912),1/7,0.0239048624297549,0.0998115776966959,0,0,48.8357843137255,182.336868459542,ITGB2,2
Glycoside Catabolic Process (GO:0016139),1/7,0.0239048624297549,0.0998115776966959,0,0,48.8357843137255,182.336868459542,FUCA1,2
Growth Hormone Receptor Signaling Pathway Via JAK-STAT (GO:0060397),1/7,0.0239048624297549,0.0998115776966959,0,0,48.8357843137255,182.336868459542,LYN,2
Positive Regulation Of Triglyceride Lipase Activity (GO:0061365),1/7,0.0239048624297549,0.0998115776966959,0,0,48.8357843137255,182.336868459542,APOC2,2
"Regulation Of CD4-positive, Alpha-Beta T Cell Activation (GO:2000514)",1/7,0.0239048624297549,0.0998115776966959,0,0,48.8357843137255,182.336868459542,HLA-DRA,2
Regulation Of Cdc42 Protein Signal Transduction (GO:0032489),1/7,0.0239048624297549,0.0998115776966959,0,0,48.8357843137255,182.336868459542,APOE,2
Regulation Of CoA-transferase Activity (GO:1905918),1/7,0.0239048624297549,0.0998115776966959,0,0,48.8357843137255,182.336868459542,APOE,2
Regulation Of Apoptotic Cell Clearance (GO:2000425),1/7,0.0239048624297549,0.0998115776966959,0,0,48.8357843137255,182.336868459542,TGM2,2
Positive Regulation Of ERK1 And ERK2 Cascade (GO:0070374),3/179,0.0240025665625352,0.0998115776966959,0,0,5.10201446280992,19.0284451521009,CD74;GPNMB;APOE,2
Cholesterol Homeostasis (GO:0042632),2/72,0.0256730757510352,0.101623468825249,0,0,8.46950959488273,31.0179906242961,APOC2;APOE,2
Negative Regulation Of Catabolic Process (GO:0009895),2/72,0.0256730757510352,0.101623468825249,0,0,8.46950959488273,31.0179906242961,SNX3;APOC1,2
Negative Regulation Of Cell Adhesion (GO:0007162),2/72,0.0256730757510352,0.101623468825249,0,0,8.46950959488273,31.0179906242961,ADAMDEC1;TGFBI,2
Sterol Homeostasis (GO:0055092),2/73,0.026338330133333,0.101623468825249,0,0,8.34980029430313,30.3659690680355,APOC2;APOE,2
Negative Regulation Of Neuron Apoptotic Process (GO:0043524),2/74,0.0270105563679365,0.101623468825249,0,0,8.23341625207297,29.7352093186879,GRN;APOE,2
Regulation Of Defense Response To Bacterium (GO:1900424),1/8,0.027273557473831,0.101623468825249,0,0,41.8571428571429,150.76263251514,GRN,2
Regulation Of Dendritic Cell Antigen Processing And Presentation (GO:0002604),1/8,0.027273557473831,0.101623468825249,0,0,41.8571428571429,150.76263251514,CD68,2
Negative Regulation Of Lipase Activity (GO:0060192),1/8,0.027273557473831,0.101623468825249,0,0,41.8571428571429,150.76263251514,APOC1,2
Regulation Of Fertilization (GO:0080154),1/8,0.027273557473831,0.101623468825249,0,0,41.8571428571429,150.76263251514,LHFPL2,2
Alcohol Catabolic Process (GO:0046164),1/8,0.027273557473831,0.101623468825249,0,0,41.8571428571429,150.76263251514,APOE,2
Angiotensin Maturation (GO:0002003),1/8,0.027273557473831,0.101623468825249,0,0,41.8571428571429,150.76263251514,CTSZ,2
Cellular Response To Hydroxyurea (GO:0072711),1/8,0.027273557473831,0.101623468825249,0,0,41.8571428571429,150.76263251514,NSMCE3,2
Cellular Response To Muramyl Dipeptide (GO:0071225),1/8,0.027273557473831,0.101623468825249,0,0,41.8571428571429,150.76263251514,VIM,2
Positive Regulation Of Blood Vessel Endothelial Cell Proliferation Involved In Sprouting Angiogenesis (GO:1903589),1/8,0.027273557473831,0.101623468825249,0,0,41.8571428571429,150.76263251514,HMOX1,2
Positive Regulation Of Epithelial Cell Proliferation Involved In Wound Healing (GO:0060054),1/8,0.027273557473831,0.101623468825249,0,0,41.8571428571429,150.76263251514,MMP12,2
Endosome To Melanosome Transport (GO:0035646),1/8,0.027273557473831,0.101623468825249,0,0,41.8571428571429,150.76263251514,CD63,2
Endosome To Pigment Granule Transport (GO:0043485),1/8,0.027273557473831,0.101623468825249,0,0,41.8571428571429,150.76263251514,CD63,2
Positive Regulation Of Macrophage Cytokine Production (GO:0060907),1/8,0.027273557473831,0.101623468825249,0,0,41.8571428571429,150.76263251514,LAPTM5,2
Positive Regulation Of Memory T Cell Differentiation (GO:0043382),1/8,0.027273557473831,0.101623468825249,0,0,41.8571428571429,150.76263251514,HLA-DRA,2
Positive Regulation Of Mitochondrial Calcium Ion Concentration (GO:0051561),1/8,0.027273557473831,0.101623468825249,0,0,41.8571428571429,150.76263251514,TGM2,2
Immune Response-Inhibiting Cell Surface Receptor Signaling Pathway (GO:0002767),1/8,0.027273557473831,0.101623468825249,0,0,41.8571428571429,150.76263251514,LYN,2
Positive Regulation Of Tumor Necrosis Factor-Mediated Signaling Pathway (GO:1903265),1/8,0.027273557473831,0.101623468825249,0,0,41.8571428571429,150.76263251514,LAPTM5,2
Membrane Lipid Catabolic Process (GO:0046466),1/8,0.027273557473831,0.101623468825249,0,0,41.8571428571429,150.76263251514,FUCA1,2
Regulation Of Angiotensin Levels In Blood (GO:0002002),1/8,0.027273557473831,0.101623468825249,0,0,41.8571428571429,150.76263251514,CTSZ,2
Regulation Of Aspartic-Type Endopeptidase Activity Involved In Amyloid Precursor Protein Catabolic Process (GO:1902959),1/8,0.027273557473831,0.101623468825249,0,0,41.8571428571429,150.76263251514,LYN,2
Endocytosis (GO:0006897),3/189,0.027604166776664,0.101623468825249,0,0,4.8252688172043,17.321694738536,ITGB2;APOE;CD14,2
Positive Regulation Of Interleukin-6 Production (GO:0032755),2/76,0.0283757066011867,0.101623468825249,0,0,8.01008471157725,28.5336991904175,CD74;TYROBP,2
Organonitrogen Compound Catabolic Process (GO:1901565),2/78,0.0297680936992517,0.101623468825249,0,0,7.79850746268657,27.4064362433262,SLC16A3;PLA2G7,2
Positive Regulation Of Tumor Necrosis Factor Production (GO:0032760),2/78,0.0297680936992517,0.101623468825249,0,0,7.79850746268657,27.4064362433262,TYROBP;CD14,2
Positive Regulation Of Protein Modification By Small Protein Conjugation Or Removal (GO:1903322),2/79,0.0304743670732638,0.101623468825249,0,0,7.69684047295988,26.8686646724611,NSMCE3;LAPTM5,2
Negative Regulation Of Establishment Of Protein Localization (GO:1904950),1/9,0.0306307952824743,0.101623468825249,0,0,36.6231617647059,127.659163938903,SNX3,2
B Cell Homeostasis (GO:0001782),1/9,0.0306307952824743,0.101623468825249,0,0,36.6231617647059,127.659163938903,LYN,2
Regulation Of Dendritic Cell Apoptotic Process (GO:2000668),1/9,0.0306307952824743,0.101623468825249,0,0,36.6231617647059,127.659163938903,LYN,2
Negative Regulation Of Leukocyte Migration (GO:0002686),1/9,0.0306307952824743,0.101623468825249,0,0,36.6231617647059,127.659163938903,HMOX1,2
Regulation Of Granulocyte Differentiation (GO:0030852),1/9,0.0306307952824743,0.101623468825249,0,0,36.6231617647059,127.659163938903,C1QC,2
Regulation Of Inflammatory Response To Wounding (GO:0106014),1/9,0.0306307952824743,0.101623468825249,0,0,36.6231617647059,127.659163938903,GRN,2
Regulation Of Mast Cell Activation (GO:0033003),1/9,0.0306307952824743,0.101623468825249,0,0,36.6231617647059,127.659163938903,LYN,2
Regulation Of Mast Cell Activation Involved In Immune Response (GO:0033006),1/9,0.0306307952824743,0.101623468825249,0,0,36.6231617647059,127.659163938903,LYN,2
Negative Regulation Of Toll-Like Receptor 4 Signaling Pathway (GO:0034144),1/9,0.0306307952824743,0.101623468825249,0,0,36.6231617647059,127.659163938903,LYN,2
Regulation Of Memory T Cell Differentiation (GO:0043380),1/9,0.0306307952824743,0.101623468825249,0,0,36.6231617647059,127.659163938903,HLA-DRA,2
Amino Sugar Metabolic Process (GO:0006040),1/9,0.0306307952824743,0.101623468825249,0,0,36.6231617647059,127.659163938903,ST3GAL1,2
Negative Regulation Of Transforming Growth Factor Beta Production (GO:0071635),1/9,0.0306307952824743,0.101623468825249,0,0,36.6231617647059,127.659163938903,TYROBP,2
Regulation Of Myeloid Leukocyte Mediated Immunity (GO:0002886),1/9,0.0306307952824743,0.101623468825249,0,0,36.6231617647059,127.659163938903,LYN,2
Neuron Remodeling (GO:0016322),1/9,0.0306307952824743,0.101623468825249,0,0,36.6231617647059,127.659163938903,C1QA,2
Phosphatidylcholine Catabolic Process (GO:0034638),1/9,0.0306307952824743,0.101623468825249,0,0,36.6231617647059,127.659163938903,PLA2G7,2
Cellular Response To Oxidised Low-Density Lipoprotein Particle Stimulus (GO:0140052),1/9,0.0306307952824743,0.101623468825249,0,0,36.6231617647059,127.659163938903,CD68,2
Response To Hydroxyurea (GO:0072710),1/9,0.0306307952824743,0.101623468825249,0,0,36.6231617647059,127.659163938903,NSMCE3,2
Dopamine Transport (GO:0015872),1/9,0.0306307952824743,0.101623468825249,0,0,36.6231617647059,127.659163938903,TGM2,2
Serine Family Amino Acid Catabolic Process (GO:0009071),1/9,0.0306307952824743,0.101623468825249,0,0,36.6231617647059,127.659163938903,SDS,2
Positive Regulation Of Leukocyte Apoptotic Process (GO:2000108),1/9,0.0306307952824743,0.101623468825249,0,0,36.6231617647059,127.659163938903,LYN,2
Positive Regulation Of Monocyte Differentiation (GO:0045657),1/9,0.0306307952824743,0.101623468825249,0,0,36.6231617647059,127.659163938903,CD74,2
Positive Regulation Of Myoblast Fusion (GO:1901741),1/9,0.0306307952824743,0.101623468825249,0,0,36.6231617647059,127.659163938903,CD53,2
Glycosphingolipid Catabolic Process (GO:0046479),1/9,0.0306307952824743,0.101623468825249,0,0,36.6231617647059,127.659163938903,GM2A,2
Granulocyte Migration (GO:0097530),1/9,0.0306307952824743,0.101623468825249,0,0,36.6231617647059,127.659163938903,ITGB2,2
High-Density Lipoprotein Particle Assembly (GO:0034380),1/9,0.0306307952824743,0.101623468825249,0,0,36.6231617647059,127.659163938903,APOE,2
"Wound Healing, Spreading Of Epidermal Cells (GO:0035313)",1/9,0.0306307952824743,0.101623468825249,0,0,36.6231617647059,127.659163938903,MMP12,2
Negative Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071901),2/80,0.0311872894154663,0.10236113918862,0,0,7.59778032912361,26.347162146717,LYN;APOE,2
Response To Type II Interferon (GO:0034341),2/80,0.0311872894154663,0.10236113918862,0,0,7.59778032912361,26.347162146717,CD74;HLA-DPA1,2
Wound Healing (GO:0042060),2/80,0.0311872894154663,0.10236113918862,0,0,7.59778032912361,26.347162146717,MMP12;HMOX1,2
Regulation Of Interleukin-8 Production (GO:0032677),2/81,0.0319068078919651,0.103051182685698,0,0,7.50122803703004,25.8412495969714,CD74;CD14,2
Positive Regulation Of Tumor Necrosis Factor Superfamily Cytokine Production (GO:1903557),2/82,0.0326328699454197,0.103051182685698,0,0,7.40708955223881,25.3502841468214,TYROBP;CD14,2
Regulation Of MAPK Cascade (GO:0043408),3/204,0.0335176797702972,0.103051182685698,0,0,4.46178199909543,15.1507938262748,LYN;CD74;LAPTM5,2
Regulation Of Angiogenesis (GO:0045765),3/205,0.0339335993240507,0.103051182685698,0,0,4.43946894689469,15.0202755964014,GRN;GPNMB;HMOX1,2
Negative Regulation Of Hemostasis (GO:1900047),1/10,0.033976614095502,0.103051182685698,0,0,32.5522875816993,110.094532313003,APOE,2
Regulation Of Dendritic Cell Differentiation (GO:2001198),1/10,0.033976614095502,0.103051182685698,0,0,32.5522875816993,110.094532313003,TMEM176B,2
L-serine Metabolic Process (GO:0006563),1/10,0.033976614095502,0.103051182685698,0,0,32.5522875816993,110.094532313003,SDS,2
N-acetylneuraminate Metabolic Process (GO:0006054),1/10,0.033976614095502,0.103051182685698,0,0,32.5522875816993,110.094532313003,ST3GAL1,2
Alpha-Amino Acid Biosynthetic Process (GO:1901607),1/10,0.033976614095502,0.103051182685698,0,0,32.5522875816993,110.094532313003,SDS,2
Basement Membrane Organization (GO:0071711),1/10,0.033976614095502,0.103051182685698,0,0,32.5522875816993,110.094532313003,CTSS,2
Regulation Of Phospholipase Activity (GO:0010517),1/10,0.033976614095502,0.103051182685698,0,0,32.5522875816993,110.094532313003,APOC2,2
Regulation Of Toll-Like Receptor 2 Signaling Pathway (GO:0034135),1/10,0.033976614095502,0.103051182685698,0,0,32.5522875816993,110.094532313003,LYN,2
Regulation Of Triglyceride Catabolic Process (GO:0010896),1/10,0.033976614095502,0.103051182685698,0,0,32.5522875816993,110.094532313003,APOC2,2
Positive Regulation Of Cholesterol Metabolic Process (GO:0090205),1/10,0.033976614095502,0.103051182685698,0,0,32.5522875816993,110.094532313003,APOE,2
Positive Regulation Of Defense Response To Bacterium (GO:1900426),1/10,0.033976614095502,0.103051182685698,0,0,32.5522875816993,110.094532313003,GRN,2
Signal Release (GO:0023061),1/10,0.033976614095502,0.103051182685698,0,0,32.5522875816993,110.094532313003,TGM2,2
Fatty Acid Homeostasis (GO:0055089),1/10,0.033976614095502,0.103051182685698,0,0,32.5522875816993,110.094532313003,APOE,2
Heme Catabolic Process (GO:0042167),1/10,0.033976614095502,0.103051182685698,0,0,32.5522875816993,110.094532313003,HMOX1,2
Very-Low-Density Lipoprotein Particle Assembly (GO:0034379),1/10,0.033976614095502,0.103051182685698,0,0,32.5522875816993,110.094532313003,APOC1,2
Positive Regulation Of Phospholipid Transport (GO:2001140),1/10,0.033976614095502,0.103051182685698,0,0,32.5522875816993,110.094532313003,APOE,2
Receptor-Mediated Endocytosis Of Virus By Host Cell (GO:0019065),1/10,0.033976614095502,0.103051182685698,0,0,32.5522875816993,110.094532313003,CTSL,2
Regulation Of B Cell Apoptotic Process (GO:0002902),1/10,0.033976614095502,0.103051182685698,0,0,32.5522875816993,110.094532313003,LYN,2
Regulation Of Axon Regeneration (GO:0048679),1/10,0.033976614095502,0.103051182685698,0,0,32.5522875816993,110.094532313003,GRN,2
Positive Regulation Of Protein Ubiquitination (GO:0031398),2/84,0.034104415909068,0.103098546777742,0,0,7.22570076447033,24.4107901334181,NSMCE3;LAPTM5,2
Defense Response To Gram-positive Bacterium (GO:0050830),2/85,0.0348497960704622,0.105006434717229,0,0,7.13828448120842,23.9611365774453,LYZ;RNASE1,2
Regulation Of Endothelial Cell Migration (GO:0010594),2/88,0.0371237484681292,0.108853513840525,0,0,6.88823325234294,22.6863851521856,GRN;APOE,2
Golgi To Lysosome Transport (GO:0090160),1/11,0.0373110520780908,0.108853513840525,0,0,29.2955882352941,96.3375368932004,LAPTM5,2
Negative Regulation Of Nitrogen Compound Metabolic Process (GO:0051172),1/11,0.0373110520780908,0.108853513840525,0,0,29.2955882352941,96.3375368932004,APOE,2
Regulation Of Homotypic Cell-Cell Adhesion (GO:0034110),1/11,0.0373110520780908,0.108853513840525,0,0,29.2955882352941,96.3375368932004,LYN,2
Aspartate Family Amino Acid Catabolic Process (GO:0009068),1/11,0.0373110520780908,0.108853513840525,0,0,29.2955882352941,96.3375368932004,SDS,2
Neutrophil Activation Involved In Immune Response (GO:0002283),1/11,0.0373110520780908,0.108853513840525,0,0,29.2955882352941,96.3375368932004,TYROBP,2
Regulation Of Stress-Activated Protein Kinase Signaling Cascade (GO:0070302),1/11,0.0373110520780908,0.108853513840525,0,0,29.2955882352941,96.3375368932004,LYN,2
Positive Regulation Of Lipid Transport (GO:0032370),1/11,0.0373110520780908,0.108853513840525,0,0,29.2955882352941,96.3375368932004,APOE,2
"Regulation Of CD4-positive, Alpha-Beta T Cell Differentiation (GO:0043370)",1/11,0.0373110520780908,0.108853513840525,0,0,29.2955882352941,96.3375368932004,HLA-DRA,2
Regulation Of Amyloid Precursor Protein Catabolic Process (GO:1902991),1/11,0.0373110520780908,0.108853513840525,0,0,29.2955882352941,96.3375368932004,APOE,2
Regulation Of Peptidyl-Tyrosine Phosphorylation (GO:0050730),2/90,0.0386707180283223,0.112463259076039,0,0,6.73100407055631,21.8937525473903,CD74;ITGB2,2
Negative Regulation Of Intrinsic Apoptotic Signaling Pathway In Response To DNA Damage By P53 Class Mediator (GO:1902166),1/12,0.0406341472797855,0.112818070544178,0,0,26.6310160427808,85.3030458253537,CD74,2
Regulation Of Leukocyte Adhesion To Vascular Endothelial Cell (GO:1904994),1/12,0.0406341472797855,0.112818070544178,0,0,26.6310160427808,85.3030458253537,ITGB2,2
Regulation Of Transcription From RNA Polymerase II Promoter In Response To Stress (GO:0043618),1/12,0.0406341472797855,0.112818070544178,0,0,26.6310160427808,85.3030458253537,HMOX1,2
Porphyrin-Containing Compound Catabolic Process (GO:0006787),1/12,0.0406341472797855,0.112818070544178,0,0,26.6310160427808,85.3030458253537,HMOX1,2
Positive Regulation By Symbiont Of Entry Into Host (GO:0075294),1/12,0.0406341472797855,0.112818070544178,0,0,26.6310160427808,85.3030458253537,CD74,2
"Positive Regulation Of CD4-positive, Alpha-Beta T Cell Activation (GO:2000516)",1/12,0.0406341472797855,0.112818070544178,0,0,26.6310160427808,85.3030458253537,HLA-DRA,2
Defense Response To Tumor Cell (GO:0002357),1/12,0.0406341472797855,0.112818070544178,0,0,26.6310160427808,85.3030458253537,LAPTM5,2
Response To Muramyl Dipeptide (GO:0032495),1/12,0.0406341472797855,0.112818070544178,0,0,26.6310160427808,85.3030458253537,VIM,2
Epithelial Cell Morphogenesis (GO:0003382),1/12,0.0406341472797855,0.112818070544178,0,0,26.6310160427808,85.3030458253537,RILPL2,2
Granulocyte Differentiation (GO:0030851),1/12,0.0406341472797855,0.112818070544178,0,0,26.6310160427808,85.3030458253537,LYN,2
Positive Regulation Of Protein Localization To Cell Surface (GO:2000010),1/12,0.0406341472797855,0.112818070544178,0,0,26.6310160427808,85.3030458253537,TYROBP,2
Positive Regulation Of Viral Entry Into Host Cell (GO:0046598),1/12,0.0406341472797855,0.112818070544178,0,0,26.6310160427808,85.3030458253537,CD74,2
Low-Density Lipoprotein Particle Remodeling (GO:0034374),1/12,0.0406341472797855,0.112818070544178,0,0,26.6310160427808,85.3030458253537,PLA2G7,2
Multicellular Organismal-Level Iron Ion Homeostasis (GO:0060586),1/12,0.0406341472797855,0.112818070544178,0,0,26.6310160427808,85.3030458253537,HMOX1,2
Negative Regulation Of Coagulation (GO:0050819),1/12,0.0406341472797855,0.112818070544178,0,0,26.6310160427808,85.3030458253537,APOE,2
Recombinational Repair (GO:0000725),2/95,0.0426437221318203,0.11638707984902,0,0,6.36751725244744,20.0887223348023,NSMCE3;SAMHD1,2
Positive Regulation Of Protein Modification Process (GO:0031401),3/225,0.0428143367731468,0.11638707984902,0,0,4.03542178542179,12.715138919942,LYN;CD74;GPNMB,2
Negative Regulation Of Neuroinflammatory Response (GO:0150079),1/13,0.0439459376578998,0.11638707984902,0,0,24.4105392156863,76.2779330882361,GRN,2
Regulation Of Immune Effector Process (GO:0002697),1/13,0.0439459376578998,0.11638707984902,0,0,24.4105392156863,76.2779330882361,HLA-DRA,2
Regulation Of Intrinsic Apoptotic Signaling Pathway In Response To DNA Damage By P53 Class Mediator (GO:1902165),1/13,0.0439459376578998,0.11638707984902,0,0,24.4105392156863,76.2779330882361,CD74,2
Regulation Of Leukocyte Migration (GO:0002685),1/13,0.0439459376578998,0.11638707984902,0,0,24.4105392156863,76.2779330882361,HMOX1,2
Regulation Of Macrophage Cytokine Production (GO:0010935),1/13,0.0439459376578998,0.11638707984902,0,0,24.4105392156863,76.2779330882361,LAPTM5,2
Regulation Of Myoblast Fusion (GO:1901739),1/13,0.0439459376578998,0.11638707984902,0,0,24.4105392156863,76.2779330882361,CD53,2
Regulation Of Nitrogen Compound Metabolic Process (GO:0051171),1/13,0.0439459376578998,0.11638707984902,0,0,24.4105392156863,76.2779330882361,APOE,2
Positive Regulation Of Fatty Acid Biosynthetic Process (GO:0045723),1/13,0.0439459376578998,0.11638707984902,0,0,24.4105392156863,76.2779330882361,APOC2,2
Ether Lipid Metabolic Process (GO:0046485),1/13,0.0439459376578998,0.11638707984902,0,0,24.4105392156863,76.2779330882361,PLA2G7,2
Positive Regulation Of Leukocyte Degranulation (GO:0043302),1/13,0.0439459376578998,0.11638707984902,0,0,24.4105392156863,76.2779330882361,ITGB2,2
Immune Response-Regulating Cell Surface Receptor Signaling Pathway (GO:0002768),1/13,0.0439459376578998,0.11638707984902,0,0,24.4105392156863,76.2779330882361,LYN,2
Lipid Oxidation (GO:0034440),1/13,0.0439459376578998,0.11638707984902,0,0,24.4105392156863,76.2779330882361,PLA2G7,2
"Negative Regulation Of DNA Damage Response, Signal Transduction By P53 Class Mediator (GO:0043518)",1/13,0.0439459376578998,0.11638707984902,0,0,24.4105392156863,76.2779330882361,CD74,2
Negative Regulation Of Bone Mineralization (GO:0030502),1/13,0.0439459376578998,0.11638707984902,0,0,24.4105392156863,76.2779330882361,SRGN,2
Apoptotic Process (GO:0006915),3/228,0.0442378705769413,0.116823572012095,0,0,3.9810101010101,12.4134824150733,ITGB2;EMP3;CD14,2
Negative Regulation Of Multicellular Organismal Process (GO:0051241),3/231,0.0456849447005304,0.11994336380717,0,0,3.9280303030303,12.1218483806213,SRGN;GRN;GPNMB,2
Positive Regulation Of Phosphorylation (GO:0042327),3/231,0.0456849447005304,0.11994336380717,0,0,3.9280303030303,12.1218483806213,LYN;CD74;GPNMB,2
Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043122),3/232,0.0461725133287167,0.11994336380717,0,0,3.91067884080985,12.0267867625632,CD74;HMOX1;LITAF,2
Negative Regulation Of Fatty Acid Biosynthetic Process (GO:0045717),1/14,0.0472464610426503,0.11994336380717,0,0,22.5316742081448,68.7751759854608,APOC1,2
Regulation Of Establishment Of Protein Localization (GO:0070201),1/14,0.0472464610426503,0.11994336380717,0,0,22.5316742081448,68.7751759854608,CTSD,2
Regulation Of Macrophage Differentiation (GO:0045649),1/14,0.0472464610426503,0.11994336380717,0,0,22.5316742081448,68.7751759854608,C1QC,2
Regulation Of Mast Cell Degranulation (GO:0043304),1/14,0.0472464610426503,0.11994336380717,0,0,22.5316742081448,68.7751759854608,LYN,2
Aminoglycan Catabolic Process (GO:0006026),1/14,0.0472464610426503,0.11994336380717,0,0,22.5316742081448,68.7751759854608,FUCA1,2
Regulation Of Microglial Cell Activation (GO:1903978),1/14,0.0472464610426503,0.11994336380717,0,0,22.5316742081448,68.7751759854608,GRN,2
Ceramide Transport (GO:0035627),1/14,0.0472464610426503,0.11994336380717,0,0,22.5316742081448,68.7751759854608,PSAP,2
Positive Regulation Of Membrane Protein Ectodomain Proteolysis (GO:0051044),1/14,0.0472464610426503,0.11994336380717,0,0,22.5316742081448,68.7751759854608,APOE,2
Positive Regulation Of Response To Cytokine Stimulus (GO:0060760),1/14,0.0472464610426503,0.11994336380717,0,0,22.5316742081448,68.7751759854608,CD74,2
Lipoprotein Biosynthetic Process (GO:0042158),1/14,0.0472464610426503,0.11994336380717,0,0,22.5316742081448,68.7751759854608,APOE,2
Prostanoid Biosynthetic Process (GO:0046457),1/14,0.0472464610426503,0.11994336380717,0,0,22.5316742081448,68.7751759854608,CD74,2
Inflammatory Response (GO:0006954),3/236,0.0481487184106496,0.121576856006214,0,0,3.84276238782677,11.656868904613,ITGB2;CD14;LYZ,2
Positive Regulation Of Inflammatory Response (GO:0050729),2/104,0.0501587908102398,0.121576856006214,0,0,5.8030436055019,17.3659648163059,GRN;PLA2G7,2
Positive Regulation Of Vasculature Development (GO:1904018),2/104,0.0501587908102398,0.121576856006214,0,0,5.8030436055019,17.3659648163059,GRN;HMOX1,2
Regulation Of Inflammatory Response (GO:0050727),3/240,0.0501661835658043,0.121576856006214,0,0,3.77713847334101,11.302762475987,GRN;APOE;PLA2G7,2
Regulation Of Cholesterol Biosynthetic Process (GO:0045540),1/15,0.0505357551625393,0.121576856006214,0,0,20.921218487395,62.4513889160488,APOE,2
B Cell Mediated Immunity (GO:0019724),1/15,0.0505357551625393,0.121576856006214,0,0,20.921218487395,62.4513889160488,CD74,2
Negative Regulation Of Immune Effector Process (GO:0002698),1/15,0.0505357551625393,0.121576856006214,0,0,20.921218487395,62.4513889160488,GRN,2
Negative Regulation Of Macrophage Activation (GO:0043031),1/15,0.0505357551625393,0.121576856006214,0,0,20.921218487395,62.4513889160488,GRN,2
Negative Regulation Of Phagocytosis (GO:0050765),1/15,0.0505357551625393,0.121576856006214,0,0,20.921218487395,62.4513889160488,SNX3,2
Negative Regulation Of Platelet Activation (GO:0010544),1/15,0.0505357551625393,0.121576856006214,0,0,20.921218487395,62.4513889160488,APOE,2
Negative Regulation Of Protein Processing (GO:0010955),1/15,0.0505357551625393,0.121576856006214,0,0,20.921218487395,62.4513889160488,CTSZ,2
Negative Regulation Of Type I Interferon-Mediated Signaling Pathway (GO:0060339),1/15,0.0505357551625393,0.121576856006214,0,0,20.921218487395,62.4513889160488,SAMHD1,2
Regulation Of Monocyte Differentiation (GO:0045655),1/15,0.0505357551625393,0.121576856006214,0,0,20.921218487395,62.4513889160488,CD74,2
Astrocyte Development (GO:0014002),1/15,0.0505357551625393,0.121576856006214,0,0,20.921218487395,62.4513889160488,C1QA,2
Ceramide Catabolic Process (GO:0046514),1/15,0.0505357551625393,0.121576856006214,0,0,20.921218487395,62.4513889160488,GM2A,2
Positive Regulation Of Collagen Biosynthetic Process (GO:0032967),1/15,0.0505357551625393,0.121576856006214,0,0,20.921218487395,62.4513889160488,VIM,2
Ganglioside Biosynthetic Process (GO:0001574),1/15,0.0505357551625393,0.121576856006214,0,0,20.921218487395,62.4513889160488,ST3GAL1,2
Glycosaminoglycan Catabolic Process (GO:0006027),1/15,0.0505357551625393,0.121576856006214,0,0,20.921218487395,62.4513889160488,FUCA1,2
Keratan Sulfate Biosynthetic Process (GO:0018146),1/15,0.0505357551625393,0.121576856006214,0,0,20.921218487395,62.4513889160488,ST3GAL1,2
Regulation Of Amyloid-Beta Clearance (GO:1900221),1/15,0.0505357551625393,0.121576856006214,0,0,20.921218487395,62.4513889160488,APOE,2
Regulation Of Neuron Apoptotic Process (GO:0043523),2/105,0.0510214654251853,0.122106059181628,0,0,5.7464135632517,17.0985043794125,GRN;APOE,2
Negative Regulation Of MAPK Cascade (GO:0043409),2/105,0.0510214654251853,0.122106059181628,0,0,5.7464135632517,17.0985043794125,LYN;APOE,2
Lipid Transport (GO:0006869),2/108,0.0536414762845534,0.12322082164066,0,0,5.58293438468037,16.3324988045561,GM2A;APOE,2
Negative Regulation Of Inflammatory Response To Antigenic Stimulus (GO:0002862),1/16,0.0538138576121539,0.12322082164066,0,0,19.5254901960784,57.0578613062652,LYN,2
Negative Regulation Of Interleukin-10 Production (GO:0032693),1/16,0.0538138576121539,0.12322082164066,0,0,19.5254901960784,57.0578613062652,TYROBP,2
Negative Regulation Of Intrinsic Apoptotic Signaling Pathway By P53 Class Mediator (GO:1902254),1/16,0.0538138576121539,0.12322082164066,0,0,19.5254901960784,57.0578613062652,CD74,2
Regulation Of Natural Killer Cell Activation (GO:0032814),1/16,0.0538138576121539,0.12322082164066,0,0,19.5254901960784,57.0578613062652,TYROBP,2
Regulation Of Plasminogen Activation (GO:0010755),1/16,0.0538138576121539,0.12322082164066,0,0,19.5254901960784,57.0578613062652,CTSZ,2
Cellular Response To Nitrogen Compound (GO:1901699),1/16,0.0538138576121539,0.12322082164066,0,0,19.5254901960784,57.0578613062652,NSMCE3,2
Positive Regulation Of Cell Migration Involved In Sprouting Angiogenesis (GO:0090050),1/16,0.0538138576121539,0.12322082164066,0,0,19.5254901960784,57.0578613062652,HMOX1,2
Positive Regulation Of Collagen Metabolic Process (GO:0010714),1/16,0.0538138576121539,0.12322082164066,0,0,19.5254901960784,57.0578613062652,VIM,2
"Synaptic Transmission, Cholinergic (GO:0007271)",1/16,0.0538138576121539,0.12322082164066,0,0,19.5254901960784,57.0578613062652,APOE,2
Regulation Of B Cell Receptor Signaling Pathway (GO:0050855),1/16,0.0538138576121539,0.12322082164066,0,0,19.5254901960784,57.0578613062652,LYN,2
Negative Regulation Of Amyloid-Beta Formation (GO:1902430),1/16,0.0538138576121539,0.12322082164066,0,0,19.5254901960784,57.0578613062652,APOE,2
Regulation Of Blood Vessel Endothelial Cell Proliferation Involved In Sprouting Angiogenesis (GO:1903587),1/16,0.0538138576121539,0.12322082164066,0,0,19.5254901960784,57.0578613062652,HMOX1,2
Cell-Matrix Adhesion (GO:0007160),2/109,0.0545253229035956,0.12322082164066,0,0,5.53047844887711,16.0886597985647,CD63;ITGB2,2
Positive Regulation Of Cysteine-Type Endopeptidase Activity Involved In Apoptotic Process (GO:0043280),2/109,0.0545253229035956,0.12322082164066,0,0,5.53047844887711,16.0886597985647,LAPTM5;CTSD,2
Extracellular Structure Organization (GO:0043062),2/109,0.0545253229035956,0.12322082164066,0,0,5.53047844887711,16.0886597985647,MMP12;TGFBI,2
External Encapsulating Structure Organization (GO:0045229),2/110,0.0554143486380865,0.12322082164066,0,0,5.47899391929243,15.8502731073595,MMP12;TGFBI,2
Double-Strand Break Repair Via Homologous Recombination (GO:0000724),2/111,0.056308508418156,0.12322082164066,0,0,5.42845405997535,15.6171717547628,NSMCE3;SAMHD1,2
Negative Regulation Of Fibroblast Proliferation (GO:0048147),1/17,0.0570808058931169,0.12322082164066,0,0,18.3042279411765,52.4102646415421,FTH1,2
Negative Regulation Of Leukocyte Activation (GO:0002695),1/17,0.0570808058931169,0.12322082164066,0,0,18.3042279411765,52.4102646415421,GRN,2
Golgi To Vacuole Transport (GO:0006896),1/17,0.0570808058931169,0.12322082164066,0,0,18.3042279411765,52.4102646415421,LAPTM5,2
Regulation Of Inflammatory Response To Antigenic Stimulus (GO:0002861),1/17,0.0570808058931169,0.12322082164066,0,0,18.3042279411765,52.4102646415421,LYN,2
Regulation Of Leukocyte Chemotaxis (GO:0002688),1/17,0.0570808058931169,0.12322082164066,0,0,18.3042279411765,52.4102646415421,LYN,2
Amyloid Precursor Protein Metabolic Process (GO:0042982),1/17,0.0570808058931169,0.12322082164066,0,0,18.3042279411765,52.4102646415421,APOE,2
Neuron Maturation (GO:0042551),1/17,0.0570808058931169,0.12322082164066,0,0,18.3042279411765,52.4102646415421,C1QA,2
Cellular Response To Alkaloid (GO:0071312),1/17,0.0570808058931169,0.12322082164066,0,0,18.3042279411765,52.4102646415421,TGM2,2
Positive Chemotaxis (GO:0050918),1/17,0.0570808058931169,0.12322082164066,0,0,18.3042279411765,52.4102646415421,GPNMB,2
Response To Acidic pH (GO:0010447),1/17,0.0570808058931169,0.12322082164066,0,0,18.3042279411765,52.4102646415421,CTSS,2
Positive Regulation Of Fatty Acid Metabolic Process (GO:0045923),1/17,0.0570808058931169,0.12322082164066,0,0,18.3042279411765,52.4102646415421,APOC2,2
Positive Regulation Of Leukocyte Adhesion To Vascular Endothelial Cell (GO:1904996),1/17,0.0570808058931169,0.12322082164066,0,0,18.3042279411765,52.4102646415421,ITGB2,2
Positive Regulation Of Leukocyte Proliferation (GO:0070665),1/17,0.0570808058931169,0.12322082164066,0,0,18.3042279411765,52.4102646415421,LYN,2
Positive Regulation Of Nitric-Oxide Synthase Activity (GO:0051000),1/17,0.0570808058931169,0.12322082164066,0,0,18.3042279411765,52.4102646415421,APOE,2
Growth Hormone Receptor Signaling Pathway (GO:0060396),1/17,0.0570808058931169,0.12322082164066,0,0,18.3042279411765,52.4102646415421,LYN,2
Positive Regulation Of Regulatory T Cell Differentiation (GO:0045591),1/17,0.0570808058931169,0.12322082164066,0,0,18.3042279411765,52.4102646415421,HLA-DRA,2
Positive Regulation Of Small GTPase Mediated Signal Transduction (GO:0051057),1/17,0.0570808058931169,0.12322082164066,0,0,18.3042279411765,52.4102646415421,TGM2,2
Keratan Sulfate Metabolic Process (GO:0042339),1/17,0.0570808058931169,0.12322082164066,0,0,18.3042279411765,52.4102646415421,ST3GAL1,2
Prostaglandin Biosynthetic Process (GO:0001516),1/17,0.0570808058931169,0.12322082164066,0,0,18.3042279411765,52.4102646415421,CD74,2
Myeloid Cell Activation Involved In Immune Response (GO:0002275),1/17,0.0570808058931169,0.12322082164066,0,0,18.3042279411765,52.4102646415421,TYROBP,2
Regulation Of Protein Ubiquitination (GO:0031396),2/113,0.0581120510271374,0.12322082164066,0,0,5.33010622562861,15.1661894740341,NSMCE3;LAPTM5,2
Positive Regulation Of Cellular Component Organization (GO:0051130),2/113,0.0581120510271374,0.12322082164066,0,0,5.33010622562861,15.1661894740341,APOC2;APOE,2
Regulation Of Interleukin-6 Production (GO:0032675),2/114,0.0590213449191201,0.12322082164066,0,0,5.28224946695096,14.9480059931035,CD74;TYROBP,2
Regulation Of MAP Kinase Activity (GO:0043405),2/114,0.0590213449191201,0.12322082164066,0,0,5.28224946695096,14.9480059931035,LYN;APOE,2
Regulation Of Collagen Biosynthetic Process (GO:0032965),1/18,0.0603366373648497,0.12322082164066,0,0,17.2266435986159,48.3692416453001,VIM,2
Negative Regulation Of Lipid Catabolic Process (GO:0050995),1/18,0.0603366373648497,0.12322082164066,0,0,17.2266435986159,48.3692416453001,APOC1,2
Actin Filament Capping (GO:0051693),1/18,0.0603366373648497,0.12322082164066,0,0,17.2266435986159,48.3692416453001,CAPG,2
Negative Regulation Of Signal Transduction By P53 Class Mediator (GO:1901797),1/18,0.0603366373648497,0.12322082164066,0,0,17.2266435986159,48.3692416453001,CD74,2
Negative Regulation Of Viral Entry Into Host Cell (GO:0046597),1/18,0.0603366373648497,0.12322082164066,0,0,17.2266435986159,48.3692416453001,SNX3,2
Antigen Processing And Presentation Of Peptide Antigen Via MHC Class I (GO:0002474),1/18,0.0603366373648497,0.12322082164066,0,0,17.2266435986159,48.3692416453001,IFI30,2
Neutrophil Activation (GO:0042119),1/18,0.0603366373648497,0.12322082164066,0,0,17.2266435986159,48.3692416453001,TYROBP,2
Nitric Oxide Mediated Signal Transduction (GO:0007263),1/18,0.0603366373648497,0.12322082164066,0,0,17.2266435986159,48.3692416453001,APOE,2
Barbed-End Actin Filament Capping (GO:0051016),1/18,0.0603366373648497,0.12322082164066,0,0,17.2266435986159,48.3692416453001,CAPG,2
Cellular Response To Inorganic Substance (GO:0071241),1/18,0.0603366373648497,0.12322082164066,0,0,17.2266435986159,48.3692416453001,NSMCE3,2
Response To Axon Injury (GO:0048678),1/18,0.0603366373648497,0.12322082164066,0,0,17.2266435986159,48.3692416453001,TYROBP,2
Positive Regulation Of Cation Transmembrane Transport (GO:1904064),1/18,0.0603366373648497,0.12322082164066,0,0,17.2266435986159,48.3692416453001,CTSS,2
Endothelial Cell Proliferation (GO:0001935),1/18,0.0603366373648497,0.12322082164066,0,0,17.2266435986159,48.3692416453001,HMOX1,2
Epithelial Cell Development (GO:0002064),1/18,0.0603366373648497,0.12322082164066,0,0,17.2266435986159,48.3692416453001,RILPL2,2
Positive Regulation Of Monocyte Chemotaxis (GO:0090026),1/18,0.0603366373648497,0.12322082164066,0,0,17.2266435986159,48.3692416453001,PLA2G7,2
Positive Regulation Of Natural Killer Cell Activation (GO:0032816),1/18,0.0603366373648497,0.12322082164066,0,0,17.2266435986159,48.3692416453001,TYROBP,2
Positive Regulation Of Neutrophil Chemotaxis (GO:0090023),1/18,0.0603366373648497,0.12322082164066,0,0,17.2266435986159,48.3692416453001,CD74,2
Positive Regulation Of Osteoclast Differentiation (GO:0045672),1/18,0.0603366373648497,0.12322082164066,0,0,17.2266435986159,48.3692416453001,TYROBP,2
Positive Regulation Of Stress-Activated Protein Kinase Signaling Cascade (GO:0070304),1/18,0.0603366373648497,0.12322082164066,0,0,17.2266435986159,48.3692416453001,LYN,2
Positive Regulation Of Triglyceride Metabolic Process (GO:0090208),1/18,0.0603366373648497,0.12322082164066,0,0,17.2266435986159,48.3692416453001,APOC2,2
Lysosomal Lumen Acidification (GO:0007042),1/18,0.0603366373648497,0.12322082164066,0,0,17.2266435986159,48.3692416453001,GRN,2
Protein Autoprocessing (GO:0016540),1/18,0.0603366373648497,0.12322082164066,0,0,17.2266435986159,48.3692416453001,CTSL,2
Negative Regulation Of T Cell Receptor Signaling Pathway (GO:0050860),1/18,0.0603366373648497,0.12322082164066,0,0,17.2266435986159,48.3692416453001,LAPTM5,2
Negative Regulation Of Amyloid Precursor Protein Catabolic Process (GO:1902992),1/18,0.0603366373648497,0.12322082164066,0,0,17.2266435986159,48.3692416453001,APOE,2
Protein Maturation (GO:0051604),2/117,0.0617787883029095,0.125886267074,0,0,5.14367293964958,14.3209895335308,SRGN;CTSS,2
Negative Regulation Of Fatty Acid Metabolic Process (GO:0045922),1/19,0.0635813892802248,0.126593807219814,0,0,16.2687908496732,44.8275871385836,APOC1,2
Regulation Of Early Endosome To Late Endosome Transport (GO:2000641),1/19,0.0635813892802248,0.126593807219814,0,0,16.2687908496732,44.8275871385836,SNX3,2
Regulation Of Integrin-Mediated Signaling Pathway (GO:2001044),1/19,0.0635813892802248,0.126593807219814,0,0,16.2687908496732,44.8275871385836,CD63,2
Cellular Response To Catecholamine Stimulus (GO:0071870),1/19,0.0635813892802248,0.126593807219814,0,0,16.2687908496732,44.8275871385836,TGM2,2
Regulation Of Tissue Remodeling (GO:0034103),1/19,0.0635813892802248,0.126593807219814,0,0,16.2687908496732,44.8275871385836,GPNMB,2
Regulation Of Vascular Endothelial Growth Factor Signaling Pathway (GO:1900746),1/19,0.0635813892802248,0.126593807219814,0,0,16.2687908496732,44.8275871385836,CD63,2
Positive Regulation Of Alpha-Beta T Cell Activation (GO:0046635),1/19,0.0635813892802248,0.126593807219814,0,0,16.2687908496732,44.8275871385836,HLA-DRA,2
Ganglioside Metabolic Process (GO:0001573),1/19,0.0635813892802248,0.126593807219814,0,0,16.2687908496732,44.8275871385836,GM2A,2
Receptor Clustering (GO:0043113),1/19,0.0635813892802248,0.126593807219814,0,0,16.2687908496732,44.8275871385836,ITGB2,2
Regulation Of Behavior (GO:0050795),1/19,0.0635813892802248,0.126593807219814,0,0,16.2687908496732,44.8275871385836,APOE,2
Positive Regulation Of Angiogenesis (GO:0045766),2/119,0.0636412828460872,0.126593807219814,0,0,5.05523663732619,13.9246135156095,GRN;HMOX1,2
Regulation Of Protein Catabolic Process (GO:0042176),2/122,0.0664704620071578,0.13036746446026,0,0,4.92810945273632,13.3600929498677,SNX3;APOE,2
Fc-gamma Receptor Signaling Pathway Involved In Phagocytosis (GO:0038096),1/20,0.0668150987603724,0.13036746446026,0,0,15.4117647058824,41.7015566467034,LYN,2
Negative Regulation Of Viral Life Cycle (GO:1903901),1/20,0.0668150987603724,0.13036746446026,0,0,15.4117647058824,41.7015566467034,SNX3,2
Cell Projection Organization (GO:0030030),1/20,0.0668150987603724,0.13036746446026,0,0,15.4117647058824,41.7015566467034,CAPG,2
Endoplasmic Reticulum Calcium Ion Homeostasis (GO:0032469),1/20,0.0668150987603724,0.13036746446026,0,0,15.4117647058824,41.7015566467034,TGM2,2
Striated Muscle Cell Differentiation (GO:0051146),1/20,0.0668150987603724,0.13036746446026,0,0,15.4117647058824,41.7015566467034,PLD3,2
Positive Regulation Of Lipid Catabolic Process (GO:0050996),1/20,0.0668150987603724,0.13036746446026,0,0,15.4117647058824,41.7015566467034,APOC2,2
Positive Regulation Of Phospholipase Activity (GO:0010518),1/20,0.0668150987603724,0.13036746446026,0,0,15.4117647058824,41.7015566467034,APOC2,2
Lipopolysaccharide-Mediated Signaling Pathway (GO:0031663),1/20,0.0668150987603724,0.13036746446026,0,0,15.4117647058824,41.7015566467034,LYN,2
Positive Regulation Of Epithelial Cell Proliferation (GO:0050679),2/123,0.0674228015502985,0.131274480137128,0,0,4.88713457505859,13.1794877621148,MMP12;GRN,2
Positive Regulation Of Defense Response (GO:0031349),2/124,0.0683797107834188,0.132856139978778,0,0,4.84683141668706,13.0024934606894,GRN;PLA2G7,2
Response To Cytokine (GO:0034097),2/125,0.0693411479130708,0.133260332918187,0,0,4.807183594224,12.8290115417499,CD74;TIMP2,2
Negative Regulation Of Interleukin-2 Production (GO:0032703),1/21,0.0700378028286012,0.133260332918187,0,0,14.6404411764706,38.924835847946,LAPTM5,2
Antigen Processing And Presentation Of Endogenous Peptide Antigen (GO:0002483),1/21,0.0700378028286012,0.133260332918187,0,0,14.6404411764706,38.924835847946,HLA-DRA,2
Regulation Of Steroid Metabolic Process (GO:0019218),1/21,0.0700378028286012,0.133260332918187,0,0,14.6404411764706,38.924835847946,APOE,2
Chaperone-Mediated Protein Complex Assembly (GO:0051131),1/21,0.0700378028286012,0.133260332918187,0,0,14.6404411764706,38.924835847946,HOPX,2
Positive Regulation Of Amyloid Precursor Protein Catabolic Process (GO:1902993),1/21,0.0700378028286012,0.133260332918187,0,0,14.6404411764706,38.924835847946,LYN,2
Positive Regulation Of Granulocyte Chemotaxis (GO:0071624),1/21,0.0700378028286012,0.133260332918187,0,0,14.6404411764706,38.924835847946,CD74,2
Positive Regulation Of Vacuole Organization (GO:0044090),1/21,0.0700378028286012,0.133260332918187,0,0,14.6404411764706,38.924835847946,GRN,2
Mitochondrial Calcium Ion Homeostasis (GO:0051560),1/21,0.0700378028286012,0.133260332918187,0,0,14.6404411764706,38.924835847946,TGM2,2
Negative Regulation Of Biomineral Tissue Development (GO:0070168),1/21,0.0700378028286012,0.133260332918187,0,0,14.6404411764706,38.924835847946,SRGN,2
Protein-Containing Complex Organization (GO:0043933),2/126,0.0703070713793241,0.133496278094213,0,0,4.76817525276842,12.6589469266312,CD74;CAPG,2
Regulation Of Response To External Stimulus (GO:0032101),2/127,0.0712774398481934,0.13450506616117,0,0,4.72979104477612,12.4922078174946,GRN;SAMHD1,2
Regulation Of Tumor Necrosis Factor Production (GO:0032680),2/127,0.0712774398481934,0.13450506616117,0,0,4.72979104477612,12.4922078174946,TYROBP;CD14,2
Regulation Of Anatomical Structure Morphogenesis (GO:0022603),2/127,0.0712774398481934,0.13450506616117,0,0,4.72979104477612,12.4922078174946,GPNMB;HMOX1,2
Fc Receptor Mediated Stimulatory Signaling Pathway (GO:0002431),1/22,0.073249538363641,0.135992577285224,0,0,13.9425770308123,36.4442697241987,LYN,2
Fc-epsilon Receptor Signaling Pathway (GO:0038095),1/22,0.073249538363641,0.135992577285224,0,0,13.9425770308123,36.4442697241987,LYN,2
Regulation Of Mononuclear Cell Migration (GO:0071675),1/22,0.073249538363641,0.135992577285224,0,0,13.9425770308123,36.4442697241987,LYN,2
Dendritic Cell Differentiation (GO:0097028),1/22,0.073249538363641,0.135992577285224,0,0,13.9425770308123,36.4442697241987,LYN,2
Positive Regulation Of Cholesterol Efflux (GO:0010875),1/22,0.073249538363641,0.135992577285224,0,0,13.9425770308123,36.4442697241987,APOE,2
Positive Regulation Of Protein Autophosphorylation (GO:0031954),1/22,0.073249538363641,0.135992577285224,0,0,13.9425770308123,36.4442697241987,GPNMB,2
Positive Regulation Of Receptor Internalization (GO:0002092),1/22,0.073249538363641,0.135992577285224,0,0,13.9425770308123,36.4442697241987,CD63,2
Positive Regulation Of Viral Life Cycle (GO:1903902),1/22,0.073249538363641,0.135992577285224,0,0,13.9425770308123,36.4442697241987,CD74,2
Positive Regulation Of Peptidyl-Tyrosine Phosphorylation (GO:0050731),2/130,0.0742148052126662,0.13750686691621,0,0,4.61823694029851,12.0110719221627,LYN;CD74,2
Plasma Membrane Bounded Cell Projection Organization (GO:0120036),2/132,0.0761945259475603,0.139124484032029,0,0,4.54672789896671,11.7053948268339,LYN;APOE,2
Regulation Of Cholesterol Metabolic Process (GO:0090181),1/23,0.0764503421503533,0.139124484032029,0,0,13.3081550802139,34.2167821259975,APOE,2
Negative Regulation Of Extrinsic Apoptotic Signaling Pathway Via Death Domain Receptors (GO:1902042),1/23,0.0764503421503533,0.139124484032029,0,0,13.3081550802139,34.2167821259975,HMOX1,2
Regulation Of Lipid Catabolic Process (GO:0050994),1/23,0.0764503421503533,0.139124484032029,0,0,13.3081550802139,34.2167821259975,APOC1,2
Positive Regulation Of Neutrophil Migration (GO:1902624),1/23,0.0764503421503533,0.139124484032029,0,0,13.3081550802139,34.2167821259975,CD74,2
Positive Regulation Of Protein Targeting To Membrane (GO:0090314),1/23,0.0764503421503533,0.139124484032029,0,0,13.3081550802139,34.2167821259975,ITGB2,2
Immune Response-Activating Cell Surface Receptor Signaling Pathway (GO:0002429),1/23,0.0764503421503533,0.139124484032029,0,0,13.3081550802139,34.2167821259975,LYN,2
Long-Chain Fatty Acid Transport (GO:0015909),1/23,0.0764503421503533,0.139124484032029,0,0,13.3081550802139,34.2167821259975,APOE,2
Lymphocyte Activation Involved In Immune Response (GO:0002285),1/23,0.0764503421503533,0.139124484032029,0,0,13.3081550802139,34.2167821259975,CD74,2
Regulation Of Cytokine Production Involved In Immune Response (GO:0002718),1/24,0.0796402508235888,0.142115321372579,0,0,12.7289002557545,32.2071172165236,LAPTM5,2
Fc-gamma Receptor Signaling Pathway (GO:0038094),1/24,0.0796402508235888,0.142115321372579,0,0,12.7289002557545,32.2071172165236,LYN,2
Negative Regulation Of Ossification (GO:0030279),1/24,0.0796402508235888,0.142115321372579,0,0,12.7289002557545,32.2071172165236,SRGN,2
Cell Morphogenesis Involved In Differentiation (GO:0000904),1/24,0.0796402508235888,0.142115321372579,0,0,12.7289002557545,32.2071172165236,RILPL2,2
Regulation Of Supramolecular Fiber Organization (GO:1902903),1/24,0.0796402508235888,0.142115321372579,0,0,12.7289002557545,32.2071172165236,APOE,2
Positive Regulation Of Lipid Metabolic Process (GO:0045834),1/24,0.0796402508235888,0.142115321372579,0,0,12.7289002557545,32.2071172165236,APOE,2
Positive Regulation Of p38MAPK Cascade (GO:1900745),1/24,0.0796402508235888,0.142115321372579,0,0,12.7289002557545,32.2071172165236,GADD45G,2
Iron Ion Transport (GO:0006826),1/24,0.0796402508235888,0.142115321372579,0,0,12.7289002557545,32.2071172165236,FTH1,2
Mononuclear Cell Differentiation (GO:1903131),1/24,0.0796402508235888,0.142115321372579,0,0,12.7289002557545,32.2071172165236,LYN,2
Negative Regulation Of Antigen Receptor-Mediated Signaling Pathway (GO:0050858),1/24,0.0796402508235888,0.142115321372579,0,0,12.7289002557545,32.2071172165236,LAPTM5,2
ATP Biosynthetic Process (GO:0006754),1/25,0.0828193009171873,0.144423031390693,0,0,12.1979166666667,30.386158751603,ATP5MG,2
Negative Regulation Of Intrinsic Apoptotic Signaling Pathway In Response To DNA Damage (GO:1902230),1/25,0.0828193009171873,0.144423031390693,0,0,12.1979166666667,30.386158751603,CD74,2
Negative Regulation Of Lipid Biosynthetic Process (GO:0051055),1/25,0.0828193009171873,0.144423031390693,0,0,12.1979166666667,30.386158751603,APOC1,2
Regulation Of Lysosomal Lumen pH (GO:0035751),1/25,0.0828193009171873,0.144423031390693,0,0,12.1979166666667,30.386158751603,GRN,2
Regulation Of Neutrophil Chemotaxis (GO:0090022),1/25,0.0828193009171873,0.144423031390693,0,0,12.1979166666667,30.386158751603,CD74,2
Regulation Of Platelet Aggregation (GO:0090330),1/25,0.0828193009171873,0.144423031390693,0,0,12.1979166666667,30.386158751603,LYN,2
Osteoclast Differentiation (GO:0030316),1/25,0.0828193009171873,0.144423031390693,0,0,12.1979166666667,30.386158751603,TYROBP,2
Secretory Granule Organization (GO:0033363),1/25,0.0828193009171873,0.144423031390693,0,0,12.1979166666667,30.386158751603,SRGN,2
Ventricular Cardiac Muscle Tissue Development (GO:0003229),1/25,0.0828193009171873,0.144423031390693,0,0,12.1979166666667,30.386158751603,HOPX,2
"Wound Healing, Spreading Of Cells (GO:0044319)",1/25,0.0828193009171873,0.144423031390693,0,0,12.1979166666667,30.386158751603,MMP12,2
Regulation Of B Cell Activation (GO:0050864),1/25,0.0828193009171873,0.144423031390693,0,0,12.1979166666667,30.386158751603,LAPTM5,2
Myotube Differentiation (GO:0014902),1/25,0.0828193009171873,0.144423031390693,0,0,12.1979166666667,30.386158751603,PLD3,2
Positive Regulation Of Cell Population Proliferation (GO:0008284),4/483,0.085491244147726,0.147982282772975,0,0,2.49905251324876,6.14602309646733,LYN;CD74;GRN;HMOX1,2
Fc Receptor Signaling Pathway (GO:0038093),1/26,0.0859875288365276,0.147982282772975,0,0,11.7094117647059,28.7296624428356,LYN,2
Regulation Of Myeloid Cell Differentiation (GO:0045637),1/26,0.0859875288365276,0.147982282772975,0,0,11.7094117647059,28.7296624428356,LYN,2
Nucleic Acid Phosphodiester Bond Hydrolysis (GO:0090305),1/26,0.0859875288365276,0.147982282772975,0,0,11.7094117647059,28.7296624428356,RNASE1,2
Plasma Membrane Invagination (GO:0099024),1/26,0.0859875288365276,0.147982282772975,0,0,11.7094117647059,28.7296624428356,ITGB2,2
Positive Regulation Of Monooxygenase Activity (GO:0032770),1/26,0.0859875288365276,0.147982282772975,0,0,11.7094117647059,28.7296624428356,APOE,2
Protein Targeting To Lysosome (GO:0006622),1/26,0.0859875288365276,0.147982282772975,0,0,11.7094117647059,28.7296624428356,LAPTM5,2
Positive Regulation Of Transferase Activity (GO:0051347),2/143,0.0873749806329771,0.150088985423749,0,0,4.18968984862919,10.2125629890182,CD74;APOE,2
T Cell Activation Involved In Immune Response (GO:0002286),1/27,0.0891449708907093,0.151993002316441,0,0,11.2584841628959,27.2172880557803,CD74,2
Peptide Cross-Linking (GO:0018149),1/27,0.0891449708907093,0.151993002316441,0,0,11.2584841628959,27.2172880557803,TGM2,2
Glycerophospholipid Catabolic Process (GO:0046475),1/27,0.0891449708907093,0.151993002316441,0,0,11.2584841628959,27.2172880557803,PLA2G7,2
Positive Regulation Of Response To Wounding (GO:1903036),1/27,0.0891449708907093,0.151993002316441,0,0,11.2584841628959,27.2172880557803,GRN,2
Negative Regulation Of Protein Metabolic Process (GO:0051248),2/147,0.0915565501542151,0.153652243677654,0,0,4.07328872876994,9.73841243264022,SNX3;APOE,2
RNA Phosphodiester Bond Hydrolysis (GO:0090501),1/28,0.0922916632318441,0.153652243677654,0,0,10.8409586056645,25.8318520374767,RNASE1,2
Regulation Of Lipid Biosynthetic Process (GO:0046890),1/28,0.0922916632318441,0.153652243677654,0,0,10.8409586056645,25.8318520374767,APOE,2
Negative Regulation Of Type II Interferon Production (GO:0032689),1/28,0.0922916632318441,0.153652243677654,0,0,10.8409586056645,25.8318520374767,LAPTM5,2
Negative Regulation Of Wound Healing (GO:0061045),1/28,0.0922916632318441,0.153652243677654,0,0,10.8409586056645,25.8318520374767,APOE,2
Regulation Of Nitric-Oxide Synthase Activity (GO:0050999),1/28,0.0922916632318441,0.153652243677654,0,0,10.8409586056645,25.8318520374767,APOE,2
Regulation Of Platelet Activation (GO:0010543),1/28,0.0922916632318441,0.153652243677654,0,0,10.8409586056645,25.8318520374767,LYN,2
Regulation Of Protein Targeting To Membrane (GO:0090313),1/28,0.0922916632318441,0.153652243677654,0,0,10.8409586056645,25.8318520374767,ITGB2,2
Regulation Of Protein Transport (GO:0051223),1/28,0.0922916632318441,0.153652243677654,0,0,10.8409586056645,25.8318520374767,SNX3,2
Positive Regulation Of Fibroblast Proliferation (GO:0048146),1/28,0.0922916632318441,0.153652243677654,0,0,10.8409586056645,25.8318520374767,CD74,2
Glycosaminoglycan Metabolic Process (GO:0030203),1/28,0.0922916632318441,0.153652243677654,0,0,10.8409586056645,25.8318520374767,FUCA1,2
Hematopoietic Progenitor Cell Differentiation (GO:0002244),1/28,0.0922916632318441,0.153652243677654,0,0,10.8409586056645,25.8318520374767,LYN,2
"Regulation Of DNA Damage Response, Signal Transduction By P53 Class Mediator (GO:0043516)",1/28,0.0922916632318441,0.153652243677654,0,0,10.8409586056645,25.8318520374767,CD74,2
Defense Response To Symbiont (GO:0140546),2/148,0.0926111028069003,0.153905250415084,0,0,4.04518503373543,9.62489581547437,SAMHD1;RNASE1,2
Protein Transport (GO:0015031),3/313,0.093792478556299,0.155587162081658,0,0,2.87697947214076,6.80886276848008,CD74;LAPTM5;APOE,2
Neuron Development (GO:0048666),2/150,0.0947309433364265,0.156324425911433,0,0,3.9901169826543,9.40356687285733,LYN;APOE,2
Regulation Of Developmental Growth (GO:0048638),1/29,0.0954276419328769,0.156324425911433,0,0,10.453256302521,24.5587444101674,APOE,2
Positive Regulation Of B Cell Proliferation (GO:0030890),1/29,0.0954276419328769,0.156324425911433,0,0,10.453256302521,24.5587444101674,CD74,2
Positive Regulation Of Endopeptidase Activity (GO:0010950),1/29,0.0954276419328769,0.156324425911433,0,0,10.453256302521,24.5587444101674,LYN,2
Vacuolar Acidification (GO:0007035),1/29,0.0954276419328769,0.156324425911433,0,0,10.453256302521,24.5587444101674,GRN,2
Heterotypic Cell-Cell Adhesion (GO:0034113),1/29,0.0954276419328769,0.156324425911433,0,0,10.453256302521,24.5587444101674,ITGB2,2
Regulation Of Blood Coagulation (GO:0030193),1/29,0.0954276419328769,0.156324425911433,0,0,10.453256302521,24.5587444101674,APOE,2
Regulation Of Apoptotic Process (GO:0042981),5/705,0.0959733164165599,0.15693857257441,0,0,2.14631696428571,5.03029104645819,CD74;CTSD;CTSB;TGM2;GADD45G,2
Negative Regulation Of Myeloid Leukocyte Differentiation (GO:0002762),1/30,0.098552942914148,0.159454497426236,0,0,10.0922920892495,23.385469502096,C1QC,2
Regulation Of Potassium Ion Transport (GO:0043266),1/30,0.098552942914148,0.159454497426236,0,0,10.0922920892495,23.385469502096,CD63,2
"Phagocytosis, Engulfment (GO:0006911)",1/30,0.098552942914148,0.159454497426236,0,0,10.0922920892495,23.385469502096,ITGB2,2
Prostaglandin Metabolic Process (GO:0006693),1/30,0.098552942914148,0.159454497426236,0,0,10.0922920892495,23.385469502096,CD74,2
Negative Regulation Of Blood Coagulation (GO:0030195),1/30,0.098552942914148,0.159454497426236,0,0,10.0922920892495,23.385469502096,APOE,2
Regulation Of Cell Migration Involved In Sprouting Angiogenesis (GO:0090049),1/30,0.098552942914148,0.159454497426236,0,0,10.0922920892495,23.385469502096,HMOX1,2
Positive Regulation Of Response To External Stimulus (GO:0032103),2/155,0.100091480692852,0.160813298178807,0,0,3.85874548824505,8.88156144543646,GRN;PLA2G7,2
Regulation Of Extrinsic Apoptotic Signaling Pathway Via Death Domain Receptors (GO:1902041),1/31,0.101667602004229,0.160813298178807,0,0,9.75539215686275,22.3012809844891,HMOX1,2
Regulation Of Macrophage Activation (GO:0043030),1/31,0.101667602004229,0.160813298178807,0,0,9.75539215686275,22.3012809844891,CD74,2
Regulation Of Protein Autophosphorylation (GO:0031952),1/31,0.101667602004229,0.160813298178807,0,0,9.75539215686275,22.3012809844891,GPNMB,2
Regulation Of Protein Localization To Cell Surface (GO:2000008),1/31,0.101667602004229,0.160813298178807,0,0,9.75539215686275,22.3012809844891,TYROBP,2
Regulation Of Response To Biotic Stimulus (GO:0002831),1/31,0.101667602004229,0.160813298178807,0,0,9.75539215686275,22.3012809844891,SAMHD1,2
Positive Regulation Of Cholesterol Transport (GO:0032376),1/31,0.101667602004229,0.160813298178807,0,0,9.75539215686275,22.3012809844891,APOE,2
Endodermal Cell Differentiation (GO:0035987),1/31,0.101667602004229,0.160813298178807,0,0,9.75539215686275,22.3012809844891,ITGB2,2
Toll-Like Receptor Signaling Pathway (GO:0002224),1/31,0.101667602004229,0.160813298178807,0,0,9.75539215686275,22.3012809844891,CTSS,2
Positive Regulation Of Mononuclear Cell Migration (GO:0071677),1/31,0.101667602004229,0.160813298178807,0,0,9.75539215686275,22.3012809844891,PLA2G7,2
Positive Regulation Of Proteolysis Involved In Protein Catabolic Process (GO:1903052),1/31,0.101667602004229,0.160813298178807,0,0,9.75539215686275,22.3012809844891,LAPTM5,2
Leukocyte Cell-Cell Adhesion (GO:0007159),1/31,0.101667602004229,0.160813298178807,0,0,9.75539215686275,22.3012809844891,ITGB2,2
Negative Regulation Of Cell-Matrix Adhesion (GO:0001953),1/31,0.101667602004229,0.160813298178807,0,0,9.75539215686275,22.3012809844891,MMP12,2
Intracellular Protein Transport (GO:0006886),3/325,0.102097401723164,0.161215656672832,0,0,2.76806888763411,6.31625710062008,MMP12;CD74;LAPTM5,2
Protein-Containing Complex Assembly (GO:0065003),3/328,0.104218729432281,0.163750256559544,0,0,2.7420979020979,6.20060568222141,CD74;CAPG;HOPX,2
Regulation Of Cholesterol Efflux (GO:0010874),1/32,0.104771654904256,0.163750256559544,0,0,9.44022770398482,21.2968894885055,APOE,2
Transition Metal Ion Transport (GO:0000041),1/32,0.104771654904256,0.163750256559544,0,0,9.44022770398482,21.2968894885055,FTH1,2
Glycosphingolipid Metabolic Process (GO:0006687),1/32,0.104771654904256,0.163750256559544,0,0,9.44022770398482,21.2968894885055,GM2A,2
Vesicle Budding From Membrane (GO:0006900),1/32,0.104771654904256,0.163750256559544,0,0,9.44022770398482,21.2968894885055,SNX3,2
Negative Regulation Of G1/S Transition Of Mitotic Cell Cycle (GO:2000134),1/32,0.104771654904256,0.163750256559544,0,0,9.44022770398482,21.2968894885055,GPNMB,2
Negative Regulation Of Epithelial Cell Migration (GO:0010633),1/33,0.10786513718526,0.164938537559491,0,0,9.14476102941176,20.3642265666262,APOE,2
Regulation Of Potassium Ion Transmembrane Transport (GO:1901379),1/33,0.10786513718526,0.164938537559491,0,0,9.14476102941176,20.3642265666262,CD63,2
Carboxylic Acid Metabolic Process (GO:0019752),1/33,0.10786513718526,0.164938537559491,0,0,9.14476102941176,20.3642265666262,ST3GAL1,2
Regulation Of Type I Interferon-Mediated Signaling Pathway (GO:0060338),1/33,0.10786513718526,0.164938537559491,0,0,9.14476102941176,20.3642265666262,SAMHD1,2
Positive Regulation Of T Cell Mediated Cytotoxicity (GO:0001916),1/33,0.10786513718526,0.164938537559491,0,0,9.14476102941176,20.3642265666262,HLA-DRA,2
Positive Regulation Of Cytokine Production Involved In Immune Response (GO:0002720),1/33,0.10786513718526,0.164938537559491,0,0,9.14476102941176,20.3642265666262,LAPTM5,2
Positive Regulation Of Interleukin-12 Production (GO:0032735),1/33,0.10786513718526,0.164938537559491,0,0,9.14476102941176,20.3642265666262,LAPTM5,2
Positive Regulation Of Ion Transmembrane Transporter Activity (GO:0032414),1/33,0.10786513718526,0.164938537559491,0,0,9.14476102941176,20.3642265666262,CTSS,2
Positive Regulation Of Reproductive Process (GO:2000243),1/33,0.10786513718526,0.164938537559491,0,0,9.14476102941176,20.3642265666262,LHFPL2,2
Positive Regulation Of Small Molecule Metabolic Process (GO:0062013),1/33,0.10786513718526,0.164938537559491,0,0,9.14476102941176,20.3642265666262,APOE,2
Regulation Of Amyloid-Beta Formation (GO:1902003),1/33,0.10786513718526,0.164938537559491,0,0,9.14476102941176,20.3642265666262,APOE,2
Negative Regulation Of Blood Vessel Endothelial Cell Migration (GO:0043537),1/33,0.10786513718526,0.164938537559491,0,0,9.14476102941176,20.3642265666262,APOE,2
Regulation Of Cell Adhesion Mediated By Integrin (GO:0033628),1/33,0.10786513718526,0.164938537559491,0,0,9.14476102941176,20.3642265666262,LYN,2
Negative Regulation Of Cell Migration (GO:0030336),2/163,0.10884022116217,0.166153095096403,0,0,3.66552331510151,8.12967007785411,CD74;HMOX1,2
Negative Regulation Of Gene Expression (GO:0010629),3/336,0.109961104039518,0.167585828544473,0,0,2.67512967512968,5.90569271361396,SRGN;GPNMB;APOE,2
Regulation Of Neuronal Synaptic Plasticity (GO:0048168),1/34,0.110948084322367,0.168252952957516,0,0,8.86720142602496,19.4962527818018,APOE,2
Protein Targeting To Vacuole (GO:0006623),1/34,0.110948084322367,0.168252952957516,0,0,8.86720142602496,19.4962527818018,LAPTM5,2
Regulation Of T Cell Receptor Signaling Pathway (GO:0050856),1/34,0.110948084322367,0.168252952957516,0,0,8.86720142602496,19.4962527818018,LAPTM5,2
Response To Nutrient Levels (GO:0031667),1/35,0.114020531650726,0.171497329929651,0,0,8.60596885813149,18.6868006433394,CD68,2
Positive Regulation Of Cell Development (GO:0010720),1/35,0.114020531650726,0.171497329929651,0,0,8.60596885813149,18.6868006433394,TGM2,2
Endoderm Formation (GO:0001706),1/35,0.114020531650726,0.171497329929651,0,0,8.60596885813149,18.6868006433394,ITGB2,2
Regulation Of Axon Extension (GO:0030516),1/35,0.114020531650726,0.171497329929651,0,0,8.60596885813149,18.6868006433394,APOE,2
Negative Regulation Of Cell Cycle G1/S Phase Transition (GO:1902807),1/35,0.114020531650726,0.171497329929651,0,0,8.60596885813149,18.6868006433394,GPNMB,2
Double-Strand Break Repair (GO:0006302),2/168,0.114408909528181,0.171800306954899,0,0,3.55421686746988,7.70545801398161,NSMCE3;SAMHD1,2
Regulation Of Erythrocyte Differentiation (GO:0045646),1/36,0.117082514418911,0.174390325366255,0,0,8.35966386554622,17.9304452465445,LYN,2
Regulation Of Receptor Internalization (GO:0002090),1/36,0.117082514418911,0.174390325366255,0,0,8.35966386554622,17.9304452465445,CD63,2
Lytic Vacuole Organization (GO:0080171),1/36,0.117082514418911,0.174390325366255,0,0,8.35966386554622,17.9304452465445,GRN,2
Regulation Of T Cell Mediated Cytotoxicity (GO:0001914),1/36,0.117082514418911,0.174390325366255,0,0,8.35966386554622,17.9304452465445,HLA-DRA,2
Negative Regulation Of T Cell Proliferation (GO:0042130),1/36,0.117082514418911,0.174390325366255,0,0,8.35966386554622,17.9304452465445,GPNMB,2
Negative Regulation Of Endothelial Cell Migration (GO:0010596),1/37,0.120134067732289,0.177497119366517,0,0,8.12704248366013,17.2223971189545,APOE,2
Negative Regulation Of Endothelial Cell Proliferation (GO:0001937),1/37,0.120134067732289,0.177497119366517,0,0,8.12704248366013,17.2223971189545,APOE,2
Regulation Of p38MAPK Cascade (GO:1900744),1/37,0.120134067732289,0.177497119366517,0,0,8.12704248366013,17.2223971189545,GADD45G,2
Melanosome Organization (GO:0032438),1/37,0.120134067732289,0.177497119366517,0,0,8.12704248366013,17.2223971189545,APOE,2
Regulation Of Cellular Component Biogenesis (GO:0044087),1/37,0.120134067732289,0.177497119366517,0,0,8.12704248366013,17.2223971189545,APOE,2
Positive Regulation Of Cellular Biosynthetic Process (GO:0031328),2/174,0.121186668416147,0.178764924999099,0,0,3.42919125303714,7.2370448049548,APOC2;VIM,2
Negative Regulation Of Type I Interferon Production (GO:0032480),1/38,0.123175226584005,0.179679417826508,0,0,7.90699523052464,16.5584129584277,TYROBP,2
Regulation Of Telomere Maintenance (GO:0032204),1/38,0.123175226584005,0.179679417826508,0,0,7.90699523052464,16.5584129584277,NSMCE3,2
Positive Regulation Of Cation Channel Activity (GO:2001259),1/38,0.123175226584005,0.179679417826508,0,0,7.90699523052464,16.5584129584277,CTSS,2
Response To Peptide (GO:1901652),1/38,0.123175226584005,0.179679417826508,0,0,7.90699523052464,16.5584129584277,MMP12,2
Establishment Of Protein Localization To Plasma Membrane (GO:0061951),1/38,0.123175226584005,0.179679417826508,0,0,7.90699523052464,16.5584129584277,RILPL2,2
Fatty Acid Transport (GO:0015908),1/38,0.123175226584005,0.179679417826508,0,0,7.90699523052464,16.5584129584277,APOE,2
Positive Regulation Of Production Of Molecular Mediator Of Immune Response (GO:0002702),1/38,0.123175226584005,0.179679417826508,0,0,7.90699523052464,16.5584129584277,LAPTM5,2
Negative Regulation Of Protein Secretion (GO:0050709),1/39,0.126206025870244,0.182363738639551,0,0,7.69852941176471,15.9347208953454,APOE,2
Negative Regulation Of Transport (GO:0051051),1/39,0.126206025870244,0.182363738639551,0,0,7.69852941176471,15.9347208953454,SNX3,2
Regulation Of Monoatomic Cation Transmembrane Transport (GO:1904062),1/39,0.126206025870244,0.182363738639551,0,0,7.69852941176471,15.9347208953454,CD63,2
Carboxylic Acid Transmembrane Transport (GO:1905039),1/39,0.126206025870244,0.182363738639551,0,0,7.69852941176471,15.9347208953454,SLC16A3,2
Retina Homeostasis (GO:0001895),1/39,0.126206025870244,0.182363738639551,0,0,7.69852941176471,15.9347208953454,LYZ,2
Positive Regulation Of Pattern Recognition Receptor Signaling Pathway (GO:0062208),1/39,0.126206025870244,0.182363738639551,0,0,7.69852941176471,15.9347208953454,CD14,2
Regulation Of Cytokine-Mediated Signaling Pathway (GO:0001959),1/40,0.12922650035539,0.184695418081809,0,0,7.50075414781297,15.3479576103274,CD74,2
Negative Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901991),1/40,0.12922650035539,0.184695418081809,0,0,7.50075414781297,15.3479576103274,GPNMB,2
Negative Regulation Of Secretion By Cell (GO:1903531),1/40,0.12922650035539,0.184695418081809,0,0,7.50075414781297,15.3479576103274,APOE,2
Regulation Of Small Molecule Metabolic Process (GO:0062012),1/40,0.12922650035539,0.184695418081809,0,0,7.50075414781297,15.3479576103274,APOE,2
Cellular Response To Heat (GO:0034605),1/40,0.12922650035539,0.184695418081809,0,0,7.50075414781297,15.3479576103274,HMOX1,2
Cyclic-Nucleotide-Mediated Signaling (GO:0019935),1/40,0.12922650035539,0.184695418081809,0,0,7.50075414781297,15.3479576103274,APOE,2
Positive Regulation Of Myeloid Leukocyte Differentiation (GO:0002763),1/40,0.12922650035539,0.184695418081809,0,0,7.50075414781297,15.3479576103274,CD74,2
Positive Regulation Of Macromolecule Metabolic Process (GO:0010604),3/364,0.130985472515402,0.18691871000257,0,0,2.46411483253589,5.00872948450303,CD74;TYROBP;LAPTM5,2
O-glycan Processing (GO:0016266),1/41,0.132236684709382,0.187250405620835,0,0,7.31286764705882,14.7951151743085,ST3GAL1,2
Cellular Response To Retinoic Acid (GO:0071300),1/41,0.132236684709382,0.187250405620835,0,0,7.31286764705882,14.7951151743085,LYN,2
Visual System Development (GO:0150063),1/41,0.132236684709382,0.187250405620835,0,0,7.31286764705882,14.7951151743085,C1QA,2
Positive Regulation Of Response To Biotic Stimulus (GO:0002833),1/41,0.132236684709382,0.187250405620835,0,0,7.31286764705882,14.7951151743085,GRN,2
Protein Localization To Lysosome (GO:0061462),1/41,0.132236684709382,0.187250405620835,0,0,7.31286764705882,14.7951151743085,LAPTM5,2
Regulation Of Ubiquitin-Dependent Protein Catabolic Process (GO:2000058),1/42,0.135236613437021,0.190910057985595,0,0,7.13414634146341,14.2734959196977,LAPTM5,2
Lipid Modification (GO:0030258),1/42,0.135236613437021,0.190910057985595,0,0,7.13414634146341,14.2734959196977,PLA2G7,2
Regulation Of Chromosome Organization (GO:0033044),1/43,0.138226321005972,0.193348537297546,0,0,6.96393557422969,13.7806739539067,NSMCE3,2
Positive Regulation Of T Cell Mediated Immunity (GO:0002711),1/43,0.138226321005972,0.193348537297546,0,0,6.96393557422969,13.7806739539067,HLA-DRA,2
Response To Amyloid-Beta (GO:1904645),1/43,0.138226321005972,0.193348537297546,0,0,6.96393557422969,13.7806739539067,MMP12,2
Ephrin Receptor Signaling Pathway (GO:0048013),1/43,0.138226321005972,0.193348537297546,0,0,6.96393557422969,13.7806739539067,LYN,2
Positive Regulation Of Receptor-Mediated Endocytosis (GO:0048260),1/43,0.138226321005972,0.193348537297546,0,0,6.96393557422969,13.7806739539067,CD63,2
Lysosome Organization (GO:0007040),1/43,0.138226321005972,0.193348537297546,0,0,6.96393557422969,13.7806739539067,GRN,2
Defense Response To Virus (GO:0051607),2/189,0.138542851420237,0.193496778807291,0,0,3.15172799106074,6.22962865969247,SAMHD1;RNASE1,2
Positive Regulation Of Protein Phosphorylation (GO:0001934),3/377,0.141200523382417,0.19661843712623,0,0,2.37688381137579,4.65292653786781,LYN;CD74;GPNMB,2
Bone Development (GO:0060348),1/44,0.141205841679338,0.19661843712623,0,0,6.80164158686731,13.3144622315092,TGM2,2
Neuron Projection Development (GO:0031175),2/192,0.142078119578382,0.197533724497024,0,0,3.10149253731343,6.05218503263149,LYN;APOE,2
Regulation Of Signal Transduction (GO:0009966),2/193,0.143260914330502,0.198877311585697,0,0,3.08509806986012,5.99461622236244,SNX3;CD63,2
Regulation Of Protein Modification Process (GO:0031399),1/45,0.144175209718273,0.199243635685855,0,0,6.64672459893048,12.8728842450404,LYN,2
Hexose Metabolic Process (GO:0019318),1/45,0.144175209718273,0.199243635685855,0,0,6.64672459893048,12.8728842450404,FUCA1,2
Zymogen Activation (GO:0031638),1/45,0.144175209718273,0.199243635685855,0,0,6.64672459893048,12.8728842450404,CTSL,2
Regulation Of Programmed Cell Death (GO:0043067),2/195,0.145632891380359,0.20002450881295,0,0,3.05281880751682,5.88176301385586,CTSB;TGM2,2
DNA Damage Response (GO:0006974),3/384,0.146810779297843,0.20002450881295,0,0,2.33237890718206,4.47492721416054,LYN;NSMCE3;SAMHD1,2
Positive Regulation Of Protein Metabolic Process (GO:0051247),2/196,0.146822017425253,0.20002450881295,0,0,3.0369287582705,5.82645166015616,APOE;VIM,2
Regulation Of Cytokine Production Involved In Inflammatory Response (GO:1900015),1/46,0.14713445914859,0.20002450881295,0,0,6.49869281045752,12.4541496351863,PLD3,2
Regulation Of Interleukin-10 Production (GO:0032653),1/46,0.14713445914859,0.20002450881295,0,0,6.49869281045752,12.4541496351863,TYROBP,2
Regulation Of mRNA Catabolic Process (GO:0061013),1/46,0.14713445914859,0.20002450881295,0,0,6.49869281045752,12.4541496351863,VIM,2
Replication Fork Processing (GO:0031297),1/46,0.14713445914859,0.20002450881295,0,0,6.49869281045752,12.4541496351863,SAMHD1,2
Positive Regulation Of Blood Vessel Endothelial Cell Migration (GO:0043536),1/46,0.14713445914859,0.20002450881295,0,0,6.49869281045752,12.4541496351863,HMOX1,2
Response To Hydrogen Peroxide (GO:0042542),1/46,0.14713445914859,0.20002450881295,0,0,6.49869281045752,12.4541496351863,HMOX1,2
Development Of Primary Male Sexual Characteristics (GO:0046546),1/46,0.14713445914859,0.20002450881295,0,0,6.49869281045752,12.4541496351863,LHFPL2,2
Protein Sumoylation (GO:0016925),1/46,0.14713445914859,0.20002450881295,0,0,6.49869281045752,12.4541496351863,NSMCE3,2
Positive Regulation Of Multicellular Organismal Process (GO:0051240),3/387,0.149237750041717,0.202238783641944,0,0,2.31380208333333,4.40134812027737,APOC2;APOE;GADD45G,2
Negative Regulation Of Hydrolase Activity (GO:0051346),1/47,0.150083623986731,0.202238783641944,0,0,6.35709718670077,12.0566330675351,CTSB,2
Regulation Of Interleukin-2 Production (GO:0032663),1/47,0.150083623986731,0.202238783641944,0,0,6.35709718670077,12.0566330675351,LAPTM5,2
Cognition (GO:0050890),1/47,0.150083623986731,0.202238783641944,0,0,6.35709718670077,12.0566330675351,HLA-DRA,2
Secondary Alcohol Metabolic Process (GO:1902652),1/47,0.150083623986731,0.202238783641944,0,0,6.35709718670077,12.0566330675351,APOE,2
Positive Regulation Of Smooth Muscle Cell Proliferation (GO:0048661),1/47,0.150083623986731,0.202238783641944,0,0,6.35709718670077,12.0566330675351,HMOX1,2
Cellular Response To Radiation (GO:0071478),1/48,0.153022738063901,0.205296198949963,0,0,6.2215269086358,11.6788559140351,NSMCE3,2
Regulation Of Tumor Necrosis Factor-Mediated Signaling Pathway (GO:0010803),1/48,0.153022738063901,0.205296198949963,0,0,6.2215269086358,11.6788559140351,LAPTM5,2
Negative Regulation Of ERK1 And ERK2 Cascade (GO:0070373),1/48,0.153022738063901,0.205296198949963,0,0,6.2215269086358,11.6788559140351,LYN,2
Erythrocyte Differentiation (GO:0030218),1/49,0.155951835161772,0.208616792596315,0,0,6.09160539215686,11.3194702890222,LYN,2
Positive Regulation Of Nervous System Development (GO:0051962),1/49,0.155951835161772,0.208616792596315,0,0,6.09160539215686,11.3194702890222,TGM2,2
Defense Response To Bacterium (GO:0042742),2/204,0.156406678592733,0.208921130271397,0,0,2.91547214422935,5.40906307779962,LYZ;RNASE1,2
Regulation Of Interleukin-12 Production (GO:0032655),1/50,0.158870948881139,0.210986130089258,0,0,5.96698679471789,10.9772451176002,LAPTM5,2
Positive Regulation Of Transport (GO:0051050),1/50,0.158870948881139,0.210986130089258,0,0,5.96698679471789,10.9772451176002,APOE,2
Pyruvate Metabolic Process (GO:0006090),1/50,0.158870948881139,0.210986130089258,0,0,5.96698679471789,10.9772451176002,SDS,2
Negative Regulation Of Cell Projection Organization (GO:0031345),1/50,0.158870948881139,0.210986130089258,0,0,5.96698679471789,10.9772451176002,APOE,2
Protein Stabilization (GO:0050821),2/208,0.16124396586987,0.213828578116032,0,0,2.85828140849152,5.21589694167561,GRN;TYROBP,2
Receptor Internalization (GO:0031623),1/51,0.161780112789419,0.21392219230716,0,0,5.84735294117647,10.6510539229955,ITGB2,2
Regulated Exocytosis (GO:0045055),1/51,0.161780112789419,0.21392219230716,0,0,5.84735294117647,10.6510539229955,LYN,2
Negative Regulation Of Response To Stimulus (GO:0048585),1/52,0.164679360266312,0.216509774084035,0,0,5.73241061130335,10.3398641118515,LYN,2
Adenylate Cyclase-Inhibiting G Protein-Coupled Receptor Signaling Pathway (GO:0007193),1/52,0.164679360266312,0.216509774084035,0,0,5.73241061130335,10.3398641118515,PSAP,2
Positive Regulation Of B Cell Activation (GO:0050871),1/52,0.164679360266312,0.216509774084035,0,0,5.73241061130335,10.3398641118515,CD74,2
Regulation Of Cell Development (GO:0060284),1/52,0.164679360266312,0.216509774084035,0,0,5.73241061130335,10.3398641118515,GRN,2
Actin Polymerization Or Depolymerization (GO:0008154),1/53,0.1675687246231,0.218433557345572,0,0,5.62188914027149,10.0427275295745,CAPG,2
Regulation Of Proteasomal Protein Catabolic Process (GO:0061136),1/53,0.1675687246231,0.218433557345572,0,0,5.62188914027149,10.0427275295745,APOE,2
Positive Regulation Of NIK/NF-kappaB Signaling (GO:1901224),1/53,0.1675687246231,0.218433557345572,0,0,5.62188914027149,10.0427275295745,LAPTM5,2
Endosome Organization (GO:0007032),1/53,0.1675687246231,0.218433557345572,0,0,5.62188914027149,10.0427275295745,SNX3,2
Protein Homotetramerization (GO:0051289),1/53,0.1675687246231,0.218433557345572,0,0,5.62188914027149,10.0427275295745,SAMHD1,2
Proton Motive Force-Driven Mitochondrial ATP Synthesis (GO:0042776),1/53,0.1675687246231,0.218433557345572,0,0,5.62188914027149,10.0427275295745,ATP5MG,2
Negative Regulation Of Neuron Projection Development (GO:0010977),1/54,0.170448239074148,0.220933613129961,0,0,5.51553829078801,9.75877212797992,APOE,2
Peptidyl-Tyrosine Modification (GO:0018212),1/54,0.170448239074148,0.220933613129961,0,0,5.51553829078801,9.75877212797992,LYN,2
Positive Regulation Of Leukocyte Chemotaxis (GO:0002690),1/54,0.170448239074148,0.220933613129961,0,0,5.51553829078801,9.75877212797992,PLA2G7,2
Regulation Of Blood Vessel Endothelial Cell Migration (GO:0043535),1/54,0.170448239074148,0.220933613129961,0,0,5.51553829078801,9.75877212797992,APOE,2
Phosphatidylcholine Metabolic Process (GO:0046470),1/55,0.173317936678806,0.224021355566558,0,0,5.41312636165577,9.48719459266821,PLA2G7,2
Positive Regulation Of Tyrosine Phosphorylation Of STAT Protein (GO:0042531),1/55,0.173317936678806,0.224021355566558,0,0,5.41312636165577,9.48719459266821,LYN,2
Cellular Response To Peptide (GO:1901653),1/56,0.176177850445797,0.227079164880347,0,0,5.3144385026738,9.2272537985839,VIM,2
Regulation Of Cation Channel Activity (GO:2001257),1/56,0.176177850445797,0.227079164880347,0,0,5.3144385026738,9.2272537985839,CTSS,2
Positive Regulation Of Cell Motility (GO:2000147),2/221,0.177148173734663,0.228010044344755,0,0,2.68683977373407,4.65029833509591,GRN;GPNMB,2
Chemokine-Mediated Signaling Pathway (GO:0070098),1/57,0.179028013226665,0.229465473019952,0,0,5.21927521008403,8.97826499865963,LYN,2
Positive Regulation Of Interleukin-1 Beta Production (GO:0032731),1/57,0.179028013226665,0.229465473019952,0,0,5.21927521008403,8.97826499865963,TYROBP,2
Myeloid Cell Differentiation (GO:0030099),1/57,0.179028013226665,0.229465473019952,0,0,5.21927521008403,8.97826499865963,LYN,2
Glycosaminoglycan Biosynthetic Process (GO:0006024),1/58,0.181868457752594,0.23213487871477,0,0,5.12745098039216,8.73959464222047,ST3GAL1,2
Memory (GO:0007613),1/58,0.181868457752594,0.23213487871477,0,0,5.12745098039216,8.73959464222047,APOE,2
Regulation Of Bone Mineralization (GO:0030500),1/58,0.181868457752594,0.23213487871477,0,0,5.12745098039216,8.73959464222047,SRGN,2
Positive Regulation Of Protein Binding (GO:0032092),1/59,0.184699216707237,0.235094986362813,0,0,5.03879310344828,8.51065574827833,APOE,2
Negative Regulation Of Cytokine-Mediated Signaling Pathway (GO:0001960),1/59,0.184699216707237,0.235094986362813,0,0,5.03879310344828,8.51065574827833,SAMHD1,2
Response To Retinoic Acid (GO:0032526),1/60,0.187520322616876,0.237698174461943,0,0,4.9531405782652,8.29090377179139,LYN,2
Sterol Metabolic Process (GO:0016125),1/60,0.187520322616876,0.237698174461943,0,0,4.9531405782652,8.29090377179139,APOE,2
Proton Motive Force-Driven ATP Synthesis (GO:0015986),1/60,0.187520322616876,0.237698174461943,0,0,4.9531405782652,8.29090377179139,ATP5MG,2
Regulation Of Cell Migration (GO:0030334),3/434,0.188842480995502,0.239044407761524,0,0,2.05652815861633,3.4279076021412,CD74;GRN;GPNMB,2
Positive Regulation Of Organelle Assembly (GO:1902117),1/61,0.190331807948841,0.240598255165041,0,0,4.8703431372549,8.0798328931582,CAPG,2
Cell Junction Organization (GO:0034330),1/62,0.193133704977151,0.243470335903981,0,0,4.79026036644166,7.87697269239826,C1QA,2
Glycerophospholipid Metabolic Process (GO:0006650),1/62,0.193133704977151,0.243470335903981,0,0,4.79026036644166,7.87697269239826,PLA2G7,2
Oxidative Phosphorylation (GO:0006119),1/63,0.195926045971874,0.246314687069976,0,0,4.71276091081594,7.68188514931118,ATP5MG,2
Regulation Of Cellular Catabolic Process (GO:0031329),1/63,0.195926045971874,0.246314687069976,0,0,4.71276091081594,7.68188514931118,PSAP,2
Positive Regulation Of T Cell Differentiation (GO:0045582),1/64,0.198708863000956,0.247443692544551,0,0,4.63772175536882,7.49416194964559,HLA-DRA,2
Positive Regulation Of Cysteine-Type Endopeptidase Activity (GO:2001056),1/64,0.198708863000956,0.247443692544551,0,0,4.63772175536882,7.49416194964559,CTSD,2
Endocytic Recycling (GO:0032456),1/64,0.198708863000956,0.247443692544551,0,0,4.63772175536882,7.49416194964559,SNX3,2
Positive Regulation Of Interleukin-1 Production (GO:0032732),1/64,0.198708863000956,0.247443692544551,0,0,4.63772175536882,7.49416194964559,TYROBP,2
Positive Regulation Of Type I Interferon Production (GO:0032481),1/64,0.198708863000956,0.247443692544551,0,0,4.63772175536882,7.49416194964559,CD14,2
Protein N-linked Glycosylation (GO:0006487),1/64,0.198708863000956,0.247443692544551,0,0,4.63772175536882,7.49416194964559,ST3GAL1,2
Negative Regulation Of Cell Death (GO:0060548),1/64,0.198708863000956,0.247443692544551,0,0,4.63772175536882,7.49416194964559,GPNMB,2
Cellular Response To Light Stimulus (GO:0071482),1/65,0.201482188061627,0.249881418122314,0,0,4.56502757352941,7.31342204566156,NSMCE3,2
Regulation Of Tyrosine Phosphorylation Of STAT Protein (GO:0042509),1/65,0.201482188061627,0.249881418122314,0,0,4.56502757352941,7.31342204566156,LYN,2
Monocarboxylic Acid Biosynthetic Process (GO:0072330),1/65,0.201482188061627,0.249881418122314,0,0,4.56502757352941,7.31342204566156,SDS,2
Negative Regulation Of Endopeptidase Activity (GO:0010951),1/66,0.204246053141344,0.251949158170329,0,0,4.49457013574661,7.13930945235832,TIMP2,2
Negative Regulation Of Immune Response (GO:0050777),1/66,0.204246053141344,0.251949158170329,0,0,4.49457013574661,7.13930945235832,LYN,2
Regulation Of Endocytosis (GO:0030100),1/66,0.204246053141344,0.251949158170329,0,0,4.49457013574661,7.13930945235832,APOE,2
Cellular Response To Type II Interferon (GO:0071346),1/66,0.204246053141344,0.251949158170329,0,0,4.49457013574661,7.13930945235832,HLA-DPA1,2
Activation Of Cysteine-Type Endopeptidase Activity Involved In Apoptotic Process (GO:0006919),1/67,0.207000489928039,0.253983244651359,0,0,4.42624777183601,6.97149125942405,LAPTM5,2
Regulation Of Neurogenesis (GO:0050767),1/67,0.207000489928039,0.253983244651359,0,0,4.42624777183601,6.97149125942405,TGM2,2
Peptidyl-Tyrosine Phosphorylation (GO:0018108),1/67,0.207000489928039,0.253983244651359,0,0,4.42624777183601,6.97149125942405,LYN,2
Cholesterol Metabolic Process (GO:0008203),1/67,0.207000489928039,0.253983244651359,0,0,4.42624777183601,6.97149125942405,APOE,2
Intermediate Filament Organization (GO:0045109),1/68,0.209745530181625,0.257008189649217,0,0,4.35996488147498,6.80965581396336,VIM,2
Regulation Of Endopeptidase Activity (GO:0052548),1/69,0.21248120548043,0.259667856165579,0,0,4.29563148788927,6.65351108310001,TIMP2,2
Response To Molecule Of Bacterial Origin (GO:0002237),1/69,0.21248120548043,0.259667856165579,0,0,4.29563148788927,6.65351108310001,CD14,2
Negative Regulation Of Epithelial Cell Proliferation (GO:0050680),1/70,0.215207547278188,0.261608116334199,0,0,4.23316283034953,6.50278315809896,APOE,2
Negative Regulation Of Extrinsic Apoptotic Signaling Pathway (GO:2001237),1/70,0.215207547278188,0.261608116334199,0,0,4.23316283034953,6.50278315809896,HMOX1,2
Neutrophil Chemotaxis (GO:0030593),1/70,0.215207547278188,0.261608116334199,0,0,4.23316283034953,6.50278315809896,ITGB2,2
Sulfur Compound Biosynthetic Process (GO:0044272),1/70,0.215207547278188,0.261608116334199,0,0,4.23316283034953,6.50278315809896,ST3GAL1,2
Negative Regulation Of Supramolecular Fiber Organization (GO:1902904),1/71,0.217924586983491,0.264211999258349,0,0,4.17247899159664,6.35721489146496,APOE,2
Myeloid Leukocyte Differentiation (GO:0002573),1/71,0.217924586983491,0.264211999258349,0,0,4.17247899159664,6.35721489146496,TYROBP,2
Cellular Response To Hypoxia (GO:0071456),1/72,0.22063235584404,0.266790967132464,0,0,4.11350455675228,6.21656465757173,HMOX1,2
Second-Messenger-Mediated Signaling (GO:0019932),1/72,0.22063235584404,0.266790967132464,0,0,4.11350455675228,6.21656465757173,APOE,2
Cellular Response To Decreased Oxygen Levels (GO:0036294),1/73,0.223330885024822,0.268288997827204,0,0,4.0561683006536,6.0806052170529,HMOX1,2
Granulocyte Chemotaxis (GO:0071621),1/73,0.223330885024822,0.268288997827204,0,0,4.0561683006536,6.0806052170529,ITGB2,2
Protein Tetramerization (GO:0051262),1/73,0.223330885024822,0.268288997827204,0,0,4.0561683006536,6.0806052170529,SAMHD1,2
Monocarboxylic Acid Transport (GO:0015718),1/73,0.223330885024822,0.268288997827204,0,0,4.0561683006536,6.0806052170529,SLC16A3,2
Regulation Of Rho Protein Signal Transduction (GO:0035023),1/73,0.223330885024822,0.268288997827204,0,0,4.0561683006536,6.0806052170529,APOE,2
Regulation Of mRNA Stability (GO:0043488),1/74,0.226020205625151,0.270545133680016,0,0,4.00040290088638,5.94912267949006,VIM,2
Import Into Nucleus (GO:0051170),1/74,0.226020205625151,0.270545133680016,0,0,4.00040290088638,5.94912267949006,MMP12,2
Cellular Component Assembly (GO:0022607),2/260,0.226092124772853,0.270545133680016,0,0,2.27617725326854,3.3842493182424,CD74;CAPG,2
Negative Regulation Of Phosphorylation (GO:0042326),1/75,0.228700348546935,0.272601323365283,0,0,3.94614467408585,5.82191555621412,LYN,2
Defense Response To Gram-negative Bacterium (GO:0050829),1/75,0.228700348546935,0.272601323365283,0,0,3.94614467408585,5.82191555621412,LYZ,2
Positive Regulation Of Neurogenesis (GO:0050769),1/75,0.228700348546935,0.272601323365283,0,0,3.94614467408585,5.82191555621412,TGM2,2
Positive Regulation Of Gene Expression (GO:0010628),3/480,0.22992435362135,0.27370528624096,0,0,1.85382123117972,2.72512633333381,CD74;TYROBP;VIM,2
Negative Regulation Of Apoptotic Process (GO:0043066),3/482,0.231750473747132,0.27552223204866,0,0,1.84589106092238,2.69886630079925,CD74;GRN;APOE,2
Neutrophil Migration (GO:1990266),1/77,0.234033224894089,0.276803775646935,0,0,3.84191176470588,5.57957843893629,ITGB2,2
Positive Regulation Of JNK Cascade (GO:0046330),1/77,0.234033224894089,0.276803775646935,0,0,3.84191176470588,5.57957843893629,GADD45G,2
Positive Regulation Of Endothelial Cell Proliferation (GO:0001938),1/77,0.234033224894089,0.276803775646935,0,0,3.84191176470588,5.57957843893629,HMOX1,2
Monoatomic Cation Homeostasis (GO:0055080),1/77,0.234033224894089,0.276803775646935,0,0,3.84191176470588,5.57957843893629,HMOX1,2
Regulation Of Innate Immune Response (GO:0045088),1/78,0.236686019655141,0.278864682132147,0,0,3.79182582123759,5.46409998366956,SAMHD1,2
Negative Regulation Of Protein Modification Process (GO:0031400),1/78,0.236686019655141,0.278864682132147,0,0,3.79182582123759,5.46409998366956,LYN,2
Cellular Response To Nutrient Levels (GO:0031669),1/78,0.236686019655141,0.278864682132147,0,0,3.79182582123759,5.46409998366956,CD68,2
Cellular Response To UV (GO:0034644),1/79,0.23932975965029,0.280183502061931,0,0,3.74302413273002,5.35219860670196,NSMCE3,2
Positive Regulation Of Catabolic Process (GO:0009896),1/79,0.23932975965029,0.280183502061931,0,0,3.74302413273002,5.35219860670196,LAPTM5,2
Positive Regulation Of Endocytosis (GO:0045807),1/79,0.23932975965029,0.280183502061931,0,0,3.74302413273002,5.35219860670196,APOE,2
Positive Regulation Of Protein Localization To Membrane (GO:1905477),1/79,0.23932975965029,0.280183502061931,0,0,3.74302413273002,5.35219860670196,ITGB2,2
Protein Import Into Nucleus (GO:0006606),1/79,0.23932975965029,0.280183502061931,0,0,3.74302413273002,5.35219860670196,MMP12,2
Positive Regulation Of Cell Migration (GO:0030335),2/272,0.241383950139248,0.282228817020317,0,0,2.17368711995578,3.08960596490552,GRN;GPNMB,2
Glycoprotein Biosynthetic Process (GO:0009101),1/80,0.241964475238469,0.282548097514807,0,0,3.69545793000745,5.24372309706388,ST3GAL1,2
Macromolecule Modification (GO:0043412),1/81,0.244590196884051,0.28525176514777,0,0,3.64908088235294,5.13853036665697,ST3GAL1,2
Plasma Membrane Bounded Cell Projection Assembly (GO:0120031),2/275,0.245216189917768,0.285619364428934,0,0,2.14947241812913,3.02133077984316,RILPL2;EMP3,2
Regulation Of Phosphorylation (GO:0042325),1/82,0.247206954743413,0.287573660011641,0,0,3.6038489469862,5.03648492763678,LYN,2
Phospholipase C-activating G Protein-Coupled Receptor Signaling Pathway (GO:0007200),1/83,0.249814779008749,0.289143302152444,0,0,3.55972022955524,4.93745839849894,TGM2,2
Vesicle-Mediated Transport To The Plasma Membrane (GO:0098876),1/83,0.249814779008749,0.289143302152444,0,0,3.55972022955524,4.93745839849894,SNX3,2
Positive Regulation Of Ubiquitin-Dependent Protein Catabolic Process (GO:2000060),1/83,0.249814779008749,0.289143302152444,0,0,3.55972022955524,4.93745839849894,LAPTM5,2
Regulation Of NIK/NF-kappaB Signaling (GO:1901222),1/83,0.249814779008749,0.289143302152444,0,0,3.55972022955524,4.93745839849894,LAPTM5,2
Regulation Of Cysteine-Type Endopeptidase Activity Involved In Apoptotic Process (GO:0043281),1/84,0.252413699721398,0.291417324175835,0,0,3.51665485471297,4.84132905507642,CTSD,2
Regulation Of Interleukin-1 Beta Production (GO:0032651),1/84,0.252413699721398,0.291417324175835,0,0,3.51665485471297,4.84132905507642,TYROBP,2
Regulation Of Kinase Activity (GO:0043549),1/85,0.25500374682657,0.291841149855066,0,0,3.47461484593838,4.74798141153483,CD74,2
Positive Regulation Of Amide Metabolic Process (GO:0034250),1/85,0.25500374682657,0.291841149855066,0,0,3.47461484593838,4.74798141153483,VIM,2
Positive Regulation Of Endothelial Cell Migration (GO:0010595),1/85,0.25500374682657,0.291841149855066,0,0,3.47461484593838,4.74798141153483,GRN,2
Establishment Of Protein Localization To Organelle (GO:0072594),1/85,0.25500374682657,0.291841149855066,0,0,3.47461484593838,4.74798141153483,MMP12,2
Positive Regulation Of Protein Localization (GO:1903829),1/85,0.25500374682657,0.291841149855066,0,0,3.47461484593838,4.74798141153483,TYROBP,2
Integrin-Mediated Signaling Pathway (GO:0007229),1/85,0.25500374682657,0.291841149855066,0,0,3.47461484593838,4.74798141153483,ITGB2,2
Macromolecule Catabolic Process (GO:0009057),1/85,0.25500374682657,0.291841149855066,0,0,3.47461484593838,4.74798141153483,SLC16A3,2
Central Nervous System Development (GO:0007417),2/283,0.255447783961535,0.291985713259515,0,0,2.08742763053062,2.84879026135034,C1QA;CAPG,2
DNA Metabolic Process (GO:0006259),2/288,0.261848726963923,0.298930410037074,0,0,2.05041227429287,2.74752849867188,NSMCE3;SAMHD1,2
Positive Regulation Of Cell Adhesion (GO:0045785),1/88,0.262720944658891,0.299554029952259,0,0,3.35429344151454,4.48355945487707,TGM2,2
Regulation Of Epithelial Cell Proliferation (GO:0050678),1/91,0.270359348927876,0.307500299089997,0,0,3.24199346405229,4.24053809418633,GRN,2
Positive Regulation Of Binding (GO:0051099),1/91,0.270359348927876,0.307500299089997,0,0,3.24199346405229,4.24053809418633,APOE,2
Positive Regulation Of Protein Catabolic Process (GO:0045732),1/92,0.2728881112536,0.309992798815894,0,0,3.20620555914674,4.16387805223831,APOE,2
Regulation Of Cell Cycle (GO:0051726),2/298,0.2746557591961,0.311316320958375,0,0,1.98013311819282,2.55880078560498,DYNLT3;GADD45G,2
Regulation Of Endothelial Cell Proliferation (GO:0001936),1/93,0.27540823606002,0.311316320958375,0,0,3.17119565217391,4.08925929023971,APOE,2
Protein O-linked Glycosylation (GO:0006493),1/93,0.27540823606002,0.311316320958375,0,0,3.17119565217391,4.08925929023971,ST3GAL1,2
Negative Regulation Of Amide Metabolic Process (GO:0034249),1/93,0.27540823606002,0.311316320958375,0,0,3.17119565217391,4.08925929023971,APOE,2
Peptidyl-Lysine Modification (GO:0018205),1/94,0.277919752411088,0.312617200080526,0,0,3.13693864642631,4.01660797636982,NSMCE3,2
"Retrograde Transport, Endosome To Golgi (GO:0042147)",1/94,0.277919752411088,0.312617200080526,0,0,3.13693864642631,4.01660797636982,SNX3,2
Sphingolipid Metabolic Process (GO:0006665),1/94,0.277919752411088,0.312617200080526,0,0,3.13693864642631,4.01660797636982,GM2A,2
Vesicle Organization (GO:0016050),1/94,0.277919752411088,0.312617200080526,0,0,3.13693864642631,4.01660797636982,SRGN,2
T Cell Receptor Signaling Pathway (GO:0050852),1/95,0.280422689260932,0.314662333859336,0,0,3.10341051314143,3.94585367133482,HLA-DPA1,2
Positive Regulation Of Epithelial Cell Migration (GO:0010634),1/95,0.280422689260932,0.314662333859336,0,0,3.10341051314143,3.94585367133482,GRN,2
Regulation Of Protein Metabolic Process (GO:0051246),1/96,0.282917075565896,0.316687932332593,0,0,3.07058823529412,3.87692913821259,APOE,2
Positive Regulation Of Supramolecular Fiber Organization (GO:1902905),1/96,0.282917075565896,0.316687932332593,0,0,3.07058823529412,3.87692913821259,APOE,2
Regulation Of Protein Localization (GO:0032880),1/97,0.285402940022551,0.319081875767304,0,0,3.03844975490196,3.80977016875974,CTSD,2
Positive Regulation Of Cold-Induced Thermogenesis (GO:0120162),1/98,0.287880311346607,0.32107039578584,0,0,3.00697392359005,3.74431541516073,GADD45G,2
Positive Regulation Of Protein-Containing Complex Assembly (GO:0031334),1/98,0.287880311346607,0.32107039578584,0,0,3.00697392359005,3.74431541516073,CAPG,2
Antimicrobial Humoral Response (GO:0019730),1/100,0.29280968888067,0.325777365715903,0,0,2.94592988710636,3.61828655610275,LYZ,2
Response To UV (GO:0009411),1/100,0.29280968888067,0.325777365715903,0,0,2.94592988710636,3.61828655610275,NSMCE3,2
Hemopoiesis (GO:0030097),1/101,0.295261752011551,0.328108283069668,0,0,2.91632352941177,3.55760272080315,LYN,2
Regulation Of Protein Secretion (GO:0050708),1/102,0.297705435794637,0.330424269921825,0,0,2.88730343622598,3.49840337924623,APOE,2
Positive Regulation Of Kinase Activity (GO:0033674),1/104,0.302567778091139,0.335415908402601,0,0,2.83095374071959,3.3842635553654,CD74,2
Positive Regulation Of Stress-Activated MAPK Cascade (GO:0032874),1/105,0.304986492833366,0.337689863751643,0,0,2.80359162895928,3.3292308251456,GADD45G,2
Regulation Of G1/S Transition Of Mitotic Cell Cycle (GO:2000045),1/106,0.307396940524649,0.33994920378117,0,0,2.77675070028011,3.27549788989155,GPNMB,2
Positive Regulation Of Metabolic Process (GO:0009893),1/108,0.31219314607078,0.34442437123535,0,0,2.72457394172622,3.17176704896272,GADD45G,2
Positive Regulation Of Translation (GO:0045727),1/108,0.31219314607078,0.34442437123535,0,0,2.72457394172622,3.17176704896272,VIM,2
Negative Regulation Of Developmental Process (GO:0051093),1/109,0.314578959322275,0.345811080881783,0,0,2.69921023965142,3.12169108880328,HOPX,2
Cellular Response To Salt (GO:1902075),1/109,0.314578959322275,0.345811080881783,0,0,2.69921023965142,3.12169108880328,TGM2,2
Regulation Of Wnt Signaling Pathway (GO:0030111),1/109,0.314578959322275,0.345811080881783,0,0,2.69921023965142,3.12169108880328,SNX3,2
Regulation Of JNK Cascade (GO:0046328),1/110,0.316956616363491,0.348008519041874,0,0,2.6743119266055,3.07275865370465,GADD45G,2
RNA Metabolic Process (GO:0016070),1/111,0.31932614467343,0.349358008279622,0,0,2.64986631016043,3.02493448608656,RNASE1,2
T Cell Activation (GO:0042110),1/111,0.31932614467343,0.349358008279622,0,0,2.64986631016043,3.02493448608656,CD74,2
Cytoskeleton Organization (GO:0007010),1/111,0.31932614467343,0.349358008279622,0,0,2.64986631016043,3.02493448608656,APOE,2
Negative Regulation Of Defense Response (GO:0031348),1/112,0.321687571618956,0.351523041995031,0,0,2.62586115527292,2.9781847075347,APOE,2
Negative Regulation Of Canonical Wnt Signaling Pathway (GO:0090090),1/114,0.326386230511903,0.356233902423324,0,0,2.57912545549193,2.88777930959139,APOE,2
Cellular Response To Oxidative Stress (GO:0034599),1/117,0.333374138038327,0.363429220471201,0,0,2.51204361054767,2.75945448944272,HMOX1,2
Regulation Of Small GTPase Mediated Signal Transduction (GO:0051056),1/118,0.335687526800486,0.365517579537496,0,0,2.4904474610357,2.71850902045275,TGM2,2
Positive Regulation Of Cellular Process (GO:0048522),3/594,0.33685570710562,0.366355496840313,0,0,1.4874634671589,1.61850990469843,LYN;GRN;TGM2,2
Regulation Of Protein-Containing Complex Assembly (GO:0043254),1/119,0.337993003343819,0.367157884247009,0,0,2.46921734795613,2.67843434096539,APOE,2
Protein Localization (GO:0008104),2/351,0.342116250957476,0.371198151865313,0,0,1.67489201556686,1.79649702209153,CD74;LAPTM5,2
Positive Regulation Of Macromolecule Biosynthetic Process (GO:0010557),1/122,0.344862226009226,0.37329609623378,0,0,2.40763247447739,2.56319029870728,VIM,2
Protein Localization To Nucleus (GO:0034504),1/122,0.344862226009226,0.37329609623378,0,0,2.40763247447739,2.56319029870728,MMP12,2
Organonitrogen Compound Biosynthetic Process (GO:1901566),1/123,0.347136319545674,0.375315620779382,0,0,2.38777724204436,2.52635839970114,APOE,2
Regulation Of Gene Expression (GO:0010468),5/1127,0.348564901419127,0.376417325974357,0,0,1.30967301693405,1.38030477678897,LYN;CD74;TYROBP;APOE;LITAF,2
Enzyme-Linked Receptor Protein Signaling Pathway (GO:0007167),1/124,0.349402633273551,0.376437303608902,0,0,2.36824485891918,2.49028133295655,LYN,2
Regulation Of DNA Metabolic Process (GO:0051052),1/124,0.349402633273551,0.376437303608902,0,0,2.36824485891918,2.49028133295655,NSMCE3,2
Regulation Of Mitotic Cell Cycle (GO:0007346),1/125,0.351661193452608,0.378426975155675,0,0,2.3490275142315,2.45493831861471,DYNLT3,2
Positive Regulation Of Intracellular Protein Transport (GO:0090316),1/126,0.353912026245742,0.380403686689867,0,0,2.33011764705882,2.42030930149287,ITGB2,2
Cytosolic Transport (GO:0016482),1/127,0.356155157686907,0.382367511582089,0,0,2.31150793650794,2.38637492066494,LAPTM5,2
Protein Homooligomerization (GO:0051260),1/129,0.360618420294138,0.386707500875511,0,0,2.27516084558824,2.32051592034116,SAMHD1,2
Epithelial Cell Differentiation (GO:0030855),1/132,0.367256200367462,0.393366489670976,0,0,2.22272114952851,2.22648995291628,CTSB,2
Negative Regulation Of Cell Motility (GO:2000146),1/133,0.369453665974705,0.395259509931029,0,0,2.20577094474153,2.19635217709371,CD74,2
Antigen Receptor-Mediated Signaling Pathway (GO:0050851),1/134,0.371643610131537,0.397140090361491,0,0,2.1890756302521,2.16679066783881,HLA-DPA1,2
Negative Regulation Of Cellular Biosynthetic Process (GO:0031327),1/137,0.378168567486814,0.403643337422047,0,0,2.14046280276817,2.0814186437173,APOC1,2
Negative Regulation Of Programmed Cell Death (GO:0043069),2/381,0.379532927649433,0.404629652563607,0,0,1.53995195526326,1.49192689044529,CD74;LAPTM5,2
Negative Regulation Of Wnt Signaling Pathway (GO:0030178),1/140,0.384626740344622,0.409585138327587,0,0,2.09394837071519,2.00072981081966,APOE,2
Actin Filament Organization (GO:0007015),1/144,0.393134913834291,0.418160863210316,0,0,2.03496503496504,1.89984830939203,CAPG,2
Regulation Of Cold-Induced Thermogenesis (GO:0120161),1/146,0.397345420432062,0.421663327225248,0,0,2.00669371196755,1.85207655664874,GADD45G,2
Negative Regulation Of Response To External Stimulus (GO:0032102),1/146,0.397345420432062,0.421663327225248,0,0,2.00669371196755,1.85207655664874,APOE,2
Protein Glycosylation (GO:0006486),1/147,0.399439864346631,0.423397041908367,0,0,1.99284850926672,1.8288212385887,ST3GAL1,2
Negative Regulation Of Protein Phosphorylation (GO:0001933),1/149,0.403607254781579,0.426829766564179,0,0,1.96571939586645,1.78352279266465,LYN,2
Skeletal System Development (GO:0001501),1/149,0.403607254781579,0.426829766564179,0,0,1.96571939586645,1.78352279266465,TGM2,2
Cellular Response To Organic Cyclic Compound (GO:0071407),1/152,0.409804959216901,0.43288592818429,0,0,1.92637319828594,1.71846733217321,TGM2,2
Regulation Of Cellular Component Organization (GO:0051128),1/153,0.411856721656433,0.434553762574353,0,0,1.91360294117647,1.69751842456346,APOE,2
Epithelium Development (GO:0060429),1/154,0.413901454302086,0.436210362962864,0,0,1.90099961553249,1.67692378471535,CTSB,2
Regulation Of Macromolecule Metabolic Process (GO:0060255),1/162,0.430009075025237,0.452149130375507,0,0,1.80580928023383,1.5240108744987,APOE,2
Protein Autophosphorylation (GO:0046777),1/162,0.430009075025237,0.452149130375507,0,0,1.80580928023383,1.5240108744987,LYN,2
Adenylate Cyclase-Modulating G Protein-Coupled Receptor Signaling Pathway (GO:0007188),1/163,0.431991598261632,0.453714604345646,0,0,1.79457153231663,1.5062720712338,PSAP,2
Membrane Organization (GO:0061024),1/167,0.439853960660312,0.46144496557857,0,0,1.75097448618001,1.4380972585138,SNX3,2
Protein Modification Process (GO:0036211),3/711,0.446367164125155,0.467743926831262,0,0,1.23414227015922,0.995475726787525,LYN;ST3GAL1;TGM2,2
Cell-Cell Adhesion Via Plasma-Membrane Adhesion Molecules (GO:0098742),1/172,0.449531227256974,0.470523004384008,0,0,1.69934640522876,1.35871234419042,ITGB2,2
Endosomal Transport (GO:0016197),1/180,0.464673209278437,0.485818747812154,0,0,1.62274071639829,1.24370239416661,SNX3,2
Macromolecule Biosynthetic Process (GO:0009059),1/183,0.470244986866026,0.491085389693043,0,0,1.5957498383969,1.20399560110433,APOE,2
Negative Regulation Of Macromolecule Metabolic Process (GO:0010605),1/186,0.475759604167064,0.496280449749752,0,0,1.56963434022258,1.16599123171463,APOE,2
Protein Localization To Membrane (GO:0072657),1/192,0.486619663175469,0.507033413217977,0,0,1.51986449029874,1.094716505092,ITGB2,2
Regulation Of Cell Differentiation (GO:0045595),1/193,0.488407989233196,0.508320432735342,0,0,1.51187193627451,1.08341374750812,HOPX,2
Endomembrane System Organization (GO:0010256),1/196,0.49373621312304,0.513284592601894,0,0,1.48838612368024,1.05043429057459,SRGN,2
Golgi Vesicle Transport (GO:0048193),1/197,0.495500105294697,0.514078576630059,0,0,1.48071728691477,1.03974148486914,SNX3,2
Regulation Of Cell Population Proliferation (GO:0042127),3/766,0.495618736555204,0.514078576630059,0,0,1.14190396759204,0.801557576380405,LYN;GPNMB;FTH1,2
Organic Substance Transport (GO:0071702),1/201,0.502495309576706,0.520623663473498,0,0,1.45080882352941,0.998401618496652,GM2A,2
Regulation Of Translation (GO:0006417),1/202,0.504229121510366,0.521831714716246,0,0,1.4435177055897,0.988411950809081,VIM,2
Regulation Of Canonical Wnt Signaling Pathway (GO:0060828),1/207,0.512809256608277,0.529518771711243,0,0,1.40812392918332,0.940417428250991,APOE,2
Negative Regulation Of Cell Differentiation (GO:0045596),1/207,0.512809256608277,0.529518771711243,0,0,1.40812392918332,0.940417428250991,HOPX,2
Regulation Of GTPase Activity (GO:0043087),1/214,0.524576082341612,0.541061077072886,0,0,1.36136426401547,0.87830430961462,TGM2,2
Cilium Organization (GO:0044782),1/228,0.547275776933609,0.563841299329582,0,0,1.27649650168437,0.76947520717281,RILPL2,2
Negative Regulation Of Intracellular Signal Transduction (GO:1902532),1/231,0.551999209496933,0.568070855014201,0,0,1.2596547314578,0.74849775605937,LYN,2
Positive Regulation Of Developmental Process (GO:0051094),1/233,0.555121148280039,0.570644670323665,0,0,1.24866886409736,0.734927664634872,APOE,2
Positive Regulation Of GTPase Activity (GO:0043547),1/234,0.556674067670158,0.571601640434497,0,0,1.24324665488513,0.728263265676071,TGM2,2
Regulation Of Autophagy (GO:0010506),1/241,0.567395924707929,0.581960775453779,0,0,1.20655637254902,0.683753009647288,PSAP,2
Cilium Assembly (GO:0060271),1/243,0.57041209262871,0.584402132804665,0,0,1.19646329606223,0.67168995962926,RILPL2,2
Positive Regulation Of Nucleic Acid-Templated Transcription (GO:1903508),2/557,0.576473216676105,0.589954216175213,0,0,1.0421406481108,0.574038580293973,CD74;APOE,2
Cytokine-Mediated Signaling Pathway (GO:0019221),1/257,0.590952720149101,0.604099610474999,0,0,1.13022748161765,0.594521428625217,LYN,2
Negative Regulation Of Signal Transduction (GO:0009968),1/267,0.605028918459031,0.617801751182055,0,0,1.08718487394958,0.546287593269299,LYN,2
Chemical Synaptic Transmission (GO:0007268),1/273,0.613244348785116,0.625495623233653,0,0,1.06287846020761,0.519738863209925,APOE,2
Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway (GO:0007169),1/284,0.627870909886904,0.639704397102067,0,0,1.02099355643317,0.475191526693505,LYN,2
Positive Regulation Of DNA-templated Transcription (GO:0045893),4/1243,0.628615941698726,0.639754208661273,0,0,0.928391382628671,0.430991582544118,MMP12;CD74;APOE;LITAF,2
DNA Repair (GO:0006281),1/291,0.63689344966256,0.647461371946784,0,0,0.995993914807302,0.449345549398685,NSMCE3,2
Gene Expression (GO:0010467),1/296,0.643205782980091,0.653155927689175,0,0,0.978863409770688,0.431963192251658,TGM2,2
Regulation Of Intracellular Signal Transduction (GO:1902531),1/297,0.644455210031492,0.653702359844306,0,0,0.975506756756757,0.428588849392669,LYN,2
Cellular Response To Cytokine Stimulus (GO:0071345),1/308,0.657917511291299,0.666622042862959,0,0,0.940026825062272,0.393566406199112,HLA-DPA1,2
Supramolecular Fiber Organization (GO:0097435),1/316,0.667391507831785,0.675476647243844,0,0,0.91577964519141,0.370321541560254,VIM,2
Organelle Assembly (GO:0070925),1/322,0.674326858727687,0.68174519600742,0,0,0.898387392340114,0.354000866360204,RILPL2,2
Protein Modification By Small Protein Conjugation (GO:0032446),1/364,0.719040404148333,0.726151792760789,0,0,0.792740236590504,0.261475638466808,NSMCE3,2
Organelle Organization (GO:0006996),1/418,0.767737820623145,0.774479755381636,0,0,0.68817886866977,0.181890480896613,APOE,2
Phosphorylation (GO:0016310),1/429,0.77658554163965,0.782546176279428,0,0,0.67011407366685,0.169437324531475,LYN,2
Nervous System Development (GO:0007399),1/433,0.779719838203572,0.784843955431635,0,0,0.663773148148148,0.165160436709893,CAPG,2
Protein Phosphorylation (GO:0006468),1/500,0.826215046024884,0.830734821987821,0,0,0.572674761287281,0.109323722495067,LYN,2
Positive Regulation Of Transcription By RNA Polymerase II (GO:0045944),2/938,0.840691819559716,0.84436697505506,0,0,0.605785176680699,0.10512198130888,MMP12;LITAF,2
Regulation Of Transcription By RNA Polymerase II (GO:0006357),4/2028,0.929087774958347,0.932130638850132,0,0,0.54445120097294,0.0400455081420344,MMP12;NSMCE3;LITAF;HOPX,2
Negative Regulation Of Transcription By RNA Polymerase II (GO:0000122),1/763,0.932018305192594,0.934051060492905,0,0,0.369943646750039,0.0260450773502666,NSMCE3,2
Regulation Of DNA-templated Transcription (GO:0006355),3/1922,0.967506085420127,0.968560013617752,0,0,0.426642664266427,0.0140935278652736,CD74;APOE;HOPX,2
Negative Regulation Of DNA-templated Transcription (GO:0045892),1/1025,0.973652024116953,0.973652024116953,0,0,0.271527458639706,0.0072501372014259,NSMCE3,2
Cellular Respiration (GO:0045333),10/85,7.53757402386107e-12,4.85419767136653e-09,0,0,31.4777777777778,806.181167078847,NDUFB9;COX7B;NDUFB10;UQCRB;NDUFA4;UQCRQ;COX4I1;ETFA;COX6C;COX7C,3
Aerobic Electron Transport Chain (GO:0019646),9/68,2.96738565394972e-11,8.34211054600162e-09,0,0,35.6177467597208,863.401062488385,NDUFB9;COX7B;NDUFB10;UQCRB;NDUFA4;UQCRQ;COX4I1;COX6C;COX7C,3
Mitochondrial ATP Synthesis Coupled Electron Transport (GO:0042775),9/70,3.8860763413051e-11,8.34211054600162e-09,0,0,34.4464802314368,825.717818629645,NDUFB9;COX7B;NDUFB10;UQCRB;NDUFA4;UQCRQ;COX4I1;COX6C;COX7C,3
Energy Derivation By Oxidation Of Organic Compounds (GO:0015980),7/43,1.13309788817263e-09,1.82428759995793e-07,0,0,44.4093231162197,914.757024924283,COX7B;UQCRB;NDUFA4;UQCRQ;COX4I1;COX6C;COX7C,3
"Mitochondrial Electron Transport, Cytochrome C To Oxygen (GO:0006123)",5/16,8.63402396928542e-09,1.11206228724396e-06,0,0,101.608784473953,1886.6267108332,COX7B;NDUFA4;COX4I1;COX6C;COX7C,3
Proton Transmembrane Transport (GO:1902600),6/49,1.08957964451857e-07,1.16948215178326e-05,0,0,31.4952431289641,504.941302203365,ATP6V0B;ATP6AP2;ATP5PO;SLC4A11;ATP6V0A4;ATP1B1,3
Vacuolar Acidification (GO:0007035),4/29,9.93095688308358e-06,0.000913648033243689,0,0,35.344,407.157709939818,ATP6V0B;ATP6AP2;ATP6V0A4;ATP6V0D2,3
Oxidative Phosphorylation (GO:0006119),5/63,1.16727820217329e-05,0.0009396589527495,0,0,19.2251065478497,218.363580850225,NDUFB9;ATP5PF;NDUFB10;UQCRB;ATP5PO,3
Intracellular pH Reduction (GO:0051452),4/32,1.48745731801807e-05,0.00106435834755959,0,0,31.552380952381,350.731764164421,ATP6V0B;ATP6AP2;ATP6V0A4;ATP6V0D2,3
Proton Motive Force-Driven Mitochondrial ATP Synthesis (GO:0042776),4/53,0.000112326616783773,0.007233834120875,0,0,18.0108843537415,163.792778165776,NDUFB9;ATP5PF;NDUFB10;ATP5PO,3
Proton Motive Force-Driven ATP Synthesis (GO:0015986),4/60,0.000182418692409125,0.0106797852646797,0,0,15.7539682539683,135.629158098764,NDUFB9;ATP5PF;NDUFB10;ATP5PO,3
Transepithelial Chloride Transport (GO:0030321),2/6,0.000323829921562084,0.0148961763918559,0,0,108.163043478261,869.121650227414,CLCNKB;CLCNKA,3
Positive Regulation Of Mitophagy (GO:1901526),2/6,0.000323829921562084,0.0148961763918559,0,0,108.163043478261,869.121650227414,VDAC1;SLC25A5,3
Ribosomal Small Subunit Export From Nucleus (GO:0000056),2/6,0.000323829921562084,0.0148961763918559,0,0,108.163043478261,869.121650227414,RPS15;RAN,3
Positive Regulation Of Ion Transmembrane Transporter Activity (GO:0032414),3/33,0.000495239329791113,0.0212622752256985,0,0,21.8417582417582,166.226033128002,NDUFA4;ANK2;ATP1B1,3
"Mitochondrial Electron Transport, NADH To Ubiquinone (GO:0006120)",3/34,0.000541322872232286,0.0217882456073495,0,0,21.1361219425736,158.975228129545,NDUFB9;NDUFB10;NDUFA4,3
Golgi Lumen Acidification (GO:0061795),2/9,0.000770079916879574,0.0291724392041438,0,0,61.7981366459627,443.031846474045,ATP6V0B;ATP6AP2,3
Muscle Filament Sliding (GO:0030049),2/10,0.000959656201021932,0.0343343663032291,0,0,54.0706521739131,375.733472322039,MYL6;MYL6B,3
Brain Morphogenesis (GO:0048854),2/11,0.00116932732435501,0.0376523398442313,0,0,48.06038647343,324.471367140383,MKKS;FBXW11,3
Endosomal Lumen Acidification (GO:0048388),2/11,0.00116932732435501,0.0376523398442313,0,0,48.06038647343,324.471367140383,ATP6V0B;ATP6AP2,3
Actin-Myosin Filament Sliding (GO:0033275),2/12,0.00139890426715547,0.0409497430930965,0,0,43.2521739130435,284.256142254044,MYL6;MYL6B,3
"Mitochondrial Electron Transport, Ubiquinol To Cytochrome C (GO:0006122)",2/12,0.00139890426715547,0.0409497430930965,0,0,43.2521739130435,284.256142254044,UQCRB;UQCRQ,3
Positive Regulation Of Potassium Ion Transmembrane Transporter Activity (GO:1901018),2/13,0.00164819930736997,0.0461495806063591,0,0,39.3181818181818,251.953736692134,ANK2;ATP1B1,3
Intracellular Monoatomic Cation Homeostasis (GO:0030003),5/190,0.00203533610951365,0.054438898864201,0,0,5.98876404494382,37.1129355829345,MT2A;SLC4A11;ANK2;ATP1B1;B2M,3
Monoatomic Cation Transmembrane Transport (GO:0098655),6/281,0.00211331129131215,0.054438898864201,0,0,4.86719008264463,29.9794535625849,ATP6V0B;ATP6AP2;ATP5PO;SLC4A11;ATP6V0A4;ATP1B1,3
Inorganic Cation Transmembrane Transport (GO:0098662),6/284,0.00222854514656284,0.0551993490148641,0,0,4.8139306736429,29.395816627285,ATP6V0B;ATP6AP2;ATP5PO;SLC4A11;ATP6V0A4;ATP1B1,3
Monoatomic Anion Transport (GO:0006820),3/57,0.00244833166823739,0.0583972442349956,0,0,12.1196581196581,72.8676075662541,CLCNKB;CLCNKA;VDAC1,3
Inorganic Anion Transport (GO:0015698),3/58,0.00257315812159066,0.0589748405745953,0,0,11.8987012987013,70.9474497273996,CLCNKB;CLCNKA;SLC4A11,3
Aerobic Respiration (GO:0009060),3/59,0.00270185273594359,0.0589748405745953,0,0,11.6856357927787,69.106717950115,NDUFB9;NDUFB10;UQCRB,3
Transepithelial Transport (GO:0070633),2/17,0.00283885102144791,0.0589748405745953,0,0,28.8275362318841,169.054931566491,CLCNKB;CLCNKA,3
Positive Regulation Of Potassium Ion Transmembrane Transport (GO:1901381),2/17,0.00283885102144791,0.0589748405745953,0,0,28.8275362318841,169.054931566491,ANK2;ATP1B1,3
Protein Stabilization (GO:0050821),5/208,0.00300994528851747,0.0603080548975543,0,0,5.45275917418498,31.6578112100015,ANK2;ATP1B1;CRYAB;GAPDH;RPL17,3
Lysosomal Lumen Acidification (GO:0007042),2/18,0.00318396563123734,0.0603080548975543,0,0,27.0244565217391,155.380566639638,ATP6V0B;ATP6AP2,3
Renal Absorption (GO:0070293),2/18,0.00318396563123734,0.0603080548975543,0,0,27.0244565217391,155.380566639638,CLCNKB;CLCNKA,3
Positive Regulation Of Signal Transduction By P53 Class Mediator (GO:1901798),2/21,0.0043303069638596,0.0774643801312662,0,0,22.754004576659,123.829951646404,RPS15;RPL17,3
Chaperone-Mediated Protein Complex Assembly (GO:0051131),2/21,0.0043303069638596,0.0774643801312662,0,0,22.754004576659,123.829951646404,MKKS;PSMG3,3
Negative Regulation Of Protein Metabolic Process (GO:0051248),4/147,0.00512220529158145,0.089154059669688,0,0,6.14234654234654,32.3957811632902,IGFBP5;ATRAID;CRYAB;GAPDH,3
ATP Biosynthetic Process (GO:0006754),2/25,0.0061111598513642,0.0989081087968695,0,0,18.7930056710775,95.7999529125064,ATP5PF;ATP5PO,3
Regulation Of Lysosomal Lumen pH (GO:0035751),2/25,0.0061111598513642,0.0989081087968695,0,0,18.7930056710775,95.7999529125064,ATP6V0B;ATP6AP2,3
Protein Import Into Nucleus (GO:0006606),3/79,0.00614336079483662,0.0989081087968695,0,0,8.60179294389821,43.8036269599021,APLP2;RPL17;RAN,3
Regulation Of Potassium Ion Transmembrane Transporter Activity (GO:1901016),2/26,0.00660028448397799,0.103672761162971,0,0,18.0090579710145,90.4170423249079,ANK2;ATP1B1,3
Positive Regulation Of Calcium Ion Transmembrane Transporter Activity (GO:1901021),2/27,0.00710663121917375,0.108968345360664,0,0,17.2878260869565,85.5181553199353,ANK2;ATP1B1,3
Defense Response To Fungus (GO:0050832),2/29,0.00817031560107782,0.122364726676607,0,0,16.0056360708535,76.9430578543766,RARRES2;GAPDH,3
Sensory Perception Of Sound (GO:0007605),3/92,0.00933848736665022,0.132840746905764,0,0,7.34053586862576,34.3068091230426,NDUFB9;MKKS;ATP6V0A4,3
Cytoplasmic Translation (GO:0002181),3/93,0.00961741689084302,0.132840746905764,0,0,7.25860805860806,33.7102792148715,RPS15;RPS25;RPL17,3
Negative Regulation Of Amide Metabolic Process (GO:0034249),3/93,0.00961741689084302,0.132840746905764,0,0,7.25860805860806,33.7102792148715,RTN3;IGFBP5;GAPDH,3
Purine Ribonucleoside Triphosphate Metabolic Process (GO:0009205),2/32,0.00989081750928976,0.132840746905764,0,0,14.4028985507246,66.4859182031573,ATP1B1;RAN,3
Muscle Contraction (GO:0006936),3/94,0.00990117368241722,0.132840746905764,0,0,7.17848085979954,33.1294211941996,MYL6;MYL6B;CRYAB,3
Regulation Of Macroautophagy (GO:0016241),3/96,0.0104832324988093,0.137779627127208,0,0,7.02339595887983,32.0124856923543,ATP6V0B;ATP6V0D2;GAPDH,3
ATP Metabolic Process (GO:0046034),2/34,0.0111192168152159,0.143215512579981,0,0,13.5013586956522,60.7436985905154,ATP5PO;ATP1B1,3
Regulation Of Cardiac Muscle Contraction (GO:0055117),2/35,0.0117573493499705,0.145610249641942,0,0,13.0915678524374,58.1694591557136,ANK2;ATP1B1,3
Skeletal Muscle Organ Development (GO:0060538),2/35,0.0117573493499705,0.145610249641942,0,0,13.0915678524374,58.1694591557136,MYL6;MYL6B,3
Muscle Tissue Development (GO:0060537),2/37,0.0130806806508725,0.158942610172866,0,0,12.3422360248447,53.5235739738421,MYL6;MYL6B,3
Skeletal Muscle Tissue Development (GO:0007519),2/42,0.0166562298986272,0.198640963976221,0,0,10.7967391304348,44.2123332499081,MYL6;MYL6B,3
Protein-Containing Complex Assembly (GO:0065003),5/328,0.0193035830267731,0.217647390669088,0,0,3.40609454899642,13.4454374903568,MKKS;PSMG3;STXBP6;COX7A1;PLEKHA7,3
Regulation Of Signal Transduction By P53 Class Mediator (GO:1901796),2/47,0.0205981683745743,0.217647390669088,0,0,9.59468599033816,37.2518780367572,RPS15;RPL17,3
Pyruvate Metabolic Process (GO:0006090),2/50,0.0231314233527167,0.217647390669088,0,0,8.99365942028986,33.875187213316,VDAC1;GAPDH,3
Negative Regulation Of Insulin-Like Growth Factor Receptor Signaling Pathway (GO:0043569),1/5,0.0232822785774214,0.217647390669088,0,0,53.5,201.163358937128,IGFBP5,3
Zymogen Inhibition (GO:0097341),1/5,0.0232822785774214,0.217647390669088,0,0,53.5,201.163358937128,CAST,3
Adiponectin-Activated Signaling Pathway (GO:0033211),1/5,0.0232822785774214,0.217647390669088,0,0,53.5,201.163358937128,APLP2,3
Positive Regulation Of Receptor Binding (GO:1900122),1/5,0.0232822785774214,0.217647390669088,0,0,53.5,201.163358937128,B2M,3
Attachment Of GPI Anchor To Protein (GO:0016255),1/5,0.0232822785774214,0.217647390669088,0,0,53.5,201.163358937128,TP53INP2,3
Presynaptic Active Zone Organization (GO:1990709),1/5,0.0232822785774214,0.217647390669088,0,0,53.5,201.163358937128,CAST,3
Protection From Natural Killer Cell Mediated Cytotoxicity (GO:0042270),1/5,0.0232822785774214,0.217647390669088,0,0,53.5,201.163358937128,HLA-B,3
Positive Regulation Of Fever Generation (GO:0031622),1/5,0.0232822785774214,0.217647390669088,0,0,53.5,201.163358937128,PTGER3,3
Regulation Of Release Of Sequestered Calcium Ion Into Cytosol (GO:0051279),2/51,0.0240029820322527,0.217647390669088,0,0,8.80967169476486,32.856350736407,DIAPH1;ANK2,3
NADH Dehydrogenase Complex Assembly (GO:0010257),2/53,0.0257859520097423,0.217647390669088,0,0,8.46334185848252,30.958273416174,NDUFB9;NDUFB10,3
Protein Homotetramerization (GO:0051289),2/53,0.0257859520097423,0.217647390669088,0,0,8.46334185848252,30.958273416174,APLP2;B2M,3
Mitochondrial Respiratory Chain Complex I Assembly (GO:0032981),2/53,0.0257859520097423,0.217647390669088,0,0,8.46334185848252,30.958273416174,NDUFB9;NDUFB10,3
Endosome Organization (GO:0007032),2/53,0.0257859520097423,0.217647390669088,0,0,8.46334185848252,30.958273416174,ATP6V0B;ATP6AP2,3
Regulation Of Autophagy (GO:0010506),4/241,0.0270057118564891,0.217647390669088,0,0,3.68851383028598,13.3218307966713,ATP6V0B;VDAC1;ATP6V0D2;GAPDH,3
Negative Regulation Of Digestive System Process (GO:0060457),1/6,0.0278739831564668,0.217647390669088,0,0,42.7978494623656,153.218934365274,PTGER3,3
Positive Regulation Of Pinocytosis (GO:0048549),1/6,0.0278739831564668,0.217647390669088,0,0,42.7978494623656,153.218934365274,APLP2,3
Adherens Junction Maintenance (GO:0034334),1/6,0.0278739831564668,0.217647390669088,0,0,42.7978494623656,153.218934365274,PLEKHA7,3
Hypotonic Response (GO:0006971),1/6,0.0278739831564668,0.217647390669088,0,0,42.7978494623656,153.218934365274,SLC4A11,3
Cellular Hypotonic Response (GO:0071476),1/6,0.0278739831564668,0.217647390669088,0,0,42.7978494623656,153.218934365274,SLC4A11,3
Phospholipase C-activating Dopamine Receptor Signaling Pathway (GO:0060158),1/6,0.0278739831564668,0.217647390669088,0,0,42.7978494623656,153.218934365274,GNA11,3
Cellular Response To Histamine (GO:0071420),1/6,0.0278739831564668,0.217647390669088,0,0,42.7978494623656,153.218934365274,DIAPH1,3
Regulation Of Rab Protein Signal Transduction (GO:0032483),1/6,0.0278739831564668,0.217647390669088,0,0,42.7978494623656,153.218934365274,ETFA,3
Regulation Of T Cell Tolerance Induction (GO:0002664),1/6,0.0278739831564668,0.217647390669088,0,0,42.7978494623656,153.218934365274,HLA-B,3
Ribosomal Large Subunit Export From Nucleus (GO:0000055),1/6,0.0278739831564668,0.217647390669088,0,0,42.7978494623656,153.218934365274,RAN,3
Selective Autophagy (GO:0061912),2/58,0.0304693080818946,0.217647390669088,0,0,7.70574534161491,26.9010297279476,LGALS8;RETREG1,3
Positive Regulation Of Protein Binding (GO:0032092),2/59,0.031443606751879,0.217647390669088,0,0,7.57017543859649,26.1894731079626,B2M;RAN,3
Negative Regulation Of Peptidase Activity (GO:0010466),2/60,0.0324301312123487,0.217647390669088,0,0,7.43928035982009,25.5068173993808,GAPDH;SERPINA5,3
ADP Transport (GO:0015866),1/7,0.0324443315283112,0.217647390669088,0,0,35.663082437276,122.261232497354,SLC25A5,3
Negative Regulation Of Fatty Acid Oxidation (GO:0046322),1/7,0.0324443315283112,0.217647390669088,0,0,35.663082437276,122.261232497354,APLP2,3
Negative Regulation Of Intracellular Transport (GO:0032387),1/7,0.0324443315283112,0.217647390669088,0,0,35.663082437276,122.261232497354,CRYAB,3
Glucocorticoid Metabolic Process (GO:0008211),1/7,0.0324443315283112,0.217647390669088,0,0,35.663082437276,122.261232497354,HSD11B2,3
Inhibition Of Cysteine-Type Endopeptidase Activity (GO:0097340),1/7,0.0324443315283112,0.217647390669088,0,0,35.663082437276,122.261232497354,CAST,3
Regulation Of Mesenchymal Stem Cell Differentiation (GO:2000739),1/7,0.0324443315283112,0.217647390669088,0,0,35.663082437276,122.261232497354,SLC4A11,3
Regulation Of Mitophagy (GO:1901524),1/7,0.0324443315283112,0.217647390669088,0,0,35.663082437276,122.261232497354,SLC25A5,3
Positive Regulation Of Vascular Associated Smooth Muscle Cell Migration (GO:1904754),1/7,0.0324443315283112,0.217647390669088,0,0,35.663082437276,122.261232497354,IGFBP5,3
Peptidyl-Proline Hydroxylation To 4-hydroxy-L-proline (GO:0018401),1/7,0.0324443315283112,0.217647390669088,0,0,35.663082437276,122.261232497354,EGLN2,3
Protein Localization To Nucleolus (GO:1902570),1/7,0.0324443315283112,0.217647390669088,0,0,35.663082437276,122.261232497354,RAN,3
Response To Hydroperoxide (GO:0033194),1/7,0.0324443315283112,0.217647390669088,0,0,35.663082437276,122.261232497354,GPX3,3
Negative Regulation Of Appetite (GO:0032099),1/7,0.0324443315283112,0.217647390669088,0,0,35.663082437276,122.261232497354,MKKS,3
Positive Regulation Of Membrane Invagination (GO:1905155),1/8,0.0369934216241738,0.222554496745797,0,0,30.5668202764977,100.779270336318,APLP2,3
Angiotensin Maturation (GO:0002003),1/8,0.0369934216241738,0.222554496745797,0,0,30.5668202764977,100.779270336318,ATP6AP2,3
Negative Regulation Of Ubiquitin Protein Ligase Activity (GO:1904667),1/8,0.0369934216241738,0.222554496745797,0,0,30.5668202764977,100.779270336318,RPL17,3
Leptin-Mediated Signaling Pathway (GO:0033210),1/8,0.0369934216241738,0.222554496745797,0,0,30.5668202764977,100.779270336318,MKKS,3
"Phototransduction, Visible Light (GO:0007603)",1/8,0.0369934216241738,0.222554496745797,0,0,30.5668202764977,100.779270336318,GNA11,3
Detection Of Mechanical Stimulus Involved In Sensory Perception Of Sound (GO:0050910),1/8,0.0369934216241738,0.222554496745797,0,0,30.5668202764977,100.779270336318,MKKS,3
Regulation Of Angiotensin Levels In Blood (GO:0002002),1/8,0.0369934216241738,0.222554496745797,0,0,30.5668202764977,100.779270336318,ATP6AP2,3
Regulation Of Cell Killing (GO:0031341),1/8,0.0369934216241738,0.222554496745797,0,0,30.5668202764977,100.779270336318,CD59,3
Peptide Biosynthetic Process (GO:0043043),3/158,0.0384857239482165,0.222554496745797,0,0,4.20085076214108,13.6841365649509,RPS15;RPS25;RPL17,3
Negative Regulation Of Endopeptidase Activity (GO:0010951),2/66,0.0385985948574923,0.222554496745797,0,0,6.7398097826087,21.9349765252957,GAPDH;SERPINA5,3
Regulation Of Neurogenesis (GO:0050767),2/67,0.0396670075092319,0.222554496745797,0,0,6.63578595317726,21.4152438784266,APLP2;B2M,3
Regulation Of Complement Activation (GO:0030449),1/9,0.0415213510214557,0.222554496745797,0,0,26.744623655914,85.0892905737451,CD59,3
Regulation Of Complement-Dependent Cytotoxicity (GO:1903659),1/9,0.0415213510214557,0.222554496745797,0,0,26.744623655914,85.0892905737451,CD59,3
Tetrapyrrole Metabolic Process (GO:0033013),1/9,0.0415213510214557,0.222554496745797,0,0,26.744623655914,85.0892905737451,UROD,3
SNARE Complex Assembly (GO:0035493),1/9,0.0415213510214557,0.222554496745797,0,0,26.744623655914,85.0892905737451,STXBP6,3
"Positive Regulation Of Phagocytosis, Engulfment (GO:0060100)",1/9,0.0415213510214557,0.222554496745797,0,0,26.744623655914,85.0892905737451,APLP2,3
Negative Regulation Of Receptor Binding (GO:1900121),1/9,0.0415213510214557,0.222554496745797,0,0,26.744623655914,85.0892905737451,B2M,3
Positive Regulation Of Sodium Ion Transmembrane Transport (GO:1902307),1/9,0.0415213510214557,0.222554496745797,0,0,26.744623655914,85.0892905737451,ATP1B1,3
Regulation Of Receptor Binding (GO:1900120),1/9,0.0415213510214557,0.222554496745797,0,0,26.744623655914,85.0892905737451,B2M,3
Protein Localization To Microtubule (GO:0035372),1/9,0.0415213510214557,0.222554496745797,0,0,26.744623655914,85.0892905737451,DIAPH1,3
Protein Localization To Microtubule Cytoskeleton (GO:0072698),1/9,0.0415213510214557,0.222554496745797,0,0,26.744623655914,85.0892905737451,DIAPH1,3
Regulation Of Sequestering Of Calcium Ion (GO:0051282),1/9,0.0415213510214557,0.222554496745797,0,0,26.744623655914,85.0892905737451,DIAPH1,3
Response To Histamine (GO:0034776),1/9,0.0415213510214557,0.222554496745797,0,0,26.744623655914,85.0892905737451,DIAPH1,3
Regulation Of Endopeptidase Activity (GO:0052548),2/69,0.0418372531622458,0.222554496745797,0,0,6.43705386112914,20.431003692887,GAPDH;SERPINA5,3
Central Nervous System Development (GO:0007417),4/283,0.0445184427254552,0.222554496745797,0,0,3.12656312226205,9.72940086846653,RTN3;COX7B;APLP2;ATP6AP2,3
Negative Regulation Of Catabolic Process (GO:0009895),2/72,0.0451742926988683,0.222554496745797,0,0,6.16024844720497,19.0796884305907,ATRAID;RPL17,3
Brain Development (GO:0007420),3/169,0.0454712554609288,0.222554496745797,0,0,3.92029657089898,12.1163622152663,RTN3;MKKS;FBXW11,3
Negative Regulation Of Exocytosis (GO:0045920),1/10,0.0460282169261212,0.222554496745797,0,0,23.7718040621266,73.1815144736219,STXBP6,3
Regulation Of Dendritic Cell Differentiation (GO:2001198),1/10,0.0460282169261212,0.222554496745797,0,0,23.7718040621266,73.1815144736219,HLA-B,3
Fatty Acid Beta-Oxidation Using acyl-CoA Dehydrogenase (GO:0033539),1/10,0.0460282169261212,0.222554496745797,0,0,23.7718040621266,73.1815144736219,ETFA,3
Negative Regulation Of Mitochondrial Outer Membrane Permeabilization Involved In Apoptotic Signaling Pathway (GO:1901029),1/10,0.0460282169261212,0.222554496745797,0,0,23.7718040621266,73.1815144736219,SLC25A5,3
"Regulation Of Phagocytosis, Engulfment (GO:0060099)",1/10,0.0460282169261212,0.222554496745797,0,0,23.7718040621266,73.1815144736219,APLP2,3
Cardiac Muscle Cell Membrane Repolarization (GO:0099622),1/10,0.0460282169261212,0.222554496745797,0,0,23.7718040621266,73.1815144736219,ATP1B1,3
Peptidyl-Proline Hydroxylation (GO:0019511),1/10,0.0460282169261212,0.222554496745797,0,0,23.7718040621266,73.1815144736219,EGLN2,3
Purine Ribonucleoside Triphosphate Biosynthetic Process (GO:0009206),1/10,0.0460282169261212,0.222554496745797,0,0,23.7718040621266,73.1815144736219,ATP5PO,3
Positive Regulation Of Autophagy Of Mitochondrion (GO:1903599),1/10,0.0460282169261212,0.222554496745797,0,0,23.7718040621266,73.1815144736219,SLC25A5,3
Positive Regulation Of Cellular Senescence (GO:2000774),1/10,0.0460282169261212,0.222554496745797,0,0,23.7718040621266,73.1815144736219,B2M,3
Protein Tetramerization (GO:0051262),2/73,0.0463079232359266,0.222554496745797,0,0,6.07317819963258,18.6594890149374,APLP2;B2M,3
Import Into Nucleus (GO:0051170),2/74,0.0474519922054399,0.224550005177089,0,0,5.98852657004831,18.2532491803073,APLP2;RAN,3
Regulation Of Plasma Membrane Bounded Cell Projection Assembly (GO:0120032),2/75,0.0486063787780944,0.224550005177089,0,0,5.90619416319238,17.860334138679,TBC1D1;MYO10,3
Epithelial Cell-Cell Adhesion (GO:0090136),1/11,0.050514116137203,0.224550005177089,0,0,21.3935483870968,63.8704912156917,PLEKHA7,3
Intracellular Copper Ion Homeostasis (GO:0006878),1/11,0.050514116137203,0.224550005177089,0,0,21.3935483870968,63.8704912156917,MT2A,3
Phasic Smooth Muscle Contraction (GO:0014821),1/11,0.050514116137203,0.224550005177089,0,0,21.3935483870968,63.8704912156917,PTGER3,3
Negative Regulation Of Amyloid Fibril Formation (GO:1905907),1/11,0.050514116137203,0.224550005177089,0,0,21.3935483870968,63.8704912156917,CRYAB,3
Positive Regulation Of Circadian Rhythm (GO:0042753),1/11,0.050514116137203,0.224550005177089,0,0,21.3935483870968,63.8704912156917,FBXW11,3
Chloride Transport (GO:0006821),2/77,0.0509456258908113,0.224550005177089,0,0,5.74811594202899,17.1121203168284,CLCNKB;CLCNKA,3
Negative Regulation Of Mitochondrial Membrane Permeability (GO:0035795),1/12,0.0549791450637696,0.224550005177089,0,0,19.4477028347996,56.4139225659317,SLC25A5,3
Positive Regulation Of Sodium Ion Transmembrane Transporter Activity (GO:2000651),1/12,0.0549791450637696,0.224550005177089,0,0,19.4477028347996,56.4139225659317,ATP1B1,3
Porphyrin-Containing Compound Catabolic Process (GO:0006787),1/12,0.0549791450637696,0.224550005177089,0,0,19.4477028347996,56.4139225659317,UROD,3
Regulation Of Vascular Associated Smooth Muscle Cell Migration (GO:1904752),1/12,0.0549791450637696,0.224550005177089,0,0,19.4477028347996,56.4139225659317,IGFBP5,3
Relaxation Of Cardiac Muscle (GO:0055119),1/12,0.0549791450637696,0.224550005177089,0,0,19.4477028347996,56.4139225659317,ATP1B1,3
Response To Iron Ion (GO:0010039),1/12,0.0549791450637696,0.224550005177089,0,0,19.4477028347996,56.4139225659317,B2M,3
Detection Of Bacterium (GO:0016045),1/12,0.0549791450637696,0.224550005177089,0,0,19.4477028347996,56.4139225659317,HLA-B,3
Negative Regulation Of Complement Activation (GO:0045916),1/12,0.0549791450637696,0.224550005177089,0,0,19.4477028347996,56.4139225659317,CD59,3
Sodium Ion Export Across Plasma Membrane (GO:0036376),1/12,0.0549791450637696,0.224550005177089,0,0,19.4477028347996,56.4139225659317,ATP1B1,3
Macromolecule Biosynthetic Process (GO:0009059),3/183,0.0552055564324761,0.224550005177089,0,0,3.61282051282051,10.4652270874248,RPS15;RPS25;RPL17,3
Negative Regulation Of Apoptotic Signaling Pathway (GO:2001234),2/82,0.0569660132489294,0.224550005177089,0,0,5.3875,15.4368061623677,CAAP1;SLC25A5,3
Phospholipase C-activating G Protein-Coupled Receptor Signaling Pathway (GO:0007200),2/83,0.0581986961152856,0.224550005177089,0,0,5.32071926999463,15.1315527114494,GNA11;PTGER3,3
ATP Transport (GO:0015867),1/13,0.0594233996587116,0.224550005177089,0,0,17.826164874552,50.3244612974021,SLC25A5,3
GTP Metabolic Process (GO:0046039),1/13,0.0594233996587116,0.224550005177089,0,0,17.826164874552,50.3244612974021,RAN,3
Positive Regulation Of Macrophage Chemotaxis (GO:0010759),1/13,0.0594233996587116,0.224550005177089,0,0,17.826164874552,50.3244612974021,RARRES2,3
Regulation Of Humoral Immune Response (GO:0002920),1/13,0.0594233996587116,0.224550005177089,0,0,17.826164874552,50.3244612974021,CD59,3
Regulation Of Immune Effector Process (GO:0002697),1/13,0.0594233996587116,0.224550005177089,0,0,17.826164874552,50.3244612974021,CD59,3
Negative Regulation Of Secretion (GO:0051048),1/13,0.0594233996587116,0.224550005177089,0,0,17.826164874552,50.3244612974021,PTGER3,3
Antigen Processing And Presentation Of Endogenous Peptide Antigen Via MHC Class I Via ER Pathway (GO:0002484),1/13,0.0594233996587116,0.224550005177089,0,0,17.826164874552,50.3244612974021,HLA-B,3
"Antigen Processing And Presentation Of Endogenous Peptide Antigen Via MHC Class I Via ER Pathway, TAP-independent (GO:0002486)",1/13,0.0594233996587116,0.224550005177089,0,0,17.826164874552,50.3244612974021,HLA-B,3
Antigen Processing And Presentation Of Endogenous Peptide Antigen Via MHC Class Ib (GO:0002476),1/13,0.0594233996587116,0.224550005177089,0,0,17.826164874552,50.3244612974021,HLA-B,3
Antigen Processing And Presentation Of Peptide Antigen Via MHC Class Ib (GO:0002428),1/13,0.0594233996587116,0.224550005177089,0,0,17.826164874552,50.3244612974021,HLA-B,3
Intracellular Potassium Ion Homeostasis (GO:0030007),1/13,0.0594233996587116,0.224550005177089,0,0,17.826164874552,50.3244612974021,ATP1B1,3
Killing By Host Of Symbiont Cells (GO:0051873),1/13,0.0594233996587116,0.224550005177089,0,0,17.826164874552,50.3244612974021,GAPDH,3
Relaxation Of Muscle (GO:0090075),1/13,0.0594233996587116,0.224550005177089,0,0,17.826164874552,50.3244612974021,ATP1B1,3
Purine Ribonucleotide Metabolic Process (GO:0009150),2/84,0.0594406483283907,0.224550005177089,0,0,5.25556733828208,14.8352944539224,ATP1B1;RAN,3
Ribosomal Small Subunit Biogenesis (GO:0042274),2/84,0.0594406483283907,0.224550005177089,0,0,5.25556733828208,14.8352944539224,RPS15;RPS25,3
Establishment Of Protein Localization To Organelle (GO:0072594),2/85,0.0606917576581086,0.224550005177089,0,0,5.19198533263489,14.547669690981,APLP2;RAN,3
Calcium-Mediated Signaling (GO:0019722),2/85,0.0606917576581086,0.224550005177089,0,0,5.19198533263489,14.547669690981,ANK2;ATP1B1,3
Negative Regulation Of Smooth Muscle Cell Migration (GO:0014912),1/14,0.0638469754894786,0.224550005177089,0,0,16.454094292804,45.2695912848153,IGFBP5,3
Neuron Cell-Cell Adhesion (GO:0007158),1/14,0.0638469754894786,0.224550005177089,0,0,16.454094292804,45.2695912848153,NRXN3,3
Primary Alcohol Metabolic Process (GO:0034308),1/14,0.0638469754894786,0.224550005177089,0,0,16.454094292804,45.2695912848153,HSD11B2,3
Membrane Repolarization During Cardiac Muscle Cell Action Potential (GO:0086013),1/14,0.0638469754894786,0.224550005177089,0,0,16.454094292804,45.2695912848153,ATP1B1,3
Positive Regulation Of Acute Inflammatory Response (GO:0002675),1/14,0.0638469754894786,0.224550005177089,0,0,16.454094292804,45.2695912848153,PTGER3,3
Copper Ion Homeostasis (GO:0055070),1/14,0.0638469754894786,0.224550005177089,0,0,16.454094292804,45.2695912848153,MT2A,3
Detection Of Mechanical Stimulus Involved In Sensory Perception (GO:0050974),1/14,0.0638469754894786,0.224550005177089,0,0,16.454094292804,45.2695912848153,MKKS,3
Electron Transport Chain (GO:0022900),1/14,0.0638469754894786,0.224550005177089,0,0,16.454094292804,45.2695912848153,ETFA,3
Sensory Perception Of Mechanical Stimulus (GO:0050954),2/89,0.0657855506703964,0.224550005177089,0,0,4.95227386306847,13.4768955329945,NDUFB9;ATP6V0A4,3
Sodium Ion Transport (GO:0006814),2/89,0.0657855506703964,0.224550005177089,0,0,4.95227386306847,13.4768955329945,SLC4A11;ATP1B1,3
Mitochondrial Respiratory Chain Complex Assembly (GO:0033108),2/90,0.0670807911085884,0.224550005177089,0,0,4.89575098814229,13.2276217633175,NDUFB9;NDUFB10,3
Positive Regulation Of Potassium Ion Transport (GO:0043268),1/15,0.06824996769315,0.224550005177089,0,0,15.2780337941628,41.0150782697223,ANK2,3
Nitric Oxide Biosynthetic Process (GO:0006809),1/15,0.06824996769315,0.224550005177089,0,0,15.2780337941628,41.0150782697223,CYB5B,3
Melanosome Transport (GO:0032402),1/15,0.06824996769315,0.224550005177089,0,0,15.2780337941628,41.0150782697223,MKKS,3
Membrane Repolarization During Action Potential (GO:0086011),1/15,0.06824996769315,0.224550005177089,0,0,15.2780337941628,41.0150782697223,ATP1B1,3
Pigment Granule Transport (GO:0051904),1/15,0.06824996769315,0.224550005177089,0,0,15.2780337941628,41.0150782697223,MKKS,3
Regulation Of Systemic Arterial Blood Pressure (GO:0003073),1/15,0.06824996769315,0.224550005177089,0,0,15.2780337941628,41.0150782697223,KLK1,3
Cellular Response To Zinc Ion (GO:0071294),1/15,0.06824996769315,0.224550005177089,0,0,15.2780337941628,41.0150782697223,MT2A,3
Regulation Of Amyloid Fibril Formation (GO:1905906),1/15,0.06824996769315,0.224550005177089,0,0,15.2780337941628,41.0150782697223,CRYAB,3
Retrograde Axonal Transport (GO:0008090),1/15,0.06824996769315,0.224550005177089,0,0,15.2780337941628,41.0150782697223,FBXW11,3
rRNA Metabolic Process (GO:0016072),2/91,0.0683845325539456,0.224550005177089,0,0,4.84049829018075,12.98516240047,RPS15;RPS25,3
Positive Regulation Of Binding (GO:0051099),2/91,0.0683845325539456,0.224550005177089,0,0,4.84049829018075,12.98516240047,B2M;RAN,3
Regulation Of MAPK Cascade (GO:0043408),3/204,0.0715022828075963,0.224550005177089,0,0,3.23191733639495,8.5258816478671,ATP6AP2;PEBP1;ETFA,3
Establishment Of Melanosome Localization (GO:0032401),1/16,0.0726324709588663,0.224550005177089,0,0,14.2587813620072,37.3914183271943,MKKS,3
Regulation Of Fatty Acid Oxidation (GO:0046320),1/16,0.0726324709588663,0.224550005177089,0,0,14.2587813620072,37.3914183271943,APLP2,3
Negative Regulation Of Natural Killer Cell Mediated Cytotoxicity (GO:0045953),1/16,0.0726324709588663,0.224550005177089,0,0,14.2587813620072,37.3914183271943,HLA-B,3
Positive Regulation Of Smooth Muscle Cell Migration (GO:0014911),1/16,0.0726324709588663,0.224550005177089,0,0,14.2587813620072,37.3914183271943,IGFBP5,3
Antifungal Innate Immune Response (GO:0061760),1/16,0.0726324709588663,0.224550005177089,0,0,14.2587813620072,37.3914183271943,RARRES2,3
Nitric Oxide Metabolic Process (GO:0046209),1/16,0.0726324709588663,0.224550005177089,0,0,14.2587813620072,37.3914183271943,CYB5B,3
Nuclear Migration (GO:0007097),1/16,0.0726324709588663,0.224550005177089,0,0,14.2587813620072,37.3914183271943,FBXW11,3
Cell Communication By Electrical Coupling Involved In Cardiac Conduction (GO:0086064),1/16,0.0726324709588663,0.224550005177089,0,0,14.2587813620072,37.3914183271943,ATP1B1,3
Cellular Response To Gamma Radiation (GO:0071480),1/16,0.0726324709588663,0.224550005177089,0,0,14.2587813620072,37.3914183271943,CRYAB,3
Negative Regulation Of Amyloid-Beta Formation (GO:1902430),1/16,0.0726324709588663,0.224550005177089,0,0,14.2587813620072,37.3914183271943,RTN3,3
Reticulophagy (GO:0061709),1/16,0.0726324709588663,0.224550005177089,0,0,14.2587813620072,37.3914183271943,RETREG1,3
Endoplasmic Reticulum Tubular Network Organization (GO:0071786),1/16,0.0726324709588663,0.224550005177089,0,0,14.2587813620072,37.3914183271943,RTN3,3
G Protein-Coupled Acetylcholine Receptor Signaling Pathway (GO:0007213),1/17,0.0769945795904841,0.224550005177089,0,0,13.366935483871,34.2730933217087,GNA11,3
Negative Regulation Of Ubiquitin-Protein Transferase Activity (GO:0051444),1/17,0.0769945795904841,0.224550005177089,0,0,13.366935483871,34.2730933217087,RPL17,3
Intracellular Estrogen Receptor Signaling Pathway (GO:0030520),1/17,0.0769945795904841,0.224550005177089,0,0,13.366935483871,34.2730933217087,EGLN2,3
Regulation Of Oxidative Phosphorylation (GO:0002082),1/17,0.0769945795904841,0.224550005177089,0,0,13.366935483871,34.2730933217087,COX7A1,3
Carboxylic Acid Catabolic Process (GO:0046395),1/17,0.0769945795904841,0.224550005177089,0,0,13.366935483871,34.2730933217087,ETFA,3
Regulation Of Receptor Signaling Pathway Via STAT (GO:1904892),1/17,0.0769945795904841,0.224550005177089,0,0,13.366935483871,34.2730933217087,TP53INP2,3
Regulation Of Ubiquitin Protein Ligase Activity (GO:1904666),1/17,0.0769945795904841,0.224550005177089,0,0,13.366935483871,34.2730933217087,RPL17,3
Regulation Of Aerobic Respiration (GO:1903715),1/17,0.0769945795904841,0.224550005177089,0,0,13.366935483871,34.2730933217087,COX7A1,3
Detection Of Visible Light (GO:0009584),1/17,0.0769945795904841,0.224550005177089,0,0,13.366935483871,34.2730933217087,GNA11,3
Ribosomal Small Subunit Assembly (GO:0000028),1/17,0.0769945795904841,0.224550005177089,0,0,13.366935483871,34.2730933217087,RPS15,3
Negative Regulation Of Macromolecule Biosynthetic Process (GO:0010558),2/98,0.0777399025264114,0.224550005177089,0,0,4.48596014492754,11.4588765155317,IGFBP5;GAPDH,3
Antimicrobial Humoral Response (GO:0019730),2/100,0.0804834345723508,0.224550005177089,0,0,4.39396628216504,11.0714939664066,RARRES2;GAPDH,3
ncRNA Processing (GO:0034470),2/100,0.0804834345723508,0.224550005177089,0,0,4.39396628216504,11.0714939664066,RPS15;RPS25,3
Positive Regulation Of Macrophage Migration (GO:1905523),1/18,0.0813363874441795,0.224550005177089,0,0,12.5800126502214,31.5652870913394,RARRES2,3
Negative Regulation Of Nervous System Development (GO:0051961),1/18,0.0813363874441795,0.224550005177089,0,0,12.5800126502214,31.5652870913394,B2M,3
Regulation Of Mitochondrial Membrane Permeability (GO:0046902),1/18,0.0813363874441795,0.224550005177089,0,0,12.5800126502214,31.5652870913394,SLC25A5,3
Regulation Of Mitochondrial Outer Membrane Permeabilization Involved In Apoptotic Signaling Pathway (GO:1901028),1/18,0.0813363874441795,0.224550005177089,0,0,12.5800126502214,31.5652870913394,SLC25A5,3
Antigen Processing And Presentation Of Peptide Antigen Via MHC Class I (GO:0002474),1/18,0.0813363874441795,0.224550005177089,0,0,12.5800126502214,31.5652870913394,B2M,3
Intracellular Sodium Ion Homeostasis (GO:0006883),1/18,0.0813363874441795,0.224550005177089,0,0,12.5800126502214,31.5652870913394,ATP1B1,3
Melanosome Localization (GO:0032400),1/18,0.0813363874441795,0.224550005177089,0,0,12.5800126502214,31.5652870913394,MKKS,3
Membrane Repolarization (GO:0086009),1/18,0.0813363874441795,0.224550005177089,0,0,12.5800126502214,31.5652870913394,ATP1B1,3
Regulation Of Ventricular Cardiac Muscle Cell Membrane Repolarization (GO:0060307),1/18,0.0813363874441795,0.224550005177089,0,0,12.5800126502214,31.5652870913394,ANK2,3
Positive Regulation Of Cation Transmembrane Transport (GO:1904064),1/18,0.0813363874441795,0.224550005177089,0,0,12.5800126502214,31.5652870913394,ANK2,3
Negative Regulation Of Amyloid Precursor Protein Catabolic Process (GO:1902992),1/18,0.0813363874441795,0.224550005177089,0,0,12.5800126502214,31.5652870913394,RTN3,3
rRNA Processing (GO:0006364),2/101,0.0818664567621044,0.224550005177089,0,0,4.34936319718928,10.88500311412,RPS15;RPS25,3
Calcium Ion Homeostasis (GO:0055074),2/102,0.0832568510559293,0.224550005177089,0,0,4.30565217391304,10.7030972061463,ANK2;ATP1B1,3
Negative Regulation Of Fatty Acid Metabolic Process (GO:0045922),1/19,0.0856579879469774,0.224550005177089,0,0,11.8805256869773,29.1951182346706,APLP2,3
Fluid Transport (GO:0042044),1/19,0.0856579879469774,0.224550005177089,0,0,11.8805256869773,29.1951182346706,SLC4A11,3
Gastrulation (GO:0007369),1/19,0.0856579879469774,0.224550005177089,0,0,11.8805256869773,29.1951182346706,MKKS,3
Regulation Of Granulocyte Chemotaxis (GO:0071622),1/19,0.0856579879469774,0.224550005177089,0,0,11.8805256869773,29.1951182346706,RARRES2,3
Regulation Of Insulin-Like Growth Factor Receptor Signaling Pathway (GO:0043567),1/19,0.0856579879469774,0.224550005177089,0,0,11.8805256869773,29.1951182346706,IGFBP5,3
Heme Biosynthetic Process (GO:0006783),1/19,0.0856579879469774,0.224550005177089,0,0,11.8805256869773,29.1951182346706,UROD,3
Neuron Apoptotic Process (GO:0051402),1/19,0.0856579879469774,0.224550005177089,0,0,11.8805256869773,29.1951182346706,GAPDH,3
Bicarbonate Transport (GO:0015701),1/19,0.0856579879469774,0.224550005177089,0,0,11.8805256869773,29.1951182346706,SLC4A11,3
Regulation Of Smooth Muscle Cell Migration (GO:0014910),1/19,0.0856579879469774,0.224550005177089,0,0,11.8805256869773,29.1951182346706,IGFBP5,3
Pore Complex Assembly (GO:0046931),1/19,0.0856579879469774,0.224550005177089,0,0,11.8805256869773,29.1951182346706,PLEKHA7,3
Regulation Of Autophagy Of Mitochondrion (GO:1903146),1/19,0.0856579879469774,0.224550005177089,0,0,11.8805256869773,29.1951182346706,VDAC1,3
Negative Regulation Of Calcium Ion Transmembrane Transport (GO:1903170),1/19,0.0856579879469774,0.224550005177089,0,0,11.8805256869773,29.1951182346706,VDAC1,3
Embryonic Digestive Tract Development (GO:0048566),1/19,0.0856579879469774,0.224550005177089,0,0,11.8805256869773,29.1951182346706,RARRES2,3
Regulation Of Neuron Apoptotic Process (GO:0043523),2/105,0.0874712898116672,0.224550005177089,0,0,4.17961165048544,10.1833924695569,EGLN2;RETREG1,3
Cellular Response To Organonitrogen Compound (GO:0071417),2/105,0.0874712898116672,0.224550005177089,0,0,4.17961165048544,10.1833924695569,DIAPH1;IGFBP5,3
Adenine Nucleotide Transport (GO:0051503),1/20,0.0899594741237406,0.224550005177089,0,0,11.2546689303905,27.1056996059924,SLC25A5,3
Hydrogen Peroxide Catabolic Process (GO:0042744),1/20,0.0899594741237406,0.224550005177089,0,0,11.2546689303905,27.1056996059924,GPX3,3
Regulation Of Macrophage Chemotaxis (GO:0010758),1/20,0.0899594741237406,0.224550005177089,0,0,11.2546689303905,27.1056996059924,RARRES2,3
Intracellular Monoatomic Ion Homeostasis (GO:0006873),1/20,0.0899594741237406,0.224550005177089,0,0,11.2546689303905,27.1056996059924,SLC4A11,3
Positive Regulation Of Vascular Associated Smooth Muscle Cell Proliferation (GO:1904707),1/20,0.0899594741237406,0.224550005177089,0,0,11.2546689303905,27.1056996059924,IGFBP5,3
Cellular Response To Copper Ion (GO:0071280),1/20,0.0899594741237406,0.224550005177089,0,0,11.2546689303905,27.1056996059924,MT2A,3
protein-DNA Complex Disassembly (GO:0032986),1/20,0.0899594741237406,0.224550005177089,0,0,11.2546689303905,27.1056996059924,RPL17,3
Regulation Of Calcium Ion Transmembrane Transport (GO:1903169),1/20,0.0899594741237406,0.224550005177089,0,0,11.2546689303905,27.1056996059924,DIAPH1,3
Sensory Perception Of Pain (GO:0019233),1/20,0.0899594741237406,0.224550005177089,0,0,11.2546689303905,27.1056996059924,RETREG1,3
Regulation Of Cardiac Muscle Contraction By Calcium Ion Signaling (GO:0010882),1/20,0.0899594741237406,0.224550005177089,0,0,11.2546689303905,27.1056996059924,ATP1B1,3
Negative Regulation Of Cytokine Production Involved In Inflammatory Response (GO:1900016),1/20,0.0899594741237406,0.224550005177089,0,0,11.2546689303905,27.1056996059924,APLP2,3
Negative Regulation Of Translation (GO:0017148),2/107,0.0903159982033329,0.224569509046125,0,0,4.09958592132505,9.85721110707074,IGFBP5;GAPDH,3
Antigen Processing And Presentation Of Endogenous Peptide Antigen (GO:0002483),1/21,0.0942409385779949,0.231645665817667,0,0,10.6913978494624,25.2520189921111,HLA-B,3
Porphyrin-Containing Compound Biosynthetic Process (GO:0006779),1/21,0.0942409385779949,0.231645665817667,0,0,10.6913978494624,25.2520189921111,UROD,3
Regulation Of Cardiac Conduction (GO:1903779),1/21,0.0942409385779949,0.231645665817667,0,0,10.6913978494624,25.2520189921111,ANK2,3
Translation (GO:0006412),3/234,0.098038492612167,0.23321909164618,0,0,2.80790637933495,6.52106800447732,RPS15;RPS25;RPL17,3
Vesicle Transport Along Microtubule (GO:0047496),1/22,0.098502473490312,0.23321909164618,0,0,10.1817716333845,23.5980235149026,FBXW11,3
Acetylcholine Receptor Signaling Pathway (GO:0095500),1/22,0.098502473490312,0.23321909164618,0,0,10.1817716333845,23.5980235149026,GNA11,3
Regulation Of Mononuclear Cell Migration (GO:0071675),1/22,0.098502473490312,0.23321909164618,0,0,10.1817716333845,23.5980235149026,RARRES2,3
Regulation Of Release Of Sequestered Calcium Ion Into Cytosol By Sarcoplasmic Reticulum (GO:0010880),1/22,0.098502473490312,0.23321909164618,0,0,10.1817716333845,23.5980235149026,ANK2,3
Response To Gamma Radiation (GO:0010332),1/22,0.098502473490312,0.23321909164618,0,0,10.1817716333845,23.5980235149026,CRYAB,3
Cytoskeleton-Dependent Intracellular Transport (GO:0030705),1/22,0.098502473490312,0.23321909164618,0,0,10.1817716333845,23.5980235149026,MYO10,3
Negative Regulation Of Cell Development (GO:0010721),1/22,0.098502473490312,0.23321909164618,0,0,10.1817716333845,23.5980235149026,B2M,3
Regulation Of Cardiac Muscle Cell Membrane Repolarization (GO:0099623),1/22,0.098502473490312,0.23321909164618,0,0,10.1817716333845,23.5980235149026,ANK2,3
Regulation Of Catabolic Process (GO:0009894),1/22,0.098502473490312,0.23321909164618,0,0,10.1817716333845,23.5980235149026,RARRES2,3
Negative Regulation Of Neuron Differentiation (GO:0045665),1/23,0.102744170595246,0.239736398055574,0,0,9.71847507331378,22.1145179349674,B2M,3
Regulation Of Lipid Catabolic Process (GO:0050994),1/23,0.102744170595246,0.239736398055574,0,0,9.71847507331378,22.1145179349674,RARRES2,3
Potassium Ion Homeostasis (GO:0055075),1/23,0.102744170595246,0.239736398055574,0,0,9.71847507331378,22.1145179349674,ATP1B1,3
Regulation Of Toll-Like Receptor 4 Signaling Pathway (GO:0034143),1/23,0.102744170595246,0.239736398055574,0,0,9.71847507331378,22.1145179349674,APLP2,3
Negative Regulation Of Cell Population Proliferation (GO:0008285),4/379,0.103400175035538,0.240396074811864,0,0,2.31478518518519,5.25259161807102,IGFBP5;APLP2;ATRAID;B2M,3
Regulation Of Protein Binding (GO:0043393),2/118,0.106427981878131,0.245146555496141,0,0,3.70877061469265,8.30870966344855,B2M;RAN,3
Ribonucleoprotein Complex Biogenesis (GO:0022613),2/118,0.106427981878131,0.245146555496141,0,0,3.70877061469265,8.30870966344855,RPS15;RPS25,3
Amyloid Fibril Formation (GO:1990000),1/24,0.10696612126462,0.245146555496141,0,0,9.29546517064049,20.7776245545477,B2M,3
Response To Copper Ion (GO:0046688),1/24,0.10696612126462,0.245146555496141,0,0,9.29546517064049,20.7776245545477,MT2A,3
Negative Regulation Of Proteolysis Involved In Protein Catabolic Process (GO:1903051),1/25,0.111168416410923,0.252086127354346,0,0,8.90770609318996,19.5676378110284,RPL17,3
Response To Zinc Ion (GO:0010043),1/25,0.111168416410923,0.252086127354346,0,0,8.90770609318996,19.5676378110284,MT2A,3
Sodium Ion Homeostasis (GO:0055078),1/25,0.111168416410923,0.252086127354346,0,0,8.90770609318996,19.5676378110284,ATP1B1,3
Regulation Of Protein Catabolic Process (GO:0042176),2/122,0.11246717444734,0.253247763440864,0,0,3.58442028985507,7.83229484804693,EGLN2;ATRAID,3
Protein Localization To Nucleus (GO:0034504),2/122,0.11246717444734,0.253247763440864,0,0,3.58442028985507,7.83229484804693,APLP2;RAN,3
Protein Export From Nucleus (GO:0006611),1/26,0.115351146561025,0.254404583511303,0,0,8.55096774193548,18.4681608357671,RAN,3
Protein Localization To Cell Surface (GO:0034394),1/26,0.115351146561025,0.254404583511303,0,0,8.55096774193548,18.4681608357671,ANK2,3
Cell-Cell Adhesion Mediated By Cadherin (GO:0044331),1/26,0.115351146561025,0.254404583511303,0,0,8.55096774193548,18.4681608357671,PLEKHA7,3
miRNA-mediated Gene Silencing (GO:0035195),1/26,0.115351146561025,0.254404583511303,0,0,8.55096774193548,18.4681608357671,RAN,3
Negative Regulation Of Catalytic Activity (GO:0043086),1/26,0.115351146561025,0.254404583511303,0,0,8.55096774193548,18.4681608357671,SERPINA5,3
Regulation Of Cardiac Muscle Cell Contraction (GO:0086004),1/26,0.115351146561025,0.254404583511303,0,0,8.55096774193548,18.4681608357671,ANK2,3
GPI Anchor Metabolic Process (GO:0006505),1/27,0.119514401824505,0.260906016186376,0,0,8.22167080231596,17.4654465436498,TP53INP2,3
Negative Regulation Of Neurogenesis (GO:0050768),1/27,0.119514401824505,0.260906016186376,0,0,8.22167080231596,17.4654465436498,B2M,3
Negative Regulation Of Cellular Response To Insulin Stimulus (GO:1900077),1/27,0.119514401824505,0.260906016186376,0,0,8.22167080231596,17.4654465436498,APLP2,3
Protein Homooligomerization (GO:0051260),2/129,0.123242917033739,0.262824841851296,0,0,3.38565559739815,7.08820157070878,APLP2;B2M,3
Regulation Of Chemotaxis (GO:0050920),1/28,0.123658271864818,0.262824841851296,0,0,7.91676622859419,16.5478891105785,RARRES2,3
Transcription By RNA Polymerase III (GO:0006383),1/28,0.123658271864818,0.262824841851296,0,0,7.91676622859419,16.5478891105785,POLR2K,3
Positive Regulation Of Protein Import Into Nucleus (GO:0042307),1/28,0.123658271864818,0.262824841851296,0,0,7.91676622859419,16.5478891105785,RAN,3
Cellular Response To Osmotic Stress (GO:0071470),1/28,0.123658271864818,0.262824841851296,0,0,7.91676622859419,16.5478891105785,SLC4A11,3
Determination Of Bilateral Symmetry (GO:0009855),1/28,0.123658271864818,0.262824841851296,0,0,7.91676622859419,16.5478891105785,MKKS,3
Diterpenoid Metabolic Process (GO:0016101),1/28,0.123658271864818,0.262824841851296,0,0,7.91676622859419,16.5478891105785,RARRES2,3
Regulation Of Cardiac Muscle Cell Action Potential (GO:0098901),1/28,0.123658271864818,0.262824841851296,0,0,7.91676622859419,16.5478891105785,ANK2,3
Establishment Of Mitotic Spindle Orientation (GO:0000132),1/29,0.127782846012622,0.268928604026563,0,0,7.63364055299539,15.7056274283881,FBXW11,3
Glycolytic Process (GO:0006096),1/29,0.127782846012622,0.268928604026563,0,0,7.63364055299539,15.7056274283881,GAPDH,3
Cardiac Muscle Cell Action Potential (GO:0086001),1/29,0.127782846012622,0.268928604026563,0,0,7.63364055299539,15.7056274283881,ATP1B1,3
Positive Regulation Of Locomotion (GO:0040017),1/30,0.131888213132039,0.273987126635591,0,0,7.37004078605858,14.9302329388544,RARRES2,3
GPI Anchor Biosynthetic Process (GO:0006506),1/30,0.131888213132039,0.273987126635591,0,0,7.37004078605858,14.9302329388544,TP53INP2,3
Nucleic Acid Metabolic Process (GO:0090304),1/30,0.131888213132039,0.273987126635591,0,0,7.37004078605858,14.9302329388544,RAN,3
Regulation Of Potassium Ion Transport (GO:0043266),1/30,0.131888213132039,0.273987126635591,0,0,7.37004078605858,14.9302329388544,ANK2,3
Cellular Response To Metal Ion (GO:0071248),2/135,0.132671166854103,0.274727432328111,0,0,3.23193854200719,6.52813332884726,MT2A;B2M,3
Protein Localization To Plasma Membrane (GO:0072659),2/137,0.135850151533199,0.277112510559865,0,0,3.18373590982287,6.35538262572839,ANK2;ATP1B1,3
Negative Regulation Of Cellular Biosynthetic Process (GO:0031327),2/137,0.135850151533199,0.277112510559865,0,0,3.18373590982287,6.35538262572839,IGFBP5;GAPDH,3
Regulation Of Extrinsic Apoptotic Signaling Pathway Via Death Domain Receptors (GO:1902041),1/31,0.135974461703288,0.277112510559865,0,0,7.12401433691756,14.214461689458,ETFA,3
Actin Filament Polymerization (GO:0030041),1/31,0.135974461703288,0.277112510559865,0,0,7.12401433691756,14.214461689458,DIAPH1,3
Cellular Response To cAMP (GO:0071320),1/31,0.135974461703288,0.277112510559865,0,0,7.12401433691756,14.214461689458,IGFBP5,3
Intracellular Calcium Ion Homeostasis (GO:0006874),2/139,0.13904624515392,0.279216228435965,0,0,3.13694065376071,6.18902299182353,ANK2;ATP1B1,3
Left/Right Pattern Formation (GO:0060972),1/32,0.140041679790088,0.279216228435965,0,0,6.89386056191467,13.5520557958363,MKKS,3
Cellular Nitrogen Compound Biosynthetic Process (GO:0044271),1/32,0.140041679790088,0.279216228435965,0,0,6.89386056191467,13.5520557958363,CYB5B,3
Mitochondrial Membrane Organization (GO:0007006),1/32,0.140041679790088,0.279216228435965,0,0,6.89386056191467,13.5520557958363,SLC25A5,3
Regulation Of Transcription By RNA Polymerase I (GO:0006356),1/32,0.140041679790088,0.279216228435965,0,0,6.89386056191467,13.5520557958363,POLR2K,3
Muscle Cell Development (GO:0055001),1/32,0.140041679790088,0.279216228435965,0,0,6.89386056191467,13.5520557958363,ANK2,3
Regulation Of Calcium Ion Transmembrane Transporter Activity (GO:1901019),1/32,0.140041679790088,0.279216228435965,0,0,6.89386056191467,13.5520557958363,ANK2,3
Protein Localization To Cell Periphery (GO:1990778),2/142,0.143871174977429,0.283773489533686,0,0,3.06925465838509,5.95078448804722,ANK2;ATP1B1,3
Cardiac Muscle Contraction (GO:0060048),1/33,0.14408995508931,0.283773489533686,0,0,6.67809139784946,12.9375832403125,ATP1B1,3
Positive Regulation Of T Cell Mediated Cytotoxicity (GO:0001916),1/33,0.14408995508931,0.283773489533686,0,0,6.67809139784946,12.9375832403125,HLA-B,3
Regulation Of Amyloid-Beta Formation (GO:1902003),1/33,0.14408995508931,0.283773489533686,0,0,6.67809139784946,12.9375832403125,RTN3,3
Establishment Of Mitotic Spindle Localization (GO:0040001),1/34,0.148119374856792,0.289057204265982,0,0,6.47539915281851,12.3663076907343,FBXW11,3
Regulation Of Metal Ion Transport (GO:0010959),1/34,0.148119374856792,0.289057204265982,0,0,6.47539915281851,12.3663076907343,B2M,3
Sister Chromatid Segregation (GO:0000819),1/34,0.148119374856792,0.289057204265982,0,0,6.47539915281851,12.3663076907343,RAN,3
Regulation Of Cellular Senescence (GO:2000772),1/35,0.152130025970577,0.293328553069017,0,0,6.28462998102467,11.8340819973395,B2M,3
Establishment Of Spindle Orientation (GO:0051294),1/35,0.152130025970577,0.293328553069017,0,0,6.28462998102467,11.8340819973395,FBXW11,3
Action Potential (GO:0001508),1/35,0.152130025970577,0.293328553069017,0,0,6.28462998102467,11.8340819973395,GNA11,3
One-Carbon Compound Transport (GO:0019755),1/35,0.152130025970577,0.293328553069017,0,0,6.28462998102467,11.8340819973395,SLC4A11,3
Regulation Of Glucose Import (GO:0046324),1/36,0.1561219949285,0.29834588941826,0,0,6.1047619047619,11.3372605242685,APLP2,3
Protein Destabilization (GO:0031648),1/36,0.1561219949285,0.29834588941826,0,0,6.1047619047619,11.3372605242685,FBXW11,3
Regulation Of T Cell Mediated Cytotoxicity (GO:0001914),1/36,0.1561219949285,0.29834588941826,0,0,6.1047619047619,11.3372605242685,HLA-B,3
Positive Regulation Of Immune Effector Process (GO:0002699),1/37,0.160095367823437,0.298849210026123,0,0,5.93488649940263,10.8726265595442,APLP2,3
Negative Regulation Of Smooth Muscle Cell Proliferation (GO:0048662),1/37,0.160095367823437,0.298849210026123,0,0,5.93488649940263,10.8726265595442,IGFBP5,3
Regulation Of Vascular Associated Smooth Muscle Cell Proliferation (GO:1904705),1/37,0.160095367823437,0.298849210026123,0,0,5.93488649940263,10.8726265595442,IGFBP5,3
Cellular Response To Organic Cyclic Compound (GO:0071407),2/152,0.160197960699001,0.298849210026123,0,0,2.8631884057971,5.24348569699534,DIAPH1;IGFBP5,3
Gene Expression (GO:0010467),3/296,0.16292096357397,0.298849210026123,0,0,2.20676593031542,4.00415489345538,RPS15;RPS25;RPL17,3
Negative Regulation Of Epithelial Cell Apoptotic Process (GO:1904036),1/38,0.164050230323901,0.298849210026123,0,0,5.7741935483871,10.4373318771166,CAST,3
Heart Looping (GO:0001947),1/38,0.164050230323901,0.298849210026123,0,0,5.7741935483871,10.4373318771166,MKKS,3
Regulation Of Intracellular Transport (GO:0032386),1/38,0.164050230323901,0.298849210026123,0,0,5.7741935483871,10.4373318771166,CRYAB,3
Amino Acid Catabolic Process (GO:0009063),1/38,0.164050230323901,0.298849210026123,0,0,5.7741935483871,10.4373318771166,ETFA,3
Regulation Of Protein Import Into Nucleus (GO:0042306),1/38,0.164050230323901,0.298849210026123,0,0,5.7741935483871,10.4373318771166,RAN,3
Response To cAMP (GO:0051591),1/38,0.164050230323901,0.298849210026123,0,0,5.7741935483871,10.4373318771166,IGFBP5,3
Positive Regulation Of Bone Mineralization (GO:0030501),1/38,0.164050230323901,0.298849210026123,0,0,5.7741935483871,10.4373318771166,ATRAID,3
Positive Regulation Of Cation Channel Activity (GO:2001259),1/38,0.164050230323901,0.298849210026123,0,0,5.7741935483871,10.4373318771166,ANK2,3
Ribosome Biogenesis (GO:0042254),2/155,0.165161955846953,0.298849210026123,0,0,2.80662119920432,5.05424410631255,RPS15;RPS25,3
Negative Regulation Of Mitochondrion Organization (GO:0010823),1/39,0.167986667747603,0.298849210026123,0,0,5.62195812110923,10.0288461517153,SLC25A5,3
Vesicle Cytoskeletal Trafficking (GO:0099518),1/39,0.167986667747603,0.298849210026123,0,0,5.62195812110923,10.0288461517153,FBXW11,3
Negative Regulation Of Transport (GO:0051051),1/39,0.167986667747603,0.298849210026123,0,0,5.62195812110923,10.0288461517153,CRYAB,3
Regulation Of Mitochondrial Membrane Potential (GO:0051881),1/39,0.167986667747603,0.298849210026123,0,0,5.62195812110923,10.0288461517153,SLC4A11,3
Negative Regulation Of Ubiquitin-Dependent Protein Catabolic Process (GO:2000059),1/39,0.167986667747603,0.298849210026123,0,0,5.62195812110923,10.0288461517153,RPL17,3
Axonal Transport (GO:0098930),1/39,0.167986667747603,0.298849210026123,0,0,5.62195812110923,10.0288461517153,FBXW11,3
Organelle Transport Along Microtubule (GO:0072384),1/39,0.167986667747603,0.298849210026123,0,0,5.62195812110923,10.0288461517153,FBXW11,3
Regulation Of Receptor-Mediated Endocytosis (GO:0048259),1/39,0.167986667747603,0.298849210026123,0,0,5.62195812110923,10.0288461517153,B2M,3
Positive Regulation Of ATP-dependent Activity (GO:0032781),1/39,0.167986667747603,0.298849210026123,0,0,5.62195812110923,10.0288461517153,ATP1B1,3
Retina Homeostasis (GO:0001895),1/39,0.167986667747603,0.298849210026123,0,0,5.62195812110923,10.0288461517153,B2M,3
Digestive Tract Development (GO:0048565),1/39,0.167986667747603,0.298849210026123,0,0,5.62195812110923,10.0288461517153,RARRES2,3
Positive Regulation Of Monoatomic Ion Transport (GO:0043270),1/40,0.171904765012116,0.302477236797274,0,0,5.47752963881996,9.64491441906839,ANK2,3
Negative Regulation Of Secretion By Cell (GO:1903531),1/40,0.171904765012116,0.302477236797274,0,0,5.47752963881996,9.64491441906839,STXBP6,3
Retinoid Metabolic Process (GO:0001523),1/40,0.171904765012116,0.302477236797274,0,0,5.47752963881996,9.64491441906839,RARRES2,3
Endothelial Cell Migration (GO:0043542),1/40,0.171904765012116,0.302477236797274,0,0,5.47752963881996,9.64491441906839,LGALS8,3
Regulation Of Heart Rate By Cardiac Conduction (GO:0086091),1/41,0.175804606678079,0.304520953416871,0,0,5.34032258064516,9.28352112896136,ANK2,3
Heart Contraction (GO:0060047),1/41,0.175804606678079,0.304520953416871,0,0,5.34032258064516,9.28352112896136,ATP1B1,3
Positive Regulation Of Ossification (GO:0045778),1/41,0.175804606678079,0.304520953416871,0,0,5.34032258064516,9.28352112896136,ATRAID,3
Regulation Of Microtubule-Based Process (GO:0032886),1/41,0.175804606678079,0.304520953416871,0,0,5.34032258064516,9.28352112896136,DIAPH1,3
Carbohydrate Catabolic Process (GO:0016052),1/41,0.175804606678079,0.304520953416871,0,0,5.34032258064516,9.28352112896136,GAPDH,3
Regulation Of Macromolecule Metabolic Process (GO:0060255),2/162,0.176847696805139,0.304520953416871,0,0,2.68288043478261,4.64800017320538,ATP1B1;ATRAID,3
Adenylate Cyclase-Modulating G Protein-Coupled Receptor Signaling Pathway (GO:0007188),2/163,0.178527948327419,0.304520953416871,0,0,2.66608155549554,4.59368549221514,GNA11;PTGER3,3
Substantia Nigra Development (GO:0021762),1/42,0.179686276860886,0.304520953416871,0,0,5.2098085496984,8.94285964215643,ATP5PF,3
Potassium Ion Import Across Plasma Membrane (GO:1990573),1/42,0.179686276860886,0.304520953416871,0,0,5.2098085496984,8.94285964215643,ATP1B1,3
Regulation Of Ubiquitin-Dependent Protein Catabolic Process (GO:2000058),1/42,0.179686276860886,0.304520953416871,0,0,5.2098085496984,8.94285964215643,RPL17,3
Monoatomic Cation Transport (GO:0006812),1/42,0.179686276860886,0.304520953416871,0,0,5.2098085496984,8.94285964215643,ATP1B1,3
Positive Regulation Of Calcium Ion Transmembrane Transport (GO:1904427),1/42,0.179686276860886,0.304520953416871,0,0,5.2098085496984,8.94285964215643,ANK2,3
Determination Of Heart Left/Right Asymmetry (GO:0061371),1/42,0.179686276860886,0.304520953416871,0,0,5.2098085496984,8.94285964215643,MKKS,3
Embryonic Heart Tube Morphogenesis (GO:0003143),1/42,0.179686276860886,0.304520953416871,0,0,5.2098085496984,8.94285964215643,MKKS,3
Regulation Of Filopodium Assembly (GO:0051489),1/43,0.183549859311719,0.304654921125637,0,0,5.08550947260625,8.62130623022426,MYO10,3
Glycolipid Biosynthetic Process (GO:0009247),1/43,0.183549859311719,0.304654921125637,0,0,5.08550947260625,8.62130623022426,TP53INP2,3
SCF-dependent Proteasomal Ubiquitin-Dependent Protein Catabolic Process (GO:0031146),1/43,0.183549859311719,0.304654921125637,0,0,5.08550947260625,8.62130623022426,FBXW11,3
Positive Regulation Of Receptor-Mediated Endocytosis (GO:0048260),1/43,0.183549859311719,0.304654921125637,0,0,5.08550947260625,8.62130623022426,B2M,3
Intracellular Steroid Hormone Receptor Signaling Pathway (GO:0030518),1/43,0.183549859311719,0.304654921125637,0,0,5.08550947260625,8.62130623022426,EGLN2,3
Learning (GO:0007612),1/43,0.183549859311719,0.304654921125637,0,0,5.08550947260625,8.62130623022426,NRXN3,3
Positive Regulation Of T Cell Mediated Immunity (GO:0002711),1/43,0.183549859311719,0.304654921125637,0,0,5.08550947260625,8.62130623022426,HLA-B,3
Positive Regulation Of Biomineral Tissue Development (GO:0070169),1/43,0.183549859311719,0.304654921125637,0,0,5.08550947260625,8.62130623022426,ATRAID,3
Regulation Of Cytokine Production (GO:0001817),2/167,0.185273668412815,0.306725559017616,0,0,2.60092226613966,4.3849501395552,HLA-B;GAPDH,3
Positive Regulation Of Nucleocytoplasmic Transport (GO:0046824),1/44,0.187395437463224,0.307863932975297,0,0,4.96699174793699,8.31739783113255,RAN,3
Positive Regulation Of Osteoblast Differentiation (GO:0045669),1/44,0.187395437463224,0.307863932975297,0,0,4.96699174793699,8.31739783113255,ATRAID,3
Positive Regulation Of Chemotaxis (GO:0050921),1/44,0.187395437463224,0.307863932975297,0,0,4.96699174793699,8.31739783113255,RARRES2,3
Zymogen Activation (GO:0031638),1/45,0.191223094244478,0.310195649101874,0,0,4.85386119257087,8.02981295118441,KLK1,3
Regulation Of Stem Cell Differentiation (GO:2000736),1/45,0.191223094244478,0.310195649101874,0,0,4.85386119257087,8.02981295118441,SLC4A11,3
Mitotic Nuclear Division (GO:0140014),1/45,0.191223094244478,0.310195649101874,0,0,4.85386119257087,8.02981295118441,RAN,3
Determination Of Left/Right Symmetry (GO:0007368),1/45,0.191223094244478,0.310195649101874,0,0,4.85386119257087,8.02981295118441,MKKS,3
Regulation Of Apoptotic Signaling Pathway (GO:2001233),1/45,0.191223094244478,0.310195649101874,0,0,4.85386119257087,8.02981295118441,ETFA,3
Regulation Of Cytokine Production Involved In Inflammatory Response (GO:1900015),1/46,0.195032912319593,0.314002988834545,0,0,4.74575866188769,7.75735519334356,APLP2,3
Vacuolar Transport (GO:0007034),1/46,0.195032912319593,0.314002988834545,0,0,4.74575866188769,7.75735519334356,ATP6V0D2,3
Cardiac Conduction (GO:0061337),1/46,0.195032912319593,0.314002988834545,0,0,4.74575866188769,7.75735519334356,ANK2,3
Negative Regulation Of Hydrolase Activity (GO:0051346),1/47,0.198824973940507,0.317725268530239,0,0,4.64235624123422,7.49893902114067,SERPINA5,3
Insulin Receptor Signaling Pathway (GO:0008286),1/47,0.198824973940507,0.317725268530239,0,0,4.64235624123422,7.49893902114067,RARRES2,3
Positive Regulation Of Smooth Muscle Cell Proliferation (GO:0048661),1/47,0.198824973940507,0.317725268530239,0,0,4.64235624123422,7.49893902114067,IGFBP5,3
Erythrocyte Differentiation (GO:0030218),1/49,0.206356154882249,0.326519321238743,0,0,4.44847670250896,7.02037105195506,SLC25A5,3
Fatty Acid Beta-Oxidation (GO:0006635),1/49,0.206356154882249,0.326519321238743,0,0,4.44847670250896,7.02037105195506,ETFA,3
Nuclear Export (GO:0051168),1/49,0.206356154882249,0.326519321238743,0,0,4.44847670250896,7.02037105195506,RAN,3
Negative Regulation Of Cysteine-Type Endopeptidase Activity Involved In Apoptotic Process (GO:0043154),1/49,0.206356154882249,0.326519321238743,0,0,4.44847670250896,7.02037105195506,CAAP1,3
Regulation Of Interleukin-12 Production (GO:0032655),1/50,0.210095436800202,0.328401605095462,0,0,4.35747202106649,6.79849904676328,HLA-B,3
Regulation Of Mitochondrion Organization (GO:0010821),1/50,0.210095436800202,0.328401605095462,0,0,4.35747202106649,6.79849904676328,VDAC1,3
Intracellular Iron Ion Homeostasis (GO:0006879),1/50,0.210095436800202,0.328401605095462,0,0,4.35747202106649,6.79849904676328,B2M,3
Ribosome Assembly (GO:0042255),1/50,0.210095436800202,0.328401605095462,0,0,4.35747202106649,6.79849904676328,RPS15,3
Positive Regulation Of Fat Cell Differentiation (GO:0045600),1/50,0.210095436800202,0.328401605095462,0,0,4.35747202106649,6.79849904676328,RARRES2,3
Positive Regulation Of Leukocyte Mediated Cytotoxicity (GO:0001912),1/51,0.213817287520603,0.332604669476493,0,0,4.27010752688172,6.58721060052849,HLA-B,3
Sensory Perception (GO:0007600),1/51,0.213817287520603,0.332604669476493,0,0,4.27010752688172,6.58721060052849,RETREG1,3
Negative Regulation Of Response To Stimulus (GO:0048585),1/52,0.217521787430049,0.335932928309237,0,0,4.18616909129243,6.38581785149954,APLP2,3
Regulation Of Proteolysis (GO:0030162),1/52,0.217521787430049,0.335932928309237,0,0,4.18616909129243,6.38581785149954,FBXW11,3
Cellular Response To Ionizing Radiation (GO:0071479),1/52,0.217521787430049,0.335932928309237,0,0,4.18616909129243,6.38581785149954,CRYAB,3
Axonogenesis (GO:0007409),2/188,0.221208043810331,0.335987279770801,0,0,2.30481533426835,3.4771634467842,APLP2;NRXN3,3
Spermatid Development (GO:0007286),1/53,0.221209016495061,0.335987279770801,0,0,4.10545905707196,6.19368951000575,MKKS,3
Gonad Development (GO:0008406),1/53,0.221209016495061,0.335987279770801,0,0,4.10545905707196,6.19368951000575,MKKS,3
Actin Polymerization Or Depolymerization (GO:0008154),1/53,0.221209016495061,0.335987279770801,0,0,4.10545905707196,6.19368951000575,DIAPH1,3
Regulation Of Receptor Signaling Pathway Via JAK-STAT (GO:0046425),1/53,0.221209016495061,0.335987279770801,0,0,4.10545905707196,6.19368951000575,TP53INP2,3
Mitochondrial Transport (GO:0006839),1/53,0.221209016495061,0.335987279770801,0,0,4.10545905707196,6.19368951000575,SLC25A5,3
Negative Regulation Of Cysteine-Type Endopeptidase Activity (GO:2000117),1/53,0.221209016495061,0.335987279770801,0,0,4.10545905707196,6.19368951000575,CAST,3
Positive Regulation Of Leukocyte Chemotaxis (GO:0002690),1/54,0.224879054416699,0.336014178757203,0,0,4.02779468452019,6.01024525028242,RARRES2,3
Regulation Of Exocytosis (GO:0017157),1/54,0.224879054416699,0.336014178757203,0,0,4.02779468452019,6.01024525028242,STXBP6,3
Negative Regulation Of Protein Catabolic Process (GO:0042177),1/54,0.224879054416699,0.336014178757203,0,0,4.02779468452019,6.01024525028242,ATRAID,3
Regulation Of Lipid Metabolic Process (GO:0019216),1/54,0.224879054416699,0.336014178757203,0,0,4.02779468452019,6.01024525028242,RARRES2,3
Organelle Disassembly (GO:1903008),1/54,0.224879054416699,0.336014178757203,0,0,4.02779468452019,6.01024525028242,RETREG1,3
Regulation Of Smooth Muscle Cell Proliferation (GO:0048660),1/54,0.224879054416699,0.336014178757203,0,0,4.02779468452019,6.01024525028242,IGFBP5,3
Endoplasmic Reticulum Organization (GO:0007029),1/54,0.224879054416699,0.336014178757203,0,0,4.02779468452019,6.01024525028242,RTN3,3
Protein Localization To Membrane (GO:0072657),2/192,0.228125801003985,0.339111971006898,0,0,2.2558352402746,3.3338042544277,ANK2;ATP1B1,3
Purine Ribonucleotide Biosynthetic Process (GO:0009152),1/55,0.22853198046117,0.339111971006898,0,0,3.95300677021107,5.83495075546462,ATP5PO,3
Response To Peptide Hormone (GO:0043434),1/55,0.22853198046117,0.339111971006898,0,0,3.95300677021107,5.83495075546462,IGFBP5,3
Cellular Response To Peptide (GO:1901653),1/56,0.232167873585097,0.342142129493828,0,0,3.88093841642229,5.66731331907353,RPL17,3
Positive Regulation Of Cellular Metabolic Process (GO:0031325),1/56,0.232167873585097,0.342142129493828,0,0,3.88093841642229,5.66731331907353,B2M,3
Regulation Of Cation Channel Activity (GO:2001257),1/56,0.232167873585097,0.342142129493828,0,0,3.88093841642229,5.66731331907353,ANK2,3
Regulation Of Programmed Cell Death (GO:0043067),2/195,0.233324588225315,0.342769090654492,0,0,2.22043252984907,3.23145033278088,ETFA;CRYAB,3
Positive Regulation Of Intracellular Signal Transduction (GO:1902533),4/525,0.233687563662845,0.342769090654492,0,0,1.65365749626786,2.40403807807668,RPS15;ETFA;GAPDH;RPL17,3
Positive Regulation Of Protein Metabolic Process (GO:0051247),2/196,0.235059262065388,0.342769090654492,0,0,2.20887494397131,3.19826894651336,EGLN2;FBXW11,3
Striated Muscle Contraction (GO:0006941),1/57,0.235786812360155,0.342769090654492,0,0,3.81144393241167,5.50687793978934,ATP1B1,3
Myeloid Cell Differentiation (GO:0030099),1/57,0.235786812360155,0.342769090654492,0,0,3.81144393241167,5.50687793978934,SLC25A5,3
Regulation Of Calcium Ion Transport (GO:0051924),1/57,0.235786812360155,0.342769090654492,0,0,3.81144393241167,5.50687793978934,ANK2,3
Regulation Of Neuron Death (GO:1901214),1/58,0.239388874981047,0.345664653560077,0,0,3.7443878513488,5.35322384222476,EGLN2,3
Response To Organic Cyclic Compound (GO:0014070),1/58,0.239388874981047,0.345664653560077,0,0,3.7443878513488,5.35322384222476,IGFBP5,3
Regulation Of Bone Mineralization (GO:0030500),1/58,0.239388874981047,0.345664653560077,0,0,3.7443878513488,5.35322384222476,ATRAID,3
Negative Regulation Of Protein-Containing Complex Assembly (GO:0031333),1/59,0.242974139280705,0.346184393134455,0,0,3.67964404894327,5.20596137193734,CRYAB,3
Positive Regulation Of Proteolysis (GO:0045862),1/59,0.242974139280705,0.346184393134455,0,0,3.67964404894327,5.20596137193734,FBXW11,3
Anterior/Posterior Pattern Specification (GO:0009952),1/59,0.242974139280705,0.346184393134455,0,0,3.67964404894327,5.20596137193734,ATP6AP2,3
Microtubule Cytoskeleton Organization Involved In Mitosis (GO:1902850),1/59,0.242974139280705,0.346184393134455,0,0,3.67964404894327,5.20596137193734,RAN,3
Regulation Of Type I Interferon Production (GO:0032479),1/59,0.242974139280705,0.346184393134455,0,0,3.67964404894327,5.20596137193734,GAPDH,3
Regulation Of Cell Death (GO:0010941),1/59,0.242974139280705,0.346184393134455,0,0,3.67964404894327,5.20596137193734,CRYAB,3
Regulation Of Translation (GO:0006417),2/202,0.245482450954454,0.348187473122417,0,0,2.14195652173913,3.00844180187827,IGFBP5;GAPDH,3
Regulation Of Extrinsic Apoptotic Signaling Pathway (GO:2001236),1/60,0.246542682832022,0.348187473122417,0,0,3.61709495170403,5.0647292176956,ETFA,3
Positive Regulation Of Phagocytosis (GO:0050766),1/60,0.246542682832022,0.348187473122417,0,0,3.61709495170403,5.0647292176956,APLP2,3
protein-DNA Complex Organization (GO:0071824),1/60,0.246542682832022,0.348187473122417,0,0,3.61709495170403,5.0647292176956,RPL17,3
Autophagosome Organization (GO:1905037),1/61,0.250094582695878,0.3524308780222,0,0,3.55663082437276,4.92919192796023,TP53INP2,3
Fat Cell Differentiation (GO:0045444),1/62,0.25362991570207,0.354311639288792,0,0,3.4981491274458,4.79903767400742,MKKS,3
Protein Lipidation (GO:0006497),1/62,0.25362991570207,0.354311639288792,0,0,3.4981491274458,4.79903767400742,TP53INP2,3
Protein-Containing Complex Disassembly (GO:0032984),1/62,0.25362991570207,0.354311639288792,0,0,3.4981491274458,4.79903767400742,RPL17,3
Regulation Of T Cell Activation (GO:0050863),1/62,0.25362991570207,0.354311639288792,0,0,3.4981491274458,4.79903767400742,B2M,3
Protein Polymerization (GO:0051258),1/63,0.257148758323109,0.358449784329182,0,0,3.44155393687131,4.67397624421167,DIAPH1,3
Positive Regulation Of Macroautophagy (GO:0016239),1/64,0.260651186597798,0.360987879933295,0,0,3.38675541901348,4.55373723649621,SLC25A5,3
Positive Regulation Of Type I Interferon Production (GO:0032481),1/64,0.260651186597798,0.360987879933295,0,0,3.38675541901348,4.55373723649621,GAPDH,3
Cellular Response To Virus (GO:0098586),1/64,0.260651186597798,0.360987879933295,0,0,3.38675541901348,4.55373723649621,LGALS8,3
RNA Export From Nucleus (GO:0006405),1/65,0.264137276322735,0.36347095288855,0,0,3.33366935483871,4.43806842387086,RAN,3
Antimicrobial Humoral Immune Response Mediated By Antimicrobial Peptide (GO:0061844),1/65,0.264137276322735,0.36347095288855,0,0,3.33366935483871,4.43806842387086,GAPDH,3
Autophagosome Assembly (GO:0000045),1/65,0.264137276322735,0.36347095288855,0,0,3.33366935483871,4.43806842387086,TP53INP2,3
Cellular Response To Type II Interferon (GO:0071346),1/66,0.267607102869758,0.367460499462951,0,0,3.28221670802316,4.32673428196329,GAPDH,3
B Cell Differentiation (GO:0030183),1/68,0.274498266375542,0.376121028820955,0,0,3.18391911410689,4.11620353214128,SLC25A5,3
Regulation Of Heart Contraction (GO:0008016),1/69,0.277919752411088,0.379195594391399,0,0,3.13693864642631,4.01660797636982,ANK2,3
Regulation Of Monoatomic Ion Transmembrane Transporter Activity (GO:0032412),1/69,0.277919752411088,0.379195594391399,0,0,3.13693864642631,4.01660797636982,ANK2,3
Negative Regulation Of Epithelial Cell Proliferation (GO:0050680),1/70,0.281325273434888,0.383030604845809,0,0,3.09131993143213,3.92054709694655,B2M,3
Regulation Of Cilium Assembly (GO:1902017),1/71,0.284714903218137,0.384394963673963,0,0,3.04700460829493,3.82785115229788,TBC1D1,3
Regulation Of Hydrolase Activity (GO:0051336),1/71,0.284714903218137,0.384394963673963,0,0,3.04700460829493,3.82785115229788,SERPINA5,3
Negative Regulation Of Protein Binding (GO:0032091),1/71,0.284714903218137,0.384394963673963,0,0,3.04700460829493,3.82785115229788,B2M,3
Negative Regulation Of Supramolecular Fiber Organization (GO:1902904),1/71,0.284714903218137,0.384394963673963,0,0,3.04700460829493,3.82785115229788,CRYAB,3
Protein Polyubiquitination (GO:0000209),2/226,0.287278352381117,0.3849152126065,0,0,1.91013198757764,2.38251462743613,FBXW11;UBE2QL1,3
Transforming Growth Factor Beta Receptor Signaling Pathway (GO:0007179),1/72,0.288088715025362,0.3849152126065,0,0,3.00393760411934,3.73836072037484,APLP2,3
Positive Regulation Of Protein Localization To Nucleus (GO:1900182),1/72,0.288088715025362,0.3849152126065,0,0,3.00393760411934,3.73836072037484,RAN,3
Cellular Response To Hypoxia (GO:0071456),1/72,0.288088715025362,0.3849152126065,0,0,3.00393760411934,3.73836072037484,EGLN2,3
Plasma Membrane Organization (GO:0007009),1/72,0.288088715025362,0.3849152126065,0,0,3.00393760411934,3.73836072037484,ANK2,3
Apoptotic Process (GO:0006915),2/228,0.290757965947565,0.387677287930086,0,0,1.89303578299346,2.33839912387494,VDAC1;GAPDH,3
Cellular Response To Decreased Oxygen Levels (GO:0036294),1/73,0.291446781927973,0.387792825540527,0,0,2.96206690561529,3.6519259376872,EGLN2,3
Negative Regulation Of Neuron Apoptotic Process (GO:0043524),1/74,0.294789176667169,0.390625987188595,0,0,2.92134334953601,3.56840580832533,RETREG1,3
Regulation Of Cell Cycle G1/S Phase Transition (GO:1902806),1/74,0.294789176667169,0.390625987188595,0,0,2.92134334953601,3.56840580832533,APLP2,3
Regulation Of Fat Cell Differentiation (GO:0045598),1/75,0.298115971484896,0.393415339418592,0,0,2.88172043010753,3.48766757171651,RARRES2,3
Defense Response To Gram-negative Bacterium (GO:0050829),1/75,0.298115971484896,0.393415339418592,0,0,2.88172043010753,3.48766757171651,RARRES2,3
Positive Regulation Of GTPase Activity (GO:0043547),2/234,0.301184539653772,0.396161513473321,0,0,1.84351574212894,2.2122780923796,TBC1D1;SOS2,3
Regulation Of Ras Protein Signal Transduction (GO:0046578),1/76,0.301427238512309,0.396161513473321,0,0,2.8431541218638,3.40958611786377,ETFA,3
Regulation Of Immune Response (GO:0050776),1/77,0.304723049468736,0.396447765369426,0,0,2.80560271646859,3.33404345740382,APLP2,3
Positive Regulation Of Response To Stimulus (GO:0048584),1/77,0.304723049468736,0.396447765369426,0,0,2.80560271646859,3.33404345740382,VDAC1,3
Cell Morphogenesis Involved In Neuron Differentiation (GO:0048667),1/77,0.304723049468736,0.396447765369426,0,0,2.80560271646859,3.33404345740382,APLP2,3
Monoatomic Cation Homeostasis (GO:0055080),1/77,0.304723049468736,0.396447765369426,0,0,2.80560271646859,3.33404345740382,SLC4A11,3
Embryonic Organ Development (GO:0048568),1/77,0.304723049468736,0.396447765369426,0,0,2.80560271646859,3.33404345740382,RARRES2,3
Regulation Of Innate Immune Response (GO:0045088),1/78,0.308003475591604,0.399103095132783,0,0,2.76902667225248,3.26092823257648,APLP2,3
Organonitrogen Compound Catabolic Process (GO:1901565),1/78,0.308003475591604,0.399103095132783,0,0,2.76902667225248,3.26092823257648,ETFA,3
Vesicle Fusion (GO:0006906),1/79,0.311268588043502,0.400113713972086,0,0,2.73338847532396,3.19013526329858,STXBP6,3
Positive Regulation Of Catabolic Process (GO:0009896),1/79,0.311268588043502,0.400113713972086,0,0,2.73338847532396,3.19013526329858,EGLN2,3
Positive Regulation Of Endocytosis (GO:0045807),1/79,0.311268588043502,0.400113713972086,0,0,2.73338847532396,3.19013526329858,B2M,3
Negative Regulation Of Cellular Component Organization (GO:0051129),1/79,0.311268588043502,0.400113713972086,0,0,2.73338847532396,3.19013526329858,CRYAB,3
Regulation Of Organelle Assembly (GO:1902115),1/80,0.314518457505698,0.402683671239899,0,0,2.69865251122907,3.12156513648193,TBC1D1,3
Response To Type II Interferon (GO:0034341),1/80,0.314518457505698,0.402683671239899,0,0,2.69865251122907,3.12156513648193,GAPDH,3
Cellular Response To Organic Substance (GO:0071310),1/82,0.320972748763277,0.409319703373367,0,0,2.6317536174167,2.99072232191542,IGFBP5,3
Sodium Ion Transmembrane Transport (GO:0035725),1/82,0.320972748763277,0.409319703373367,0,0,2.6317536174167,2.99072232191542,ATP1B1,3
Regulation Of Osteoblast Differentiation (GO:0045667),1/85,0.33054161283751,0.418209820564551,0,0,2.5373783922171,2.80893552657812,ATRAID,3
Mitotic Spindle Organization (GO:0007052),1/85,0.33054161283751,0.418209820564551,0,0,2.5373783922171,2.80893552657812,RAN,3
Positive Regulation Of Canonical Wnt Signaling Pathway (GO:0090263),1/85,0.33054161283751,0.418209820564551,0,0,2.5373783922171,2.80893552657812,ATP6AP2,3
Defense Response To Gram-positive Bacterium (GO:0050830),1/85,0.33054161283751,0.418209820564551,0,0,2.5373783922171,2.80893552657812,RARRES2,3
Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901990),1/86,0.33370149159208,0.421379922716273,0,0,2.50740037950664,2.75189303728322,APLP2,3
Glucose Homeostasis (GO:0042593),1/87,0.336846613448384,0.424519019688375,0,0,2.47811952988247,2.69651026948874,APLP2,3
Negative Regulation Of Neuron Death (GO:1901215),1/88,0.339977046551018,0.427627378864952,0,0,2.44951180323817,2.64272237145486,RETREG1,3
Organic Anion Transport (GO:0015711),1/89,0.343092858858194,0.429867317324274,0,0,2.42155425219941,2.59046769359986,SLC4A11,3
Cellular Response To Chemical Stress (GO:0062197),1/89,0.343092858858194,0.429867317324274,0,0,2.42155425219941,2.59046769359986,SLC4A11,3
Regulation Of Epithelial Cell Proliferation (GO:0050678),1/91,0.349280890792371,0.435924212539316,0,0,2.36750298685783,2.49032628560744,B2M,3
Lymphocyte Differentiation (GO:0030098),1/91,0.349280890792371,0.435924212539316,0,0,2.36750298685783,2.49032628560744,SLC25A5,3
B Cell Activation (GO:0042113),1/92,0.352353244626921,0.437216742851132,0,0,2.34136830911024,2.44233061754333,SLC25A5,3
Steroid Metabolic Process (GO:0008202),1/92,0.352353244626921,0.437216742851132,0,0,2.34136830911024,2.44233061754333,HSD11B2,3
Positive Regulation Of Protein Catabolic Process (GO:0045732),1/92,0.352353244626921,0.437216742851132,0,0,2.34136830911024,2.44233061754333,EGLN2,3
Cellular Response To Transforming Growth Factor Beta Stimulus (GO:0071560),1/96,0.364499797099579,0.451418979484863,0,0,2.24233163554046,2.2630267514479,APLP2,3
Regulation Of Defense Response (GO:0031347),1/97,0.367501048871114,0.453392098607275,0,0,2.21886200716846,2.22114545195513,APLP2,3
Monocarboxylic Acid Metabolic Process (GO:0032787),1/97,0.367501048871114,0.453392098607275,0,0,2.21886200716846,2.22114545195513,VDAC1,3
Phosphatidylinositol Biosynthetic Process (GO:0006661),1/98,0.370488276762405,0.45533292029578,0,0,2.19587628865979,2.180359077073,TP53INP2,3
Positive Regulation Of Cold-Induced Thermogenesis (GO:0120162),1/98,0.370488276762405,0.45533292029578,0,0,2.19587628865979,2.180359077073,APLP2,3
Axon Development (GO:0061564),1/99,0.373461545681247,0.457241892431032,0,0,2.17335966644722,2.14062938362316,APLP2,3
Cellular Response To Insulin Stimulus (GO:0032869),1/99,0.373461545681247,0.457241892431032,0,0,2.17335966644722,2.14062938362316,RARRES2,3
Regulation Of Organelle Organization (GO:0033043),1/100,0.376420920115876,0.459990650008775,0,0,2.15129792549147,2.10191981526176,DIAPH1,3
Activation Of GTPase Activity (GO:0090630),1/102,0.38229824214873,0.466288007469285,0,0,2.10848504205259,2.02742272453832,TBC1D1,3
Positive Regulation Of Cell Differentiation (GO:0045597),2/283,0.384891440740877,0.468074166783924,0,0,1.51825777502708,1.44962334809241,RARRES2;ATRAID,3
Inorganic Cation Import Across Plasma Membrane (GO:0098659),1/103,0.385216317384285,0.468074166783924,0,0,2.08770820156019,1.9915697381426,ATP1B1,3
Negative Regulation Of MAPK Cascade (GO:0043409),1/105,0.391011612973462,0.474221240593051,0,0,2.04735318444996,1.92250153092003,PEBP1,3
Positive Regulation Of Gene Expression (GO:0010628),3/480,0.393229473701678,0.475918367236084,0,0,1.34280185223581,1.25332013508256,ANK2;GAPDH;RPL17,3
Regulation Of G1/S Transition Of Mitotic Cell Cycle (GO:2000045),1/106,0.393888959218684,0.475918367236084,0,0,2.02775217613927,1.88922879820525,APLP2,3
Negative Regulation Of Apoptotic Process (GO:0043066),3/482,0.395773330483258,0.476695593892431,0,0,1.33705751451054,1.2393368334639,VDAC1;CRYAB;RETREG1,3
Monoatomic Ion Transport (GO:0006811),1/107,0.396752854544011,0.476695593892431,0,0,2.00852099817407,1.85676061581607,VDAC1,3
Positive Regulation Of T Cell Activation (GO:0050870),1/107,0.396752854544011,0.476695593892431,0,0,2.00852099817407,1.85676061581607,B2M,3
Positive Regulation Of Metabolic Process (GO:0009893),1/108,0.399603361045303,0.479226377119507,0,0,1.98964928147925,1.8250711061513,APLP2,3
Positive Regulation Of Wnt Signaling Pathway (GO:0030177),1/109,0.402440540735339,0.480838048670794,0,0,1.97112704101951,1.79413543995639,ATP6AP2,3
Regulation Of Wnt Signaling Pathway (GO:0030111),1/109,0.402440540735339,0.480838048670794,0,0,1.97112704101951,1.79413543995639,ATP6AP2,3
Adenylate Cyclase-Activating G Protein-Coupled Receptor Signaling Pathway (GO:0007189),1/110,0.405264455310451,0.48153193583013,0,0,1.95294465818289,1.76392978611074,PTGER3,3
Response To Lipid (GO:0033993),1/110,0.405264455310451,0.48153193583013,0,0,1.95294465818289,1.76392978611074,GPX3,3
Sensory Perception Of Chemical Stimulus (GO:0007606),1/110,0.405264455310451,0.48153193583013,0,0,1.95294465818289,1.76392978611074,MKKS,3
Mitotic Sister Chromatid Segregation (GO:0000070),1/111,0.408075165987637,0.483088983264776,0,0,1.93509286412512,1.73443126391861,RAN,3
Cytoskeleton Organization (GO:0007010),1/111,0.408075165987637,0.483088983264776,0,0,1.93509286412512,1.73443126391861,DIAPH1,3
Small GTPase Mediated Signal Transduction (GO:0007264),1/112,0.410872733966244,0.485508331512406,0,0,1.91756272401434,1.70561789517071,SOS2,3
Regulation Of Cytoskeleton Organization (GO:0051493),1/114,0.41642868448074,0.489379694900724,0,0,1.88343324769245,1.64996297111925,DIAPH1,3
Regulation Of Interleukin-6 Production (GO:0032675),1/114,0.41642868448074,0.489379694900724,0,0,1.88343324769245,1.64996297111925,HLA-B,3
Response To Endoplasmic Reticulum Stress (GO:0034976),1/114,0.41642868448074,0.489379694900724,0,0,1.88343324769245,1.64996297111925,ERP27,3
Regulation Of Apoptotic Process (GO:0042981),4/705,0.424018557445098,0.496342313155557,0,0,1.21762561420193,1.04469605880754,EGLN2;ETFA;VDAC1;CRYAB,3
Protein Processing (GO:0016485),1/117,0.424665550541478,0.496342313155557,0,0,1.83444568038561,1.57111716626324,KLK1,3
Cellular Response To Oxidative Stress (GO:0034599),1/117,0.424665550541478,0.496342313155557,0,0,1.83444568038561,1.57111716626324,SLC4A11,3
Cellular Response To Cytokine Stimulus (GO:0071345),2/308,0.426015927910809,0.497018582562611,0,0,1.39244103438477,1.18814005835571,MT2A;GAPDH,3
Regulation Of Protein-Containing Complex Assembly (GO:0043254),1/119,0.430092784530704,0.500867546542085,0,0,1.80317113176599,1.52143342418003,CRYAB,3
Negative Regulation Of Growth (GO:0045926),1/124,0.443440268709876,0.513625059440935,0,0,1.7294343911181,1.40636250176118,MT2A,3
Neuron Projection Guidance (GO:0097485),1/124,0.443440268709876,0.513625059440935,0,0,1.7294343911181,1.40636250176118,NRXN3,3
Protein Dephosphorylation (GO:0006470),1/124,0.443440268709876,0.513625059440935,0,0,1.7294343911181,1.40636250176118,FBXW11,3
Organelle Assembly (GO:0070925),2/322,0.448429943355431,0.51784552613382,0,0,1.33057065217391,1.06712140432896,MKKS;TP53INP2,3
Positive Regulation Of Intracellular Protein Transport (GO:0090316),1/126,0.448692241588,0.51784552613382,0,0,1.70159139784946,1.36368607190074,RAN,3
Regulation Of Response To External Stimulus (GO:0032101),1/127,0.451299810354023,0.519923216221808,0,0,1.68800136542072,1.34301337268258,APLP2,3
Intracellular Protein Transport (GO:0006886),2/325,0.453170457042052,0.521146025598359,0,0,1.31801049939427,1.043188096283,APLP2;RAN,3
Transmembrane Receptor Protein Serine/Threonine Kinase Signaling Pathway (GO:0007178),1/130,0.459049526260387,0.526028282761013,0,0,1.64849545719763,1.28351390497376,APLP2,3
Regulation Of Cell Cycle Process (GO:0010564),1/130,0.459049526260387,0.526028282761013,0,0,1.64849545719763,1.28351390497376,RPL17,3
Synapse Organization (GO:0050808),1/131,0.461608622222119,0.528021230392619,0,0,1.63573200992556,1.26448281333381,CAST,3
Epithelial Cell Differentiation (GO:0030855),1/132,0.464155739838701,0.52905539195774,0,0,1.6231634244439,1.24583496114028,VDAC1,3
Circulatory System Development (GO:0072359),1/132,0.464155739838701,0.52905539195774,0,0,1.6231634244439,1.24583496114028,MKKS,3
Negative Regulation Of Cell Motility (GO:2000146),1/133,0.466690934728058,0.53100523315348,0,0,1.61078527207559,1.22756020762573,IGFBP5,3
Negative Regulation Of Gene Expression (GO:0010629),2/336,0.470355267156896,0.534230673807833,0,0,1.27388700859151,0.960850909696902,IGFBP5;GAPDH,3
Potassium Ion Transmembrane Transport (GO:0071805),1/137,0.476713586787692,0.53954929682122,0,0,1.56309297912713,1.15800088890404,ATP1B1,3
Protein Localization To Organelle (GO:0033365),1/137,0.476713586787692,0.53954929682122,0,0,1.56309297912713,1.15800088890404,ANK2,3
Ras Protein Signal Transduction (GO:0007265),1/144,0.493806785241469,0.557915034553519,0,0,1.48605158282578,1.04857428589275,SOS2,3
Regulation Of Cold-Induced Thermogenesis (GO:0120161),1/146,0.498588273520981,0.561347636621524,0,0,1.46540600667408,1.01988539886919,APLP2,3
Neuron Projection Morphogenesis (GO:0048812),1/146,0.498588273520981,0.561347636621524,0,0,1.46540600667408,1.01988539886919,APLP2,3
Dephosphorylation (GO:0016311),1/147,0.500962233012394,0.563036087364715,0,0,1.45529533068199,1.00593588036552,FBXW11,3
Axon Guidance (GO:0007411),1/149,0.505676841508221,0.567344749009223,0,0,1.43548387096774,0.978795395985457,NRXN3,3
protein-RNA Complex Assembly (GO:0022618),1/150,0.508017593408656,0.568979704617695,0,0,1.42577758533593,0.965592470285837,RPS15,3
Positive Regulation Of Macromolecule Metabolic Process (GO:0010604),2/364,0.512628202447407,0.573146809680781,0,0,1.17367283209224,0.784253407059539,ANK2;RPL17,3
Regulation Of Cellular Component Organization (GO:0051128),1/153,0.514974251664672,0.574771955064209,0,0,1.39742501414827,0.927384867440544,EGLN2,3
Epithelium Development (GO:0060429),1/154,0.517271440590205,0.576337037612616,0,0,1.38822123831612,0.915098104328148,VDAC1,3
Positive Regulation Of Response To External Stimulus (GO:0032103),1/155,0.519557864656604,0.576888387653194,0,0,1.37913699204022,0.903027305475037,RARRES2,3
Cellular Response To Growth Factor Stimulus (GO:0071363),1/155,0.519557864656604,0.576888387653194,0,0,1.37913699204022,0.903027305475037,APLP2,3
Mitochondrion Organization (GO:0007005),1/162,0.535265581461312,0.593306427643864,0,0,1.31870700594403,0.824181647279319,COX7A1,3
Negative Regulation Of Programmed Cell Death (GO:0043069),2/381,0.537210317258617,0.593703560707236,0,0,1.12005277044855,0.695962271708005,VDAC1;CRYAB,3
Negative Regulation Of Cell Migration (GO:0030336),1/163,0.537467664429067,0.593703560707236,0,0,1.31050046462233,0.813672282606929,IGFBP5,3
Positive Regulation Of Multicellular Organismal Process (GO:0051240),2/387,0.545684309208334,0.601257373968196,0,0,1.10225861095426,0.667654198350546,APLP2;GAPDH,3
Membrane Organization (GO:0061024),1/167,0.546173235669868,0.601257373968196,0,0,1.27866303925379,0.773359792947563,ANK2,3
Heart Development (GO:0007507),1/171,0.554716664664444,0.608581826309885,0,0,1.2483238456673,0.735634508061154,MKKS,3
Metal Ion Transport (GO:0030001),1/171,0.554716664664444,0.608581826309885,0,0,1.2483238456673,0.735634508061154,SLC4A11,3
Generation Of Neurons (GO:0048699),1/172,0.556827538562054,0.609858732710821,0,0,1.24096082500157,0.726582206337367,RTN3,3
Neuron Differentiation (GO:0030182),1/173,0.55892851173922,0.611120478030658,0,0,1.23368342085521,0.717675221019935,RTN3,3
Positive Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043123),1/175,0.5631009394772,0.614638991564943,0,0,1.21937955753306,0.700285263689774,GAPDH,3
Positive Regulation Of Hydrolase Activity (GO:0051345),1/176,0.565172485302154,0.615856312241265,0,0,1.21235023041475,0.691796514563053,SOS2,3
Negative Regulation Of Cytokine Production (GO:0001818),1/178,0.569286467382188,0.61929135978738,0,0,1.19852985845331,0.675217580852404,APLP2,3
Transcription By RNA Polymerase II (GO:0006366),1/192,0.597025723787158,0.648371949610337,0,0,1.10989134718235,0.572476494099229,POLR2K,3
Regulation Of Signal Transduction (GO:0009966),1/193,0.598938055370561,0.649353716597039,0,0,1.10405465949821,0.565935216279583,IGFBP5,3
Nervous System Development (GO:0007399),2/433,0.60706403458248,0.656218990038562,0,0,0.982295974982346,0.490284549270812,COX7B;APLP2,3
Protein Ubiquitination (GO:0016567),2/434,0.608327231448791,0.656218990038562,0,0,0.979971819645733,0.48708747870651,FBXW11;UBE2QL1,3
Regulation Of Cell Migration (GO:0030334),2/434,0.608327231448791,0.656218990038562,0,0,0.979971819645733,0.48708747870651,IGFBP5;APLP2,3
DNA-templated Transcription (GO:0006351),1/199,0.610224938635646,0.657165318530696,0,0,1.07027261865972,0.528637226470743,POLR2K,3
Defense Response To Bacterium (GO:0042742),1/204,0.61939016979829,0.66592198555943,0,0,1.04364637957519,0.499927365689424,RARRES2,3
Regulation Of Canonical Wnt Signaling Pathway (GO:0060828),1/207,0.624786620026615,0.670604305495233,0,0,1.02829105334586,0.483651653683762,ATP6AP2,3
Negative Regulation Of Nucleic Acid-Templated Transcription (GO:1903507),2/456,0.635350561469277,0.680808255551106,0,0,0.93143076039073,0.422476843379163,FBXW11;CRYAB,3
Regulation Of GTPase Activity (GO:0043087),1/214,0.637085719846623,0.681533560766155,0,0,0.994144075925085,0.448210914813056,SOS2,3
Proteasomal Protein Catabolic Process (GO:0010498),1/220,0.647309740705647,0.691322509145003,0,0,0.966612657730643,0.420409196364181,FBXW11,3
Positive Regulation Of Protein Modification Process (GO:0031401),1/225,0.655611672150229,0.699029663683357,0,0,0.944796466973886,0.398880435013305,RARRES2,3
Regulation Of Cell Growth (GO:0001558),1/227,0.658878043957857,0.701351174064231,0,0,0.936340279760205,0.390656917597327,EGLN2,3
Cilium Organization (GO:0044782),1/228,0.660499716832802,0.701917190825617,0,0,0.932168064042442,0.386624706046427,MKKS,3
Sensory Perception Of Smell (GO:0007608),1/230,0.663720214886558,0.702930200300147,0,0,0.923932948302578,0.378715109110861,MKKS,3
Negative Regulation Of Intracellular Signal Transduction (GO:1902532),1/231,0.665319110853519,0.702930200300147,0,0,0.91986909770921,0.374836067305104,PEBP1,3
Positive Regulation Of Phosphorylation (GO:0042327),1/231,0.665319110853519,0.702930200300147,0,0,0.91986909770921,0.374836067305104,RARRES2,3
Positive Regulation Of Cell Population Proliferation (GO:0008284),2/483,0.666524448085127,0.702930200300147,0,0,0.877926421404682,0.356155837520908,SLC25A5;RPL17,3
Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043122),1/232,0.666910485067375,0.702930200300147,0,0,0.915840431969464,0.371006452869144,GAPDH,3
Inflammatory Response (GO:0006954),1/236,0.673201462142491,0.708401538594386,0,0,0.900068634179822,0.356166739540658,PTGER3,3
Cilium Assembly (GO:0060271),1/243,0.683929063316788,0.718516014316496,0,0,0.873722562872123,0.331928141182964,MKKS,3
Cytokine-Mediated Signaling Pathway (GO:0019221),1/257,0.704349893902654,0.738764383832751,0,0,0.825352822580645,0.289269688545046,APLP2,3
Cellular Component Assembly (GO:0022607),1/260,0.708552942768408,0.741964382346106,0,0,0.815668202764977,0.281022571688413,RTN3,3
Regulation Of Protein Phosphorylation (GO:0001932),1/265,0.715427041062578,0.747946452019967,0,0,0.800016291951776,0.267905979257733,RARRES2,3
Positive Regulation Of Signal Transduction (GO:0009967),1/266,0.716782486976855,0.748148981544724,0,0,0.796956786366403,0.265372941932251,ATP6AP2,3
Negative Regulation Of Signal Transduction (GO:0009968),1/267,0.718131544977594,0.748344198973416,0,0,0.793920284582424,0.262869004077735,IGFBP5,3
Negative Regulation Of Cellular Process (GO:0048523),2/537,0.722476810303604,0.7516560029653,0,0,0.787119057293783,0.25586875730256,APLP2;CRYAB,3
Plasma Membrane Bounded Cell Projection Assembly (GO:0120031),1/275,0.728697594420564,0.756905243236844,0,0,0.770426183188133,0.243837156206891,MKKS,3
Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway (GO:0007169),1/284,0.740116533631154,0.767338792431555,0,0,0.745583038869258,0.22438144650456,RARRES2,3
Positive Regulation Of Nucleic Acid-Templated Transcription (GO:1903508),2/557,0.741125355423023,0.767338792431555,0,0,0.757971014492754,0.227077123378267,FBXW11;TP53INP2,3
DNA Metabolic Process (GO:0006259),1/288,0.745037732810689,0.770151364253746,0,0,0.735041774380878,0.216337799208642,RAN,3
Regulation Of Intracellular Signal Transduction (GO:1902531),1/297,0.755775865520805,0.779952021238626,0,0,0.71236559139785,0.19946978910948,ATP6AP2,3
Regulation Of Cell Cycle (GO:0051726),1/298,0.756941014400841,0.779952021238626,0,0,0.709930849715796,0.19769440736542,ETFA,3
Positive Regulation Of MAPK Cascade (GO:0043410),1/310,0.770501070138476,0.792656052985908,0,0,0.68194313950656,0.177792284158114,ETFA,3
Positive Regulation Of Cellular Process (GO:0048522),2/594,0.772841695255546,0.793795935796765,0,0,0.709239130434783,0.182757479612429,SLC25A5;RPL17,3
Supramolecular Fiber Organization (GO:0097435),1/316,0.776997645032775,0.796793763377559,0,0,0.668748933265062,0.16873736623579,B2M,3
Proteasome-Mediated Ubiquitin-Dependent Protein Catabolic Process (GO:0043161),1/319,0.780177362752865,0.798587873849529,0,0,0.662338540609995,0.164414943304466,FBXW11,3
Positive Regulation Of Cytokine Production (GO:0001819),1/320,0.781227267896278,0.798587873849529,0,0,0.660228536758014,0.163003279047174,GAPDH,3
Regulation Of Gene Expression (GO:0010468),4/1127,0.783090094492109,0.799223487881011,0,0,0.743365983971505,0.181758577952473,ANK2;ATP1B1;ATRAID;RPL17,3
Protein Localization (GO:0008104),1/351,0.811424733768737,0.826831532511181,0,0,0.600798771121352,0.12554510163199,ANK2,3
Protein Modification By Small Protein Conjugation (GO:0032446),1/364,0.822824993331303,0.837123689897882,0,0,0.578897479190734,0.112891808007061,FBXW11,3
Ubiquitin-Dependent Protein Catabolic Process (GO:0006511),1/367,0.825357414076738,0.838375669819273,0,0,0.574064281097597,0.110185184712824,FBXW11,3
Positive Regulation Of Protein Phosphorylation (GO:0001934),1/377,0.833542936857944,0.845356931238608,0,0,0.558510638297872,0.101688067766439,RARRES2,3
Protein Modification Process (GO:0036211),2/711,0.852011608035765,0.862728735180869,0,0,0.588612252406942,0.0942692705032937,FBXW11;TP53INP2,3
Cellular Response To Oxygen-Containing Compound (GO:1901701),1/406,0.85519517238225,0.864592921529308,0,0,0.517748572945706,0.080989112690267,IGFBP5,3
Organelle Organization (GO:0006996),1/418,0.863317036107451,0.871436005099057,0,0,0.502539903561022,0.0738599430984586,DIAPH1,3
Negative Regulation Of DNA-templated Transcription (GO:0045892),3/1025,0.86658707509495,0.873367881629339,0,0,0.609148190361498,0.08722556450631,FBXW11;CRYAB;RPL17,3
Regulation Of Cell Population Proliferation (GO:0042127),2/766,0.879854831041685,0.885353923735696,0,0,0.544673343956294,0.0697172892301031,SLC25A5;RPL17,3
Negative Regulation Of Transcription By RNA Polymerase II (GO:0000122),1/763,0.974393646649002,0.978953991329107,0,0,0.270143651398414,0.00700749992901327,RPL17,3
Positive Regulation Of DNA-templated Transcription (GO:0045893),2/1243,0.98281124935783,0.985085804344622,0,0,0.326962828013874,0.00566894434376079,FBXW11;TP53INP2,3
Regulation Of DNA-templated Transcription (GO:0006355),4/1922,0.983556168002472,0.985085804344622,0,0,0.416823079596802,0.00691114860173086,FBXW11;TP53INP2;CRYAB;POLR2K,3
Regulation Of Transcription By RNA Polymerase II (GO:0006357),1/2028,0.999954706985583,0.999954706985583,0,0,0.0948432717454154,4.29583496094632e-06,RPL17,3
Cytoplasmic Translation (GO:0002181),6/93,3.15604388846405e-10,5.11279109931176e-08,0,0,97.9950738916256,2143.7923326626,RPS15A;RPS29;RPLP1;RPL36;RPL29;RPS21,4
Peptide Biosynthetic Process (GO:0043043),6/158,7.81550404636837e-09,6.33055827755838e-07,0,0,55.906015037594,1043.60632516958,RPS15A;RPS29;RPLP1;RPL36;RPL29;RPS21,4
Macromolecule Biosynthetic Process (GO:0009059),6/183,1.88335971898134e-08,1.01701424824992e-06,0,0,47.9491525423729,852.901471488062,RPS15A;RPS29;RPLP1;RPL36;RPL29;RPS21,4
Translation (GO:0006412),6/234,8.12925525982555e-08,3.29234838022935e-06,0,0,37.1278195488722,606.119504016243,RPS15A;RPS29;RPLP1;RPL36;RPL29;RPS21,4
Gene Expression (GO:0010467),6/296,3.25187085907597e-07,1.05360615834061e-05,0,0,29.0985221674877,434.698899343965,RPS15A;RPS29;RPLP1;RPL36;RPL29;RPS21,4
Negative Regulation Of Proteasomal Protein Catabolic Process (GO:1901799),2/39,0.00068851543924297,0.0185899168595602,0,0,59.8888888888889,436.049371955513,UBXN1;PSME3IP1,4
Negative Regulation Of MAPK Cascade (GO:0043409),2/105,0.00487678836445658,0.0768130531024078,0,0,21.4422869471413,114.143048482535,STK38;PPIA,4
Negative Regulation Of Protein Polyubiquitination (GO:1902915),1/5,0.00499044069595166,0.0768130531024078,0,0,262.842105263158,1393.12388948095,PPIA,4
Negative Regulation Of ERAD Pathway (GO:1904293),1/5,0.00499044069595166,0.0768130531024078,0,0,262.842105263158,1393.12388948095,UBXN1,4
Nucleoside Triphosphate Biosynthetic Process (GO:0009142),1/5,0.00499044069595166,0.0768130531024078,0,0,262.842105263158,1393.12388948095,NME2,4
Negative Regulation Of Stress-Activated Protein Kinase Signaling Cascade (GO:0070303),1/6,0.00598569086674517,0.0768130531024078,0,0,210.263157894737,1076.20748088462,PPIA,4
Negative Regulation Of RIG-I Signaling Pathway (GO:0039536),1/6,0.00598569086674517,0.0768130531024078,0,0,210.263157894737,1076.20748088462,UFD1,4
"Endonucleolytic Cleavage In ITS1 To Separate SSU-rRNA From 5.8S rRNA And LSU-rRNA From Tricistronic rRNA Transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",1/7,0.00697999589418079,0.0768130531024078,0,0,175.210526315789,869.868917789248,RPS21,4
Protein Targeting (GO:0006605),2/129,0.00726914161333907,0.0768130531024078,0,0,17.3692038495188,85.5279931130271,TIMM10;SRP14,4
AMP Biosynthetic Process (GO:0006167),1/8,0.0079733565142536,0.0768130531024078,0,0,150.172932330827,725.583008139666,APRT,4
Regulation Of Epidermis Development (GO:0045682),1/8,0.0079733565142536,0.0768130531024078,0,0,150.172932330827,725.583008139666,NME2,4
ER-associated Misfolded Protein Catabolic Process (GO:0071712),1/9,0.00896577349631743,0.0768130531024078,0,0,131.394736842105,619.439581424405,UFD1,4
rRNA 3'-End Processing (GO:0031125),1/9,0.00896577349631743,0.0768130531024078,0,0,131.394736842105,619.439581424405,RPS21,4
Regulation Of ERAD Pathway (GO:1904292),1/10,0.0099572476243862,0.0768130531024078,0,0,116.789473684211,538.335775363175,UBXN1,4
Heme Catabolic Process (GO:0042167),1/10,0.0099572476243862,0.0768130531024078,0,0,116.789473684211,538.335775363175,HMOX2,4
Nucleoside Triphosphate Metabolic Process (GO:0009141),1/10,0.0099572476243862,0.0768130531024078,0,0,116.789473684211,538.335775363175,NME2,4
Nucleoside Phosphate Biosynthetic Process (GO:1901293),1/11,0.010947779702856,0.0775561257173632,0,0,105.105263157895,474.510177076512,NME2,4
Protein Insertion Into Mitochondrial Inner Membrane (GO:0045039),1/12,0.0119373705403343,0.0775561257173632,0,0,95.5454545454545,423.083051849273,TIMM10,4
Porphyrin-Containing Compound Catabolic Process (GO:0006787),1/12,0.0119373705403343,0.0775561257173632,0,0,95.5454545454545,423.083051849273,HMOX2,4
Cotranslational Protein Targeting To Membrane (GO:0006613),1/13,0.0129260209528939,0.0775561257173632,0,0,87.5789473684211,380.838179873743,SRP14,4
Positive Regulation Of Keratinocyte Differentiation (GO:0045618),1/13,0.0129260209528939,0.0775561257173632,0,0,87.5789473684211,380.838179873743,NME2,4
"Endonucleolytic Cleavage Of Tricistronic rRNA Transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",1/13,0.0129260209528939,0.0775561257173632,0,0,87.5789473684211,380.838179873743,RPS21,4
Endoplasmic Reticulum To Cytosol Transport (GO:1903513),1/15,0.0149005037888986,0.0803483796441169,0,0,75.0601503759399,315.730033295706,UFD1,4
Establishment Of Protein Localization To Endoplasmic Reticulum (GO:0072599),1/16,0.0158863378646896,0.0803483796441169,0,0,70.0526315789474,290.178721072392,SRP14,4
DNA-templated Transcription Termination (GO:0006353),1/16,0.0158863378646896,0.0803483796441169,0,0,70.0526315789474,290.178721072392,POLR3K,4
Negative Regulation Of Viral-Induced Cytoplasmic Pattern Recognition Receptor Signaling Pathway (GO:0039532),1/16,0.0158863378646896,0.0803483796441169,0,0,70.0526315789474,290.178721072392,UFD1,4
"Retrograde Protein Transport, ER To Cytosol (GO:0030970)",1/17,0.0168712348172724,0.0803483796441169,0,0,65.671052631579,268.078771560399,UFD1,4
Negative Regulation Of Oxidative Stress-Induced Intrinsic Apoptotic Signaling Pathway (GO:1902176),1/17,0.0168712348172724,0.0803483796441169,0,0,65.671052631579,268.078771560399,PPIA,4
Regulation Of RIG-I Signaling Pathway (GO:0039535),1/18,0.0178551954764704,0.0803483796441169,0,0,61.8049535603715,248.793414712821,UFD1,4
Regulation Of Oxidative Stress-Induced Intrinsic Apoptotic Signaling Pathway (GO:1902175),1/18,0.0178551954764704,0.0803483796441169,0,0,61.8049535603715,248.793414712821,PPIA,4
Positive Regulation Of Epidermal Cell Differentiation (GO:0045606),1/18,0.0178551954764704,0.0803483796441169,0,0,61.8049535603715,248.793414712821,NME2,4
Cellular Response To Misfolded Protein (GO:0071218),1/19,0.0188382206720143,0.0824808580774679,0,0,58.3684210526316,231.831632180327,UFD1,4
Negative Regulation Of Viral Life Cycle (GO:1903901),1/20,0.0198203112382321,0.0827854871294229,0,0,55.2936288088643,216.808975250484,PPIA,4
"Maturation Of 5.8S rRNA From Tricistronic rRNA Transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",1/21,0.0208014680109953,0.0827854871294229,0,0,52.5263157894737,203.420329151527,RPS21,4
Protein Peptidyl-Prolyl Isomerization (GO:0000413),1/22,0.0217816918149241,0.0827854871294229,0,0,50.0225563909774,191.420590566052,PPIA,4
Protein Targeting To ER (GO:0045047),1/23,0.0227609834903901,0.0827854871294229,0,0,47.7464114832536,180.610706872738,SRP14,4
Negative Regulation Of Oxidative Stress-Induced Cell Death (GO:1903202),1/23,0.0227609834903901,0.0827854871294229,0,0,47.7464114832536,180.610706872738,PPIA,4
Regulation Of Viral Life Cycle (GO:1903900),1/24,0.0237393438664972,0.0827854871294229,0,0,45.6681922196796,170.827422984315,PPIA,4
Protein Exit From Endoplasmic Reticulum (GO:0032527),1/24,0.0237393438664972,0.0827854871294229,0,0,45.6681922196796,170.827422984315,UFD1,4
Negative Regulation Of Proteolysis Involved In Protein Catabolic Process (GO:1903051),1/25,0.0247167737784927,0.0827854871294229,0,0,43.7631578947368,161.935638794938,PSME3IP1,4
Activation Of Protein Kinase B Activity (GO:0032148),1/25,0.0247167737784927,0.0827854871294229,0,0,43.7631578947368,161.935638794938,PPIA,4
Negative Regulation Of Response To Endoplasmic Reticulum Stress (GO:1903573),1/25,0.0247167737784927,0.0827854871294229,0,0,43.7631578947368,161.935638794938,UBXN1,4
Regulation Of Keratinocyte Differentiation (GO:0045616),1/26,0.0256932740553108,0.0827854871294229,0,0,42.0105263157895,153.822635691485,NME2,4
Peptide Cross-Linking (GO:0018149),1/27,0.0266688455361458,0.0827854871294229,0,0,40.3927125506073,146.393661234119,PI3,4
Peptidyl-Proline Modification (GO:0018208),1/27,0.0266688455361458,0.0827854871294229,0,0,40.3927125506073,146.393661234119,PPIA,4
Protein Quality Control For Misfolded Or Incompletely Synthesized Proteins (GO:0006515),1/27,0.0266688455361458,0.0827854871294229,0,0,40.3927125506073,146.393661234119,UFD1,4
Protein Insertion Into Mitochondrial Membrane (GO:0051204),1/28,0.0276434890482457,0.0827854871294229,0,0,38.8947368421053,139.5685145544,TIMM10,4
Transcription By RNA Polymerase III (GO:0006383),1/28,0.0276434890482457,0.0827854871294229,0,0,38.8947368421053,139.5685145544,POLR3K,4
Positive Regulation Of Dephosphorylation (GO:0035306),1/29,0.0286172054274548,0.0827854871294229,0,0,37.5037593984962,133.278878214163,PPIA,4
Positive Regulation Of Viral Genome Replication (GO:0045070),1/29,0.0286172054274548,0.0827854871294229,0,0,37.5037593984962,133.278878214163,PPIA,4
Lipid Droplet Organization (GO:0034389),1/29,0.0286172054274548,0.0827854871294229,0,0,37.5037593984962,133.278878214163,PPIA,4
"Maturation Of SSU-rRNA From Tricistronic rRNA Transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",1/30,0.0295899955032417,0.0840978819565818,0,0,36.2087114337568,127.46621354177,RPS21,4
Negative Regulation Of Proteasomal Ubiquitin-Dependent Protein Catabolic Process (GO:0032435),1/32,0.0315328000758389,0.0880743726256191,0,0,33.8692699490662,117.076819992966,UBXN1,4
Positive Regulation Of Protein Dephosphorylation (GO:0035307),1/33,0.0325028162269629,0.089245020826576,0,0,32.8092105263158,112.418415330875,PPIA,4
Inner Mitochondrial Membrane Organization (GO:0007007),1/34,0.0334719094011011,0.0903741553829731,0,0,31.8133971291866,108.071659909081,TIMM10,4
Platelet Aggregation (GO:0070527),1/35,0.0344400804224879,0.0914638201384105,0,0,30.8761609907121,104.007406246565,PPIA,4
Negative Regulation Of Stress-Activated MAPK Cascade (GO:0032873),1/37,0.0363736593292806,0.0950408517958623,0,0,29.1578947368421,96.6266509340829,PPIA,4
Negative Regulation Of Type I Interferon Production (GO:0032480),1/38,0.0373390688738263,0.0960147485326961,0,0,28.3684210526316,93.267285622618,UFD1,4
Negative Regulation Of Ubiquitin-Dependent Protein Catabolic Process (GO:2000059),1/39,0.0383035595748703,0.0969558851738906,0,0,27.6204986149585,90.1039343967808,UBXN1,4
Regulation Of Protein Dephosphorylation (GO:0035304),1/40,0.039267132268101,0.0972720241764348,0,0,26.9109311740891,87.1205723383493,PPIA,4
Proteasome-Mediated Ubiquitin-Dependent Protein Catabolic Process (GO:0043161),2/319,0.0398852240283585,0.0972720241764348,0,0,6.89204346302138,22.2044365387346,UBXN1;UFD1,4
Positive Regulation Of Viral Process (GO:0048524),1/41,0.0402297877766736,0.0972720241764348,0,0,26.2368421052632,84.3028454099992,PPIA,4
Establishment Of Protein Localization To Mitochondrion (GO:0072655),1/44,0.0431122594296054,0.102708618052883,0,0,24.4026927784578,76.7207942465504,TIMM10,4
Regulation Of Apoptotic Signaling Pathway (GO:2001233),1/45,0.044071254437806,0.103471640853979,0,0,23.8468899521531,74.4487393242377,PPIA,4
Homotypic Cell-Cell Adhesion (GO:0034109),1/46,0.0450293363875486,0.10421074992547,0,0,23.3157894736842,72.2892315410458,PPIA,4
Antibacterial Humoral Response (GO:0019731),1/49,0.0478981120694179,0.10798883132841,0,0,21.8552631578947,66.4111333354799,PI3,4
Negative Regulation Of MAP Kinase Activity (GO:0043407),1/51,0.0498060789247287,0.10798883132841,0,0,20.9789473684211,62.9288330908361,STK38,4
Regulation Of Stress-Activated MAPK Cascade (GO:0032872),1/51,0.0498060789247287,0.10798883132841,0,0,20.9789473684211,62.9288330908361,PPIA,4
Ubiquitin-Dependent Protein Catabolic Process (GO:0006511),2/367,0.0513337956854126,0.10798883132841,0,0,5.97108066971081,17.7305625188368,UBXN1;UFD1,4
Regulation Of Proteasomal Protein Catabolic Process (GO:0061136),1/53,0.0517104132281891,0.10798883132841,0,0,20.17004048583,59.7455982870142,PSME3IP1,4
Mitochondrial Transport (GO:0006839),1/53,0.0517104132281891,0.10798883132841,0,0,20.17004048583,59.7455982870142,TIMM10,4
Negative Regulation Of Protein Modification By Small Protein Conjugation Or Removal (GO:1903321),1/54,0.0526612202157059,0.10798883132841,0,0,19.7884806355511,58.2548323012124,UBXN1,4
Negative Regulation Of Protein Ubiquitination (GO:0031397),1/54,0.0526612202157059,0.10798883132841,0,0,19.7884806355511,58.2548323012124,UBXN1,4
Negative Regulation Of Protein Catabolic Process (GO:0042177),1/54,0.0526612202157059,0.10798883132841,0,0,19.7884806355511,58.2548323012124,PSME3IP1,4
Protein Targeting To Mitochondrion (GO:0006626),1/59,0.0574016861834188,0.114348000071361,0,0,18.0780399274047,51.6612820658813,TIMM10,4
Regulation Of Type I Interferon Production (GO:0032479),1/59,0.0574016861834188,0.114348000071361,0,0,18.0780399274047,51.6612820658813,UFD1,4
Negative Regulation Of Peptidase Activity (GO:0010466),1/60,0.058347071283324,0.114348000071361,0,0,17.7707404103479,50.4928242032279,UBXN1,4
Negative Regulation Of Intrinsic Apoptotic Signaling Pathway (GO:2001243),1/61,0.0592915555925577,0.114348000071361,0,0,17.4736842105263,49.3681970360476,PPIA,4
Negative Regulation Of Viral Process (GO:0048525),1/61,0.0592915555925577,0.114348000071361,0,0,17.4736842105263,49.3681970360476,PPIA,4
Negative Regulation Of Kinase Activity (GO:0033673),1/62,0.0602351399190366,0.114801090198634,0,0,17.1863675582399,48.2850889542995,PPIA,4
Positive Regulation Of Cell Cycle (GO:0045787),1/65,0.0630605011079274,0.118788385807956,0,0,16.3782894736842,45.2640345973959,RPS15A,4
Regulation Of Viral Genome Replication (GO:0045069),1/67,0.0649395901837057,0.120921995514486,0,0,15.8803827751196,43.4216960507128,PPIA,4
Positive Regulation Of Protein Transport (GO:0051222),1/70,0.0677515123929905,0.121595477090641,0,0,15.187643020595,40.8837452863319,PPIA,4
Neutrophil Chemotaxis (GO:0030593),1/70,0.0677515123929905,0.121595477090641,0,0,15.187643020595,40.8837452863319,PPIA,4
Negative Regulation Of Protein Binding (GO:0032091),1/71,0.0686870333104677,0.121595477090641,0,0,14.9699248120301,40.0923754051721,PSME3IP1,4
Protein Targeting To Membrane (GO:0006612),1/72,0.0696216623496152,0.121595477090641,0,0,14.7583395107487,39.3262450348165,SRP14,4
Positive Regulation Of Secretion By Cell (GO:1903532),1/73,0.0705554002871622,0.121595477090641,0,0,14.5526315789474,38.5842224505161,PPIA,4
Ubiquitin-Dependent ERAD Pathway (GO:0030433),1/73,0.0705554002871622,0.121595477090641,0,0,14.5526315789474,38.5842224505161,UFD1,4
Granulocyte Chemotaxis (GO:0071621),1/73,0.0705554002871622,0.121595477090641,0,0,14.5526315789474,38.5842224505161,PPIA,4
Negative Regulation Of Phosphorylation (GO:0042326),1/75,0.0724202061022377,0.12349550935329,0,0,14.1578947368421,37.1682953065987,PPIA,4
Positive Regulation Of Protein Secretion (GO:0050714),1/76,0.0733512756104792,0.123780277592684,0,0,13.9684210526316,36.4924355190928,PPIA,4
Neutrophil Migration (GO:1990266),1/77,0.0742814572247087,0.124057691447452,0,0,13.7839335180055,35.8367650118558,PPIA,4
Negative Regulation Of Protein Modification Process (GO:0031400),1/78,0.0752107517706809,0.12432797741684,0,0,13.6042378673958,35.2004360399448,PPIA,4
Negative Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071901),1/80,0.0770666828500711,0.125098198004291,0,0,13.2584943371086,33.9826376278017,STK38,4
Activation Of Protein Kinase Activity (GO:0032147),1/81,0.0779933209779837,0.125098198004291,0,0,13.0921052631579,33.3996897897899,PPIA,4
Macromolecule Modification (GO:0043412),1/81,0.0779933209779837,0.125098198004291,0,0,13.0921052631579,33.3996897897899,STK38,4
Ribosomal Small Subunit Biogenesis (GO:0042274),1/84,0.0807679353123667,0.126887129487453,0,0,12.6169942929613,31.7465685474136,RPS15A,4
Integrin-Mediated Signaling Pathway (GO:0007229),1/85,0.0816910427282764,0.126887129487453,0,0,12.4661654135338,31.2253872490644,NME2,4
Negative Regulation Of Binding (GO:0051100),1/86,0.0826132694677771,0.126887129487453,0,0,12.3188854489164,30.7181875292471,PSME3IP1,4
Positive Regulation Of Cell Population Proliferation (GO:0008284),2/483,0.0830893885665929,0.126887129487453,0,0,4.5042735042735,11.2059040476141,RPS15A;NME2,4
Negative Regulation Of Protein Kinase Activity (GO:0006469),1/88,0.0844550840845328,0.126887129487453,0,0,12.0344827586207,29.7436505826784,PPIA,4
ERAD Pathway (GO:0036503),1/89,0.0853746735440269,0.126887129487453,0,0,11.8971291866029,29.2753346130257,UFD1,4
Cellular Response To Chemical Stress (GO:0062197),1/89,0.0853746735440269,0.126887129487453,0,0,11.8971291866029,29.2753346130257,PPIA,4
Sensory Perception Of Mechanical Stimulus (GO:0050954),1/89,0.0853746735440269,0.126887129487453,0,0,11.8971291866029,29.2753346130257,TIMM10,4
Regulation Of Epithelial Cell Proliferation (GO:0050678),1/91,0.0872112207421384,0.128438343274786,0,0,11.6315789473684,28.3743328138059,NME2,4
Sensory Perception Of Sound (GO:0007605),1/92,0.0881281800641534,0.128619506039575,0,0,11.5031810294968,27.9408003283993,TIMM10,4
Antimicrobial Humoral Response (GO:0019730),1/100,0.0954324164624815,0.138036173811804,0,0,10.5693779904306,24.8310303892707,PI3,4
Regulation Of Protein Secretion (GO:0050708),1/102,0.0972497716409989,0.13942002660037,0,0,10.3590411672746,24.1414620651458,PPIA,4
Regulation Of Proteasomal Ubiquitin-Dependent Protein Catabolic Process (GO:0032434),1/109,0.103583237627188,0.147197232417584,0,0,9.68421052631579,21.9577829506941,UBXN1,4
Regulation Of Protein Ubiquitination (GO:0031396),1/113,0.107183384917932,0.150697302470346,0,0,9.33646616541353,20.8503272666542,UBXN1,4
Regulation Of MAP Kinase Activity (GO:0043405),1/114,0.108081273165397,0.150697302470346,0,0,9.25337680484397,20.5875771592915,STK38,4
Endoplasmic Reticulum To Golgi Vesicle-Mediated Transport (GO:0006888),1/115,0.108978303522462,0.150697302470346,0,0,9.17174515235457,20.3301496167228,YIF1A,4
Cellular Response To Oxidative Stress (GO:0034599),1/117,0.110769793727799,0.150697302470346,0,0,9.01270417422868,19.830663463908,PPIA,4
Regulation Of Protein Binding (GO:0043393),1/118,0.111664255122004,0.150697302470346,0,0,8.93522267206478,19.5883190315039,PSME3IP1,4
Ribonucleoprotein Complex Biogenesis (GO:0022613),1/118,0.111664255122004,0.150697302470346,0,0,8.93522267206478,19.5883190315039,RPS15A,4
Regulation Of Protein Kinase Activity (GO:0045859),1/119,0.112557861721678,0.150697302470346,0,0,8.85905441570027,19.3507250391397,PPIA,4
Positive Regulation Of Epithelial Cell Proliferation (GO:0050679),1/123,0.116123755882744,0.154197118467251,0,0,8.56686798964625,18.4453131497958,NME2,4
Negative Regulation Of Protein Phosphorylation (GO:0001933),1/149,0.138972403819006,0.181560721118379,0,0,7.05263157894737,13.9182266577843,PPIA,4
Skeletal System Development (GO:0001501),1/149,0.138972403819006,0.181560721118379,0,0,7.05263157894737,13.9182266577843,UFD1,4
Positive Regulation Of NF-kappaB Transcription Factor Activity (GO:0051092),1/152,0.14157238091539,0.183477805666345,0,0,6.91146741024747,13.511532897552,PPIA,4
Ribosome Biogenesis (GO:0042254),1/155,0.144164898501854,0.185354869502384,0,0,6.7758031442242,13.1233586314262,RPS15A,4
Peptidyl-Serine Phosphorylation (GO:0018105),1/158,0.14674997685019,0.187192883856148,0,0,6.64532349983238,12.7525417832277,STK38,4
Mitochondrion Organization (GO:0007005),1/162,0.150185210808816,0.190078157429908,0,0,6.47891467799935,12.2832836839006,TIMM10,4
Peptidyl-Serine Modification (GO:0018209),1/166,0.153607303214666,0.192902194734697,0,0,6.32057416267943,11.8406849775977,STK38,4
Regulation Of Apoptotic Process (GO:0042981),2/705,0.155572197455609,0.193866892213913,0,0,3.04678362573099,5.66898382465351,NME2;PPIA,4
Protein Modification Process (GO:0036211),2/711,0.157682424802784,0.194996586397336,0,0,3.02005955179439,5.57857016195909,STK38;PI3,4
Negative Regulation Of Cytokine Production (GO:0001818),1/178,0.163795206668992,0.201021390002854,0,0,5.88849241748439,10.6530975816179,UFD1,4
Modification-Dependent Protein Catabolic Process (GO:0019941),1/192,0.175533852908093,0.213218971163688,0,0,5.45301736015431,9.48783229076986,UFD1,4
Regulation Of Signal Transduction (GO:0009966),1/193,0.176366309481075,0.213218971163688,0,0,5.42434210526316,9.41227580192371,PPIA,4
Regulation Of Programmed Cell Death (GO:0043067),1/195,0.178028827720883,0.213634593265059,0,0,5.36787845903418,9.26393718708641,NME2,4
Golgi Vesicle Transport (GO:0048193),1/197,0.179688157607636,0.214040305385567,0,0,5.312567132116,9.11919354712362,YIF1A,4
DNA-templated Transcription (GO:0006351),1/199,0.181344304944999,0.214436331394817,0,0,5.25837320574163,8.97792459969949,POLR3K,4
Regulation Of MAPK Cascade (GO:0043408),1/204,0.185470787558798,0.216160198449822,0,0,5.12756028001037,8.6392103880896,PPIA,4
Defense Response To Bacterium (GO:0042742),1/204,0.185470787558798,0.216160198449822,0,0,5.12756028001037,8.6392103880896,PI3,4
Proteasomal Protein Catabolic Process (GO:0010498),1/220,0.198543154094923,0.229742792595554,0,0,4.74909877433309,7.67809975161327,UBXN1,4
Positive Regulation Of Protein Modification Process (GO:0031401),1/225,0.202587225601359,0.232759791116455,0,0,4.64191729323308,7.41121432153503,PPIA,4
Apoptotic Process (GO:0006915),1/228,0.205004355383459,0.233878208254369,0,0,4.57987479712497,7.25783775667,PPIA,4
Positive Regulation Of Phosphorylation (GO:0042327),1/231,0.207414523583631,0.234973096647191,0,0,4.51945080091533,7.10925862348963,PPIA,4
Positive Regulation Of DNA-binding Transcription Factor Activity (GO:0051091),1/246,0.219361604572863,0.246781805144471,0,0,4.23952738990333,6.43150612776001,PPIA,4
Regulation Of Protein Phosphorylation (GO:0001932),1/265,0.234249089939519,0.261712776346221,0,0,3.93062200956938,5.7047878206505,PPIA,4
Regulation Of Cell Cycle (GO:0051726),1/298,0.259467344435592,0.287902121907985,0,0,3.48803827751196,4.70579763420095,RPS15A,4
Positive Regulation Of MAPK Cascade (GO:0043410),1/310,0.268440429741813,0.295832310327713,0,0,3.35053653551354,4.40637855884445,PPIA,4
Positive Regulation Of Protein Phosphorylation (GO:0001934),1/377,0.316672063066454,0.346627528491659,0,0,2.7441209406495,3.15543322734601,PPIA,4
Negative Regulation Of Programmed Cell Death (GO:0043069),1/381,0.31945383948605,0.347325650984833,0,0,2.71468144044321,3.09783834652431,NME2,4
Positive Regulation Of Multicellular Organismal Process (GO:0051240),1/387,0.323606340724513,0.349494847982475,0,0,2.67166621216253,3.01424729047918,NME2,4
Organelle Organization (GO:0006996),1/418,0.344680271361955,0.369789430202892,0,0,2.46914047709201,2.62997545152422,PPIA,4
Phosphorylation (GO:0016310),1/429,0.352007029159232,0.375165386340761,0,0,2.40432857845548,2.5103694091759,STK38,4
Negative Regulation Of Apoptotic Process (GO:0043066),1/482,0.386231193488607,0.408950675458525,0,0,2.1336032388664,2.02973760246591,NME2,4
Protein Phosphorylation (GO:0006468),1/500,0.397458623075324,0.418105824274042,0,0,2.05474106106951,1.89583651702788,STK38,4
Positive Regulation Of Intracellular Signal Transduction (GO:1902533),1/525,0.412728994401819,0.431368368342546,0,0,1.95419847328244,1.72939547221137,PPIA,4
Positive Regulation Of Nucleic Acid-Templated Transcription (GO:1903508),1/557,0.431739060722593,0.448344409211924,0,0,1.83869746308217,1.5443843298739,NME2,4
Positive Regulation Of Cellular Process (GO:0048522),1/594,0.452990640241461,0.467417093752335,0,0,1.72068873701962,1.36258556224057,RPS15A,4
Regulation Of Cell Population Proliferation (GO:0042127),1/766,0.542249766136238,0.555977608316902,0,0,1.32198142414861,0.809090388107767,RPS15A,4
Positive Regulation Of Transcription By RNA Polymerase II (GO:0045944),1/938,0.61755663644986,0.629208648458347,0,0,1.06965118238499,0.51555528575823,NME2,4
Positive Regulation Of DNA-templated Transcription (GO:0045893),1/1243,0.72305373713085,0.732091908844986,0,0,0.794050343249428,0.257488081982422,NME2,4
Regulation Of DNA-templated Transcription (GO:0006355),1/1922,0.867574141279411,0.872962800542015,0,0,0.49478067892271,0.0702857256505662,NME2,4
Regulation Of Transcription By RNA Polymerase II (GO:0006357),1/2028,0.882275437218657,0.882275437218657,0,0,0.466154285565913,0.0583862832570109,NME2,4
Positive Regulation Of Telomerase RNA Localization To Cajal Body (GO:1904874),2/14,0.000114153105118571,0.0206847911466719,0,0,158.452380952381,1438.42595806313,RUVBL2;NOP10,5
Regulation Of Telomerase RNA Localization To Cajal Body (GO:1904872),2/17,0.000170245194622814,0.0206847911466719,0,0,126.742857142857,1099.90884116267,RUVBL2;NOP10,5
Positive Regulation Of Protein Modification By Small Protein Conjugation Or Removal (GO:1903322),2/79,0.00369337323145086,0.0992628544600808,0,0,24.6134817563389,137.865405274751,LAPTM5;SAE1,5
Contact Inhibition (GO:0060242),1/5,0.00573728911332865,0.0992628544600808,0,0,226.965909090909,1171.31850515834,PAK1,5
Lipoprotein Metabolic Process (GO:0042157),1/5,0.00573728911332865,0.0992628544600808,0,0,226.965909090909,1171.31850515834,CTSD,5
snRNA Modification (GO:0040031),1/5,0.00573728911332865,0.0992628544600808,0,0,226.965909090909,1171.31850515834,NOP10,5
Positive Regulation Of Intracellular Estrogen Receptor Signaling Pathway (GO:0033148),1/6,0.00688096832442016,0.0992628544600808,0,0,181.563636363636,904.004599611462,PAK1,5
Mitochondrion-Endoplasmic Reticulum Membrane Tethering (GO:1990456),1/6,0.00688096832442016,0.0992628544600808,0,0,181.563636363636,904.004599611462,PDZD8,5
Hepatocyte Growth Factor Receptor Signaling Pathway (GO:0048012),1/6,0.00688096832442016,0.0992628544600808,0,0,181.563636363636,904.004599611462,PAK1,5
Positive Regulation Of Receptor Catabolic Process (GO:2000646),1/6,0.00688096832442016,0.0992628544600808,0,0,181.563636363636,904.004599611462,LAPTM5,5
Positive Regulation Of Cysteine-Type Endopeptidase Activity Involved In Apoptotic Process (GO:0043280),2/109,0.00690989676121043,0.0992628544600808,0,0,17.6858032932799,87.9833445130925,LAPTM5;CTSD,5
Positive Regulation Of Intracellular Steroid Hormone Receptor Signaling Pathway (GO:0033145),1/7,0.00802338980417862,0.0992628544600808,0,0,151.295454545455,730.06022058339,PAK1,5
Protein Localization To Cytoplasmic Stress Granule (GO:1903608),1/7,0.00802338980417862,0.0992628544600808,0,0,151.295454545455,730.06022058339,PAK1,5
Positive Regulation Of Microtubule Nucleation (GO:0090063),1/7,0.00802338980417862,0.0992628544600808,0,0,151.295454545455,730.06022058339,PAK1,5
rRNA Pseudouridine Synthesis (GO:0031118),1/7,0.00802338980417862,0.0992628544600808,0,0,151.295454545455,730.06022058339,NOP10,5
Establishment Of Protein Localization To Chromatin (GO:0071169),1/8,0.00916455474573022,0.0992628544600808,0,0,129.675324675325,608.490047133173,RUVBL2,5
Manganese Ion Transport (GO:0006828),1/8,0.00916455474573022,0.0992628544600808,0,0,129.675324675325,608.490047133173,SLC41A2,5
Positive Regulation Of Macrophage Cytokine Production (GO:0060907),1/8,0.00916455474573022,0.0992628544600808,0,0,129.675324675325,608.490047133173,LAPTM5,5
Cyclooxygenase Pathway (GO:0019371),1/8,0.00916455474573022,0.0992628544600808,0,0,129.675324675325,608.490047133173,PTGS1,5
Positive Regulation Of Tumor Necrosis Factor-Mediated Signaling Pathway (GO:1903265),1/8,0.00916455474573022,0.0992628544600808,0,0,129.675324675325,608.490047133173,LAPTM5,5
Box C/D snoRNP Assembly (GO:0000492),1/8,0.00916455474573022,0.0992628544600808,0,0,129.675324675325,608.490047133173,RUVBL2,5
Regulation Of Anatomical Structure Morphogenesis (GO:0022603),2/127,0.00927585912065813,0.0992628544600808,0,0,15.1253333333333,70.7917033274622,PAK1;PDZD8,5
Regulation Of High Voltage-Gated Calcium Channel Activity (GO:1901841),1/9,0.0103044643785071,0.0992628544600808,0,0,113.460227272727,519.100740554472,NIPSNAP2,5
Positive Regulation Of Protein Sumoylation (GO:0033235),1/9,0.0103044643785071,0.0992628544600808,0,0,113.460227272727,519.100740554472,SAE1,5
Regulation Of Microtubule Nucleation (GO:0010968),1/10,0.0114431199495764,0.0992628544600808,0,0,100.848484848485,450.82969906826,PAK1,5
Small Nucleolar Ribonucleoprotein Complex Assembly (GO:0000491),1/10,0.0114431199495764,0.0992628544600808,0,0,100.848484848485,450.82969906826,RUVBL2,5
Lipoprotein Catabolic Process (GO:0042159),1/10,0.0114431199495764,0.0992628544600808,0,0,100.848484848485,450.82969906826,CTSD,5
Magnesium Ion Transport (GO:0015693),1/11,0.0125805227255512,0.0992628544600808,0,0,90.7590909090909,397.125975220578,SLC41A2,5
Golgi To Lysosome Transport (GO:0090160),1/11,0.0125805227255512,0.0992628544600808,0,0,90.7590909090909,397.125975220578,LAPTM5,5
Pseudouridine Synthesis (GO:0001522),1/12,0.013716673976595,0.0992628544600808,0,0,82.504132231405,353.872030109198,NOP10,5
Positive Regulation Of Regulated Secretory Pathway (GO:1903307),1/12,0.013716673976595,0.0992628544600808,0,0,82.504132231405,353.872030109198,RAB15,5
Defense Response To Tumor Cell (GO:0002357),1/12,0.013716673976595,0.0992628544600808,0,0,82.504132231405,353.872030109198,LAPTM5,5
Positive Regulation Of Voltage-Gated Calcium Channel Activity (GO:1901387),1/12,0.013716673976595,0.0992628544600808,0,0,82.504132231405,353.872030109198,NIPSNAP2,5
Regulation Of Macrophage Cytokine Production (GO:0010935),1/13,0.0148515749863377,0.0992628544600808,0,0,75.625,318.354732825143,LAPTM5,5
Prostanoid Biosynthetic Process (GO:0046457),1/14,0.015985227036696,0.0992628544600808,0,0,69.8041958041958,288.716456708675,PTGS1,5
Establishment Of Protein Localization To Chromosome (GO:0070199),1/14,0.015985227036696,0.0992628544600808,0,0,69.8041958041958,288.716456708675,RUVBL2,5
Regulation Of Establishment Of Protein Localization (GO:0070201),1/14,0.015985227036696,0.0992628544600808,0,0,69.8041958041958,288.716456708675,CTSD,5
Positive Regulation Of Telomere Maintenance In Response To DNA Damage (GO:1904507),1/14,0.015985227036696,0.0992628544600808,0,0,69.8041958041958,288.716456708675,RUVBL2,5
Regulation Of Telomere Maintenance In Response To DNA Damage (GO:1904505),1/15,0.01711763141868,0.0992628544600808,0,0,64.8149350649351,263.64422882818,RUVBL2,5
Positive Regulation Of Myeloid Leukocyte Cytokine Production Involved In Immune Response (GO:0061081),1/16,0.0182487894189074,0.0992628544600808,0,0,60.4909090909091,242.184823451457,LAPTM5,5
Regulation Of DNA Strand Elongation (GO:0060382),1/16,0.0182487894189074,0.0992628544600808,0,0,60.4909090909091,242.184823451457,RUVBL2,5
Prostaglandin Biosynthetic Process (GO:0001516),1/17,0.0193787023349684,0.0992628544600808,0,0,56.7073863636364,223.630150653724,PTGS1,5
Regulation Of Protein Sumoylation (GO:0033233),1/17,0.0193787023349684,0.0992628544600808,0,0,56.7073863636364,223.630150653724,SAE1,5
Golgi To Vacuole Transport (GO:0006896),1/17,0.0193787023349684,0.0992628544600808,0,0,56.7073863636364,223.630150653724,LAPTM5,5
rRNA Modification (GO:0000154),1/17,0.0193787023349684,0.0992628544600808,0,0,56.7073863636364,223.630150653724,NOP10,5
Negative Regulation Of T Cell Receptor Signaling Pathway (GO:0050860),1/18,0.0205073714570784,0.0992628544600808,0,0,53.3689839572193,207.443686227371,LAPTM5,5
Stimulatory C-type Lectin Receptor Signaling Pathway (GO:0002223),1/19,0.0216347980764043,0.0992628544600808,0,0,50.4015151515152,193.211801083395,PAK1,5
Negative Regulation Of Leukocyte Cell-Cell Adhesion (GO:1903038),1/19,0.0216347980764043,0.0992628544600808,0,0,50.4015151515152,193.211801083395,LAPTM5,5
Telomere Maintenance Via Telomerase (GO:0007004),1/19,0.0216347980764043,0.0992628544600808,0,0,50.4015151515152,193.211801083395,NOP10,5
Cellular Response To Lectin (GO:1990858),1/19,0.0216347980764043,0.0992628544600808,0,0,50.4015151515152,193.211801083395,PAK1,5
RNA-templated DNA Biosynthetic Process (GO:0006278),1/19,0.0216347980764043,0.0992628544600808,0,0,50.4015151515152,193.211801083395,NOP10,5
Regulation Of MAPK Cascade (GO:0043408),2/204,0.0227555693390793,0.0992628544600808,0,0,9.32343234323432,35.270035098169,PAK1;LAPTM5,5
Fc-gamma Receptor Signaling Pathway Involved In Phagocytosis (GO:0038096),1/20,0.0227609834903901,0.0992628544600808,0,0,47.7464114832536,180.610706872738,PAK1,5
Cellular Response To Estradiol Stimulus (GO:0071392),1/20,0.0227609834903901,0.0992628544600808,0,0,47.7464114832536,180.610706872738,RUVBL2,5
Negative Regulation Of B Cell Activation (GO:0050869),1/20,0.0227609834903901,0.0992628544600808,0,0,47.7464114832536,180.610706872738,LAPTM5,5
Negative Regulation Of Interleukin-2 Production (GO:0032703),1/21,0.0238859289927227,0.0992628544600808,0,0,45.3568181818182,169.383483507259,LAPTM5,5
Mitochondrial Calcium Ion Homeostasis (GO:0051560),1/21,0.0238859289927227,0.0992628544600808,0,0,45.3568181818182,169.383483507259,PDZD8,5
Histone H2A Acetylation (GO:0043968),1/21,0.0238859289927227,0.0992628544600808,0,0,45.3568181818182,169.383483507259,RUVBL2,5
Fc Receptor Mediated Stimulatory Signaling Pathway (GO:0002431),1/22,0.0250096358786987,0.0992628544600808,0,0,43.1948051948052,159.323783819131,PAK1,5
Negative Regulation Of Lymphocyte Activation (GO:0051250),1/23,0.0261321054395983,0.0992628544600808,0,0,41.2293388429752,150.264061909767,LAPTM5,5
Regulation Of Cytokine Production Involved In Immune Response (GO:0002718),1/24,0.0272533389718204,0.0992628544600808,0,0,39.4347826086957,142.066928935349,LAPTM5,5
Fc-gamma Receptor Signaling Pathway (GO:0038094),1/24,0.0272533389718204,0.0992628544600808,0,0,39.4347826086957,142.066928935349,PAK1,5
Negative Regulation Of Antigen Receptor-Mediated Signaling Pathway (GO:0050858),1/24,0.0272533389718204,0.0992628544600808,0,0,39.4347826086957,142.066928935349,LAPTM5,5
Iron Ion Transport (GO:0006826),1/24,0.0272533389718204,0.0992628544600808,0,0,39.4347826086957,142.066928935349,SLC41A2,5
Chromatin Remodeling (GO:0006338),2/228,0.0279708271929821,0.0992628544600808,0,0,8.32321955330805,29.7687704390925,PAK1;RUVBL2,5
Regulation Of B Cell Activation (GO:0050864),1/25,0.0283733377644313,0.0992628544600808,0,0,37.7897727272727,134.618710917761,LAPTM5,5
Regulation Of Intracellular Estrogen Receptor Signaling Pathway (GO:0033146),1/25,0.0283733377644313,0.0992628544600808,0,0,37.7897727272727,134.618710917761,PAK1,5
Telomere Maintenance Via Telomere Lengthening (GO:0010833),1/26,0.0294921031126647,0.0992628544600808,0,0,36.2763636363636,127.824582690399,NOP10,5
Protein Targeting To Lysosome (GO:0006622),1/26,0.0294921031126647,0.0992628544600808,0,0,36.2763636363636,127.824582690399,LAPTM5,5
Positive Regulation Of Microtubule Polymerization Or Depolymerization (GO:0031112),1/26,0.0294921031126647,0.0992628544600808,0,0,36.2763636363636,127.824582690399,PAK1,5
Antigen Processing And Presentation Of Exogenous Peptide Antigen Via MHC Class II (GO:0019886),1/26,0.0294921031126647,0.0992628544600808,0,0,36.2763636363636,127.824582690399,CTSD,5
Negative Regulation Of Type II Interferon Production (GO:0032689),1/28,0.0317259386336052,0.0992628544600808,0,0,33.5858585858586,115.892058167056,LAPTM5,5
Antigen Processing And Presentation Of Peptide Antigen Via MHC Class II (GO:0002495),1/28,0.0317259386336052,0.0992628544600808,0,0,33.5858585858586,115.892058167056,CTSD,5
Positive Regulation Of Programmed Cell Death (GO:0043068),2/245,0.0319296697356481,0.0992628544600808,0,0,7.73427395649618,26.6385380741316,LAPTM5;CTSD,5
Positive Regulation Of Microtubule Polymerization (GO:0031116),1/29,0.0328410113902878,0.0992628544600808,0,0,32.3847402597403,110.628772743736,PAK1,5
Vacuolar Acidification (GO:0007035),1/29,0.0328410113902878,0.0992628544600808,0,0,32.3847402597403,110.628772743736,ATP6V0A4,5
Prostaglandin Metabolic Process (GO:0006693),1/30,0.0339548558617346,0.0992628544600808,0,0,31.2664576802508,105.765778199073,PTGS1,5
Positive Regulation Of JUN Kinase Activity (GO:0043507),1/30,0.0339548558617346,0.0992628544600808,0,0,31.2664576802508,105.765778199073,PAK1,5
Positive Regulation Of Protein Targeting To Mitochondrion (GO:1903955),1/30,0.0339548558617346,0.0992628544600808,0,0,31.2664576802508,105.765778199073,SAE1,5
Innate Immune Response Activating Cell Surface Receptor Signaling Pathway (GO:0002220),1/30,0.0339548558617346,0.0992628544600808,0,0,31.2664576802508,105.765778199073,PAK1,5
Protein Localization To Chromatin (GO:0071168),1/31,0.0350674733320937,0.0992628544600808,0,0,30.2227272727273,101.260681469549,RUVBL2,5
Response To Estradiol (GO:0032355),1/31,0.0350674733320937,0.0992628544600808,0,0,30.2227272727273,101.260681469549,RUVBL2,5
Positive Regulation Of Proteolysis Involved In Protein Catabolic Process (GO:1903052),1/31,0.0350674733320937,0.0992628544600808,0,0,30.2227272727273,101.260681469549,LAPTM5,5
Antigen Processing And Presentation Of Exogenous Peptide Antigen (GO:0002478),1/31,0.0350674733320937,0.0992628544600808,0,0,30.2227272727273,101.260681469549,CTSD,5
Regulation Of Cell Morphogenesis (GO:0022604),1/31,0.0350674733320937,0.0992628544600808,0,0,30.2227272727273,101.260681469549,PDZD8,5
Transition Metal Ion Transport (GO:0000041),1/32,0.0361788650960567,0.0992628544600808,0,0,29.2463343108504,97.0767774581286,SLC41A2,5
Intracellular pH Reduction (GO:0051452),1/32,0.0361788650960567,0.0992628544600808,0,0,29.2463343108504,97.0767774581286,ATP6V0A4,5
Epithelial Tube Morphogenesis (GO:0060562),1/33,0.0372890324289426,0.0992628544600808,0,0,28.3309659090909,93.1821343249523,PAK1,5
Positive Regulation Of Interleukin-12 Production (GO:0032735),1/33,0.0372890324289426,0.0992628544600808,0,0,28.3309659090909,93.1821343249523,LAPTM5,5
Positive Regulation Of Cytokine Production Involved In Immune Response (GO:0002720),1/33,0.0372890324289426,0.0992628544600808,0,0,28.3309659090909,93.1821343249523,LAPTM5,5
Positive Regulation Of Establishment Of Protein Localization To Mitochondrion (GO:1903749),1/33,0.0372890324289426,0.0992628544600808,0,0,28.3309659090909,93.1821343249523,SAE1,5
Chromatin Organization (GO:0006325),2/268,0.0376170012855341,0.0992628544600808,0,0,7.05728607232367,23.1500096379541,PAK1;RUVBL2,5
Protein Targeting To Vacuole (GO:0006623),1/34,0.0383979766224181,0.0992628544600808,0,0,27.4710743801653,89.5488488006926,LAPTM5,5
Regulation Of T Cell Receptor Signaling Pathway (GO:0050856),1/34,0.0383979766224181,0.0992628544600808,0,0,27.4710743801653,89.5488488006926,LAPTM5,5
Regulation Of Regulated Secretory Pathway (GO:1903305),1/35,0.0395056989616673,0.101051419449317,0,0,26.6617647058824,86.1524359760047,RAB15,5
Positive Regulation Of Double-Strand Break Repair Via Homologous Recombination (GO:1905168),1/36,0.0406122007207396,0.102569693992902,0,0,25.8987012987013,82.9713261191909,RUVBL2,5
Monoatomic Cation Transmembrane Transport (GO:0098655),2/281,0.0409926755397273,0.102569693992902,0,0,6.72401433691756,21.4789350354519,SLC41A2;ATP6V0A4,5
Positive Regulation Of Exocytosis (GO:0045921),1/37,0.0417174831924768,0.102569693992902,0,0,25.1780303030303,79.986447314411,RAB15,5
Inorganic Cation Transmembrane Transport (GO:0098662),2/284,0.0417876531082194,0.102569693992902,0,0,6.65146909827761,21.1194411295576,SLC41A2;ATP6V0A4,5
Positive Regulation Of Production Of Molecular Mediator Of Immune Response (GO:0002702),1/38,0.0428215476525958,0.103627457047497,0,0,24.4963144963145,77.1808774372472,LAPTM5,5
Regulation Of Protein Targeting To Mitochondrion (GO:1903214),1/39,0.043924395374042,0.103627457047497,0,0,23.8504784688995,74.5395523795542,SAE1,5
Histone H4 Acetylation (GO:0043967),1/39,0.043924395374042,0.103627457047497,0,0,23.8504784688995,74.5395523795542,RUVBL2,5
Internal Peptidyl-Lysine Acetylation (GO:0018393),1/39,0.043924395374042,0.103627457047497,0,0,23.8504784688995,74.5395523795542,RUVBL2,5
Regulation Of Microtubule Polymerization (GO:0031113),1/40,0.0450260276423818,0.10484505006441,0,0,23.2377622377622,72.0490202613887,PAK1,5
Protein Localization To Lysosome (GO:0061462),1/41,0.0461264457320206,0.10484505006441,0,0,22.6556818181818,69.6972334432732,LAPTM5,5
Regulation Of Ubiquitin-Dependent Protein Catabolic Process (GO:2000058),1/42,0.0472256509142421,0.10484505006441,0,0,22.1019955654102,67.473371719961,LAPTM5,5
Regulation Of Axonogenesis (GO:0050770),1/42,0.0472256509142421,0.10484505006441,0,0,22.1019955654102,67.473371719961,PAK1,5
Branching Morphogenesis Of An Epithelial Tube (GO:0048754),1/42,0.0472256509142421,0.10484505006441,0,0,22.1019955654102,67.473371719961,PAK1,5
Regulation Of Chromosome Organization (GO:0033044),1/43,0.0483236444741316,0.10484505006441,0,0,21.5746753246753,65.3676914067237,RUVBL2,5
Regulation Of JUN Kinase Activity (GO:0043506),1/43,0.0483236444741316,0.10484505006441,0,0,21.5746753246753,65.3676914067237,PAK1,5
Positive Regulation Of Stress Fiber Assembly (GO:0051496),1/43,0.0483236444741316,0.10484505006441,0,0,21.5746753246753,65.3676914067237,PAK1,5
Ephrin Receptor Signaling Pathway (GO:0048013),1/43,0.0483236444741316,0.10484505006441,0,0,21.5746753246753,65.3676914067237,PAK1,5
Positive Regulation Of Cytokine-Mediated Signaling Pathway (GO:0001961),1/44,0.0494204276755101,0.106275786948221,0,0,21.0718816067653,63.3713960436082,LAPTM5,5
Protein Sumoylation (GO:0016925),1/46,0.0516103681028748,0.110011574114023,0,0,20.1333333333333,59.6758582483111,SAE1,5
Regulation Of Interleukin-2 Production (GO:0032663),1/47,0.052703527862134,0.111364845830422,0,0,19.6946640316206,57.9628316575578,LAPTM5,5
Regulation Of Tumor Necrosis Factor-Mediated Signaling Pathway (GO:0010803),1/48,0.0537954823572278,0.112692260455227,0,0,19.2746615087041,56.331466269691,LAPTM5,5
Proton Transmembrane Transport (GO:1902600),1/49,0.0548862328463383,0.112736445738808,0,0,18.8721590909091,54.7763045558682,ATP6V0A4,5
Negative Regulation Of T Cell Activation (GO:0050868),1/49,0.0548862328463383,0.112736445738808,0,0,18.8721590909091,54.7763045558682,LAPTM5,5
Plasma Membrane Bounded Cell Projection Morphogenesis (GO:0120039),1/50,0.0559757805878795,0.112736445738808,0,0,18.4860853432282,53.2923554931915,PAK1,5
Regulation Of Interleukin-12 Production (GO:0032655),1/50,0.0559757805878795,0.112736445738808,0,0,18.4860853432282,53.2923554931915,LAPTM5,5
RNA Modification (GO:0009451),1/51,0.0570641268554459,0.112736445738808,0,0,18.1154545454545,51.8750462798315,NOP10,5
Positive Regulation Of DNA Recombination (GO:0045911),1/51,0.0570641268554459,0.112736445738808,0,0,18.1154545454545,51.8750462798315,RUVBL2,5
Positive Regulation Of Actin Filament Bundle Assembly (GO:0032233),1/51,0.0570641268554459,0.112736445738808,0,0,18.1154545454545,51.8750462798315,PAK1,5
Arachidonic Acid Metabolic Process (GO:0019369),1/52,0.0581512729120792,0.113046074541082,0,0,17.7593582887701,50.5201798987898,PTGS1,5
Positive Regulation Of Telomere Maintenance (GO:0032206),1/52,0.0581512729120792,0.113046074541082,0,0,17.7593582887701,50.5201798987898,RUVBL2,5
Positive Regulation Of NIK/NF-kappaB Signaling (GO:1901224),1/53,0.0592372200228127,0.113343657209004,0,0,17.416958041958,49.2238977007414,LAPTM5,5
Actin Cytoskeleton Reorganization (GO:0031532),1/53,0.0592372200228127,0.113343657209004,0,0,17.416958041958,49.2238977007414,PAK1,5
Ribosomal Large Subunit Biogenesis (GO:0042273),1/54,0.0603219694450494,0.114517488868336,0,0,17.0874785591767,47.9826463468622,NOP16,5
Aerobic Respiration (GO:0009060),1/59,0.0657277952904182,0.122860417350551,0,0,15.6105015673981,42.4954284324617,NIPSNAP2,5
Regulation Of Multicellular Organismal Development (GO:2000026),1/59,0.0657277952904182,0.122860417350551,0,0,15.6105015673981,42.4954284324617,RUVBL2,5
Histone Acetylation (GO:0016573),1/60,0.0668053849974009,0.123921439346324,0,0,15.3451463790447,41.523530114707,RUVBL2,5
Regulation Of Embryonic Development (GO:0045995),1/62,0.0689569990042959,0.125989103443939,0,0,14.8405365126677,39.6876338058496,RUVBL2,5
Regulation Of T Cell Activation (GO:0050863),1/62,0.0689569990042959,0.125989103443939,0,0,14.8405365126677,39.6876338058496,LAPTM5,5
Oxidative Phosphorylation (GO:0006119),1/63,0.0700310257894275,0.126055846420969,0,0,14.6004398826979,38.819896447204,NIPSNAP2,5
Telomere Organization (GO:0032200),1/63,0.0700310257894275,0.126055846420969,0,0,14.6004398826979,38.819896447204,RUVBL2,5
Positive Regulation Of Cysteine-Type Endopeptidase Activity (GO:2001056),1/64,0.0711038674321035,0.12704588077942,0,0,14.3679653679654,37.983347923908,CTSD,5
Cellular Response To Light Stimulus (GO:0071482),1/65,0.0721755251798537,0.128019362180324,0,0,14.1427556818182,37.1764152113068,RUVBL2,5
Activation Of Cysteine-Type Endopeptidase Activity Involved In Apoptotic Process (GO:0006919),1/67,0.0743152939821416,0.130859539403336,0,0,13.7128099173554,35.6456061451566,LAPTM5,5
Telomere Maintenance (GO:0000723),1/68,0.0753834075225753,0.131785381496301,0,0,13.5074626865672,34.9190614813173,RUVBL2,5
Positive Regulation Of Protein Polymerization (GO:0032273),1/70,0.0775160991028362,0.133591575049569,0,0,13.1146245059289,33.5376310081815,PAK1,5
Regulation Of Actin Filament-Based Process (GO:0032970),1/70,0.0775160991028362,0.133591575049569,0,0,13.1146245059289,33.5376310081815,PAK1,5
Regulation Of Double-Strand Break Repair Via Homologous Recombination (GO:0010569),1/71,0.0785806796212511,0.134472571464535,0,0,12.9266233766234,32.8805394717248,RUVBL2,5
Organelle Organization (GO:0006996),2/418,0.0826562521027875,0.138807066857095,0,0,4.47825091575092,11.1645697775862,PDZD8;NIPSNAP2,5
Regulation Of Stress Fiber Assembly (GO:0051492),1/75,0.0828272621163734,0.138807066857095,0,0,12.22542997543,30.4535218522911,PAK1,5
Regulation Of DNA Replication (GO:0006275),1/75,0.0828272621163734,0.138807066857095,0,0,12.22542997543,30.4535218522911,RUVBL2,5
Positive Regulation Of Response To Stimulus (GO:0048584),1/77,0.0849435269348038,0.141378609898338,0,0,11.9025119617225,29.3488406407707,RUVBL2,5
Cellular Response To UV (GO:0034644),1/79,0.0870551206102124,0.142935096677578,0,0,11.5961538461538,28.3086906884965,RUVBL2,5
Positive Regulation Of Catabolic Process (GO:0009896),1/79,0.0870551206102124,0.142935096677578,0,0,11.5961538461538,28.3086906884965,LAPTM5,5
Wound Healing (GO:0042060),1/80,0.0881091688442001,0.143694818987521,0,0,11.4487917146145,27.8111607255401,PAK1,5
Histone Modification (GO:0016570),1/81,0.0891620529898079,0.144442525843489,0,0,11.3051136363636,27.3278483083795,RUVBL2,5
Regulation Of NIK/NF-kappaB Signaling (GO:1901222),1/83,0.0912643338868602,0.144724110566704,0,0,11.0282705099778,26.4016268324241,LAPTM5,5
Positive Regulation Of Ubiquitin-Dependent Protein Catabolic Process (GO:2000060),1/83,0.0912643338868602,0.144724110566704,0,0,11.0282705099778,26.4016268324241,LAPTM5,5
Regulation Of Cysteine-Type Endopeptidase Activity Involved In Apoptotic Process (GO:0043281),1/84,0.0923137330775272,0.144724110566704,0,0,10.894852135816,25.9576646289328,CTSD,5
Positive Regulation Of Protein Ubiquitination (GO:0031398),1/84,0.0923137330775272,0.144724110566704,0,0,10.894852135816,25.9576646289328,LAPTM5,5
Positive Regulation Of Double-Strand Break Repair (GO:2000781),1/84,0.0923137330775272,0.144724110566704,0,0,10.894852135816,25.9576646289328,RUVBL2,5
Regulation Of Type II Interferon Production (GO:0032649),1/87,0.0954549804193163,0.148143986504661,0,0,10.5132135306554,24.6965957067427,LAPTM5,5
Regulation Of Double-Strand Break Repair (GO:2000779),1/88,0.0964997501676387,0.148143986504661,0,0,10.3918495297806,24.2983769890205,RUVBL2,5
Positive Regulation Of DNA Repair (GO:0045739),1/89,0.0975433655997771,0.148143986504661,0,0,10.2732438016529,23.9105457782376,RUVBL2,5
Positive Regulation Of Peptidyl-Serine Phosphorylation (GO:0033138),1/89,0.0975433655997771,0.148143986504661,0,0,10.2732438016529,23.9105457782376,PAK1,5
Sensory Perception Of Mechanical Stimulus (GO:0050954),1/89,0.0975433655997771,0.148143986504661,0,0,10.2732438016529,23.9105457782376,ATP6V0A4,5
Positive Regulation Of MAP Kinase Activity (GO:0043406),1/91,0.0996271383895574,0.149440707584336,0,0,10.0439393939394,23.1645451099596,PAK1,5
Regulation Of Actin Cytoskeleton Organization (GO:0032956),1/91,0.0996271383895574,0.149440707584336,0,0,10.0439393939394,23.1645451099596,PAK1,5
Sensory Perception Of Sound (GO:0007605),1/92,0.100667298168532,0.150074561073333,0,0,9.93306693306693,22.8056688483342,ATP6V0A4,5
Regulation Of Peptidyl-Serine Phosphorylation (GO:0033135),1/93,0.10170630850222,0.150698981500241,0,0,9.824604743083,22.4557645074165,PAK1,5
Peptidyl-Lysine Modification (GO:0018205),1/94,0.102744170595246,0.151314142149362,0,0,9.71847507331378,22.1145179349674,SAE1,5
Positive Regulation Of Supramolecular Fiber Organization (GO:1902905),1/96,0.104816454902684,0.153436135791279,0,0,9.51291866028708,21.4568114296548,PAK1,5
Regulation Of Protein Localization (GO:0032880),1/97,0.105850879528965,0.154022537278674,0,0,9.41335227272727,21.1397908579509,CTSD,5
MAPK Cascade (GO:0000165),1/98,0.106884160764475,0.154600303962902,0,0,9.31583880037488,20.8303053683161,PAK1,5
Response To UV (GO:0009411),1/100,0.108947297836033,0.155730549259741,0,0,9.1267217630854,20.2329475165344,RUVBL2,5
Regulation Of Organelle Organization (GO:0033043),1/100,0.108947297836033,0.155730549259741,0,0,9.1267217630854,20.2329475165344,RUVBL2,5
Protein Catabolic Process (GO:0030163),1/102,0.111005875751784,0.157745191857798,0,0,8.94509450945095,19.6628575794324,CTSD,5
Lysosomal Transport (GO:0007041),1/105,0.114085215222488,0.161178530808515,0,0,8.68575174825175,18.8551133467344,LAPTM5,5
Regulation Of Cellular Response To Stress (GO:0080135),1/107,0.116132437275187,0.16312244079694,0,0,8.52101200686106,18.3459436828817,RUVBL2,5
Positive Regulation Of DNA Metabolic Process (GO:0051054),1/108,0.117154350629052,0.163612110361263,0,0,8.44095157179269,18.0996199499791,RUVBL2,5
Cytoskeleton Organization (GO:0007010),1/111,0.120213314180467,0.166924773404877,0,0,8.20950413223141,17.3917318535009,PDZD8,5
Regulation Of Protein Ubiquitination (GO:0031396),1/113,0.122246988120224,0.168273593069259,0,0,8.06209415584416,16.9441983231749,LAPTM5,5
Regulation Of Cytoskeleton Organization (GO:0051493),1/114,0.123262138133037,0.168273593069259,0,0,7.99034593724859,16.7273256762546,PAK1,5
Negative Regulation Of Canonical Wnt Signaling Pathway (GO:0090090),1/114,0.123262138133037,0.168273593069259,0,0,7.99034593724859,16.7273256762546,RUVBL2,5
Ribonucleoprotein Complex Biogenesis (GO:0022613),1/118,0.127311519408163,0.172830721878121,0,0,7.71561771561772,15.9028007712284,NOP16,5
Regulation Of DNA Metabolic Process (GO:0051052),1/124,0.133352065146115,0.180025287947256,0,0,7.3370288248337,14.7823708444845,RUVBL2,5
Positive Regulation Of Intracellular Protein Transport (GO:0090316),1/126,0.135356677793767,0.181721948640251,0,0,7.21890909090909,14.4366770665603,SAE1,5
Cytosolic Transport (GO:0016482),1/127,0.13635732018313,0.182059498925828,0,0,7.16125541125541,14.2686330058518,LAPTM5,5
Regulation Of DNA Repair (GO:0006282),1/129,0.138355282907338,0.18371767074581,0,0,7.04865056818182,13.9417401559299,RUVBL2,5
Protein Localization To Organelle (GO:0033365),1/137,0.146303011266983,0.193215389879766,0,0,6.63135026737968,12.7459551404257,PAK1,5
Intracellular Calcium Ion Homeostasis (GO:0006874),1/139,0.148278959301343,0.194766416812035,0,0,6.53458498023715,12.472300440344,PDZD8,5
Negative Regulation Of Wnt Signaling Pathway (GO:0030178),1/140,0.14926529207402,0.195007881580574,0,0,6.48724656638326,12.3389380569873,RUVBL2,5
Positive Regulation Of Cellular Catabolic Process (GO:0031331),1/146,0.155160384318645,0.200553049943781,0,0,6.21692789968652,11.5839766359584,LAPTM5,5
Neuron Projection Morphogenesis (GO:0048812),1/146,0.155160384318645,0.200553049943781,0,0,6.21692789968652,11.5839766359584,PAK1,5
Cellular Response To Organic Cyclic Compound (GO:0071407),1/152,0.161016391387454,0.207021074641013,0,0,5.96809151113787,10.8992218065557,RUVBL2,5
Ribosome Biogenesis (GO:0042254),1/155,0.163929815349397,0.20965760594686,0,0,5.85094451003542,10.5803618264268,NOP16,5
Protein Autophosphorylation (GO:0046777),1/162,0.170690218562696,0.216029807868412,0,0,5.59457933370977,9.89068451256785,PAK1,5
Mitochondrion Organization (GO:0007005),1/162,0.170690218562696,0.216029807868412,0,0,5.59457933370977,9.89068451256785,NIPSNAP2,5
Metal Ion Transport (GO:0030001),1/171,0.179305362191695,0.2257575285626,0,0,5.29598930481283,9.10203141916599,SLC41A2,5
Regulation Of Neuron Projection Development (GO:0010975),1/174,0.182158004330988,0.22816698480634,0,0,5.20336311087756,8.86070720390759,PAK1,5
Negative Regulation Of Cytokine Production (GO:0001818),1/178,0.185946776731365,0.231718291003701,0,0,5.08474576271186,8.55404131943519,LAPTM5,5
"RNA Splicing, Via Transesterification Reactions With Bulged Adenosine As Nucleophile (GO:0000377)",1/180,0.187834861371431,0.232876894455397,0,0,5.0274250888776,8.40682051258573,PNN,5
Phosphate-Containing Compound Metabolic Process (GO:0006796),1/184,0.191598472034143,0.236337201544654,0,0,4.91654247391952,8.12386561524014,PAK1,5
Regulation Of Apoptotic Process (GO:0042981),2/705,0.193746293468632,0.23777954198423,0,0,2.61112240059608,4.28538907539862,RUVBL2;CTSD,5
Neuron Projection Development (GO:0031175),1/192,0.199075706490468,0.243092445613988,0,0,4.70871013802951,7.60018820559213,PAK1,5
Regulation Of Programmed Cell Death (GO:0043067),1/195,0.201862577343833,0.245263031472757,0,0,4.63519212746017,7.41708668762141,RUVBL2,5
Regulation Of Canonical Wnt Signaling Pathway (GO:0060828),1/207,0.212917586122392,0.257233780115831,0,0,4.36253309796999,6.74818479269535,RUVBL2,5
Protein Stabilization (GO:0050821),1/208,0.213832195816452,0.257233780115831,0,0,4.34123847167325,6.69663689356076,RUVBL2,5
"mRNA Splicing, Via Spliceosome (GO:0000398)",1/211,0.216569929408784,0.259243807124801,0,0,4.27857142857143,6.54553734774509,PNN,5
mRNA Processing (GO:0006397),1/214,0.219298542294468,0.261223263615469,0,0,4.21766965428937,6.39955987908919,PNN,5
Positive Regulation Of Cell Motility (GO:2000147),1/221,0.225629999106661,0.267454096502042,0,0,4.08202479338843,6.07755850865615,PAK1,5
Positive Regulation Of Protein Modification Process (GO:0031401),1/225,0.229225891449228,0.270397532146419,0,0,4.00831980519481,5.90444481121249,PAK1,5
Cellular Response To Lipid (GO:0071396),1/228,0.231912323242682,0.272244901197931,0,0,3.9547456948338,5.77944912737027,RUVBL2,5
Positive Regulation Of Phosphorylation (GO:0042327),1/231,0.234589797535694,0.274064042313335,0,0,3.90256916996047,5.65840072941816,PAK1,5
Regulation Of Protein Phosphorylation (GO:0001932),1/265,0.264317266523357,0.307316247680267,0,0,3.39411157024793,4.51622226799917,PAK1,5
Positive Regulation Of Apoptotic Process (GO:0043065),1/270,0.26859469014977,0.310802427173305,0,0,3.33017911456573,4.3776928285036,CTSD,5
Positive Regulation Of Cell Migration (GO:0030335),1/272,0.270298989998352,0.311292201751656,0,0,3.30526668903053,4.32403767808102,PAK1,5
Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway (GO:0007169),1/284,0.280445291803672,0.321453801454209,0,0,3.16318663668487,4.02160150666205,PAK1,5
DNA Metabolic Process (GO:0006259),1/288,0.283797300632231,0.323768751425503,0,0,3.1184668989547,3.92769354740457,RUVBL2,5
Regulation Of Intracellular Signal Transduction (GO:1902531),1/297,0.291284795551894,0.330154608690695,0,0,3.02226658476658,3.72782623844642,PAK1,5
Regulation Of Cell Cycle (GO:0051726),1/298,0.292112102339504,0.330154608690695,0,0,3.0119375573921,3.70654348348756,RUVBL2,5
Positive Regulation Of MAPK Cascade (GO:0043410),1/310,0.301968007850112,0.339714008831376,0,0,2.89320388349515,3.46442128198034,LAPTM5,5
Protein Transport (GO:0015031),1/313,0.304411397164468,0.340884652124266,0,0,2.86494755244755,3.40749760338611,LAPTM5,5
Positive Regulation Of Cytokine Production (GO:0001819),1/320,0.31008086433221,0.345640596480399,0,0,2.80108292960958,3.27985008221736,LAPTM5,5
Intracellular Protein Transport (GO:0006886),1/325,0.314103393355286,0.348525683038058,0,0,2.75715488215488,3.19287653009006,LAPTM5,5
Proteolysis (GO:0006508),1/330,0.318103483221815,0.351359756467732,0,0,2.71456203371097,3.1092010723159,CTSD,5
Protein Localization (GO:0008104),1/351,0.334661511800173,0.367976232431864,0,0,2.54896103896104,2.79018367597355,LAPTM5,5
Protein Modification By Small Protein Conjugation (GO:0032446),1/364,0.344718238077903,0.375634671986235,0,0,2.45604808414726,2.6157597256375,SAE1,5
Positive Regulation Of Macromolecule Metabolic Process (GO:0010604),1/364,0.344718238077903,0.375634671986235,0,0,2.45604808414726,2.6157597256375,LAPTM5,5
Positive Regulation Of Protein Phosphorylation (GO:0001934),1/377,0.354629468028658,0.384553002561938,0,0,2.36955996131528,2.45647965421648,PAK1,5
Negative Regulation Of Cell Population Proliferation (GO:0008285),1/379,0.356141487228676,0.384553002561938,0,0,2.35678210678211,2.43320593042497,PAK1,5
Negative Regulation Of Programmed Cell Death (GO:0043069),1/381,0.357650117609045,0.384553002561938,0,0,2.34413875598086,2.41024369297439,LAPTM5,5
DNA Damage Response (GO:0006974),1/384,0.359906725129118,0.385274600028086,0,0,2.32542131497745,2.37637217492097,PAK1,5
Cellular Response To Oxygen-Containing Compound (GO:1901701),1/406,0.376225007787392,0.400976653036563,0,0,2.196632996633,2.14735788276751,RUVBL2,5
Phosphorylation (GO:0016310),1/429,0.39285924131682,0.416876836855839,0,0,2.07614698385726,1.93975221539038,PAK1,5
Regulation Of Cell Migration (GO:0030334),1/434,0.396418806503225,0.418825086870799,0,0,2.05164812093219,1.89835725051436,PAK1,5
Regulation Of Nucleic Acid-Templated Transcription (GO:1903506),1/452,0.409068680899773,0.430319001985475,0,0,1.96795001007861,1.75909583073321,RUVBL2,5
Positive Regulation Of Cell Population Proliferation (GO:0008284),1/483,0.430262332020165,0.450662701210776,0,0,1.83845718596756,1.55048158667884,PAK1,5
Protein Phosphorylation (GO:0006468),1/500,0.441573947641707,0.460525619214312,0,0,1.77427582437602,1.45031041327831,PAK1,5
Positive Regulation Of Intracellular Signal Transduction (GO:1902533),1/525,0.457819214066447,0.475427645376695,0,0,1.68745662734212,1.31837763573805,LAPTM5,5
Positive Regulation Of Nucleic Acid-Templated Transcription (GO:1903508),1/557,0.477954339157694,0.494225125171573,0,0,1.58772073250491,1.17211907395837,RUVBL2,5
Positive Regulation Of Cellular Process (GO:0048522),1/594,0.500344100885141,0.515184815741903,0,0,1.48581940824774,1.02886934179788,PAK1,5
Protein Modification Process (GO:0036211),1/711,0.56525802091368,0.579568350557064,0,0,1.23348271446863,0.703668557306297,PAK1,5
Regulation Of Cell Population Proliferation (GO:0042127),1/766,0.592907570730178,0.605363612132073,0,0,1.14153297682709,0.596698418357706,PAK1,5
Positive Regulation Of Transcription By RNA Polymerase II (GO:0045944),1/938,0.668933395348042,0.680128933345498,0,0,0.923644125351703,0.37137031607771,RUVBL2,5
Regulation Of Gene Expression (GO:0010468),1/1127,0.736776309994248,0.745986013869176,0,0,0.760980138866462,0.232457323757012,RUVBL2,5
Positive Regulation Of DNA-templated Transcription (GO:0045893),1/1243,0.771595120120842,0.777998399125994,0,0,0.685660957400088,0.177788678961187,RUVBL2,5
Regulation Of DNA-templated Transcription (GO:0006355),1/1922,0.902233431040687,0.905961668359037,0,0,0.427239600586816,0.0439552644476694,RUVBL2,5
Regulation Of Transcription By RNA Polymerase II (GO:0006357),1/2028,0.914608571568668,0.914608571568668,0,0,0.402520518455398,0.0359286175466415,RUVBL2,5
